Unnamed: 0
stringlengths 3
8
| Date
stringlengths 23
23
| Article_title
stringlengths 1
250
| Stock_symbol
stringlengths 1
5
| Url
stringlengths 44
135
| Publisher
stringclasses 1
value | Author
stringclasses 1
value | Article
stringlengths 1
343k
| Lsa_summary
stringlengths 3
53.9k
| Luhn_summary
stringlengths 1
53.9k
| Textrank_summary
stringlengths 1
53.9k
| Lexrank_summary
stringlengths 1
53.9k
| uuid
stringlengths 36
36
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
711700.0
|
2023-12-14 00:00:00 UTC
|
Cathie Wood Thinks Bitcoin Could Skyrocket 3,356% By 2030. Is She Right?
|
DCOMP
|
https://www.nasdaq.com/articles/cathie-wood-thinks-bitcoin-could-skyrocket-3356-by-2030.-is-she-right
|
nan
|
nan
|
Ark Invest CEO Cathie Wood is known for her wild price targets. In 2018, she famously predicted that Tesla would hit a pre-split price target of $4,000, representing more than a 1,000% gain at the time, and that prediction came true.
Now, Wood has caught the attention of Bitcoin (CRYPTO: BTC) bulls with a splashy price target on the leading cryptocurrency. The renowned disruptive growth investor sees Bitcoin hitting $1.48 million per token by 2030 in her bull case for the cryptocurrency, or a gain of 33,557% as of Wednesday afternoon. In other words, $1,000 invested in Bitcoin today would be worth $34,557 by 2030, according to Wood.
That would be an astronomical return, but early Bitcoin holders have already experienced such gains. Can Bitcoin deliver those kinds of returns again? Let's take a closer look at Wood's bull case for Bitcoin.
Image source: Getty Images.
Cathie Wood's Bitcoin thesis
Wood has long been bullish on crypto. Coinbase currently makes up the biggest holding of Ark Invest's flagship Ark Innovation ETF, and its Ark Next Generation Internet ETF also offers exposure to Bitcoin through its ownership of Grayscale Bitcoin Investment Trust.
As far as her Bitcoin target, Wood has argued that a number of different factors will drive the price higher. First, she sees institutional adoption pushing Bitcoin's price higher and expects it to be the latest new asset class to gain adoption the way emerging markets and real estate have earlier. She also sees it as an obvious hedge against inflation. It makes more sense for corporations to hold Bitcoin on their balance sheets, rather than holding cash, which loses its purchasing power over time.
As far as utility, Wood expects remittances to be a major market for Bitcoin as well, arguing that sending money across borders with Bitcoin would protect populations from currency swings and hyperinflation.
Is Cathie Wood right about Bitcoin?
Wood's arguments sound logical, but there are a few things investors should remember before jumping on the bandwagon here. Bitcoin has been around for nearly 15 years, created in early 2009 by the anonymous Satoshi Nakamoto.
There are plenty of innovations that are roughly as old as Bitcoin or younger that have been much more disruptive than it has. Those include the iPhone, Airbnb-style home-sharing, ride-sharing platforms like Uber, new social media apps like Instagram and TikTok, and electric vehicles, led by Tesla. Most of those had a noticeable effect within just a few years. Despite all the hype around Bitcoin, its adoption around the world as something more than a speculative asset to hold and trade has been mostly negligible.
No country more fully embraced Bitcoin than El Salvador, which has long used U.S. dollars in place of its own currency and made the cryptocurrency legal tender in 2021. However, adoption has been slow in the small Central American country, impeded by limited internet access and a lack of enthusiasm among Salvadorians. Even remittances, Wood's primary use case of Bitcoin, have not gained traction. Through the first six months of 2023, only around 1% of remittances were received via Bitcoin, according to the country's central bank.
Similarly, Remitly CEO Matt Oppenheimer said in a 2022 interview that his company, which processed over $10 billion in remittances in its most recent quarter, could facilitate transfers in Bitcoin or another cryptocurrency but "we're not seeing customer demand for it." Oppenheimer noted problems like "[t]he volatility, the lack of trust, and the lack of security" that have stood in the way of Bitcoin adoption for remittances.
Regarding Wood's other arguments, institutional adoption seems far from a foregone conclusion. Few mainstream corporations are now holding Bitcoin, and some of the world's most admired financiers have repeatedly trashed it. Warren Buffett, for example, has called it "rat poison squared," and JPMorgan Chase CEO Jamie Dimon said recently he'd "close it down" if he were the government, arguing that the only true use case for crypto is "criminals, drug traffickers, money laundering, tax avoidance."
Finally, the argument that Bitcoin is a good hedge against inflation simply has not been borne out. In fact, the opposite has been true. Inflation, according to the Consumer Price Index, peaked last June at 9% -- yet Bitcoin crashed in 2022 along with the stock market. Historically, Bitcoin has traded like a high-beta risk asset, rather than a safe haven from inflation, the way gold traditionally has. Without fundamentals, Bitcoin trades mostly on momentum, which explains much of its recent gains, as well as hopes for a Bitcoin exchange-traded fund (ETF).
Will Bitcoin reach $1 million?
Wood's price target would translate into huge gains for Bitcoin, but the idea of having a reachable price target on a cryptocurrency is a bit illogical. Even price targets on stocks, which represent the earnings and valuations of a real business, are rarely accurate, and predicting movements in cryptocurrency is even more difficult.
Anything could happen with the leading cryptocurrency, and adoption could increase, but at this point, Bitcoin is already a household name. It's reached 100% brand awareness and has had that for several years. Most people have concluded that it doesn't have any utility for them.
Bitcoin bulls like Wood, therefore, need to ask themselves what new opportunities are going to arise for the cryptocurrency that it hasn't had previously. Institutions are largely ignoring it. Immigrants aren't interested in sending money with it, and it's not treated like an inflation hedge the way you would expect "digital gold" to be. El Salvador's experiment with Bitcoin has hardly been encouraging.
At this point, the most likely change seems to be increased regulation, including the Digital Asset Anti-Money Laundering Act, which is now going through Congress. That is unlikely to be bullish for Bitcoin or the rest of the cryptocurrency universe.
It's easy to cheer outlandish price targets like Wood's, but even Bitcoin bulls should be clear-eyed about the obstacles standing in the way of further gains.
Should you invest $1,000 in Bitcoin right now?
Before you buy stock in Bitcoin, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Bitcoin wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of the
S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company. Jeremy Bowman has positions in Airbnb, Ark ETF Trust-Ark Innovation ETF, and Ark ETF Trust-Ark Next Generation Internet ETF. The Motley Fool has positions in and recommends Airbnb, Bitcoin, Coinbase Global, JPMorgan Chase, Tesla, and Uber Technologies. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Those include the iPhone, Airbnb-style home-sharing, ride-sharing platforms like Uber, new social media apps like Instagram and TikTok, and electric vehicles, led by Tesla. Similarly, Remitly CEO Matt Oppenheimer said in a 2022 interview that his company, which processed over $10 billion in remittances in its most recent quarter, could facilitate transfers in Bitcoin or another cryptocurrency but "we're not seeing customer demand for it." Warren Buffett, for example, has called it "rat poison squared," and JPMorgan Chase CEO Jamie Dimon said recently he'd "close it down" if he were the government, arguing that the only true use case for crypto is "criminals, drug traffickers, money laundering, tax avoidance."
|
Coinbase currently makes up the biggest holding of Ark Invest's flagship Ark Innovation ETF, and its Ark Next Generation Internet ETF also offers exposure to Bitcoin through its ownership of Grayscale Bitcoin Investment Trust. Jeremy Bowman has positions in Airbnb, Ark ETF Trust-Ark Innovation ETF, and Ark ETF Trust-Ark Next Generation Internet ETF. The Motley Fool has positions in and recommends Airbnb, Bitcoin, Coinbase Global, JPMorgan Chase, Tesla, and Uber Technologies.
|
Coinbase currently makes up the biggest holding of Ark Invest's flagship Ark Innovation ETF, and its Ark Next Generation Internet ETF also offers exposure to Bitcoin through its ownership of Grayscale Bitcoin Investment Trust. As far as utility, Wood expects remittances to be a major market for Bitcoin as well, arguing that sending money across borders with Bitcoin would protect populations from currency swings and hyperinflation. Before you buy stock in Bitcoin, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Bitcoin wasn't one of them.
|
Ark Invest CEO Cathie Wood is known for her wild price targets. The renowned disruptive growth investor sees Bitcoin hitting $1.48 million per token by 2030 in her bull case for the cryptocurrency, or a gain of 33,557% as of Wednesday afternoon. First, she sees institutional adoption pushing Bitcoin's price higher and expects it to be the latest new asset class to gain adoption the way emerging markets and real estate have earlier.
|
edd1d933-0385-4f24-81dc-090d27c90be7
|
711701.0
|
2023-12-14 00:00:00 UTC
|
Oxy's $12 Billion Acquisition: Is Warren Buffett's Second-Favorite Oil Stock a Buy?
|
DCOMP
|
https://www.nasdaq.com/articles/oxys-%2412-billion-acquisition%3A-is-warren-buffetts-second-favorite-oil-stock-a-buy
|
nan
|
nan
|
Occidental Petroleum (NYSE: OXY) recently agreed to a $12 billion deal to buy privately owned CrownRock. Soon after the deal, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) disclosed multiple Oxy stock buys, expanding its already-sizable ownership in the company. But is it really a good deal? In this video, Motley Fool contributors Jason Hall and Tyler Crowe break things down.
*Stock prices used were from the afternoon of Dec. 13, 2023. The video was published on Dec. 16, 2023.
Should you invest $1,000 in Occidental Petroleum right now?
Before you buy stock in Occidental Petroleum, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Occidental Petroleum wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Jason Hall has positions in Berkshire Hathaway. Tyler Crowe has positions in Berkshire Hathaway. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool recommends Occidental Petroleum. The Motley Fool has a disclosure policy. Jason Hall is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Occidental Petroleum (NYSE: OXY) recently agreed to a $12 billion deal to buy privately owned CrownRock. In this video, Motley Fool contributors Jason Hall and Tyler Crowe break things down. If you choose to subscribe through their link, they will earn some extra money that supports their channel.
|
Soon after the deal, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) disclosed multiple Oxy stock buys, expanding its already-sizable ownership in the company. Before you buy stock in Occidental Petroleum, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Occidental Petroleum wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jason Hall has positions in Berkshire Hathaway.
|
Soon after the deal, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) disclosed multiple Oxy stock buys, expanding its already-sizable ownership in the company. Before you buy stock in Occidental Petroleum, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Occidental Petroleum wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jason Hall has positions in Berkshire Hathaway.
|
Before you buy stock in Occidental Petroleum, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Occidental Petroleum wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jason Hall has positions in Berkshire Hathaway. The Motley Fool recommends Occidental Petroleum.
|
00604c23-8e6a-4770-8a73-d0db8876d303
|
711702.0
|
2023-12-14 00:00:00 UTC
|
Should You Worry About the Latest Wave of Bad News from Pfizer?
|
DCOMP
|
https://www.nasdaq.com/articles/should-you-worry-about-the-latest-wave-of-bad-news-from-pfizer
|
nan
|
nan
|
Earlier in the pandemic, Pfizer (NYSE: PFE) stood out as an earnings and stock-market star thanks to its leading coronavirus vaccine and treatment. But these days, those products are weighing on growth -- and pushing some investors to flee the stock. That's because, as we head toward a post-pandemic world, demand for those blockbusters is on the decline.
Earlier this fall, Pfizer sounded the alarm, cutting its forecast for coronavirus product revenue this year and announcing details of a cost-cutting plan. Just this past week, the big pharma released guidance on earnings and coronavirus product revenue for next year that fell short of analysts' expectations. And the company aims to make even deeper cost cuts than initially planned.
Pfizer shares responded by dropping to a 10-year low. Considering this latest wave of bad news, should you worry about Pfizer and avoid the shares -- or is it time to buy?
Image source: Getty Images.
Pfizer's $100 billion in revenue
Today's troubles begin with yesterday's successes. Pfizer's coronavirus vaccine Comirnaty and treatment Paxlovid brought in revenue of $37 billion and $18 billion, respectively, at their peak last year. This helped Pfizer post its highest annual revenue ever, more than $100 billion.
After such a performance, seeing 2024 annual revenue forecast at a level of $58.5 billion to $61.5 billion may be particularly disappointing. And as part of this, Pfizer predicts coronavirus product revenue will total only $8 billion next year, a far cry from last year's figures.
On top of that, Pfizer's cost realignment plan will include an additional $500 million in cost cuts to reach cost savings of $4 billion. The company announced this effort earlier in the fall vaccination season, when it noticed lower-than-expected sales of coronavirus products. The idea was to rein in costs to match long-term revenue opportunities. The recent increase in the cost savings forecast may worry investors, as it suggests coronavirus product revenue may be even lower than the company predicted just months ago.
Pandemic versus post-pandemic
All of this may sound grim, but it's important to put the latest news into perspective. With its coronavirus products, Pfizer served a pandemic environment. It's very unlikely demand would remain at the same levels once the world shifted toward a post-pandemic mindset. And it's been difficult for vaccine companies to truly predict vaccine uptake in this evolving situation, other than using demand for influenza vaccines as a guide.
These days, coronavirus vaccine coverage hasn't reached 50% of the population, as the flu vaccine has in recent years. But it could eventually, especially if Pfizer and others are successful in producing combined flu-COVID vaccine candidates. Even if coronavirus vaccination doesn't hit the 50% mark, the vaccine still could remain a solid source of recurrent revenue for Pfizer.
Meanwhile, other elements also are weighing on Pfizer right now -- but they don't signal negative long-term situations. Pfizer's costs to finance the recent acquisition of oncology company Seagen are set to impact earnings, shaving off 40 cents per share. This is a headwind right now, but the Seagen addition should bring the pharma company a solid portfolio of oncology drugs that will add to revenue over time. Pfizer predicts the Seagen portfolio will start this off by generating $3.1 billion in revenue next year.
Pfizer's time of transition
So what does all of this mean for investors? It's clear Pfizer is going through a time of transition right now, and it may be a tough period for the company and for investors who have watched the shares decline. But the business's long-term prospects remain bright.
In addition to the positive points mentioned above, Pfizer also is in the middle of its most aggressive series of product launches ever -- with the goal of bringing 19 new products or indications to market over an 18-month period.
Yes, Pfizer faces declining sales from certain products, and the need to bring costs in line with future revenue; these factors could continue weighing on the stock in the near term. I don't see this as a moment to sell the stock or to avoid it, though. Instead, I see it as a time to get in on Pfizer shares for a good price considering its long-term story.
Pfizer trades for about 17 times forward earnings estimates, a very reasonable level for this top pharma stock. Even if the near-term path looks bumpy, the company is preparing the terrain to deliver rewards to investors over the long haul.
Should you invest $1,000 in Pfizer right now?
Before you buy stock in Pfizer, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Pfizer. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Earlier this fall, Pfizer sounded the alarm, cutting its forecast for coronavirus product revenue this year and announcing details of a cost-cutting plan. Just this past week, the big pharma released guidance on earnings and coronavirus product revenue for next year that fell short of analysts' expectations. The recent increase in the cost savings forecast may worry investors, as it suggests coronavirus product revenue may be even lower than the company predicted just months ago.
|
Earlier this fall, Pfizer sounded the alarm, cutting its forecast for coronavirus product revenue this year and announcing details of a cost-cutting plan. On top of that, Pfizer's cost realignment plan will include an additional $500 million in cost cuts to reach cost savings of $4 billion. This is a headwind right now, but the Seagen addition should bring the pharma company a solid portfolio of oncology drugs that will add to revenue over time.
|
Pfizer's coronavirus vaccine Comirnaty and treatment Paxlovid brought in revenue of $37 billion and $18 billion, respectively, at their peak last year. Even if coronavirus vaccination doesn't hit the 50% mark, the vaccine still could remain a solid source of recurrent revenue for Pfizer. Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Pfizer wasn't one of them.
|
Even if coronavirus vaccination doesn't hit the 50% mark, the vaccine still could remain a solid source of recurrent revenue for Pfizer. Instead, I see it as a time to get in on Pfizer shares for a good price considering its long-term story. Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Pfizer wasn't one of them.
|
5ade0de2-e9f6-45fe-9287-641a8eb01bb8
|
711703.0
|
2023-12-14 00:00:00 UTC
|
1 Incredible AI Stock You'll Regret Not Buying on the Dip
|
DCOMP
|
https://www.nasdaq.com/articles/1-incredible-ai-stock-youll-regret-not-buying-on-the-dip
|
nan
|
nan
|
Oracle (NYSE: ORCL) may not be among the esteemed ranks of the "Magnificent Seven" tech stocks, but the database software kingpin has a long track record of delivering superior returns to investors.
Since its initial public offering (IPO) in 1986, the stock has appreciated by an incredible 158,000%, remarkably turning $1,000 into roughly $1.59 million today.
More recently, Oracle's returns haven't been too shabby either. The enterprise software giant has beaten the S&P 500 solidly over the last decade, as well as the last three and five years, but the stock fell after its second-quarter (ending November 2023) earnings report disappointed investors.
Revenue in the quarter grew just 5% to $12.94 billion as the company transitions from traditional on-premise solutions to cloud-based ones. Its largest segment, cloud services and license support, grew 12% to $9.63 billion, but its three other segments experienced declines.
On the bottom line, the company's performance was more impressive as the cloud business offers higher margins than on-premise. Adjusted earnings per share increased 11% to $1.34, which beat estimates by a penny. For the third quarter, the company forecast revenue growth of 6% to 8% and adjusted earnings per share up 10% to 14%, to between $1.35 and $1.39.
Investors were underwhelmed by the modest revenue growth and guidance, and the stock fell 12.4% on the news. However, there's more to the story.
Image source: Getty Images.
Oracle's AI business is ramping up
Looking beyond the headline figures shows key parts of Oracle's business are growing much faster than the company overall.
Its cloud infrastructure division saw revenue jump 52% to $1.6 billion, and overall cloud revenue rose 25% to $4.8 billion. CEO Safra Catz noted on the earnings call that margins from the cloud infrastructure business improved substantially as the company fills new data center capacity.
The other thing investors need to understand about Oracle's growth is that it's still constrained by the supply of its data centers, which it's rapidly expanding to meet what it called "exploding demand." The company is currently building 100 new cloud data centers and expanding 66 of its existing cloud data centers, or the majority of what it already has.
Demand is being driven in large part by new generative artificial intelligence (AI) technologies that require enormous computing power, which has led to a shortage of graphics processing units (GPUs) that have affected a number of companies, including OpenAI. That's a sign that Oracle is well positioned to benefit from the AI bonanza that investors are so excited about, but it will take time to build out that capacity.
The company's remaining performance obligations (RPOs) are now $65 billion, the equivalent of more than a year's worth of total revenue.
Additionally, Oracle's new partnership with Microsoft seems to be paying off, as Chief Technology Officer Larry Ellison said on the call that Microsoft just ordered 20 cloud data centers to meet demand for Azure. Azure is the only other hyperscaler to offer Oracle Cloud Infrastructure Database Services besides Oracle.
Why Oracle's a buy on the dip
Oracle stock is down 21% from the peak it reached earlier in 2023, but the company appears to be in a stronger position than ever as it ramps up spending on data centers. As the success of Amazon Web Services and Microsoft Azure show, cloud infrastructure businesses are highly profitable at scale and these tend to be sticky relationships, especially for customers that are running Oracle database software in Oracle's case.
Revenue growth and profits should rise over the coming years as it builds out those data centers and capitalizes on excess demand, and as Oracle Cloud Infrastructure (OCI) becomes a larger percentage of the business. The stock also looks well priced at a price-to-earnings ratio of around 20 based on adjusted earnings.
Investors would be wise to take advantage of the dip and scoop up shares of Oracle. After the latest update, the company looks positioned to be among the leaders in AI stocks.
Should you invest $1,000 in Oracle right now?
Before you buy stock in Oracle, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Oracle wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Jeremy Bowman has positions in Amazon. The Motley Fool has positions in and recommends Amazon, Microsoft, and Oracle. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Oracle (NYSE: ORCL) may not be among the esteemed ranks of the "Magnificent Seven" tech stocks, but the database software kingpin has a long track record of delivering superior returns to investors. Demand is being driven in large part by new generative artificial intelligence (AI) technologies that require enormous computing power, which has led to a shortage of graphics processing units (GPUs) that have affected a number of companies, including OpenAI. Revenue growth and profits should rise over the coming years as it builds out those data centers and capitalizes on excess demand, and as Oracle Cloud Infrastructure (OCI) becomes a larger percentage of the business.
|
Azure is the only other hyperscaler to offer Oracle Cloud Infrastructure Database Services besides Oracle. As the success of Amazon Web Services and Microsoft Azure show, cloud infrastructure businesses are highly profitable at scale and these tend to be sticky relationships, especially for customers that are running Oracle database software in Oracle's case. Before you buy stock in Oracle, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Oracle wasn't one of them.
|
Why Oracle's a buy on the dip Oracle stock is down 21% from the peak it reached earlier in 2023, but the company appears to be in a stronger position than ever as it ramps up spending on data centers. As the success of Amazon Web Services and Microsoft Azure show, cloud infrastructure businesses are highly profitable at scale and these tend to be sticky relationships, especially for customers that are running Oracle database software in Oracle's case. Before you buy stock in Oracle, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Oracle wasn't one of them.
|
Azure is the only other hyperscaler to offer Oracle Cloud Infrastructure Database Services besides Oracle. After the latest update, the company looks positioned to be among the leaders in AI stocks. The Motley Fool has positions in and recommends Amazon, Microsoft, and Oracle.
|
13a2bb50-189e-46a9-80a8-96e7b308507b
|
711704.0
|
2023-12-14 00:00:00 UTC
|
Down 68% in 2023, Is Plug Stock a Buy for 2024?
|
DCOMP
|
https://www.nasdaq.com/articles/down-68-in-2023-is-plug-stock-a-buy-for-2024
|
nan
|
nan
|
Fool.com contributor Parkev Tatevosian reviews Plug Power's (NASDAQ: PLUG) prospects in 2024 and answers whether growth stock investors should buy today.
*Stock prices used were the afternoon prices of Dec. 14, 2023. The video was published on Dec. 16, 2023.
Should you invest $1,000 in Plug Power right now?
Before you buy stock in Plug Power, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Plug Power wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The 10 stocks that made the cut could produce monster returns in the coming years. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel.
|
Fool.com contributor Parkev Tatevosian reviews Plug Power's (NASDAQ: PLUG) prospects in 2024 and answers whether growth stock investors should buy today. Before you buy stock in Plug Power, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Plug Power wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Parkev Tatevosian, CFA has no position in any of the stocks mentioned.
|
Fool.com contributor Parkev Tatevosian reviews Plug Power's (NASDAQ: PLUG) prospects in 2024 and answers whether growth stock investors should buy today. Before you buy stock in Plug Power, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Plug Power wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Parkev Tatevosian, CFA has no position in any of the stocks mentioned.
|
Before you buy stock in Plug Power, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Plug Power wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Parkev Tatevosian, CFA has no position in any of the stocks mentioned. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services.
|
1d21269b-4565-42b0-a0f4-9600ef9cf372
|
711705.0
|
2023-12-14 00:00:00 UTC
|
These 8 Winning Bank Stocks Are 12% of My Portfolio. Here Is What I Think About All of Them.
|
DCOMP
|
https://www.nasdaq.com/articles/these-8-winning-bank-stocks-are-12-of-my-portfolio.-here-is-what-i-think-about-all-of-them
|
nan
|
nan
|
In this video, Motley Fool contributor Jason Hall discusses the eight bank stocks that he owns, making up over 12% of his portfolio. In addition to a review of how they've done in 2023, Jason shares his most recent thoughts on whether any are still buys, and his expectations going forward. Stocks discussed include Axos Financial (NYSE: AX), Central Pacific Financial (NYSE: CPF), Live Oak Bancshares (NYSE: LOB), SoFi Technologies (NASDAQ: SOFI), Bank of N.T. Butterfield & Son (NYSE: NTB), Truist Financial (NYSE: TFC), M&T Bank (NYSE: MTB), and PNC Bank (NYSE: PNC).
*Stock prices used were from the morning of Dec. 13, 2023. The video was published on Dec 16, 2023.
Should you invest $1,000 in SoFi Technologies right now?
Before you buy stock in SoFi Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and SoFi Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Jason Hall has positions in Axos Financial, Bank Of N.t. Butterfield & Son, Central Pacific Financial, Live Oak Bancshares, M & T Bank, PNC Financial Services, SoFi Technologies, and Truist Financial. The Motley Fool has positions in and recommends Axos Financial, Bank Of N.t. Butterfield & Son, Central Pacific Financial, Live Oak Bancshares, PNC Financial Services, and Truist Financial. The Motley Fool has a disclosure policy. Jason Hall is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In this video, Motley Fool contributor Jason Hall discusses the eight bank stocks that he owns, making up over 12% of his portfolio. In addition to a review of how they've done in 2023, Jason shares his most recent thoughts on whether any are still buys, and his expectations going forward. Jason Hall is an affiliate of The Motley Fool and may be compensated for promoting its services.
|
Stocks discussed include Axos Financial (NYSE: AX), Central Pacific Financial (NYSE: CPF), Live Oak Bancshares (NYSE: LOB), SoFi Technologies (NASDAQ: SOFI), Bank of N.T. Butterfield & Son, Central Pacific Financial, Live Oak Bancshares, M & T Bank, PNC Financial Services, SoFi Technologies, and Truist Financial. Butterfield & Son, Central Pacific Financial, Live Oak Bancshares, PNC Financial Services, and Truist Financial.
|
Stocks discussed include Axos Financial (NYSE: AX), Central Pacific Financial (NYSE: CPF), Live Oak Bancshares (NYSE: LOB), SoFi Technologies (NASDAQ: SOFI), Bank of N.T. Before you buy stock in SoFi Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and SoFi Technologies wasn't one of them. Butterfield & Son, Central Pacific Financial, Live Oak Bancshares, M & T Bank, PNC Financial Services, SoFi Technologies, and Truist Financial.
|
In this video, Motley Fool contributor Jason Hall discusses the eight bank stocks that he owns, making up over 12% of his portfolio. Before you buy stock in SoFi Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and SoFi Technologies wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jason Hall has positions in Axos Financial, Bank Of N.t.
|
978258b9-fd7c-4e7c-b462-f42ec7f4ee35
|
711706.0
|
2023-12-14 00:00:00 UTC
|
2 Cryptocurrencies That Are Down 70% and Ready to Pop
|
DCOMP
|
https://www.nasdaq.com/articles/2-cryptocurrencies-that-are-down-70-and-ready-to-pop
|
nan
|
nan
|
In 2023, not a single top cryptocurrency is in the red. In fact, quite the contrary. Many top cryptocurrencies are up triple-digit percentages for the year. For example, Bitcoin (CRYPTO: BTC) is up more than 107%, while Solana (CRYPTO: SOL) is up more than 650%.
That's the good news. The bad news is that, even with remarkable rallies this year, many top cryptocurrencies are still down 70% or more from their all-time highs from just two years ago. Two bargain-priced cryptos that particularly stand out right now are Avalanche (CRYPTO: AVAX) and Chainlink (CRYPTO: LINK).
Avalanche
During the last crypto bull market rally, Avalanche soared to a high of $146. Given today's price of just $40, that means Avalanche is trading more than 70% below its peak.
That just seems like too much of a discount, given that Avalanche is one of the top competitors to Ethereum (CRYPTO: ETH). In fact, Avalanche has been called an "Ethereum killer," due to the fact that it is simply so much faster and cheaper to use than Ethereum. Just like Ethereum, Avalanche offers everything that you'd expect from a Layer-1 blockchain, including non-fungible tokens (NFTs), decentralized finance (DeFi), blockchain gaming, and Web3 applications.
Image source: Getty Images.
The latest buzz around Avalanche involves the launch of a new type of crypto collectible. In many ways, these collectibles are similar to the highly popular Bitcoin Ordinals, which in turn are based on the concept of traditional NFTs. To give you an idea of how popular they are, 95% of all transactions on the Avalanche blockchain are now related to these crypto collectibles. Depending on your view of NFTs, that's either exciting or terrifying.
During the past 30 days, Avalanche is up more than 90%, and that potentially sets the stage for a strong start to 2024. From my perspective, one major reason for Avalanche's sharp rally at year-end has to do with Solana's recent blistering performance. Since Solana and Avalanche are very similar in what they do (both are direct rivals to Ethereum), and Solana is up more than 650% this year, many investors may now be expecting the same type of performance from Avalanche. That could lead to a big influx of investor money next year.
Chainlink
Chainlink is another crypto that soared during the last crypto bull market rally. Chainlink eventually hit a high of $53 back in 2021. At today's current price of $15, that means Chainlink is now trading at a discount of more than 70%.
Chainlink is unique in that it is a decentralized blockchain data oracle. Its primary purpose is to serve up data to smart contracts, which are small pieces of self-executable computer code. That might sound like a lot of crypto mumbo-jumbo, but what it really means in practical terms is that Chainlink is at the very center of how data is exchanged in the blockchain world. The most immediate application is in the world of decentralized finance, where smart contracts require constant access to real-time data.
That explains why Chainlink skyrocketed in value during the last boom. In the summer of 2020, DeFi was all the rage, and many people thought decentralized finance would eventually take over from traditional finance (the world of Wall Street and financial intermediaries). In many ways, Chainlink benefited from all the buzz and hype around DeFi.
In 2023, Chainlink is back with another big idea, and it involves artificial intelligence (AI). In May, Chainlink outlined all the ways that integration of AI and blockchain would make a lot of sense. Some of the ideas, quite frankly, weren't all that sexy. "Authenticity verification" is highly important for blockchain users, but it's also not the type of thing you'd probably bring up at a holiday party. But if Chainlink can come up with a really big idea -- a sort of "killer app" for blockchain and AI -- then it could soar in the years ahead.
How risky is 70%?
Just keep in mind that both Avalanche and Chainlink are highly speculative investments in a highly volatile crypto market. We've already seen them soar once before later collapsing. So the same thing could happen again. It's absolutely essential to do your due diligence on these two cryptos. If you believe that the market is efficient, then there must be a very good reason both are trading at such steep discounts.
That said, I'm the type of person who enjoys poking through the "final markdown" bins in stores, so I'm intrigued by the deep discounts on these cryptos. Heading into 2024, both look like cryptos that could pop.
Should you invest $1,000 in Avalanche right now?
Before you buy stock in Avalanche, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Avalanche wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of the S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Dominic Basulto has positions in Bitcoin and Ethereum. The Motley Fool has positions in and recommends Avalanche, Bitcoin, Chainlink, Ethereum, and Solana. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In many ways, these collectibles are similar to the highly popular Bitcoin Ordinals, which in turn are based on the concept of traditional NFTs. That might sound like a lot of crypto mumbo-jumbo, but what it really means in practical terms is that Chainlink is at the very center of how data is exchanged in the blockchain world. That said, I'm the type of person who enjoys poking through the "final markdown" bins in stores, so I'm intrigued by the deep discounts on these cryptos.
|
Avalanche During the last crypto bull market rally, Avalanche soared to a high of $146. Just like Ethereum, Avalanche offers everything that you'd expect from a Layer-1 blockchain, including non-fungible tokens (NFTs), decentralized finance (DeFi), blockchain gaming, and Web3 applications. Before you buy stock in Avalanche, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Avalanche wasn't one of them.
|
Two bargain-priced cryptos that particularly stand out right now are Avalanche (CRYPTO: AVAX) and Chainlink (CRYPTO: LINK). Chainlink Chainlink is another crypto that soared during the last crypto bull market rally. Before you buy stock in Avalanche, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Avalanche wasn't one of them.
|
Avalanche During the last crypto bull market rally, Avalanche soared to a high of $146. That just seems like too much of a discount, given that Avalanche is one of the top competitors to Ethereum (CRYPTO: ETH). But if Chainlink can come up with a really big idea -- a sort of "killer app" for blockchain and AI -- then it could soar in the years ahead.
|
2c3d9b6a-9110-4c6b-aca8-ae7175a9172e
|
711707.0
|
2023-12-14 00:00:00 UTC
|
3 Growth Stocks Poised for a Comeback in 2024
|
DCOMP
|
https://www.nasdaq.com/articles/3-growth-stocks-poised-for-a-comeback-in-2024
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Santa came early this year for growth stocks. The existing December rally accelerated on news that the Federal Reserve will likely begin cutting rates next year. And to be clear, growth stocks are most impacted by higher rates. These companies tend to be smaller and need debt to expand their operational reach. As interest rates rise, debt costs become prohibitive to these growth stocks, stalling expansion and pushing share prices down.
At the same time, since they’re younger and often unprofitable, growth stocks are a very speculative investment and investors expect returns to beat safer alternatives. When rates are higher, the risk-free rate is higher and investors can generate substantial yield through bond laddering and similar strategies.
But we seem to have hit an inflection point that could mean the bear market is over for speculative growth stocks. Still, don’t start throwing cash at every opportunity that comes. Due diligence principles still apply.
To find the best growth stocks to buy, look to companies suppressed by short-term news that nevertheless have great long-term prospects.
ChargePoint Holdings (CHPT)
Source: YuniqueB / Shutterstock.com
ChargePoint Holdings (NYSE:CHPT) raced other growth starts to the top during this week’s rally, positioning the electric vehicle (EV) charging stock for a comeback in 2024. Just one month ago, CHPT cratered on poor earnings. A 12% revenue drop and double-digit negative margins sent shares down nearly 40%. But, in just a few days, CHPT is nearly back to its pre-earnings pricing on the Fed’s dovish outlook.
Despite its national dominance, ChargePoint is still in an expansionary phase as it spreads charging infrastructure globally. As you can imagine, negotiating with landowners and then developing and maintaining a range of EV chargers is extremely expensive. As interest rates rose, debt costs became prohibitive, forcing ChargePoint to slow its takeover campaign. And, of course, tightened household budgets put a halt to EV adoption trends.
But the Fed’s implied rate cuts negate both downsides. We’ll likely see EV adoption ticking back up as car loan rates come down. At the same time, ChargePoint’s financial strategy over the high-rate period positioned it well for what’s to come. The company operated mostly on cash, not touching a $150 million revolving credit account and delaying its earliest debt maturities to 2028. That means ChargePoint can quickly begin accumulating cheaper debt to expand, setting this growth stock up for a record year.
RocketLab (RKLB)
Source: Andrzej Puchta / Shutterstock.com
RocketLab (NASDAQ:RKLB) shares tumbled this fall as the space stock had a catastrophic mission failure, losing 40% of its market cap in a few short weeks. But that failure seemed to be a one-off scenario, and RocketLab’s future looks bright. This small-cap space stock is on track to beat other growth stocks as shares begin soaring in 2024.
This week, RocketLab hit a major milestone as it launched its 42nd rocket and 10th for 2023, beating its previous annual record. Today, RocketLab’s Electron rocket stands as the second most launched rocket nationally (behind SpaceX). Likewise, the company’s launch queue for 2024 is already full, meaning RocketLab’s growth strategy paid off and positions it for further expansion.
Space is set to be a $1 trillion industry, and RocketLab is one of the few publicly traded companies best positioned as a pure-space play. Better yet, though still in its infancy, RocketLab’s developing hypersonic flight platform could herald the much-awaited sea change in commercial and tourism flight. This catalyst would turn RocketLab into the biggest thing since cars replaced the horse and buggy.
Planet Fitness (PLNT)
Source: Ken Wolter / Shutterstock.com
Planet Fitness (NYSE:PLNT) shares are down about 10% this month as a series of poor earnings and worse guidance put pressure on the company. But, among the other growth stocks listed, PLNT stands to gain the quickest in 2024. The reason, of course, is New Year’s resolution time is upon us. Losing weight and other fitness goals make up the vast majority of resolution goals. At the same time, households are still watching their budget (alongside their weight), so Planet Fitness’ value pricing makes it ideal for those wishing to balance both objectives.
After a string of disappointments, PLNT’s most recent earnings also signaled shifting winds for the growth stock. Profit climbed 45% year-over-year, and management revenue forecasts for the year’s end pushed higher to 14% annual growth. Before that earnings report, in September, the company’s board ejected former CEO Chris Rondeau from the seat. We still don’t know the reasoning behind the move, and the company hasn’t yet brought a new executive on board. But, considering the stock’s performance prior to his ouster, it’s safe to say that fresh blood could put the growth stock back on track.
On the date of publication, Jeremy Flint held no positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Jeremy Flint, an MBA graduate and skilled finance writer, excels in content strategy for wealth managers and investment funds. Passionate about simplifying complex market concepts, he focuses on fixed-income investing, alternative investments, economic analysis, and the oil, gas, and utilities sectors. Jeremy’s work can also be found at www.jeremyflint.work.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post 3 Growth Stocks Poised for a Comeback in 2024 appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
At the same time, households are still watching their budget (alongside their weight), so Planet Fitness’ value pricing makes it ideal for those wishing to balance both objectives. Jeremy Flint, an MBA graduate and skilled finance writer, excels in content strategy for wealth managers and investment funds. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires.
|
As interest rates rise, debt costs become prohibitive to these growth stocks, stalling expansion and pushing share prices down. ChargePoint Holdings (CHPT) Source: YuniqueB / Shutterstock.com ChargePoint Holdings (NYSE:CHPT) raced other growth starts to the top during this week’s rally, positioning the electric vehicle (EV) charging stock for a comeback in 2024. Planet Fitness (PLNT) Source: Ken Wolter / Shutterstock.com Planet Fitness (NYSE:PLNT) shares are down about 10% this month as a series of poor earnings and worse guidance put pressure on the company.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Santa came early this year for growth stocks. ChargePoint Holdings (CHPT) Source: YuniqueB / Shutterstock.com ChargePoint Holdings (NYSE:CHPT) raced other growth starts to the top during this week’s rally, positioning the electric vehicle (EV) charging stock for a comeback in 2024. This small-cap space stock is on track to beat other growth stocks as shares begin soaring in 2024.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Santa came early this year for growth stocks. That means ChargePoint can quickly begin accumulating cheaper debt to expand, setting this growth stock up for a record year. Likewise, the company’s launch queue for 2024 is already full, meaning RocketLab’s growth strategy paid off and positions it for further expansion.
|
a82d5bd5-bc8a-4890-ad94-88c19372f617
|
711708.0
|
2023-12-14 00:00:00 UTC
|
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
|
DCOMP
|
https://www.nasdaq.com/articles/ai-meets-biotech%3A-3-top-stocks-transforming-medical-science
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
One of the biggest stories of the year has been the rise of AI in every industry. This trend will hit biotech stocks no less than any others.
Already, cutting edge healthcare stocks are getting into the AI boom. Medical science has much to gain from AI innovation. AI is bringing the ability to test and study drugs in ways never thought possible. Also, it provides the ability to process enormous amounts of data to synthesize a conclusion.
The best cutting-edge healthcare companies have a long history of using machine learning to quicken drug development. And AI is just the next stage of machine learning. So, for an investor who wants to gain from the inevitable future of AI in biotech stocks, explore three transformative stocks to buy this year.
Recursion Pharmaceuticals (RXRX)
Source: Piotr Swat / Shutterstock.com
Recursion Pharmaceuticals (NASDAQ:RXRX) has built one of the world’s most advanced AI-powered platforms to help decode human biology.
RXRX gathers data and experiments on millions of biological and chemical interactions. From those results, it has built its “Recursion OS,” a platform that teases apart every relational variable from those millions of experiments. AI and machine learning then distill this data to find novel drugs. In fact, the platform can be used to test those drugs “in silico,” weeding out bad ones and focusing on good ones, before even bringing any of them into the clinic.
The potential of Recursion OS has not gone unnoticed. Pharma giant Bayer (OTCMKTS:BAYRY) signed a deal with RXRX in November to test Bayer’s drug library using Recursion’s platform. This makes RXRX eligible for milestone payments of up to $1.5 billion dollars. And, it shows that AI in biotech is already paying dividends.
As for Recursion Pharmaceuticals itself, those milestone payments will be welcome indeed. The company’s most recent earnings report shows $387 cash and cash equivalents, with a net loss of $93 million. RXRX is operating in a highly competitive space, but cash injections from Bayer and other partners should see it through into profitability. Because the AI revolution will further accelerate, Recursion Pharmaceuticals should be at the top of your list.
AbCellera (ABCL)
Source: motorolka / Shutterstock.com
AbCellera (NASDAQ:ABCL) has developed an engine combining machine learning, big data, and high throughput microfluids to discover and characterize antibodies.
Also, the company’s platform has plenty of interested customers. Prelude (NASDAQ:PRLD), Incyte (NASDAQ:INCY), and Regeneron (NASDAQ:REGN) have all announced collaborations to use AbCellera’s platform for drug discovery. Since antibodies can be specifically targeted, they have the potential to deliver treatments in ways that no other molecule could. Therefore, AbCellera’s engine is a synthesis of both the antibody and the AI revolutions.
Understandably, AI in biotech can take time to reach profitability. Most tech companies expect to spend years burning cash before getting into the black. AbCellera’s earnings in particular have been “chunky” due to staggered royalty and milestone payments. While last year AbCellera posted a profit, their most recent earnings report shows a loss of $29 million. With cash and cash equivalents of $387 million, AbCellera isn’t in danger of bankruptcy. Yet, earnings have not moved in the right direction.
However, those earnings are based on royalty and milestones. And this year, AbCellera signed collaborations to achieve those future benchmarks. True, 2023 was difficult for AbCellera, but their technology is still incredible. Thus, turning that technology into profit makes them one of the highest potential AI/biotech stocks to find.
Ginkgo Bioworks (DNA)
Source: T. Schneider / Shutterstock.com
Ginkgo Bioworks (NYSE:DNA) began as part of the synthetic biology revolution. Promising to make products more cheaply than any competitor, they hoped to license the technology from their Foundry much like drug companies license drugs. But, a new partnership with Alphabet (NASDAQ:GOOGL, GOOG) has shown their potential as an AI company.
As a synthetic biology company, Ginkgo Bioworks has created and tested an incredible amount of genes, proteins, and organisms. From this data, it has built a platform showing the interactions of genes, proteins, and organisms. Then, it has built an AI which can design new interactions as needed.
As Ginkgo Bioworks’ database grows, the AI will continue to learn workable methods and solutions, guiding the design process to a successful product. That can bring huge savings, as testing and altering designs is the greatest expense in synthetic biology.
DNA’s cutting edge AI in a burgeoning industry can bring big dividends. But Ginkgo Bioworks needs to survive to make that happen. A most recent earnings report shows cash and cash equivalents of $1,049 million and a net loss of $303 million, so survival isn’t guaranteed. But the company has cut its net loss in half since 2022. So, if it can survive and prosper, it will become the centerpiece of the AI in biotech revolution.
On the date of publication, John Blankenhorn held a LONG position in GOOGL. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
John Blankenhorn is a neuroscientist at Emory University. He has significant experience in biochemistry, biotechnology and pharmaceutical research.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post AI Meets Biotech: 3 Top Stocks Transforming Medical Science appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
As Ginkgo Bioworks’ database grows, the AI will continue to learn workable methods and solutions, guiding the design process to a successful product. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post AI Meets Biotech: 3 Top Stocks Transforming Medical Science appeared first on InvestorPlace.
|
The company’s most recent earnings report shows $387 cash and cash equivalents, with a net loss of $93 million. AbCellera (ABCL) Source: motorolka / Shutterstock.com AbCellera (NASDAQ:ABCL) has developed an engine combining machine learning, big data, and high throughput microfluids to discover and characterize antibodies. A most recent earnings report shows cash and cash equivalents of $1,049 million and a net loss of $303 million, so survival isn’t guaranteed.
|
Recursion Pharmaceuticals (RXRX) Source: Piotr Swat / Shutterstock.com Recursion Pharmaceuticals (NASDAQ:RXRX) has built one of the world’s most advanced AI-powered platforms to help decode human biology. The company’s most recent earnings report shows $387 cash and cash equivalents, with a net loss of $93 million. A most recent earnings report shows cash and cash equivalents of $1,049 million and a net loss of $303 million, so survival isn’t guaranteed.
|
Recursion Pharmaceuticals (RXRX) Source: Piotr Swat / Shutterstock.com Recursion Pharmaceuticals (NASDAQ:RXRX) has built one of the world’s most advanced AI-powered platforms to help decode human biology. While last year AbCellera posted a profit, their most recent earnings report shows a loss of $29 million. Thus, turning that technology into profit makes them one of the highest potential AI/biotech stocks to find.
|
c7d531c3-802e-40f2-9f33-15d6766e2202
|
711709.0
|
2023-12-14 00:00:00 UTC
|
Is Rivian Stock Still a Buy Now if Production Slows in 2024?
|
DCOMP
|
https://www.nasdaq.com/articles/is-rivian-stock-still-a-buy-now-if-production-slows-in-2024
|
nan
|
nan
|
Rivian (NASDAQ: RIVN) and its investors found out quickly in 2023 that you don't want to disappoint Wall Street when it comes to production and deliveries. As Rivian worked through production bottlenecks, which we'll cover more in a second, its stock price slid lower as its production roughly flatlined sequentially.
Should investors be worried that we might see that again with a production adjustment on the way? Let's dig in.
What happened?
Let's briefly recap what happened toward the end of 2022 and the beginning of 2023, when Rivian hit a snag with its quad-motor, causing production to slow. You can see the flatline in the graph below.
Image source: Author. Data source: Rivian production press releases.
It didn't take long for management to find a solution: Use the Enduro drive unit, which was built in-house, in place of the outsourced quad motor. That adjustment quickly sent production and deliveries substantially higher through the remainder of the year.
So what's happening that could cause a slowdown as we head into 2024? And more importantly, is it potentially another snag that could derail production enough to send investors fleeing?
Battery developments
Let's be clear about one thing: increasing production is one of the primary levers for Rivian to reach profitability. Anything that slows, stalls, or complicates production isn't going to sit well with Wall Street or near-sighted investors.
Recently, Rivian's Chief Financial Officer Claire McDonough teased some new details about upcoming battery developments. However, when news hit that a new battery introduction could slow down production during the second and third quarters of 2024, it was met with healthy caution.
But fear not investors, the teased new "simplified" battery and the introduction of the standard pack next year will do numerous positive things.
First, the new battery for R1 vehicles will significantly simplify the battery pack and module, cutting thousands of dollars of costs out and making manufacturing easier. Not only will the simplified battery improve operational and cost efficiency, introducing the standard battery pack will also give R1 vehicles a starting price in the low $70,000 area -- roughly $8,000 less than the cheapest starting price today.
Further, if investors were also worried about yet another new battery -- the Max pack, which will boost range up to 410 miles -- fear not, because it's not available in configurations with the quad motor, which contributed to prior production delays.
Is Rivian still a buy?
Rivian is one of few automakers that seems to have some momentum going into 2024. It recently negotiated with Amazon to enable sales of its electric delivery van to other customers, it avoided price wars ignited by Tesla, it avoided tense negotiations that Detroit automakers had to navigate with Union Auto Workers (UAW), it's preparing to break ground on its Georgia plant for its upcoming R2 vehicles, it significantly reduced its loss per vehicle by tens of thousands of dollars over the past year, and it still has a nearly-$8 billion cash pile to fund operations in the near term.
While production might slow slightly during production line adjustments for the new batteries, it shouldn't be nearly as drastic as the production speed bump seen in late 2022 and early 2023. Further, these new battery options will increase the number of price points for consumers, improve operations and production simplicity, and reduce costs.
In other words, the addition of the standard pack, max pack, and the new "simplified" battery when it launches will all be worth the slight production hiccups in 2024, and should set the company up for a strong finish in production and deliveries next year. Now, to be fair, if production slows due to a lack of demand, that will be reason for investors to become concerned -- but for now, that isn't an issue.
Should you invest $1,000 in Rivian Automotive right now?
Before you buy stock in Rivian Automotive, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Rivian Automotive wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Daniel Miller has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
It didn't take long for management to find a solution: Use the Enduro drive unit, which was built in-house, in place of the outsourced quad motor. Further, if investors were also worried about yet another new battery -- the Max pack, which will boost range up to 410 miles -- fear not, because it's not available in configurations with the quad motor, which contributed to prior production delays. It recently negotiated with Amazon to enable sales of its electric delivery van to other customers, it avoided price wars ignited by Tesla, it avoided tense negotiations that Detroit automakers had to navigate with Union Auto Workers (UAW), it's preparing to break ground on its Georgia plant for its upcoming R2 vehicles, it significantly reduced its loss per vehicle by tens of thousands of dollars over the past year, and it still has a nearly-$8 billion cash pile to fund operations in the near term.
|
First, the new battery for R1 vehicles will significantly simplify the battery pack and module, cutting thousands of dollars of costs out and making manufacturing easier. Not only will the simplified battery improve operational and cost efficiency, introducing the standard battery pack will also give R1 vehicles a starting price in the low $70,000 area -- roughly $8,000 less than the cheapest starting price today. Before you buy stock in Rivian Automotive, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Rivian Automotive wasn't one of them.
|
As Rivian worked through production bottlenecks, which we'll cover more in a second, its stock price slid lower as its production roughly flatlined sequentially. While production might slow slightly during production line adjustments for the new batteries, it shouldn't be nearly as drastic as the production speed bump seen in late 2022 and early 2023. Before you buy stock in Rivian Automotive, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Rivian Automotive wasn't one of them.
|
Let's briefly recap what happened toward the end of 2022 and the beginning of 2023, when Rivian hit a snag with its quad-motor, causing production to slow. But fear not investors, the teased new "simplified" battery and the introduction of the standard pack next year will do numerous positive things. Before you buy stock in Rivian Automotive, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Rivian Automotive wasn't one of them.
|
584caac0-cf99-4227-98cf-8bde21debd11
|
711710.0
|
2023-12-14 00:00:00 UTC
|
Is AT&T an Excellent Dividend Stock to Buy for 2024?
|
DCOMP
|
https://www.nasdaq.com/articles/is-att-an-excellent-dividend-stock-to-buy-for-2024
|
nan
|
nan
|
Fool.com contributor Parkev Tatevosian reviews AT&T (NYSE: T) from the viewpoint of a passive income investor to determine whether it's an excellent dividend stock to buy.
*Stock prices used were the afternoon prices of Dec. 14, 2023. The video was published on Dec. 16, 2023.
Should you invest $1,000 in AT&T right now?
Before you buy stock in AT&T, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and AT&T wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Fool.com contributor Parkev Tatevosian reviews AT&T (NYSE: T) from the viewpoint of a passive income investor to determine whether it's an excellent dividend stock to buy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel.
|
Before you buy stock in AT&T, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and AT&T wasn't one of them. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Parkev Tatevosian, CFA has no position in any of the stocks mentioned.
|
Before you buy stock in AT&T, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and AT&T wasn't one of them. Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Parkev Tatevosian, CFA has no position in any of the stocks mentioned.
|
Before you buy stock in AT&T, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and AT&T wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Parkev Tatevosian, CFA has no position in any of the stocks mentioned. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services.
|
7d8bc2ec-ceee-4bb4-badf-7639d3886561
|
711711.0
|
2023-12-14 00:00:00 UTC
|
3 Semiconductor Stocks to Turn $200,000 Into $1 Million: December 2023
|
DCOMP
|
https://www.nasdaq.com/articles/3-semiconductor-stocks-to-turn-%24200000-into-%241-million%3A-december-2023
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Semiconductors form the backbone of many devices and appliances. Semiconductor chips power up computers, smartphones, cars, refrigerators and other products that people use every day.
The semiconductor industry has large corporations lining up for chips and services. The industry has rewarded many investors, and the VanEck Semiconductor ETF (NASDAQ:SMH) captures this trend. The ETF has gained 317% over the past five years. That growth rate comfortably exceeds the S&P 500 and Nasdaq 100.
Investors can choose from several semiconductor stocks. Many of these companies have growing revenue and attractive profit margins. Here are some of the top semiconductor stocks to get rich.
Nvidia (NVDA)
Source: Poetra.RH / Shutterstock.com
Nvidia (NASDAQ:NVDA) continues to thrive as artificial intelligence (AI) tools gain momentum. The company produces the best chips that enable AI tools to operate at a high level. Investors have seen their shares gain 238% year-to-date. The stock has soared by almost 1,400% over the past five years.
While the company appeared overvalued at the start of the year, a sudden net income surge brought the forward P/E ratio to a reasonable 24. The company has a PEG ratio under 0.50. The valuation has dropped drastically due to earning reports like the one Nvidia released in the third quarter of fiscal 2024.
During that quarter, Nvidia reported 206% year-over-year (YoY) revenue growth and 1,259% YoY net income growth. Large demand for Nvidia’s data center business has driven considerable growth. However, investors should also look at other segments like Gaming and Professional Visualization, which achieved year-over-year revenue growth rates of 81% and 108%, respectively.
Nvidia has attracted many investors due to its stellar performance and tremendous runway. The AI boom seems like it’s here to stay, which is good news for Nvidia investors.
Broadcom (AVGO)
Source: Broadcom
Broadcom (NASDAQ:AVGO) hasn’t had a year as good as Nvidia, but a 100% year-to-date gain still beats most of the market. Shares have also gained 352% over the past five years.
Broadcom regularly posts high-profit margins that exceed 30% and hands out a generous dividend. The yield currently sits at 2%, but it has a good history of raising its dividend. The firm recently raised its quarterly dividend by 14% to $5.25 per share.
The company expects to grow semiconductor revenue by the mid to high single digits in 2024. However, the company can still generate impressive revenue growth through its completed acquisition of VMware. The acquisition gives Broadcom exposure to the rapidly growing cloud computing and cybersecurity industries.
Broadcom has the potential to become a trillion-dollar company by 2030. Shares would have to more than double to reach that valuation. Investors who wait long enough can see their position quintuple. While they wait, Broadcom will provide a steady dividend that continues to grow at a high rate.
Lam Research (LRCX)
Lam Research (NASDAQ:LRCX) does not produce chips, but it offers essential equipment for chipmakers. The company’s wafer fabrication technology allows corporations to develop smaller, more effective devices.
Smaller chips result in faster devices since electrical signals within each chip do not have to travel as far. Large corporations seeking better products frequently turn to Lam Research for assistance.
Investors have turned to Lam Research for higher returns and have been greatly rewarded. Shares are up by 85% year-to-date and surged 503% over the past five years. The company is dealing with some headwinds at the moment but remains an enticing long-term stock.
Shares trade at a 26 P/E ratio and come with a 1.04% dividend yield. Just like Broadcom, Lam Research also does a great job at raising its annual dividend. The corporation hiked its quarterly dividend from $1.725 to $2.00 in 2023. That comes out to a 16% year-over-year growth rate.
On this date of publication, Marc Guberti held long positions in NVDA and AVGO. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Marc Guberti is a finance freelance writer at InvestorPlace.com who hosts the Breakthrough Success Podcast. He has contributed to several publications, including the U.S. News & World Report, Benzinga, and Joy Wallet.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post 3 Semiconductor Stocks to Turn $200,000 Into $1 Million: December 2023 appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
While the company appeared overvalued at the start of the year, a sudden net income surge brought the forward P/E ratio to a reasonable 24. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post 3 Semiconductor Stocks to Turn $200,000 Into $1 Million: December 2023 appeared first on InvestorPlace.
|
Nvidia (NVDA) Source: Poetra.RH / Shutterstock.com Nvidia (NASDAQ:NVDA) continues to thrive as artificial intelligence (AI) tools gain momentum. During that quarter, Nvidia reported 206% year-over-year (YoY) revenue growth and 1,259% YoY net income growth. Lam Research (LRCX) Lam Research (NASDAQ:LRCX) does not produce chips, but it offers essential equipment for chipmakers.
|
During that quarter, Nvidia reported 206% year-over-year (YoY) revenue growth and 1,259% YoY net income growth. Broadcom (AVGO) Source: Broadcom Broadcom (NASDAQ:AVGO) hasn’t had a year as good as Nvidia, but a 100% year-to-date gain still beats most of the market. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post 3 Semiconductor Stocks to Turn $200,000 Into $1 Million: December 2023 appeared first on InvestorPlace.
|
Investors can choose from several semiconductor stocks. Broadcom (AVGO) Source: Broadcom Broadcom (NASDAQ:AVGO) hasn’t had a year as good as Nvidia, but a 100% year-to-date gain still beats most of the market. While they wait, Broadcom will provide a steady dividend that continues to grow at a high rate.
|
43c9802e-244a-411c-9b4d-f2719907c028
|
711712.0
|
2023-12-14 00:00:00 UTC
|
1 Dividend Aristocrat to Buy for Breakout AI Growth
|
DCOMP
|
https://www.nasdaq.com/articles/1-dividend-aristocrat-to-buy-for-breakout-ai-growth
|
nan
|
nan
|
McDonald's (MCD) has been serving up its signature burgers and other popular offerings, like Chicken McNuggets and Eggs McMuffin, for decades. Apart from its reliably consistent menu, McDonald's is also a part of the elite “Dividend Aristocrats” group - members of the S&P 500 Index ($SPX) that have raised their dividend payments for 25 consecutive years or more.
And as the fast food chain embarks on a major investment initiative that includes a Google (GOOGL) partnership on artificial intelligence (AI), now may be an opportune time to scoop up shares of MCD for a combo of income and growth.
McDonald's Plans for Aggressive Growth
Earlier this month, McDonald's lifted the curtain on some of the milestones it plans to achieve during the “fastest period of growth in [the] brand’s history.”
Chiefly, the company is planning to open about 10,000 restaurants globally by 2027, and double both the user base and revenue of its loyalty program by 2027, as well - which translates to targets of 250 million users and $45 billion in sales.
The company is looking to add about 7,000 stores in its international developmental licensed markets such as China, Japan, India and Brazil. Notably, this expansion would raise its global footprint to about 50,000 by 2027.
Separately, in its second-largest market of China (where it operates about 5,500 stores), McDonald's recently agreed to acquire Carlyle Group's 28% stake in the partnership that manages the burger chain's business across mainland China, Hong Kong and Macau. This will allow McDonald's to have greater control over its business in the region.
Leveraging AI and Doubling Down on Digital
Notably, McDonald's also said it's looking to further hone its competitive edge via the use of AI. To that end, McDonald's recently announced a strategic partnership with Google Cloud to utilize the latest cloud technology and apply generative AI solutions across its restaurants worldwide, with the goal of helping to accelerate automation innovation from equipment manufacturers, as well as allow restaurant general managers to quickly spot and enact solutions to reduce business disruptions. The company is set to deploy this software in 2024 in its restaurants, mobile apps and kiosks.
Already, McDonald's has also been doubling down to enhance its revenues from digital means. Notably, across its top six markets, digital sales accounted for over 40% of system-wide sales during the third quarter, reaching nearly $9 billion. The company now has over 57 million 90-day active members, up ~10% sequentially, across these top markets, contributing to the continued growth of the digital channel. Furthermore, these active members are also helping the company with consumer insights regarding their changing preferences, food choices, and number of visits.
Digital initiatives are yielding results, too. In the German market, the company extended its McSmart menu strategy to its digital app, which contributed to the addition of an extra 1 million 90-day active loyalty members in the third quarter. Meanwhile, the reintroduction of its MONOPOLY promotional game on the MCD app drove customer engagement and digital sales.
How is MCD Stock Performing in 2023?
In Q3 2023, McDonald's reported revenues of $6.7 billion, up 14% from the previous year and above the consensus estimate of $6.58 billion. Adjusted EPS of $3.19 also surpassed the consensus estimate, and was up more than 19% compared to the year-ago period. MCD's EPS have topped expectations in each of the past five quarters.
Cash flow from operations increased by a solid 24.5% from the previous year to $3 billion, as the cash balance swelled to end at $3.5 billion at the end of the quarter.
Notably, over the past 3 years, revenue at MCD has grown at a CAGR of about 9%, while EPS has grown at a rate of 20%. Looking ahead, Wall Street is expecting McDonald's to report EPS growth of 8.49% for the current quarter, and 16.44% for FY 2023.
www.barchart.com
McDonald's stock hasn't exactly been on a tear in 2023, rising just about 8.7% on a YTD basis. However, compared to the performance of the broader S&P 500 Dividend Aristocrats ETF (NOBL), MCD is still outperforming.
www.barchart.com
Overall, analysts remain quite upbeat about McDonald's stock, giving it an average rating of “Strong Buy” with a mean target price of $314.31. This indicates an upside potential of about 9.4% from current levels. Out of 29 analysts covering the stock, 19 have a “Strong Buy” rating, 3 have a “Moderate Buy” rating and 7 have a “Hold” rating.
www.barchart.com
On the date of publication, Pathikrit Bose did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
To that end, McDonald's recently announced a strategic partnership with Google Cloud to utilize the latest cloud technology and apply generative AI solutions across its restaurants worldwide, with the goal of helping to accelerate automation innovation from equipment manufacturers, as well as allow restaurant general managers to quickly spot and enact solutions to reduce business disruptions. In the German market, the company extended its McSmart menu strategy to its digital app, which contributed to the addition of an extra 1 million 90-day active loyalty members in the third quarter. www.barchart.com Overall, analysts remain quite upbeat about McDonald's stock, giving it an average rating of “Strong Buy” with a mean target price of $314.31.
|
Apart from its reliably consistent menu, McDonald's is also a part of the elite “Dividend Aristocrats” group - members of the S&P 500 Index ($SPX) that have raised their dividend payments for 25 consecutive years or more. In Q3 2023, McDonald's reported revenues of $6.7 billion, up 14% from the previous year and above the consensus estimate of $6.58 billion. Looking ahead, Wall Street is expecting McDonald's to report EPS growth of 8.49% for the current quarter, and 16.44% for FY 2023. www.barchart.com McDonald's stock hasn't exactly been on a tear in 2023, rising just about 8.7% on a YTD basis.
|
McDonald's Plans for Aggressive Growth Earlier this month, McDonald's lifted the curtain on some of the milestones it plans to achieve during the “fastest period of growth in [the] brand’s history.” Chiefly, the company is planning to open about 10,000 restaurants globally by 2027, and double both the user base and revenue of its loyalty program by 2027, as well - which translates to targets of 250 million users and $45 billion in sales. To that end, McDonald's recently announced a strategic partnership with Google Cloud to utilize the latest cloud technology and apply generative AI solutions across its restaurants worldwide, with the goal of helping to accelerate automation innovation from equipment manufacturers, as well as allow restaurant general managers to quickly spot and enact solutions to reduce business disruptions. Looking ahead, Wall Street is expecting McDonald's to report EPS growth of 8.49% for the current quarter, and 16.44% for FY 2023. www.barchart.com McDonald's stock hasn't exactly been on a tear in 2023, rising just about 8.7% on a YTD basis.
|
Notably, across its top six markets, digital sales accounted for over 40% of system-wide sales during the third quarter, reaching nearly $9 billion. In the German market, the company extended its McSmart menu strategy to its digital app, which contributed to the addition of an extra 1 million 90-day active loyalty members in the third quarter. In Q3 2023, McDonald's reported revenues of $6.7 billion, up 14% from the previous year and above the consensus estimate of $6.58 billion.
|
5c139d57-b528-4140-9419-94b921b48f5c
|
711713.0
|
2023-12-14 00:00:00 UTC
|
3 Passive Income Powerhouses to Buy Before the End of the Year
|
DCOMP
|
https://www.nasdaq.com/articles/3-passive-income-powerhouses-to-buy-before-the-end-of-the-year
|
nan
|
nan
|
When the S&P 500 is up big on the year, it's easy to miss the value of reliable dividend stocks. After all, what good is a 3% yield if the market is up nearly 20%?
But the value of quality dividend stocks isn't how they perform during a strong market -- it's that they deliver regular quarterly payments no matter what the market is doing. The best dividend-paying companies take it a step further by raising their dividends every year, even during recessions. That way, investors can count on a growing income stream when they need it most.
Coca-Cola (NYSE: KO), Clorox (NYSE: CLX), and Target (NYSE: TGT) have raised their dividends every year for decades. Here's why each stock is worth buying before the end of the year.
Image source: Getty Images.
Coca-Cola's moat was put on display this year
Depending on whom you ask, Coca-Cola stock could have a phenomenal or mediocre reputation. The easiest criticism is that Coke is a low-growth, market-underperforming stock that isn't worth owning. But proponents of Coca-Cola will argue that the company's track record of dividend raises and buybacks, as well as its wide moat, make it worth owning.
Coke's 10-year chart is certainly disappointing. Its trailing-12-month revenue is actually lower today than it was a decade ago. Meanwhile, net income is up just 26% in 10 years and the stock is up just 43% compared to a 150% gain in the S&P 500. However, the consumer staples sector tends to underperform strong bull markets. Coca-Cola's underperformance isn't so bad when you compare it to the sector instead of the S&P 500.
KO data by YCharts
Coke's redeeming quality is its history of dividend raises. Coke is one of the longest-tenured Dividend Kings, having paid and raised its dividend for 61 consecutive years. The dividend has increased by over 50% in the last decade alone. And over the past year, Coke has achieved strong bottom-line growth thanks to price increases, proving its brand's power and ability to combat inflation.
Investors who care more about capital preservation than capital appreciation will probably gravitate toward Coke's pros outweighing the cons. The trick is to get the stock at a good price. Coke's 24 price-to-earnings (P/E) ratio is reasonable relative to the S&P 500. With a 3.1% dividend yield, now is a good time to buy Coke if it aligns with your financial goals.
Time to start valuing Clorox normally again
Earlier this fall, Clorox stock underwent a swift and brutal sell-off, largely due to a cyberattack. The stock has recently been recovering is now up 22% from its 52-week low. But zoom out, and the stock is essentially flat year to date.
Like Coke, Clorox has a portfolio of strong brands that support stable dividend increases. In addition to the flagship Clorox brand, Clorox owns Burt's Bees, Glad trash bags, Brita water filters, Kingsford charcoal, and more. There's a bit more potential growth with Clorox than with Coke, given the product categories Clorox is in and the fact that Clorox's market capitalization is far smaller than Coke's. But Clorox is still primarily a dividend stock. And the stock is simply not as beaten down as it was during the worst of the cyberattack scare.
Still, Clorox is a good value. It features a 3.4% dividend yield. And although its P/E ratio is high right now, it has made meaningful cost cuts and price increases that set the stage for strong bottom-line results once Clorox has fully recovered from the cyberattack.
Target is too cheap to ignore
Like Clorox, Target suffered a massive sell-off that saw the stock trade as low as around $103 a share. Since Nov. 1, Target is up 24.9%. But it is still down in 2023 and down over 20% in the last three years.
Target has been dealing with inflationary pressures, weak consumer spending on discretionary goods, inventory challenges, and theft. The last few years have been an extremely challenging period for predicting buyer behavior, which has gone from a wave of excitement during the pandemic to more reserved today. High interest rates make borrowing money more expensive and pressure consumers to spend within their means.
Unfortunately for Target, that means a potentially subdued holiday season, which is why Target has chosen to keep a lean inventory instead of risking being over-optimistic and then having to implement steep discounts after the holidays just to move products off shelves.
Even after the stock's recent partial rebound, it still yields 3.2%. Like Coke, it is a Dividend King with over 50 consecutive years of dividend increases. Target also has more growth potential than Coke or Clorox. It has done an excellent job leaning into its rewards program, curbside pickup, and e-commerce. Its margins are showing signs of improvement, with last quarter's operating margin coming in at 5.2%, which is a sizable improvement over last year's epic margin collapse.
TGT Operating Margin (Quarterly) data by YCharts
Target certainly isn't out of the woods yet. And it may take a while before it fully recovers. But the stock is still cheap, trading at a 17.4 P/E ratio. That's simply too low for a company with Target's brand power and dividend track record.
Companies you can count on in 2024
Coke, Clorox, and Target are three stocks ideally suited for investors whose financial goals include generating a steady stream of passive income. Each stock yields over 3%, which is close to the risk-free 10-year Treasury Rate of 4.2%. Only with stocks, you get the potential reward (and take on the risk) that comes with investing.
High-quality dividend stocks like Coke, Clorox, and Target should prove to be a worthwhile investment that blends dividend income and capital gains over time.
Should you invest $1,000 in Coca-Cola right now?
Before you buy stock in Coca-Cola, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coca-Cola wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Daniel Foelber has positions in Target and has the following options: long November 2024 $130 calls on Target and short November 2024 $135 calls on Target. The Motley Fool has positions in and recommends Target. The Motley Fool recommends the following options: long January 2024 $47.50 calls on Coca-Cola. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
And over the past year, Coke has achieved strong bottom-line growth thanks to price increases, proving its brand's power and ability to combat inflation. And although its P/E ratio is high right now, it has made meaningful cost cuts and price increases that set the stage for strong bottom-line results once Clorox has fully recovered from the cyberattack. Companies you can count on in 2024 Coke, Clorox, and Target are three stocks ideally suited for investors whose financial goals include generating a steady stream of passive income.
|
Coca-Cola (NYSE: KO), Clorox (NYSE: CLX), and Target (NYSE: TGT) have raised their dividends every year for decades. And over the past year, Coke has achieved strong bottom-line growth thanks to price increases, proving its brand's power and ability to combat inflation. TGT Operating Margin (Quarterly) data by YCharts Target certainly isn't out of the woods yet.
|
High-quality dividend stocks like Coke, Clorox, and Target should prove to be a worthwhile investment that blends dividend income and capital gains over time. Before you buy stock in Coca-Cola, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coca-Cola wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Daniel Foelber has positions in Target and has the following options: long November 2024 $130 calls on Target and short November 2024 $135 calls on Target.
|
But it is still down in 2023 and down over 20% in the last three years. High-quality dividend stocks like Coke, Clorox, and Target should prove to be a worthwhile investment that blends dividend income and capital gains over time. Before you buy stock in Coca-Cola, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coca-Cola wasn't one of them.
|
224e4892-623e-460b-9a4a-ccb4060ea48a
|
711714.0
|
2023-12-14 00:00:00 UTC
|
Nissan to export China-developed EVs to global markets
|
DCOMP
|
https://www.nasdaq.com/articles/nissan-to-export-china-developed-evs-to-global-markets
|
nan
|
nan
|
Recasts, adds details on Nissan exports plan in paragraphs 1-4
BEIJING, Dec 17 (Reuters) - Nissan Motor 7201.T said on Sunday it would sell China-developed electric vehicles (EVs) globally as it struck a deal with the country's top university to leverage local resources to accelerate research and development on electrification.
The Japanese automaker is considering exporting the line-up of existing internal combustion engine vehicles and upcoming pure electric and plug-in hybrid cars manufactured and developed in China to overseas markets, Masashi Matsuyama, vice president of Nissan Motor and president of Nissan China, told reporters in Beijing.
Nissan is considering aiming at the same markets as Chinese rivals such as BYD 1211.HK, he said.
The company is joining foreign brands including Tesla TSLA.O, BMW BMWG.DE and Ford F.N that are expanding their exports of China-made cars to exploit the country's lower manufacturing costs and increase the capacity utilisation of their factories.
China accounted for just over a fifth of Nissan's worldwide sales of about 2.8 million vehicles over the first 10 months of the year, down from over a third for the same period last year.
Japanese automakers have faced a severe sales challenge this year in China, the world's biggest auto market, due to the popularity of domestic brands and heavy price competition amid a rapid shift to EVs.
Nissan announced it would establish a joint research centre with China's leading Tsinghua University next year, focussing on research and development of EVs, including charging infrastructure and battery recycling.
"We hope that this collaboration will help us gain a deeper understanding of the Chinese market and develop strategies that better meet the needs of customers in China," Nissan President and Chief Executive Makoto Uchida said in a statement.
The launch of the research centre is an extension of joint research efforts the company has had with Tsinghua since in 2016 that focussed on intelligent mobility and autonomous driving technology.
(Reporting by Zhang Yan in Beijing and Daniel Leussink in Tokyo; Editing by Antoni Slodkowski and William Mallard)
((antoni.slodkowski@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The company is joining foreign brands including Tesla TSLA.O, BMW BMWG.DE and Ford F.N that are expanding their exports of China-made cars to exploit the country's lower manufacturing costs and increase the capacity utilisation of their factories. Japanese automakers have faced a severe sales challenge this year in China, the world's biggest auto market, due to the popularity of domestic brands and heavy price competition amid a rapid shift to EVs. "We hope that this collaboration will help us gain a deeper understanding of the Chinese market and develop strategies that better meet the needs of customers in China," Nissan President and Chief Executive Makoto Uchida said in a statement.
|
Recasts, adds details on Nissan exports plan in paragraphs 1-4 BEIJING, Dec 17 (Reuters) - Nissan Motor 7201.T said on Sunday it would sell China-developed electric vehicles (EVs) globally as it struck a deal with the country's top university to leverage local resources to accelerate research and development on electrification. The Japanese automaker is considering exporting the line-up of existing internal combustion engine vehicles and upcoming pure electric and plug-in hybrid cars manufactured and developed in China to overseas markets, Masashi Matsuyama, vice president of Nissan Motor and president of Nissan China, told reporters in Beijing. Nissan announced it would establish a joint research centre with China's leading Tsinghua University next year, focussing on research and development of EVs, including charging infrastructure and battery recycling.
|
Recasts, adds details on Nissan exports plan in paragraphs 1-4 BEIJING, Dec 17 (Reuters) - Nissan Motor 7201.T said on Sunday it would sell China-developed electric vehicles (EVs) globally as it struck a deal with the country's top university to leverage local resources to accelerate research and development on electrification. The Japanese automaker is considering exporting the line-up of existing internal combustion engine vehicles and upcoming pure electric and plug-in hybrid cars manufactured and developed in China to overseas markets, Masashi Matsuyama, vice president of Nissan Motor and president of Nissan China, told reporters in Beijing. Nissan announced it would establish a joint research centre with China's leading Tsinghua University next year, focussing on research and development of EVs, including charging infrastructure and battery recycling.
|
Recasts, adds details on Nissan exports plan in paragraphs 1-4 BEIJING, Dec 17 (Reuters) - Nissan Motor 7201.T said on Sunday it would sell China-developed electric vehicles (EVs) globally as it struck a deal with the country's top university to leverage local resources to accelerate research and development on electrification. Nissan is considering aiming at the same markets as Chinese rivals such as BYD 1211.HK, he said. Nissan announced it would establish a joint research centre with China's leading Tsinghua University next year, focussing on research and development of EVs, including charging infrastructure and battery recycling.
|
ceeea80a-f59c-485c-9953-78d2a8c5bb75
|
711715.0
|
2023-12-14 00:00:00 UTC
|
These 3 Stocks Have Made Warren Buffett the Most Money in 2023. Are They No-Brainer Buys for the New Year?
|
DCOMP
|
https://www.nasdaq.com/articles/these-3-stocks-have-made-warren-buffett-the-most-money-in-2023.-are-they-no-brainer-buys
|
nan
|
nan
|
Nearly $121 billion. That's how much Warren Buffett is worth at the time of this writing. The total is substantially more than it was 12 months ago thanks to Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) solid gains this year.
But Berkshire Hathaway's gains stemmed in large part from great performances from several of its equity holdings. These three stocks have made Buffett the most money in 2023.
1. Apple
Other stocks in Berkshire's portfolio have delivered greater returns than Apple (NASDAQ: AAPL) has this year. However, there's no doubt whatsoever that Apple ranks as Buffett's biggest moneymaker in 2023.
Nearly half of Berkshire's equity investments are in Apple stock (48.5%, to be precise). Shares of the tech giant have skyrocketed more than 50% this year. Apple is on track to generate an unrealized gain of more than $65 billion for Berkshire in 2023. As Berkshire's biggest shareholder, Buffet's net worth benefited tremendously as a result.
Improving investor sentiment no doubt played a key role in Apple's impressive year-to-date gains. The company also beat Wall Street earnings estimates in each of its quarterly updates in 2023.
2. American Express
Buffett has owned shares of American Express (NYSE: AXP) longer than nearly any other stock in Berkshire's portfolio. The financial services company remains one of Buffett's favorites. Berkshire's 20.8% stake in Amex makes it the conglomerate's third-largest holding.
Just a few months ago, American Express wouldn't have made our list. However, the stock has roared back since late October and is now up more than 20% year to date. That's enough to generate roughly $4.7 billion in gains for Berkshire this year.
What provided the much-needed recent catalyst for American Express stock? The company reported better-than-expected Q3 revenue and earnings on Oct. 20, 2023. Amex posted record results on both its top and bottom lines.
3. Moody's
Several of Berkshire's other top holdings have declined this year. However, the conglomerate's eighth-largest position, credit rating agency Moody's (NYSE: MCO), is a notable exception.
After a multi-month pullback, Moody's stock began a strong comeback in October. The company's shares have soared more than 40% year to date. This tremendous gain has made Berkshire in the ballpark of $3 billion in 2023.
Business is booming for Moody's. The company reported 15% year-over-year revenue growth in the third quarter with diluted earnings per share jumping 28%. CEO Rob Fauber said that this impressive growth demonstrated "the resiliency and relevance of our business and the increasing demand for our unparalleled research, data, and solutions."
Are they no-brainer buys for the new year?
Are Apple, American Express, and Moody's no-brainer stocks to buy for the new year after making Buffett a ton of money in 2023? Not necessarily. The big winners of one year don't always carry their momentum into the next year.
Apple's valuation could be a limiting factor headed into 2024. The stock currently trades at 30 times expected earnings. Moody's is even more expensive with a forward price-to-earnings ratio of nearly 35. American Express, on the other hand, remains attractively valued with a forward earnings multiple of 14.
But with the economy appearing to be in healthy shape, all three of these stocks could perform well again next year. More importantly, they should all deliver solid long-term returns thanks to their strong underlying businesses.
I wouldn't go as far as saying that Apple, American Express, and Moody's are no-brainer buys for the new year. However, I do think they're no-brainer picks for long-term investors.
Should you invest $1,000 in Apple right now?
Before you buy stock in Apple, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Apple wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
American Express is an advertising partner of The Ascent, a Motley Fool company. Keith Speights has positions in Apple and Berkshire Hathaway. The Motley Fool has positions in and recommends Apple, Berkshire Hathaway, and Moody's. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Improving investor sentiment no doubt played a key role in Apple's impressive year-to-date gains. CEO Rob Fauber said that this impressive growth demonstrated "the resiliency and relevance of our business and the increasing demand for our unparalleled research, data, and solutions." Are Apple, American Express, and Moody's no-brainer stocks to buy for the new year after making Buffett a ton of money in 2023?
|
The total is substantially more than it was 12 months ago thanks to Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) solid gains this year. Are Apple, American Express, and Moody's no-brainer stocks to buy for the new year after making Buffett a ton of money in 2023? Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Apple wasn't one of them.
|
Apple Other stocks in Berkshire's portfolio have delivered greater returns than Apple (NASDAQ: AAPL) has this year. Are Apple, American Express, and Moody's no-brainer stocks to buy for the new year after making Buffett a ton of money in 2023? Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Apple wasn't one of them.
|
But Berkshire Hathaway's gains stemmed in large part from great performances from several of its equity holdings. Apple Other stocks in Berkshire's portfolio have delivered greater returns than Apple (NASDAQ: AAPL) has this year. Are Apple, American Express, and Moody's no-brainer stocks to buy for the new year after making Buffett a ton of money in 2023?
|
a7ff1fde-d9ab-42d4-9797-6294edb16db9
|
711716.0
|
2023-12-14 00:00:00 UTC
|
Virgin Galactic: Buy, Sell, or Hold?
|
DCOMP
|
https://www.nasdaq.com/articles/virgin-galactic%3A-buy-sell-or-hold-1
|
nan
|
nan
|
The excitement around Virgin Galactic (NYSE: SPCE) has faded considerably. The shares are now down over 90% from the peak levels reached in 2021. But the idea of a space tourism business might still get the science fiction geek in you all worked up, and there's good reason for that.
However, an idea is not a business and Virgin Galactic has years of work ahead before it becomes a sustainable business. Given where the company is today, should you buy it, sell it, or just hold on?
An interesting few months for Virgin Galactic
When Virgin Galactic reported third-quarter 2023 earnings, revenue of $1.7 million was well ahead of the roughly $770,000 or so it brought in during the year-ago quarter. That's good news, for sure, driven largely by the fact that the company has actually started to fly customers into space on a regular basis.
As you work down the rest of the income statement, however, you start to get a sense that there's still a lot of work to be done, noting the $0.28 per share of red ink on the bottom line.
Image source: Getty Images.
This shouldn't be at all shocking to investors, as the company has been very clear that it won't even be cash-flow positive until the next generation of its spacecraft comes out and starts regular flights. The target date on that is 2026. Meanwhile, the company recently enacted some money-saving plans to ensure it could achieve that goal, which could be viewed as a bit troubling.
Essentially, the cost of operating the current spaceships the company has is expensive and the flights aren't actually doing much for the company's profitability. So, to reduce the cash drain, the company is decreasing the number of flights it will operate and shutting down the service earlier than it had previously planned. Doing that will also reduce the number of employees the company needs by around 18%. This move makes business sense, but suggests that getting to 2026 might be a bit more of a touch-and-go situation than investors would like.
Adding to the negative view, Richard Branson, the billionaire behind the Virgin brand, recently said he won't invest any more money in Virgin Galactic. The stock fell sharply on the news, which is hardly surprising. What is an investor to do from here?
Option 1: Buy Virgin Galactic
There's only one reason to buy a money-losing company that still has to invest huge sums of time and money into building a profitable business -- you believe it can do it. The company has stated that the $1.1 billion in cash and investments it has will be enough to support the business through the launch of the next generation rocket. So there is a reason to be positive, looking at the current unprofitable space operation as a proof of concept rather than a profit-making enterprise.
Still, buying Virgin Galactic requires a great deal of trust in management and emotional fortitude. Indeed, there's at least another year or two of huge cash outflows ahead before Virgin Galactic hopes to be cash-flow positive. Note, too, that cash-flow positive is different from generating positive earnings. In other words, 2026 is just the starting point for the company as it looks to create a profitable business.
Option 2: Hold Virgin Galactic
Although holding Virgin Galactic rests on the same logic as buying it, there's another factor to consider. Given the steep stock price decline, you may be sitting on paper losses. Given the change in business plans and the target of 2026 for turning cash-flow positive, it seems unlikely that the stock is going to rocket higher anytime soon.
So you might consider capturing the loss if you have capital gains to offset. You have to wait at least 30 days before buying the stock back, or risk losing out on the tax-loss harvesting benefit, but that's unlikely to be a material issue here. If you still love the stock after 30 days you can buy it back. But at least you can put that steep stock price decline to good use.
Option 3: Sell Virgin Galactic
As noted, Virgin Galactic appears to be pulling in its horns in an effort to afford its long-term plans. That's probably a good idea, but it hints that earlier expectations for the future aren't working out the way management had hoped. So there's more doubt now, particularly as Branson backs away from funding the company, than there was before.
If you are a conservative investor, you'll probably want to wait until the introduction of the new line of spaceships is closer at hand. Or, perhaps even better, wait until the company is cash-flow positive for at least one quarter. That would provide a little evidence that there is a potential business here, which right now there really isn't.
Only aggressive investors should own Virgin Galactic
It should be pretty obvious at this point that Virgin Galactic is not an appropriate choice for risk-averse investors. The entire investment thesis rests on the belief that the company can actually build a profitable space flight business, but that won't even be testable until 2026. A lot could go wrong between now and then. This is an exciting business idea on many levels, but investors should still tread carefully.
Should you invest $1,000 in Virgin Galactic right now?
Before you buy stock in Virgin Galactic, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Virgin Galactic wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
So, to reduce the cash drain, the company is decreasing the number of flights it will operate and shutting down the service earlier than it had previously planned. You have to wait at least 30 days before buying the stock back, or risk losing out on the tax-loss harvesting benefit, but that's unlikely to be a material issue here. The entire investment thesis rests on the belief that the company can actually build a profitable space flight business, but that won't even be testable until 2026.
|
Option 2: Hold Virgin Galactic Although holding Virgin Galactic rests on the same logic as buying it, there's another factor to consider. Option 3: Sell Virgin Galactic As noted, Virgin Galactic appears to be pulling in its horns in an effort to afford its long-term plans. Before you buy stock in Virgin Galactic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Virgin Galactic wasn't one of them.
|
Option 1: Buy Virgin Galactic There's only one reason to buy a money-losing company that still has to invest huge sums of time and money into building a profitable business -- you believe it can do it. Only aggressive investors should own Virgin Galactic It should be pretty obvious at this point that Virgin Galactic is not an appropriate choice for risk-averse investors. Before you buy stock in Virgin Galactic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Virgin Galactic wasn't one of them.
|
However, an idea is not a business and Virgin Galactic has years of work ahead before it becomes a sustainable business. Option 1: Buy Virgin Galactic There's only one reason to buy a money-losing company that still has to invest huge sums of time and money into building a profitable business -- you believe it can do it. Before you buy stock in Virgin Galactic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Virgin Galactic wasn't one of them.
|
7ec94906-3d30-449b-b995-2a5951383645
|
711717.0
|
2023-12-13 00:00:00 UTC
|
2 Great Income Opportunities From Friday’s Unusual Options Activity
|
DCOMP
|
https://www.nasdaq.com/articles/2-great-income-opportunities-from-fridays-unusual-options-activity
|
nan
|
nan
|
As I write this midday Friday, the second last Friday before Christmas, we all could use a little extra money to buy presents to put under the tree on Dec. 25.
If all holds, the Dow Jones Industrial Average will finish up for the week, the seventh consecutive week in positive territory. The S&P 500 will also likely deliver a seventh week in positive territory.
At this point, I doubt too many investors want the page to turn on the calendar, killing the momentum the markets have been riding since Halloween.
If you’re an income investor, I’ve got two put options for income to consider before you break for the holidays. They all have volume-to-open-interest (Vol/OI) ratios above 10, suggesting they are unusually active today.
Have an excellent weekend.
U.S. Steel
The U.S. Steel (X) Dec. 22 38.50 put currently has a Vol/OI ratio of 11.52. Its bid price is $0.42. Based on its $39.36 share price, its annualized yield, at 57%, is attractive. Out of the money by 86 cents, the current speculation about multiple $40+ bids for the Pittsburgh-based steel manufacturer suggests you won’t have to buy the shares in seven days.
Barron’s reported on Wednesday that a U.S. Steel jet was seen in Nucor’s (NUE) hometown of Charlotte, North Carolina. Nucor is a much larger and, arguably, far more successful American steelmaker.
The pursuit of a sale by U.S. Steel started in earnest in August when the company announced it was looking at strategic alternatives, often considered code words for selling the business.
“We’re actually most interested to know where Nucor stands in all this and that goes double because U.S. Steel was briefly in Charlotte yesterday before it flew on to NYC,” Barron’s reported comments from Gordon Haskett analyst Don Bilson. “Nucor, of course, is based in Charlotte, and outside of a flight on Oct. 2022, our jet tracker hasn’t seen U.S. Steel in Charlotte in years.”
It reminds me of the Blue Jays fans watching Flight Tracker while waiting to see who would sign Shohei Ohtani. Blue Jays fans know how that ended. Not well.
The flip side of any Nucor bid would be that it’s a non-union shop, and U.S. Steel is the epitome of union representation.
Nonetheless, there are supposed to be several bids out there over $40, so even if you did have to buy the shares at $38.08 (net), you’d probably make money on the trade.
In mid-August, I suggested options buyers sell Aug. 25 $28.50 puts for a surefire 20% annualized yield as part of an ongoing M&A arbitrage play. You might have to go a little higher now.
B. Riley Financial
B. Riley Financial (RILY) is a Los Angeles-based small-cap investment bank. In addition to providing investment banking services, it invests in other businesses on behalf of other investors and with its own capital.
One of the companies it's invested in is the Franchise Group, which was taken private in September for $2.6 billion. B. Riley sunk $217 million into the management-led buyout of the former public company. Franchise Group owns several franchises, including The Vitamin Shoppe and Pet Supplies Plus.
The CEO of Franchise Group, Brian Kahn, is rumored to be associated with someone who pled guilty in a $294 million fraud case. Kahn has denied any wrongdoing. RILY shares fell on the news in mid-November. They’re down more than 50% since.
As Clint Eastwood’s Dirty Harry’s character would say, “Do you feel lucky, punk? Well, do ya? They separate the professionals from the amateurs by making a bet like this.
B.Riley CEO Bryan Riley is adamant he bet on the right horse.
“We would have bought all of Franchise Group. We are a huge fan of that business,” The Motley Fool reported Riley’s comments on Nov. 13. “I want to just be clear. I believe we are going to make a lot of money for our shareholders and Franchise Group.”
So, the Dec. 29 $15 put currently has a $1.25 bid for an annualized yield of 162% based on its $20.24 share price. Out of the money by more than $5, this is a dream bet for an aggressive investor interested in a little income before the end of the year.
As an aside, the company announced on Nov. 29 that it had launched a U.S.-based Executive Search practice to be based in Los Angeles and headed up by Ian Brenner, who’s in charge of the firm's Executive Search & Interim Management practice.
Interestingly, this practice began in the Canadian market where I’m from. U.S. companies often dip their toes into new businesses by operating off-the-radar north of the border. It gives them time to work out the kinks before entering the big leagues.
It’s a smart move.
More Options News from Barchart
Meta Platforms Stock is in a Trading Range - Good for Short Put Income Plays
I’ve Got 5 Stocks and 5 DTEs: Which Call Should I Buy?
Naked Put Trade Ideas For December 13th
AMD Stock Has Large Unusual Options Activity Today - AMD Is at a Peak
On the date of publication, Will Ashworth did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Out of the money by 86 cents, the current speculation about multiple $40+ bids for the Pittsburgh-based steel manufacturer suggests you won’t have to buy the shares in seven days. The pursuit of a sale by U.S. Steel started in earnest in August when the company announced it was looking at strategic alternatives, often considered code words for selling the business. “We’re actually most interested to know where Nucor stands in all this and that goes double because U.S. Steel was briefly in Charlotte yesterday before it flew on to NYC,” Barron’s reported comments from Gordon Haskett analyst Don Bilson.
|
“Nucor, of course, is based in Charlotte, and outside of a flight on Oct. 2022, our jet tracker hasn’t seen U.S. Steel in Charlotte in years.” It reminds me of the Blue Jays fans watching Flight Tracker while waiting to see who would sign Shohei Ohtani. B. Riley Financial B. Riley Financial (RILY) is a Los Angeles-based small-cap investment bank. Naked Put Trade Ideas For December 13th AMD Stock Has Large Unusual Options Activity Today - AMD Is at a Peak On the date of publication, Will Ashworth did not have (either directly or indirectly) positions in any of the securities mentioned in this article.
|
“Nucor, of course, is based in Charlotte, and outside of a flight on Oct. 2022, our jet tracker hasn’t seen U.S. Steel in Charlotte in years.” It reminds me of the Blue Jays fans watching Flight Tracker while waiting to see who would sign Shohei Ohtani. I believe we are going to make a lot of money for our shareholders and Franchise Group.” So, the Dec. 29 $15 put currently has a $1.25 bid for an annualized yield of 162% based on its $20.24 share price. Naked Put Trade Ideas For December 13th AMD Stock Has Large Unusual Options Activity Today - AMD Is at a Peak On the date of publication, Will Ashworth did not have (either directly or indirectly) positions in any of the securities mentioned in this article.
|
U.S. Steel The U.S. Steel (X) Dec. 22 38.50 put currently has a Vol/OI ratio of 11.52. The CEO of Franchise Group, Brian Kahn, is rumored to be associated with someone who pled guilty in a $294 million fraud case. I believe we are going to make a lot of money for our shareholders and Franchise Group.” So, the Dec. 29 $15 put currently has a $1.25 bid for an annualized yield of 162% based on its $20.24 share price.
|
686eaf30-47e1-491a-8684-2e7317771bf5
|
711718.0
|
2023-12-13 00:00:00 UTC
|
Technology Sector Update for 12/15/2023: DOCU
|
DCOMP
|
https://www.nasdaq.com/articles/technology-sector-update-for-12-15-2023%3A-docu
|
nan
|
nan
|
Tech stocks climbed late Friday afternoon with the Technology Select Sector SPDR Fund (XLK) rising 0.8% and the SPDR S&P Semiconductor ETF (XSD) up 0.2%
The Philadelphia Semiconductor index gained 0.6%.
In corporate news, DocuSign (DOCU) is exploring a potential sale and has begun preliminary talks with financial advisers, The Wall Street Journal reported. Its shares jumped 12%.
Palantir (PLTR) said it received a one-year extension worth up to $115 million to its existing contract for the US Army's Vantage data-driven operations and decision-making platform. Its shares fell 0.1%.
Intel (INTC) shares gained 2.2% after Chief Executive Officer Pat Gelsinger said the company has no plans to spin out its contract chip manufacturing unit as a separate entity, Reuters said.
R1 RCM (RCM) was upgraded to overweight from equalweight by Morgan Stanley. Its shares still shed 2.3%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In corporate news, DocuSign (DOCU) is exploring a potential sale and has begun preliminary talks with financial advisers, The Wall Street Journal reported. Palantir (PLTR) said it received a one-year extension worth up to $115 million to its existing contract for the US Army's Vantage data-driven operations and decision-making platform. Intel (INTC) shares gained 2.2% after Chief Executive Officer Pat Gelsinger said the company has no plans to spin out its contract chip manufacturing unit as a separate entity, Reuters said.
|
Tech stocks climbed late Friday afternoon with the Technology Select Sector SPDR Fund (XLK) rising 0.8% and the SPDR S&P Semiconductor ETF (XSD) up 0.2% The Philadelphia Semiconductor index gained 0.6%. Intel (INTC) shares gained 2.2% after Chief Executive Officer Pat Gelsinger said the company has no plans to spin out its contract chip manufacturing unit as a separate entity, Reuters said. R1 RCM (RCM) was upgraded to overweight from equalweight by Morgan Stanley.
|
Tech stocks climbed late Friday afternoon with the Technology Select Sector SPDR Fund (XLK) rising 0.8% and the SPDR S&P Semiconductor ETF (XSD) up 0.2% The Philadelphia Semiconductor index gained 0.6%. Intel (INTC) shares gained 2.2% after Chief Executive Officer Pat Gelsinger said the company has no plans to spin out its contract chip manufacturing unit as a separate entity, Reuters said. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Tech stocks climbed late Friday afternoon with the Technology Select Sector SPDR Fund (XLK) rising 0.8% and the SPDR S&P Semiconductor ETF (XSD) up 0.2% The Philadelphia Semiconductor index gained 0.6%. In corporate news, DocuSign (DOCU) is exploring a potential sale and has begun preliminary talks with financial advisers, The Wall Street Journal reported. Its shares jumped 12%.
|
67dfd402-8a31-4870-944f-41066b9e1416
|
711719.0
|
2023-12-13 00:00:00 UTC
|
Fed Decision Highlights Dow's Record-Breaking Week
|
DCOMP
|
https://www.nasdaq.com/articles/fed-decision-highlights-dows-record-breaking-week
|
nan
|
nan
|
The U.S. Federal Reserve injected much-needed positivity into the market this week after holding interest rates steady for the third-straight meeting. The central bank also indicated three rate cuts to come next year and lowered its 2024 inflation forecast. Inflation data bolstered sentiment as well, along with Thursday's retail sales and jobless claims data.
This week's rally sent the Dow Jones Industrial Average (DJIA) on a record-breaking run, repeatedly hitting all-time highs and rising above the 37,000 level, while the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) hit their highest levels since January 2022. Meanwhile, oil prices hit their lowest levels since June, the 10-year Treasury yield fell below 4% for the first time since August, and the Cboe Volatility Index (VIX) marked its lowest since Jan. 2020.
Stocks Making Headlines
Moderna (MRNA) made headlines this week, after mid-stage trial data showed the company's experimental cancer vaccine with Merck (MRK), combined with immunotherapy Keytruda, helped melanoma patients reduce the risk of death or relapse after three years. Warren Buffet's Berkshire Hathaway (BRK.A) bought 10.5 million shares of Occidental Petroleum (OXY), the same day reports came that the oil name bought CrownRock for $12 billion. Macy's (M) is in the midst of a merger as well, after news that Arkhouse Management and Brigade Capital reportedly made a $5.8 billion offer to take the retailer private. Plus, the departure of Lucid Group's (LCID) CFO sent the stock lower.
Analyst Notes This Week
Retail stocks Nike (NKE) and Best Buy (BBY) received analyst upgrades on Monday, along with 2023 outperformers Pinterest (PINS) and Snap (SNAP). Meanwhile, analysts see massive upside for Zillow Group (ZG) and Roblox (RBLX), while Hertz (HTZ) was downgraded on potential 2024 challenges.
Looking Ahead as the Year Winds Down
The week before Christmas will bring a flood of economic data, as well as a handful of earnings, including reports from General Mills (GIS) and Nike. There are a couple ways to play the S&P 500 heading into the end of the year, per Schaeffer's V.P. of Research Todd Salamone, while the VIX's recent plunge poses an interesting opportunity for options traders, according to Schaeffer's Senior Quantitative Analyst Rocky White.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Macy's (M) is in the midst of a merger as well, after news that Arkhouse Management and Brigade Capital reportedly made a $5.8 billion offer to take the retailer private. Looking Ahead as the Year Winds Down The week before Christmas will bring a flood of economic data, as well as a handful of earnings, including reports from General Mills (GIS) and Nike. of Research Todd Salamone, while the VIX's recent plunge poses an interesting opportunity for options traders, according to Schaeffer's Senior Quantitative Analyst Rocky White.
|
Meanwhile, oil prices hit their lowest levels since June, the 10-year Treasury yield fell below 4% for the first time since August, and the Cboe Volatility Index (VIX) marked its lowest since Jan. 2020. Stocks Making Headlines Moderna (MRNA) made headlines this week, after mid-stage trial data showed the company's experimental cancer vaccine with Merck (MRK), combined with immunotherapy Keytruda, helped melanoma patients reduce the risk of death or relapse after three years. Analyst Notes This Week Retail stocks Nike (NKE) and Best Buy (BBY) received analyst upgrades on Monday, along with 2023 outperformers Pinterest (PINS) and Snap (SNAP).
|
This week's rally sent the Dow Jones Industrial Average (DJIA) on a record-breaking run, repeatedly hitting all-time highs and rising above the 37,000 level, while the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) hit their highest levels since January 2022. Stocks Making Headlines Moderna (MRNA) made headlines this week, after mid-stage trial data showed the company's experimental cancer vaccine with Merck (MRK), combined with immunotherapy Keytruda, helped melanoma patients reduce the risk of death or relapse after three years. Analyst Notes This Week Retail stocks Nike (NKE) and Best Buy (BBY) received analyst upgrades on Monday, along with 2023 outperformers Pinterest (PINS) and Snap (SNAP).
|
The U.S. Federal Reserve injected much-needed positivity into the market this week after holding interest rates steady for the third-straight meeting. The central bank also indicated three rate cuts to come next year and lowered its 2024 inflation forecast. Inflation data bolstered sentiment as well, along with Thursday's retail sales and jobless claims data.
|
a62ca4c7-11b5-44c6-bf9e-456a1375b1b1
|
711720.0
|
2023-12-13 00:00:00 UTC
|
US STOCKS-S&P 500 slips, but benchmark on track for 7th week of gains
|
DCOMP
|
https://www.nasdaq.com/articles/us-stocks-sp-500-slips-but-benchmark-on-track-for-7th-week-of-gains
|
nan
|
nan
|
By Caroline Valetkevitch
NEW YORK, Dec 15 (Reuters) - The Dow and S&P 500 edged lower Friday afternoon after Federal Reserve Bank of New York President John Williams said it was too soon to be talking about rate cuts, but the S&P 500 was still on track for a seventh straight week of gains.
That would be the benchmark index's longest weekly winning streak since September 2017.
Stocks rallied this week after the Fed in its policy statement Wednesday signaled lower borrowing costs in 2024.
The real estate sector .SPLRCR was down the most of the S&P 500 sectors on the day, followed by utilities .SPLRCU, with both groups giving back some of their big gains tied to the Fed statement.
An index of semiconductors .SOX was up 0.4% and is up about 9% for the week.
"I don't know if we're going to get whatever is considered a Santa Claus rally, but it looks like all things being considered, we could drift higher from here."
The Dow Jones Industrial Average .DJI fell 53.06 points, or 0.14%, to 37,195.29, the S&P 500 .SPX lost 8.42 points, or 0.18%, to 4,711.13 and the Nasdaq Composite .IXIC added 34.89 points, or 0.24%, to 14,796.45.
The expiry of quarterly derivatives contracts tied to stocks, index options and futures, also known as "triple witching", could potentially add to market volatility late in the day.
Shares of Costco WholesaleCOST.O rose 4.4% after the retailer topped Wall Street estimates for first-quarter results due to demand for cheaper groceries.
Earlier on Friday, a survey showed domestic business activity picked up in December amid rising orders and demand for workers, which could further help to allay fears of a sharp slowdown in economic growth in the fourth quarter.
Declining issues outnumbered advancing ones on the NYSE by a 2.43-to-1 ratio; on Nasdaq, a 1.72-to-1 ratio favored decliners.
The S&P 500 posted 48 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 149 new highs and 69 new lows.
(Reporting by Caroline Valetkevitch; additional reporting by Shristi Achar A and Johann M Cherian in Bengaluru; Editing by Shounak Dasgupta, Maju Samuel and Aurora Ellis)
((caroline.valetkevitch@thomsonreuters.com))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The expiry of quarterly derivatives contracts tied to stocks, index options and futures, also known as "triple witching", could potentially add to market volatility late in the day. Shares of Costco WholesaleCOST.O rose 4.4% after the retailer topped Wall Street estimates for first-quarter results due to demand for cheaper groceries. Earlier on Friday, a survey showed domestic business activity picked up in December amid rising orders and demand for workers, which could further help to allay fears of a sharp slowdown in economic growth in the fourth quarter.
|
The real estate sector .SPLRCR was down the most of the S&P 500 sectors on the day, followed by utilities .SPLRCU, with both groups giving back some of their big gains tied to the Fed statement. The S&P 500 posted 48 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 149 new highs and 69 new lows. (Reporting by Caroline Valetkevitch; additional reporting by Shristi Achar A and Johann M Cherian in Bengaluru; Editing by Shounak Dasgupta, Maju Samuel and Aurora Ellis) ((caroline.valetkevitch@thomsonreuters.com)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Caroline Valetkevitch NEW YORK, Dec 15 (Reuters) - The Dow and S&P 500 edged lower Friday afternoon after Federal Reserve Bank of New York President John Williams said it was too soon to be talking about rate cuts, but the S&P 500 was still on track for a seventh straight week of gains. The expiry of quarterly derivatives contracts tied to stocks, index options and futures, also known as "triple witching", could potentially add to market volatility late in the day. (Reporting by Caroline Valetkevitch; additional reporting by Shristi Achar A and Johann M Cherian in Bengaluru; Editing by Shounak Dasgupta, Maju Samuel and Aurora Ellis) ((caroline.valetkevitch@thomsonreuters.com)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Caroline Valetkevitch NEW YORK, Dec 15 (Reuters) - The Dow and S&P 500 edged lower Friday afternoon after Federal Reserve Bank of New York President John Williams said it was too soon to be talking about rate cuts, but the S&P 500 was still on track for a seventh straight week of gains. That would be the benchmark index's longest weekly winning streak since September 2017. Stocks rallied this week after the Fed in its policy statement Wednesday signaled lower borrowing costs in 2024.
|
d14cc9b6-5d6b-4977-8cce-d41b635fe242
|
711721.0
|
2023-12-13 00:00:00 UTC
|
JPMorgan Chase's Preferred Stock Series MM Crosses Above 5.5% Yield Territory
|
DCOMP
|
https://www.nasdaq.com/articles/jpmorgan-chases-preferred-stock-series-mm-crosses-above-5.5-yield-territory
|
nan
|
nan
|
In trading on Friday, shares of JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM (Symbol: JPM.PRM) were yielding above the 5.5% mark based on its quarterly dividend (annualized to $1.05), with shares changing hands as low as $19.09 on the day. This compares to an average yield of 6.81% in the "Financial" preferred stock category, according to Preferred Stock Channel. As of last close, JPM.PRM was trading at a 23.00% discount to its liquidation preference amount, versus the average discount of 11.76% in the "Financial" category.
The chart below shows the one year performance of JPM.PRM shares, versus JPM:
Below is a dividend history chart for JPM.PRM, showing historical dividend payments on JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM:
Free Report: Top 8%+ Dividends (paid monthly)
In Friday trading, JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM (Symbol: JPM.PRM) is currently down about 0.8% on the day, while the common shares (Symbol: JPM) are up about 0.4%.
Also see:
HYSA Options Chain
CTO Split History
MDGL Stock Predictions
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Friday, shares of JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM (Symbol: JPM.PRM) were yielding above the 5.5% mark based on its quarterly dividend (annualized to $1.05), with shares changing hands as low as $19.09 on the day. The chart below shows the one year performance of JPM.PRM shares, versus JPM: Below is a dividend history chart for JPM.PRM, showing historical dividend payments on JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM: Free Report: Top 8%+ Dividends (paid monthly) In Friday trading, JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM (Symbol: JPM.PRM) is currently down about 0.8% on the day, while the common shares (Symbol: JPM) are up about 0.4%. Also see: HYSA Options Chain CTO Split History MDGL Stock Predictions The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Friday, shares of JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM (Symbol: JPM.PRM) were yielding above the 5.5% mark based on its quarterly dividend (annualized to $1.05), with shares changing hands as low as $19.09 on the day. This compares to an average yield of 6.81% in the "Financial" preferred stock category, according to Preferred Stock Channel. The chart below shows the one year performance of JPM.PRM shares, versus JPM: Below is a dividend history chart for JPM.PRM, showing historical dividend payments on JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM: Free Report: Top 8%+ Dividends (paid monthly) In Friday trading, JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM (Symbol: JPM.PRM) is currently down about 0.8% on the day, while the common shares (Symbol: JPM) are up about 0.4%.
|
In trading on Friday, shares of JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM (Symbol: JPM.PRM) were yielding above the 5.5% mark based on its quarterly dividend (annualized to $1.05), with shares changing hands as low as $19.09 on the day. This compares to an average yield of 6.81% in the "Financial" preferred stock category, according to Preferred Stock Channel. The chart below shows the one year performance of JPM.PRM shares, versus JPM: Below is a dividend history chart for JPM.PRM, showing historical dividend payments on JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM: Free Report: Top 8%+ Dividends (paid monthly) In Friday trading, JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM (Symbol: JPM.PRM) is currently down about 0.8% on the day, while the common shares (Symbol: JPM) are up about 0.4%.
|
In trading on Friday, shares of JPMorgan Chase & Co's 4.20% Dep Shares Non-Cumulative Preferred Stock Series MM (Symbol: JPM.PRM) were yielding above the 5.5% mark based on its quarterly dividend (annualized to $1.05), with shares changing hands as low as $19.09 on the day. This compares to an average yield of 6.81% in the "Financial" preferred stock category, according to Preferred Stock Channel. As of last close, JPM.PRM was trading at a 23.00% discount to its liquidation preference amount, versus the average discount of 11.76% in the "Financial" category.
|
a2405503-fc30-45b0-86ea-8fd45c5c6eaf
|
711722.0
|
2023-12-13 00:00:00 UTC
|
Two Harbors Investment's Series C Preferred Stock Shares Cross 8.5% Yield Mark
|
DCOMP
|
https://www.nasdaq.com/articles/two-harbors-investments-series-c-preferred-stock-shares-cross-8.5-yield-mark-1
|
nan
|
nan
|
In trading on Friday, shares of Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Symbol: TWO.PRC) were yielding above the 8.5% mark based on its quarterly dividend (annualized to $1.8125), with shares changing hands as low as $21.12 on the day. This compares to an average yield of 7.99% in the "Real Estate" preferred stock category, according to Preferred Stock Channel. As of last close, TWO.PRC was trading at a 14.36% discount to its liquidation preference amount, versus the average discount of 14.46% in the "Real Estate" category.
The chart below shows the one year performance of TWO.PRC shares, versus TWO:
Below is a dividend history chart for TWO.PRC, showing historical dividend payments on Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock:
In Friday trading, Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Symbol: TWO.PRC) is currently off about 1.2% on the day, while the common shares (Symbol: TWO) are down about 1.4%.
Also see:
Funds Holding BFZ
SEDG Historical Stock Prices
RCAT Historical Stock Prices
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Friday, shares of Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Symbol: TWO.PRC) were yielding above the 8.5% mark based on its quarterly dividend (annualized to $1.8125), with shares changing hands as low as $21.12 on the day. The chart below shows the one year performance of TWO.PRC shares, versus TWO: Below is a dividend history chart for TWO.PRC, showing historical dividend payments on Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock: In Friday trading, Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Symbol: TWO.PRC) is currently off about 1.2% on the day, while the common shares (Symbol: TWO) are down about 1.4%. Also see: Funds Holding BFZ SEDG Historical Stock Prices RCAT Historical Stock Prices The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Friday, shares of Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Symbol: TWO.PRC) were yielding above the 8.5% mark based on its quarterly dividend (annualized to $1.8125), with shares changing hands as low as $21.12 on the day. The chart below shows the one year performance of TWO.PRC shares, versus TWO: Below is a dividend history chart for TWO.PRC, showing historical dividend payments on Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock: In Friday trading, Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Symbol: TWO.PRC) is currently off about 1.2% on the day, while the common shares (Symbol: TWO) are down about 1.4%. Also see: Funds Holding BFZ SEDG Historical Stock Prices RCAT Historical Stock Prices The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Friday, shares of Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Symbol: TWO.PRC) were yielding above the 8.5% mark based on its quarterly dividend (annualized to $1.8125), with shares changing hands as low as $21.12 on the day. This compares to an average yield of 7.99% in the "Real Estate" preferred stock category, according to Preferred Stock Channel. The chart below shows the one year performance of TWO.PRC shares, versus TWO: Below is a dividend history chart for TWO.PRC, showing historical dividend payments on Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock: In Friday trading, Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Symbol: TWO.PRC) is currently off about 1.2% on the day, while the common shares (Symbol: TWO) are down about 1.4%.
|
In trading on Friday, shares of Two Harbors Investment Corp's 7.25% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Symbol: TWO.PRC) were yielding above the 8.5% mark based on its quarterly dividend (annualized to $1.8125), with shares changing hands as low as $21.12 on the day. This compares to an average yield of 7.99% in the "Real Estate" preferred stock category, according to Preferred Stock Channel. As of last close, TWO.PRC was trading at a 14.36% discount to its liquidation preference amount, versus the average discount of 14.46% in the "Real Estate" category.
|
211d52b2-dc87-47f9-92df-707a6c913daa
|
711723.0
|
2023-12-13 00:00:00 UTC
|
3 Stocks to Buy for a Cooling Job Market
|
DCOMP
|
https://www.nasdaq.com/articles/3-stocks-to-buy-for-a-cooling-job-market
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
There are certain economic indicators that capture investors’ attention without fail, and anything suggesting a cooling job market tends to fall toward the top of the list. That’s because the stock market and the unemployment rate are correlated— at least they have been for the most part. When unemployment is high, the economy tends to stall and stocks fall. The opposite is true when unemployment is low.
Inflation recently threw somewhat of a wrench into this correlation. But now that central banks appear to have a better handle on rising costs, this correlation is expected to continue. As we march forward into a period of uncertainty, job data is starting to look shaky, so it’s fair to assume we’re in for a bumpy ride on the market.
With that in mind, it’s worth thinking about adding some resilience to your portfolio with stocks that will continue to perform even in a cooling job market. There are a few ways to go about this. One is to look at companies that serve job seekers. These firms will have a larger group of consumers to serve and will likely see their business pick up.
Another good strategy is to look for businesses that appeal to people reining in their spending. That means discount retailers and those with strong brand power have the upper hand. Finally, it might pay to add some steady-eddies stocks to your portfolio. Those who pay a reliable dividend and offer necessities are a good place to start.
Microsoft (MSFT)
Source: Asif Islam / Shutterstock.com
There are many reasons to buy Microsoft (NASDAQ:MSFT), one of which is its ability to thrive in a cooling job market. Microsoft’s most recent results showed the business is resilient despite the increasingly challenging environment. That’s thanks to the group’s impressive mashup of successful businesses— from cloud solutions to software and gaming; there’s no arguing about the earning power of this tech titan.
Where Microsoft will really shine in a cooling job market is with LinkedIn. The professional social network is one-of-a-kind, and it’s where job seekers will flock as they look to find employment. Aside from being able to use their professional network and browse employment ads, jobseekers can use LinkedIn’s suite of services to improve their appeal. From specific training courses to resume glow-ups, LinkedIn is able to help polish a candidate and improve their chances of getting hired.
Costco (COST)
Source: Helen89 / Shutterstock.com
Discount retailers tend to shine amid a cooling job market because they allow people to stretch their dollars a little further. Costco (NASDAQ:COST) offers the discount aspect and a layer of insulation against an economic storm. The group makes the bulk of its money from membership fees, which might sound worrisome in times of economic trouble. But so loyal are Costco’s members, the group has long held a renewal rate upwards of 90% for years— even through the pandemic.
The group’s most recent results showed shoppers are still flocking to its giant warehouses. The group’s on the precipice of raising membership prices, a move that some believe will send customers packing. However Costco’s track record of delivering quality at rock-bottom prices has earned it some die-hard shoppers. That’s why the membership price increase is likely to protect margins as intended rather than dent revenue.
American Electric Power (AEP)
Source: Casimiro PT / Shutterstock.com
When in doubt about the direction of the economy always look to utilities, which can hold up almost any condition— even a cooling job market. At the end of the day people will always need power, and American Electric Power(NASDAQ:AEP) is giving them just that while delivering exceptional net income growth. Not only does it generate electricity, it also delivers it around the country. This oversight of the entire value chain means the group can make efficiency improvements more easily and ultimately offer a compelling proposition to customers.
Plus, AEP pays a dividend yield of 4.3%. While that doesn’t shoot the lights out, the group has a history of increasing its payouts in line with earnings growth. And since AEP’s revenues are relatively predictable, this dividend is reliable— though no dividend is ever guaranteed.
On the date of publication, Marie Brodbeck held COST. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Marie Brodbeck has a Finance degree from Duquesne University and has been a financial journalist for more than a decade. Her work can be seen in a variety of publications including InvestorPlace, Benzinga, Yahoo Finance and CCN.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post 3 Stocks to Buy for a Cooling Job Market appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Costco (COST) Source: Helen89 / Shutterstock.com Discount retailers tend to shine amid a cooling job market because they allow people to stretch their dollars a little further. American Electric Power (AEP) Source: Casimiro PT / Shutterstock.com When in doubt about the direction of the economy always look to utilities, which can hold up almost any condition— even a cooling job market. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post 3 Stocks to Buy for a Cooling Job Market appeared first on InvestorPlace.
|
Costco (COST) Source: Helen89 / Shutterstock.com Discount retailers tend to shine amid a cooling job market because they allow people to stretch their dollars a little further. American Electric Power (AEP) Source: Casimiro PT / Shutterstock.com When in doubt about the direction of the economy always look to utilities, which can hold up almost any condition— even a cooling job market. On the date of publication, Marie Brodbeck held COST.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are certain economic indicators that capture investors’ attention without fail, and anything suggesting a cooling job market tends to fall toward the top of the list. Costco (COST) Source: Helen89 / Shutterstock.com Discount retailers tend to shine amid a cooling job market because they allow people to stretch their dollars a little further. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post 3 Stocks to Buy for a Cooling Job Market appeared first on InvestorPlace.
|
Where Microsoft will really shine in a cooling job market is with LinkedIn. The group’s on the precipice of raising membership prices, a move that some believe will send customers packing. On the date of publication, Marie Brodbeck held COST.
|
ff04a928-d1bb-4afa-ad9c-74d1bb2804af
|
711724.0
|
2023-12-13 00:00:00 UTC
|
Why Rocket Lab Stock Just Dropped 10%
|
DCOMP
|
https://www.nasdaq.com/articles/why-rocket-lab-stock-just-dropped-10
|
nan
|
nan
|
Good news became bad news for Rocket Lab USA (NASDAQ: RKLB) on Friday after the company announced its successful return to launch operations for the first time since a mishap resulted in the destruction of an Electron rocket in September -- and the stock promptly fell.
As of 2:50 p.m. ET, Rocket Lab stock is down 9.6%.
What happened to Rocket Lab's rocket?
This is...a bit strange, to say the least, because, by all accounts, Rocket Lab's launch went swimmingly. Launching out of New Zealand this morning, a Rocket Lab Electron rocket successfully deployed an Earth-imaging satellite for its customer, Japan's Institute for Q-shu Pioneers of Space, Inc. (iQPS).
This success means Rocket Lab has now launched more rockets (10) in 2023 than in any previous year and remains America's No. 2 space company by number of rockets launched annually -- for the fifth straight year, as the company pointed out.
Are investors right to be upset?
So, what's wrong with any of this? Honestly, I'm at a loss to find a connection between what Rocket Lab said and how investors are reacting to it.
On the other hand, earlier this week, Rocket Lab stock did go on something of a run in the run-up to today's launch. Perhaps caught up in general market enthusiasm over the Fed's announcement that it won't raise interest rates again this year and might even cut them a bit next year, Rocket Lab stock was at one point up nearly 8% from last week's close...before giving that all back today.
Perhaps that exuberance was a bit irrational, and maybe Rocket Lab did deserve to give a bit of it back today after the initial rate-news excitement passed. Even so, the company has just proven it correctly identified the issue with its last rocket, fixed it, and is back in business today.
I call that good news -- and not a good reason to sell Rocket Lab stock today.
Should you invest $1,000 in Rocket Lab USA right now?
Before you buy stock in Rocket Lab USA, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Rocket Lab USA wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Rich Smith has positions in Rocket Lab USA. The Motley Fool recommends Rocket Lab USA. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Good news became bad news for Rocket Lab USA (NASDAQ: RKLB) on Friday after the company announced its successful return to launch operations for the first time since a mishap resulted in the destruction of an Electron rocket in September -- and the stock promptly fell. On the other hand, earlier this week, Rocket Lab stock did go on something of a run in the run-up to today's launch. Even so, the company has just proven it correctly identified the issue with its last rocket, fixed it, and is back in business today.
|
Good news became bad news for Rocket Lab USA (NASDAQ: RKLB) on Friday after the company announced its successful return to launch operations for the first time since a mishap resulted in the destruction of an Electron rocket in September -- and the stock promptly fell. Launching out of New Zealand this morning, a Rocket Lab Electron rocket successfully deployed an Earth-imaging satellite for its customer, Japan's Institute for Q-shu Pioneers of Space, Inc. (iQPS). Before you buy stock in Rocket Lab USA, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Rocket Lab USA wasn't one of them.
|
Good news became bad news for Rocket Lab USA (NASDAQ: RKLB) on Friday after the company announced its successful return to launch operations for the first time since a mishap resulted in the destruction of an Electron rocket in September -- and the stock promptly fell. Before you buy stock in Rocket Lab USA, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Rocket Lab USA wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Rich Smith has positions in Rocket Lab USA.
|
ET, Rocket Lab stock is down 9.6%. 2 space company by number of rockets launched annually -- for the fifth straight year, as the company pointed out. Before you buy stock in Rocket Lab USA, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Rocket Lab USA wasn't one of them.
|
98d5219a-456f-4803-b5aa-ff6ed0d55f9b
|
711725.0
|
2023-12-13 00:00:00 UTC
|
1 Wall Street Analyst Thinks Coca-Cola Stock Is Going to $67. Is It a Buy?
|
DCOMP
|
https://www.nasdaq.com/articles/1-wall-street-analyst-thinks-coca-cola-stock-is-going-to-%2467.-is-it-a-buy
|
nan
|
nan
|
As of this writing, shares of quintessential beverage enterprise Coca-Cola (NYSE: KO) are trading at almost $59 per share. However, according to TheFly, Citi analyst Filippo Falorni says Coca-Cola stock is headed to $67 per share, a jump of about 13%.
With a 13% jump in stock price and a dividend that pays about a 3% yield, investors could be looking at market-beating returns for Coca-Cola stock if Falorni is right. So, should investors buy the stock now? Well, there's something investors should be aware of first.
Buy Coca-Cola stock for good reasons
Falorni raised his price target for Coca-Cola stock on Dec. 13. But according to TipRanks, this is the fifth time he's given a price target this year alone. Previous price targets were $68, $71, $74, and $65.
In short, Falorni customarily changes his price targets for Coca-Cola stock, even though the business doesn't fundamentally change anywhere near as often.
Don't misunderstand: I'm not singling out Falorni in the least. But investors need to understand that Wall Street incessantly upgrades and downgrades its outlooks on stocks. Therefore, constantly reacting to the changes would be counterproductive for investors. Rather, investors should build investment theses around fundamentals for the business, not an analyst's opinion on the future stock price.
For Coca-Cola, it's one of the best examples of having a competitive advantage due to its scale, giving it stability year in and year out. The company also is enjoying double-digit organic growth in 2023, which management believes will carry into next year. Management believes it has opportunities to increase profits, too.
These are the kinds of things that can lead to a higher price per share for Coca-Cola in the future. Investors should keep their perspectives grounded in fundamental things like those mentioned above rather than get derailed by the constantly changing opinions on Wall Street.
Should you invest $1,000 in Coca-Cola right now?
Before you buy stock in Coca-Cola, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coca-Cola wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Citigroup is an advertising partner of The Ascent, a Motley Fool company. Jon Quast has no position in any of the stocks mentioned. The Motley Fool recommends the following options: long January 2024 $47.50 calls on Coca-Cola. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
However, according to TheFly, Citi analyst Filippo Falorni says Coca-Cola stock is headed to $67 per share, a jump of about 13%. Rather, investors should build investment theses around fundamentals for the business, not an analyst's opinion on the future stock price. Investors should keep their perspectives grounded in fundamental things like those mentioned above rather than get derailed by the constantly changing opinions on Wall Street.
|
In short, Falorni customarily changes his price targets for Coca-Cola stock, even though the business doesn't fundamentally change anywhere near as often. Rather, investors should build investment theses around fundamentals for the business, not an analyst's opinion on the future stock price. Before you buy stock in Coca-Cola, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coca-Cola wasn't one of them.
|
With a 13% jump in stock price and a dividend that pays about a 3% yield, investors could be looking at market-beating returns for Coca-Cola stock if Falorni is right. Buy Coca-Cola stock for good reasons Falorni raised his price target for Coca-Cola stock on Dec. 13. Before you buy stock in Coca-Cola, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coca-Cola wasn't one of them.
|
Rather, investors should build investment theses around fundamentals for the business, not an analyst's opinion on the future stock price. Investors should keep their perspectives grounded in fundamental things like those mentioned above rather than get derailed by the constantly changing opinions on Wall Street. Before you buy stock in Coca-Cola, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coca-Cola wasn't one of them.
|
d9e28c93-9823-4c8d-b18a-24e447184ebf
|
711726.0
|
2023-12-13 00:00:00 UTC
|
Friday 12/15 Insider Buying Report: LIND, CHWY
|
DCOMP
|
https://www.nasdaq.com/articles/friday-12-15-insider-buying-report%3A-lind-chwy
|
nan
|
nan
|
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Wednesday, Lindblad Expeditions Holdings', Alex P. Schultz, made a $342,259 purchase of LIND, buying 39,293 shares at a cost of $8.71 a piece. So far Schultz is in the green, up about 23.4% on their purchase based on today's trading high of $10.75. Lindblad Expeditions Holdings is trading up about 2% on the day Friday. This purchase marks the first one filed by Schultz in the past twelve months.
And on Tuesday, Director James A. Star purchased $300,992 worth of Chewy, purchasing 15,353 shares at a cost of $19.60 a piece. This purchase marks the first one filed by Star in the past twelve months. Chewy is trading up about 3.8% on the day Friday. Star was up about 10.2% on the purchase at the high point of today's trading session, with CHWY trading as high as $21.60 in trading on Friday.
VIDEO: Friday 12/15 Insider Buying Report: LIND, CHWY
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. On Wednesday, Lindblad Expeditions Holdings', Alex P. Schultz, made a $342,259 purchase of LIND, buying 39,293 shares at a cost of $8.71 a piece. So far Schultz is in the green, up about 23.4% on their purchase based on today's trading high of $10.75.
|
On Wednesday, Lindblad Expeditions Holdings', Alex P. Schultz, made a $342,259 purchase of LIND, buying 39,293 shares at a cost of $8.71 a piece. Star was up about 10.2% on the purchase at the high point of today's trading session, with CHWY trading as high as $21.60 in trading on Friday. VIDEO: Friday 12/15 Insider Buying Report: LIND, CHWY The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. On Wednesday, Lindblad Expeditions Holdings', Alex P. Schultz, made a $342,259 purchase of LIND, buying 39,293 shares at a cost of $8.71 a piece. Star was up about 10.2% on the purchase at the high point of today's trading session, with CHWY trading as high as $21.60 in trading on Friday.
|
Today we look at two noteworthy recent insider buys. So far Schultz is in the green, up about 23.4% on their purchase based on today's trading high of $10.75. Star purchased $300,992 worth of Chewy, purchasing 15,353 shares at a cost of $19.60 a piece.
|
c4eb543d-8ef6-4289-829e-3afba2cab88d
|
711727.0
|
2023-12-13 00:00:00 UTC
|
Insider Buying: C-Suite EV Executive Just Loaded Up on $2M of this Auto Stock
|
DCOMP
|
https://www.nasdaq.com/articles/insider-buying%3A-c-suite-ev-executive-just-loaded-up-on-%242m-of-this-auto-stock
|
nan
|
nan
|
When executives, directors, and major shareholders buy company shares, it's often considered a bullish sign. As per Peter Lynch, while company insiders might sell their shares for any number of reasons, they tend to buy stock for only one reason - because they think the share price is going higher.
Publicly available through Form 4 filings, insider buys by C-suite executives are particularly notable - like the one that just popped up on Ford Motor Company (F) after a long two-year drought of insider buying on the automaker. Here's a closer look.
About Ford
Synonymous with American engineering and an icon of the automobile industry, Henry Ford founded Ford Motor Company in Dearborn, Mich., in 1903. It has gone on to become a global auto giant, designing, manufacturing, and selling cars, trucks, SUVs, electric vehicles, and commercial vehicles. They also offer financing, leasing, and service solutions.
Commanding a market cap of $48.3 billion, Ford stock is up less than 3% on a YTD basis. The stock is underperforming the broader S&P 500 Index ($SPX), up over 22%, by a considerable margin.
www.barchart.com
A Rare C-Suite Buy on Ford Stock
John Douglas Field is the Chief EV, Digital and Design Officer at Ford. Formerly of Apple (AAPL) and Tesla (TSLA), this is Field's second stint with Ford after serving as a development engineer from 1987 to 1993. In his current role, Field plays a vital role in developing Ford's electric vehicles, creating digital platforms and software for Ford’s entire product lineup, and leading the company’s vehicle and digital design studios.
On Dec. 8, Field purchased 182,000 shares of the company at an average price of $11.0472 per share for a total value of just over $2 million. This marks the first insider buy on Ford stock since Feb. 23, 2021, and the first purchase by a member of the C-suite since April 2020.
Though Ford has underperformed on a YTD basis, the stock is already up more than 8% from Field's Dec. 8 entry price.
Ford's EV Future After UAW Strikes
The UAW strike against Detroit's “Big Three” had a material impact on Ford's operations, but the automaker has since updated its guidance to reflect expected labor costs through 2028, along with a reduction to its earnings guidance. This offers some key visibility for shareholders and removes a significant overhang.
During Q3, revenues were up 11% from the year-ago period to $44 billion, supported by sales growth across its gas, hybrid and electric vehicles. All three core segments of the company reported year-over-year revenue increases, including Ford Blue (revenues of $25.6 billion, up 8% YoY), Ford Pro (revenues of $13.8 billion, up 15% YoY), and Ford E (revenues of $1.8 billion, up 29% YoY).
EPS improved 30% from the prior year to $0.39, up 30% from the previous year, but fell short of Wall Street's expectations.
The company closed the quarter with $51 billion of available liquidity. For the nine months ended Sept. 30, it recorded net cash from operating activities of $12.4 billion, substantially up from $5.7 billion in the same period last year.
Ford has scaled back its electric vehicle (EV) ambitions amid a tough macro environment, but remains committed to the market. Recently, Ford announced a partnership with Xcel Energy (XEL) to develop 30,000 commercial EV charging ports in Xcel Energy service territories across the U.S. by 2030.
Is Ford Stock a Good Value?
Ford stock currently offers a forward dividend yield right around 5%, based on the quarterly dividend of $0.15. Management has said they remain committed to returning 40% to 50% of free cash flow to shareholders.
At current levels, the auto stock looks attractively valued. Ford stock is trading at a forward price/earnings ratio of 6.44, forward price/sales of 0.29, and price/book of 1.09, representing a significant discount to sector medians.
Overall, analysts remain optimistic about the stock, which has an average “Moderate Buy” rating and a mean target price of $14.23. This denotes an expected upside potential of about 18.7% from current levels. Out of 14 analysts covering Ford shares, 6 have a “Strong Buy” rating, 2 have a “Moderate Buy” rating, 4 have a “Hold” rating, and 2 have a “Strong Sell” rating.
www.barchart.com
On the date of publication, Pathikrit Bose did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In his current role, Field plays a vital role in developing Ford's electric vehicles, creating digital platforms and software for Ford’s entire product lineup, and leading the company’s vehicle and digital design studios. During Q3, revenues were up 11% from the year-ago period to $44 billion, supported by sales growth across its gas, hybrid and electric vehicles. Ford has scaled back its electric vehicle (EV) ambitions amid a tough macro environment, but remains committed to the market.
|
In his current role, Field plays a vital role in developing Ford's electric vehicles, creating digital platforms and software for Ford’s entire product lineup, and leading the company’s vehicle and digital design studios. All three core segments of the company reported year-over-year revenue increases, including Ford Blue (revenues of $25.6 billion, up 8% YoY), Ford Pro (revenues of $13.8 billion, up 15% YoY), and Ford E (revenues of $1.8 billion, up 29% YoY). Out of 14 analysts covering Ford shares, 6 have a “Strong Buy” rating, 2 have a “Moderate Buy” rating, 4 have a “Hold” rating, and 2 have a “Strong Sell” rating.
|
www.barchart.com A Rare C-Suite Buy on Ford Stock John Douglas Field is the Chief EV, Digital and Design Officer at Ford. In his current role, Field plays a vital role in developing Ford's electric vehicles, creating digital platforms and software for Ford’s entire product lineup, and leading the company’s vehicle and digital design studios. All three core segments of the company reported year-over-year revenue increases, including Ford Blue (revenues of $25.6 billion, up 8% YoY), Ford Pro (revenues of $13.8 billion, up 15% YoY), and Ford E (revenues of $1.8 billion, up 29% YoY).
|
Though Ford has underperformed on a YTD basis, the stock is already up more than 8% from Field's Dec. 8 entry price. For the nine months ended Sept. 30, it recorded net cash from operating activities of $12.4 billion, substantially up from $5.7 billion in the same period last year. For more information please view the Barchart Disclosure Policy here.
|
63ba50f2-67fb-4b50-820c-293ef5ed40b5
|
711728.0
|
2023-12-13 00:00:00 UTC
|
Friday Sector Leaders: Technology & Communications, Materials
|
DCOMP
|
https://www.nasdaq.com/articles/friday-sector-leaders%3A-technology-communications-materials-0
|
nan
|
nan
|
The best performing sector as of midday Friday is the Technology & Communications sector, losing just 0.2%. Within that group, First Solar Inc (Symbol: FSLR) and Enphase Energy Inc. (Symbol: ENPH) are two large stocks leading the way, showing a gain of 5.0% and 3.3%, respectively. Among technology ETFs, one ETF following the sector is the Technology Select Sector SPDR ETF (Symbol: XLK), which is up 0.4% on the day, and up 56.20% year-to-date. First Solar Inc, meanwhile, is up 13.88% year-to-date, and Enphase Energy Inc., is down 50.99% year-to-date. Combined, FSLR and ENPH make up approximately 0.4% of the underlying holdings of XLK.
The next best performing sector is the Materials sector, losing just 0.3%. Among large Materials stocks, Steel Dynamics Inc. (Symbol: STLD) and Albemarle Corp. (Symbol: ALB) are the most notable, showing a gain of 4.7% and 1.9%, respectively. One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is down 0.3% in midday trading, and up 11.16% on a year-to-date basis. Steel Dynamics Inc., meanwhile, is up 32.34% year-to-date, and Albemarle Corp., is down 29.92% year-to-date. Combined, STLD and ALB make up approximately 3.5% of the underlying holdings of XLB.
Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom:
Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Friday. As you can see, none of the sectors are up on the day, while nine sectors are down.
SECTOR % CHANGE
Technology & Communications -0.2%
Materials -0.3%
Industrial -0.5%
Services -0.7%
Energy -0.8%
Consumer Products -1.0%
Healthcare -1.1%
Utilities -1.4%
Financial -1.5%
25 Dividend Giants Widely Held By ETFs »
Also see:
Funds Holding LNBB
GES Videos
TRCA shares outstanding history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Combined, FSLR and ENPH make up approximately 0.4% of the underlying holdings of XLK. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Friday. Technology & Communications -0.2% Materials -0.3% Industrial -0.5% Services -0.7% Energy -0.8% Consumer Products -1.0% Healthcare -1.1% Utilities -1.4% Financial -1.5% 25 Dividend Giants Widely Held By ETFs » Also see: Funds Holding LNBB GES Videos TRCA shares outstanding history The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Within that group, First Solar Inc (Symbol: FSLR) and Enphase Energy Inc. (Symbol: ENPH) are two large stocks leading the way, showing a gain of 5.0% and 3.3%, respectively. Among technology ETFs, one ETF following the sector is the Technology Select Sector SPDR ETF (Symbol: XLK), which is up 0.4% on the day, and up 56.20% year-to-date. Among large Materials stocks, Steel Dynamics Inc. (Symbol: STLD) and Albemarle Corp. (Symbol: ALB) are the most notable, showing a gain of 4.7% and 1.9%, respectively.
|
Among technology ETFs, one ETF following the sector is the Technology Select Sector SPDR ETF (Symbol: XLK), which is up 0.4% on the day, and up 56.20% year-to-date. One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is down 0.3% in midday trading, and up 11.16% on a year-to-date basis. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Friday.
|
The best performing sector as of midday Friday is the Technology & Communications sector, losing just 0.2%. Among technology ETFs, one ETF following the sector is the Technology Select Sector SPDR ETF (Symbol: XLK), which is up 0.4% on the day, and up 56.20% year-to-date. One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is down 0.3% in midday trading, and up 11.16% on a year-to-date basis.
|
918c5f1d-aaa0-4fa9-ac7e-99bca053f892
|
711729.0
|
2023-12-13 00:00:00 UTC
|
Consumer Sector Update for 12/15/2023: SCHL, GETR, COST, GM
|
DCOMP
|
https://www.nasdaq.com/articles/consumer-sector-update-for-12-15-2023%3A-schl-getr-cost-gm
|
nan
|
nan
|
Consumer stocks were edging slightly higher late Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) and the Consumer Discretionary Select Sector SPDR Fund (XLY) both fractionally higher.
In corporate news, Scholastic (SCHL) shares tumbled nearly 12% after the company said overnight it now expects full-year revenue to be about "level with or slightly below the prior year," compared with prior guidance looking for a 3% to 5% increase for the current fiscal year.
Getaround (GETR) shares soared 110% after the company reported late Thursday a surge in sales and a sharply narrower Q3 net loss.
Costco (COST) shares jumped 4.6% after its fiscal Q1 results exceeded expectations. The company reported fiscal Q1 earnings of $3.58 per diluted share. Analysts surveyed by Capital IQ expected $3.42. Revenue was $57.80 billion, compared with the analysts' estimate of $57.79 billion.
General Motors (GM) is planning to cut 1,300 jobs at two Michigan plants starting Jan. 1, the company said in state filings. Its shares fell 1.7%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In corporate news, Scholastic (SCHL) shares tumbled nearly 12% after the company said overnight it now expects full-year revenue to be about "level with or slightly below the prior year," compared with prior guidance looking for a 3% to 5% increase for the current fiscal year. Getaround (GETR) shares soared 110% after the company reported late Thursday a surge in sales and a sharply narrower Q3 net loss. General Motors (GM) is planning to cut 1,300 jobs at two Michigan plants starting Jan. 1, the company said in state filings.
|
Consumer stocks were edging slightly higher late Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) and the Consumer Discretionary Select Sector SPDR Fund (XLY) both fractionally higher. In corporate news, Scholastic (SCHL) shares tumbled nearly 12% after the company said overnight it now expects full-year revenue to be about "level with or slightly below the prior year," compared with prior guidance looking for a 3% to 5% increase for the current fiscal year. The company reported fiscal Q1 earnings of $3.58 per diluted share.
|
Consumer stocks were edging slightly higher late Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) and the Consumer Discretionary Select Sector SPDR Fund (XLY) both fractionally higher. In corporate news, Scholastic (SCHL) shares tumbled nearly 12% after the company said overnight it now expects full-year revenue to be about "level with or slightly below the prior year," compared with prior guidance looking for a 3% to 5% increase for the current fiscal year. Getaround (GETR) shares soared 110% after the company reported late Thursday a surge in sales and a sharply narrower Q3 net loss.
|
Consumer stocks were edging slightly higher late Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) and the Consumer Discretionary Select Sector SPDR Fund (XLY) both fractionally higher. In corporate news, Scholastic (SCHL) shares tumbled nearly 12% after the company said overnight it now expects full-year revenue to be about "level with or slightly below the prior year," compared with prior guidance looking for a 3% to 5% increase for the current fiscal year. Getaround (GETR) shares soared 110% after the company reported late Thursday a surge in sales and a sharply narrower Q3 net loss.
|
60499d52-05b5-4f7c-aacd-7caa3e8941b3
|
711730.0
|
2023-12-13 00:00:00 UTC
|
Huge News for Etsy Stock Investors!
|
DCOMP
|
https://www.nasdaq.com/articles/huge-news-for-etsy-stock-investors
|
nan
|
nan
|
Fool.com contributor Parkev Tatevosian discusses the new developments out of Etsy (NASDAQ: ETSY) that were significant enough to earn a recommendation downgrade.
*Stock prices used were the afternoon prices of Dec. 13, 2023. The video was published on Dec. 15, 2023.
Should you invest $1,000 in Etsy right now?
Before you buy stock in Etsy, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Etsy wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Etsy. The Motley Fool has a disclosure policy.
Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The 10 stocks that made the cut could produce monster returns in the coming years. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel.
|
Before you buy stock in Etsy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Etsy wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Etsy.
|
Before you buy stock in Etsy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Etsy wasn't one of them. Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Parkev Tatevosian, CFA has no position in any of the stocks mentioned.
|
Before you buy stock in Etsy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Etsy wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Etsy.
|
b0da9cfb-71f6-4981-967c-296c5fc4d09e
|
711731.0
|
2023-12-13 00:00:00 UTC
|
Notable Friday Option Activity: MRCY, ASPN, PZZA
|
DCOMP
|
https://www.nasdaq.com/articles/notable-friday-option-activity%3A-mrcy-aspn-pzza
|
nan
|
nan
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Mercury Systems Inc (Symbol: MRCY), where a total of 3,556 contracts have traded so far, representing approximately 355,600 underlying shares. That amounts to about 101.4% of MRCY's average daily trading volume over the past month of 350,540 shares. Particularly high volume was seen for the $35 strike call option expiring February 16, 2024, with 2,024 contracts trading so far today, representing approximately 202,400 underlying shares of MRCY. Below is a chart showing MRCY's trailing twelve month trading history, with the $35 strike highlighted in orange:
Aspen Aerogels Inc (Symbol: ASPN) options are showing a volume of 8,264 contracts thus far today. That number of contracts represents approximately 826,400 underlying shares, working out to a sizeable 101.2% of ASPN's average daily trading volume over the past month, of 816,950 shares. Particularly high volume was seen for the $15 strike call option expiring April 19, 2024, with 4,002 contracts trading so far today, representing approximately 400,200 underlying shares of ASPN. Below is a chart showing ASPN's trailing twelve month trading history, with the $15 strike highlighted in orange:
And Papa John's International, Inc. (Symbol: PZZA) saw options trading volume of 5,200 contracts, representing approximately 520,000 underlying shares or approximately 100.5% of PZZA's average daily trading volume over the past month, of 517,425 shares. Particularly high volume was seen for the $67.50 strike put option expiring January 19, 2024, with 5,001 contracts trading so far today, representing approximately 500,100 underlying shares of PZZA. Below is a chart showing PZZA's trailing twelve month trading history, with the $67.50 strike highlighted in orange:
For the various different available expirations for MRCY options, ASPN options, or PZZA options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
ITP Videos
EOSE Insider Buying
Institutional Holders of ELWS
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Particularly high volume was seen for the $35 strike call option expiring February 16, 2024, with 2,024 contracts trading so far today, representing approximately 202,400 underlying shares of MRCY. Particularly high volume was seen for the $15 strike call option expiring April 19, 2024, with 4,002 contracts trading so far today, representing approximately 400,200 underlying shares of ASPN. Particularly high volume was seen for the $67.50 strike put option expiring January 19, 2024, with 5,001 contracts trading so far today, representing approximately 500,100 underlying shares of PZZA.
|
Below is a chart showing MRCY's trailing twelve month trading history, with the $35 strike highlighted in orange: Aspen Aerogels Inc (Symbol: ASPN) options are showing a volume of 8,264 contracts thus far today. Below is a chart showing ASPN's trailing twelve month trading history, with the $15 strike highlighted in orange: And Papa John's International, Inc. (Symbol: PZZA) saw options trading volume of 5,200 contracts, representing approximately 520,000 underlying shares or approximately 100.5% of PZZA's average daily trading volume over the past month, of 517,425 shares. Below is a chart showing PZZA's trailing twelve month trading history, with the $67.50 strike highlighted in orange: For the various different available expirations for MRCY options, ASPN options, or PZZA options, visit StockOptionsChannel.com.
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Mercury Systems Inc (Symbol: MRCY), where a total of 3,556 contracts have traded so far, representing approximately 355,600 underlying shares. Particularly high volume was seen for the $35 strike call option expiring February 16, 2024, with 2,024 contracts trading so far today, representing approximately 202,400 underlying shares of MRCY. Below is a chart showing ASPN's trailing twelve month trading history, with the $15 strike highlighted in orange: And Papa John's International, Inc. (Symbol: PZZA) saw options trading volume of 5,200 contracts, representing approximately 520,000 underlying shares or approximately 100.5% of PZZA's average daily trading volume over the past month, of 517,425 shares.
|
Below is a chart showing ASPN's trailing twelve month trading history, with the $15 strike highlighted in orange: And Papa John's International, Inc. (Symbol: PZZA) saw options trading volume of 5,200 contracts, representing approximately 520,000 underlying shares or approximately 100.5% of PZZA's average daily trading volume over the past month, of 517,425 shares. Particularly high volume was seen for the $67.50 strike put option expiring January 19, 2024, with 5,001 contracts trading so far today, representing approximately 500,100 underlying shares of PZZA. Below is a chart showing PZZA's trailing twelve month trading history, with the $67.50 strike highlighted in orange: For the various different available expirations for MRCY options, ASPN options, or PZZA options, visit StockOptionsChannel.com.
|
c5494e78-c7d1-45dc-ad84-05923f20e9af
|
711732.0
|
2023-12-13 00:00:00 UTC
|
BlackRock, State Street subpoenaed by House in ESG probe
|
DCOMP
|
https://www.nasdaq.com/articles/blackrock-state-street-subpoenaed-by-house-in-esg-probe
|
nan
|
nan
|
By Makini Brice
Dec 15 (Reuters) - The U.S. House Judiciary committee said it had subpoenaed BlackRock Inc BLK.N and State Street Corp STT.N in its environmental, social, and governance (ESG) probe.
BlackRock in August already drew scrutiny from the U.S. House committee on China that the New York-based asset manager was facilitating investments into blacklisted Chinese companies.
BlackRock and State Street did not immediately respond to Reuters' requests for comment.
House Judiciary Chairman Jim Jordan has earlier also sent a subpoena to asset manager Vanguard to which the company told Reuters that it is "committed to working constructively with lawmakers and has cooperated with the Committee’s requests, including producing tens of thousands of pages of relevant documents to date".
Bloomberg News, which first reported the development, said the panel is looking into allegations from critics of these investment firms that they colluded in committing to make the investments.
(Reporting by Jaiveer Singh Shekhawat in Bengaluru; Editing by Maju Samuel)
((JaiveerSingh.Shekhawat@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Makini Brice Dec 15 (Reuters) - The U.S. House Judiciary committee said it had subpoenaed BlackRock Inc BLK.N and State Street Corp STT.N in its environmental, social, and governance (ESG) probe. BlackRock in August already drew scrutiny from the U.S. House committee on China that the New York-based asset manager was facilitating investments into blacklisted Chinese companies. House Judiciary Chairman Jim Jordan has earlier also sent a subpoena to asset manager Vanguard to which the company told Reuters that it is "committed to working constructively with lawmakers and has cooperated with the Committee’s requests, including producing tens of thousands of pages of relevant documents to date".
|
By Makini Brice Dec 15 (Reuters) - The U.S. House Judiciary committee said it had subpoenaed BlackRock Inc BLK.N and State Street Corp STT.N in its environmental, social, and governance (ESG) probe. BlackRock and State Street did not immediately respond to Reuters' requests for comment. House Judiciary Chairman Jim Jordan has earlier also sent a subpoena to asset manager Vanguard to which the company told Reuters that it is "committed to working constructively with lawmakers and has cooperated with the Committee’s requests, including producing tens of thousands of pages of relevant documents to date".
|
By Makini Brice Dec 15 (Reuters) - The U.S. House Judiciary committee said it had subpoenaed BlackRock Inc BLK.N and State Street Corp STT.N in its environmental, social, and governance (ESG) probe. BlackRock in August already drew scrutiny from the U.S. House committee on China that the New York-based asset manager was facilitating investments into blacklisted Chinese companies. House Judiciary Chairman Jim Jordan has earlier also sent a subpoena to asset manager Vanguard to which the company told Reuters that it is "committed to working constructively with lawmakers and has cooperated with the Committee’s requests, including producing tens of thousands of pages of relevant documents to date".
|
By Makini Brice Dec 15 (Reuters) - The U.S. House Judiciary committee said it had subpoenaed BlackRock Inc BLK.N and State Street Corp STT.N in its environmental, social, and governance (ESG) probe. BlackRock in August already drew scrutiny from the U.S. House committee on China that the New York-based asset manager was facilitating investments into blacklisted Chinese companies. BlackRock and State Street did not immediately respond to Reuters' requests for comment.
|
6aceef3d-4de9-4291-ba5d-741604a0b4c0
|
711733.0
|
2023-12-13 00:00:00 UTC
|
Micron (MU) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
DCOMP
|
https://www.nasdaq.com/articles/micron-mu-expected-to-beat-earnings-estimates%3A-can-the-stock-move-higher
|
nan
|
nan
|
The market expects Micron (MU) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended November 2023. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on December 20. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on theearnings callwill mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus Estimate
This chipmaker is expected to post quarterly loss of $1 per share in its upcoming report, which represents a year-over-year change of -2400%.
Revenues are expected to be $4.6 billion, up 12.6% from the year-ago quarter.
Estimate Revisions Trend
The consensus EPS estimate for the quarter has been revised 16.89% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Earnings Whisper
Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Micron?
For Micron, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.63%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Micron will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?
Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Micron would post a loss of $1.18 per share when it actually produced a loss of $1.07, delivering a surprise of +9.32%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom Line
An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Micron appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Micron Technology, Inc. (MU) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. While management's discussion of business conditions on theearnings callwill mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
|
Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
|
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). For Micron, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects.
|
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on December 20. So, this combination indicates that Micron will most likely beat the consensus EPS estimate. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
913b3250-a120-4f5c-8ee4-03359b17f540
|
711734.0
|
2023-12-13 00:00:00 UTC
|
Noteworthy Friday Option Activity: URI, DOCU, RH
|
DCOMP
|
https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-uri-docu-rh
|
nan
|
nan
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in United Rentals Inc (Symbol: URI), where a total of 15,309 contracts have traded so far, representing approximately 1.5 million underlying shares. That amounts to about 221.3% of URI's average daily trading volume over the past month of 691,740 shares. Particularly high volume was seen for the $480 strike put option expiring March 15, 2024, with 2,801 contracts trading so far today, representing approximately 280,100 underlying shares of URI. Below is a chart showing URI's trailing twelve month trading history, with the $480 strike highlighted in orange:
DocuSign Inc (Symbol: DOCU) options are showing a volume of 96,532 contracts thus far today. That number of contracts represents approximately 9.7 million underlying shares, working out to a sizeable 169.6% of DOCU's average daily trading volume over the past month, of 5.7 million shares. Especially high volume was seen for the $57 strike call option expiring December 15, 2023, with 11,512 contracts trading so far today, representing approximately 1.2 million underlying shares of DOCU. Below is a chart showing DOCU's trailing twelve month trading history, with the $57 strike highlighted in orange:
And RH (Symbol: RH) options are showing a volume of 14,896 contracts thus far today. That number of contracts represents approximately 1.5 million underlying shares, working out to a sizeable 159.6% of RH's average daily trading volume over the past month, of 933,350 shares. Especially high volume was seen for the $330 strike call option expiring December 15, 2023, with 1,185 contracts trading so far today, representing approximately 118,500 underlying shares of RH. Below is a chart showing RH's trailing twelve month trading history, with the $330 strike highlighted in orange:
For the various different available expirations for URI options, DOCU options, or RH options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Top Ten Hedge Funds Holding CPPL
Institutional Holders of NVAX
RBB YTD Return
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Particularly high volume was seen for the $480 strike put option expiring March 15, 2024, with 2,801 contracts trading so far today, representing approximately 280,100 underlying shares of URI. Especially high volume was seen for the $57 strike call option expiring December 15, 2023, with 11,512 contracts trading so far today, representing approximately 1.2 million underlying shares of DOCU. Especially high volume was seen for the $330 strike call option expiring December 15, 2023, with 1,185 contracts trading so far today, representing approximately 118,500 underlying shares of RH.
|
Below is a chart showing URI's trailing twelve month trading history, with the $480 strike highlighted in orange: DocuSign Inc (Symbol: DOCU) options are showing a volume of 96,532 contracts thus far today. That number of contracts represents approximately 9.7 million underlying shares, working out to a sizeable 169.6% of DOCU's average daily trading volume over the past month, of 5.7 million shares. Below is a chart showing DOCU's trailing twelve month trading history, with the $57 strike highlighted in orange: And RH (Symbol: RH) options are showing a volume of 14,896 contracts thus far today.
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in United Rentals Inc (Symbol: URI), where a total of 15,309 contracts have traded so far, representing approximately 1.5 million underlying shares. Especially high volume was seen for the $57 strike call option expiring December 15, 2023, with 11,512 contracts trading so far today, representing approximately 1.2 million underlying shares of DOCU. Below is a chart showing DOCU's trailing twelve month trading history, with the $57 strike highlighted in orange: And RH (Symbol: RH) options are showing a volume of 14,896 contracts thus far today.
|
That number of contracts represents approximately 1.5 million underlying shares, working out to a sizeable 159.6% of RH's average daily trading volume over the past month, of 933,350 shares. Especially high volume was seen for the $330 strike call option expiring December 15, 2023, with 1,185 contracts trading so far today, representing approximately 118,500 underlying shares of RH. Below is a chart showing RH's trailing twelve month trading history, with the $330 strike highlighted in orange: For the various different available expirations for URI options, DOCU options, or RH options, visit StockOptionsChannel.com.
|
973ec0f7-52df-40fc-9572-244d0456575b
|
711735.0
|
2023-12-13 00:00:00 UTC
|
Noteworthy Friday Option Activity: ABR, SIG, SIX
|
DCOMP
|
https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-abr-sig-six
|
nan
|
nan
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Arbor Realty Trust Inc (Symbol: ABR), where a total volume of 42,042 contracts has been traded thus far today, a contract volume which is representative of approximately 4.2 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 75.9% of ABR's average daily trading volume over the past month, of 5.5 million shares. Particularly high volume was seen for the $20 strike call option expiring March 15, 2024, with 7,356 contracts trading so far today, representing approximately 735,600 underlying shares of ABR. Below is a chart showing ABR's trailing twelve month trading history, with the $20 strike highlighted in orange:
Signet Jewelers Ltd (Symbol: SIG) saw options trading volume of 6,312 contracts, representing approximately 631,200 underlying shares or approximately 74.7% of SIG's average daily trading volume over the past month, of 844,670 shares. Especially high volume was seen for the $75 strike call option expiring December 15, 2023, with 2,007 contracts trading so far today, representing approximately 200,700 underlying shares of SIG. Below is a chart showing SIG's trailing twelve month trading history, with the $75 strike highlighted in orange:
And Six Flags Entertainment Corp (Symbol: SIX) options are showing a volume of 9,370 contracts thus far today. That number of contracts represents approximately 937,000 underlying shares, working out to a sizeable 71.4% of SIX's average daily trading volume over the past month, of 1.3 million shares. Particularly high volume was seen for the $27.50 strike call option expiring January 19, 2024, with 6,053 contracts trading so far today, representing approximately 605,300 underlying shares of SIX. Below is a chart showing SIX's trailing twelve month trading history, with the $27.50 strike highlighted in orange:
For the various different available expirations for ABR options, SIG options, or SIX options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
SIVR Average Annual Return
Funds Holding PFEB
Top Ten Hedge Funds Holding LITE
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Particularly high volume was seen for the $20 strike call option expiring March 15, 2024, with 7,356 contracts trading so far today, representing approximately 735,600 underlying shares of ABR. Especially high volume was seen for the $75 strike call option expiring December 15, 2023, with 2,007 contracts trading so far today, representing approximately 200,700 underlying shares of SIG. Particularly high volume was seen for the $27.50 strike call option expiring January 19, 2024, with 6,053 contracts trading so far today, representing approximately 605,300 underlying shares of SIX.
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Arbor Realty Trust Inc (Symbol: ABR), where a total volume of 42,042 contracts has been traded thus far today, a contract volume which is representative of approximately 4.2 million underlying shares (given that every 1 contract represents 100 underlying shares). Below is a chart showing ABR's trailing twelve month trading history, with the $20 strike highlighted in orange: Signet Jewelers Ltd (Symbol: SIG) saw options trading volume of 6,312 contracts, representing approximately 631,200 underlying shares or approximately 74.7% of SIG's average daily trading volume over the past month, of 844,670 shares. Below is a chart showing SIG's trailing twelve month trading history, with the $75 strike highlighted in orange: And Six Flags Entertainment Corp (Symbol: SIX) options are showing a volume of 9,370 contracts thus far today.
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Arbor Realty Trust Inc (Symbol: ABR), where a total volume of 42,042 contracts has been traded thus far today, a contract volume which is representative of approximately 4.2 million underlying shares (given that every 1 contract represents 100 underlying shares). Particularly high volume was seen for the $20 strike call option expiring March 15, 2024, with 7,356 contracts trading so far today, representing approximately 735,600 underlying shares of ABR. Below is a chart showing ABR's trailing twelve month trading history, with the $20 strike highlighted in orange: Signet Jewelers Ltd (Symbol: SIG) saw options trading volume of 6,312 contracts, representing approximately 631,200 underlying shares or approximately 74.7% of SIG's average daily trading volume over the past month, of 844,670 shares.
|
Particularly high volume was seen for the $20 strike call option expiring March 15, 2024, with 7,356 contracts trading so far today, representing approximately 735,600 underlying shares of ABR. Below is a chart showing ABR's trailing twelve month trading history, with the $20 strike highlighted in orange: Signet Jewelers Ltd (Symbol: SIG) saw options trading volume of 6,312 contracts, representing approximately 631,200 underlying shares or approximately 74.7% of SIG's average daily trading volume over the past month, of 844,670 shares. That number of contracts represents approximately 937,000 underlying shares, working out to a sizeable 71.4% of SIX's average daily trading volume over the past month, of 1.3 million shares.
|
b6070545-fb6b-48fa-bf28-c5d168f4d94b
|
711736.0
|
2023-12-13 00:00:00 UTC
|
Notable Friday Option Activity: PLTR, LVS, TIPT
|
DCOMP
|
https://www.nasdaq.com/articles/notable-friday-option-activity%3A-pltr-lvs-tipt
|
nan
|
nan
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Palantir Technologies Inc (Symbol: PLTR), where a total of 463,800 contracts have traded so far, representing approximately 46.4 million underlying shares. That amounts to about 71.2% of PLTR's average daily trading volume over the past month of 65.2 million shares. Especially high volume was seen for the $18.50 strike call option expiring December 15, 2023, with 45,973 contracts trading so far today, representing approximately 4.6 million underlying shares of PLTR. Below is a chart showing PLTR's trailing twelve month trading history, with the $18.50 strike highlighted in orange:
Las Vegas Sands Corp (Symbol: LVS) saw options trading volume of 50,287 contracts, representing approximately 5.0 million underlying shares or approximately 70% of LVS's average daily trading volume over the past month, of 7.2 million shares. Especially high volume was seen for the $49 strike put option expiring December 15, 2023, with 10,577 contracts trading so far today, representing approximately 1.1 million underlying shares of LVS. Below is a chart showing LVS's trailing twelve month trading history, with the $49 strike highlighted in orange:
And Tiptree Inc (Symbol: TIPT) saw options trading volume of 459 contracts, representing approximately 45,900 underlying shares or approximately 67.4% of TIPT's average daily trading volume over the past month, of 68,100 shares. Particularly high volume was seen for the $20 strike call option expiring June 21, 2024, with 459 contracts trading so far today, representing approximately 45,900 underlying shares of TIPT. Below is a chart showing TIPT's trailing twelve month trading history, with the $20 strike highlighted in orange:
For the various different available expirations for PLTR options, LVS options, or TIPT options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Closed End Fund Screener
RCAT YTD Return
American International Group shares outstanding history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Especially high volume was seen for the $18.50 strike call option expiring December 15, 2023, with 45,973 contracts trading so far today, representing approximately 4.6 million underlying shares of PLTR. Especially high volume was seen for the $49 strike put option expiring December 15, 2023, with 10,577 contracts trading so far today, representing approximately 1.1 million underlying shares of LVS. Particularly high volume was seen for the $20 strike call option expiring June 21, 2024, with 459 contracts trading so far today, representing approximately 45,900 underlying shares of TIPT.
|
Especially high volume was seen for the $18.50 strike call option expiring December 15, 2023, with 45,973 contracts trading so far today, representing approximately 4.6 million underlying shares of PLTR. Below is a chart showing PLTR's trailing twelve month trading history, with the $18.50 strike highlighted in orange: Las Vegas Sands Corp (Symbol: LVS) saw options trading volume of 50,287 contracts, representing approximately 5.0 million underlying shares or approximately 70% of LVS's average daily trading volume over the past month, of 7.2 million shares. Below is a chart showing LVS's trailing twelve month trading history, with the $49 strike highlighted in orange: And Tiptree Inc (Symbol: TIPT) saw options trading volume of 459 contracts, representing approximately 45,900 underlying shares or approximately 67.4% of TIPT's average daily trading volume over the past month, of 68,100 shares.
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Palantir Technologies Inc (Symbol: PLTR), where a total of 463,800 contracts have traded so far, representing approximately 46.4 million underlying shares. Below is a chart showing PLTR's trailing twelve month trading history, with the $18.50 strike highlighted in orange: Las Vegas Sands Corp (Symbol: LVS) saw options trading volume of 50,287 contracts, representing approximately 5.0 million underlying shares or approximately 70% of LVS's average daily trading volume over the past month, of 7.2 million shares. Below is a chart showing LVS's trailing twelve month trading history, with the $49 strike highlighted in orange: And Tiptree Inc (Symbol: TIPT) saw options trading volume of 459 contracts, representing approximately 45,900 underlying shares or approximately 67.4% of TIPT's average daily trading volume over the past month, of 68,100 shares.
|
Especially high volume was seen for the $18.50 strike call option expiring December 15, 2023, with 45,973 contracts trading so far today, representing approximately 4.6 million underlying shares of PLTR. Below is a chart showing PLTR's trailing twelve month trading history, with the $18.50 strike highlighted in orange: Las Vegas Sands Corp (Symbol: LVS) saw options trading volume of 50,287 contracts, representing approximately 5.0 million underlying shares or approximately 70% of LVS's average daily trading volume over the past month, of 7.2 million shares. Below is a chart showing LVS's trailing twelve month trading history, with the $49 strike highlighted in orange: And Tiptree Inc (Symbol: TIPT) saw options trading volume of 459 contracts, representing approximately 45,900 underlying shares or approximately 67.4% of TIPT's average daily trading volume over the past month, of 68,100 shares.
|
959b6f56-f433-4166-817e-baf096807f8f
|
711737.0
|
2023-12-13 00:00:00 UTC
|
Notable Friday Option Activity: CNK, ATMU, HUN
|
DCOMP
|
https://www.nasdaq.com/articles/notable-friday-option-activity%3A-cnk-atmu-hun
|
nan
|
nan
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Cinemark Holdings Inc (Symbol: CNK), where a total of 22,078 contracts have traded so far, representing approximately 2.2 million underlying shares. That amounts to about 80.6% of CNK's average daily trading volume over the past month of 2.7 million shares. Especially high volume was seen for the $11 strike put option expiring February 16, 2024, with 10,000 contracts trading so far today, representing approximately 1.0 million underlying shares of CNK. Below is a chart showing CNK's trailing twelve month trading history, with the $11 strike highlighted in orange:
Atmus Filtration Technologies Inc (Symbol: ATMU) options are showing a volume of 2,928 contracts thus far today. That number of contracts represents approximately 292,800 underlying shares, working out to a sizeable 80.6% of ATMU's average daily trading volume over the past month, of 363,150 shares. Especially high volume was seen for the $25 strike call option expiring December 15, 2023, with 908 contracts trading so far today, representing approximately 90,800 underlying shares of ATMU. Below is a chart showing ATMU's trailing twelve month trading history, with the $25 strike highlighted in orange:
And Huntsman Corp (Symbol: HUN) options are showing a volume of 12,744 contracts thus far today. That number of contracts represents approximately 1.3 million underlying shares, working out to a sizeable 78.4% of HUN's average daily trading volume over the past month, of 1.6 million shares. Especially high volume was seen for the $24 strike put option expiring January 19, 2024, with 12,468 contracts trading so far today, representing approximately 1.2 million underlying shares of HUN. Below is a chart showing HUN's trailing twelve month trading history, with the $24 strike highlighted in orange:
For the various different available expirations for CNK options, ATMU options, or HUN options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Services Stocks Hedge Funds Are Selling
MDY YTD Return
LFL Videos
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Especially high volume was seen for the $11 strike put option expiring February 16, 2024, with 10,000 contracts trading so far today, representing approximately 1.0 million underlying shares of CNK. Especially high volume was seen for the $25 strike call option expiring December 15, 2023, with 908 contracts trading so far today, representing approximately 90,800 underlying shares of ATMU. Especially high volume was seen for the $24 strike put option expiring January 19, 2024, with 12,468 contracts trading so far today, representing approximately 1.2 million underlying shares of HUN.
|
That number of contracts represents approximately 292,800 underlying shares, working out to a sizeable 80.6% of ATMU's average daily trading volume over the past month, of 363,150 shares. Below is a chart showing ATMU's trailing twelve month trading history, with the $25 strike highlighted in orange: And Huntsman Corp (Symbol: HUN) options are showing a volume of 12,744 contracts thus far today. That number of contracts represents approximately 1.3 million underlying shares, working out to a sizeable 78.4% of HUN's average daily trading volume over the past month, of 1.6 million shares.
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Cinemark Holdings Inc (Symbol: CNK), where a total of 22,078 contracts have traded so far, representing approximately 2.2 million underlying shares. Especially high volume was seen for the $11 strike put option expiring February 16, 2024, with 10,000 contracts trading so far today, representing approximately 1.0 million underlying shares of CNK. That number of contracts represents approximately 1.3 million underlying shares, working out to a sizeable 78.4% of HUN's average daily trading volume over the past month, of 1.6 million shares.
|
Especially high volume was seen for the $11 strike put option expiring February 16, 2024, with 10,000 contracts trading so far today, representing approximately 1.0 million underlying shares of CNK. That number of contracts represents approximately 1.3 million underlying shares, working out to a sizeable 78.4% of HUN's average daily trading volume over the past month, of 1.6 million shares. Below is a chart showing HUN's trailing twelve month trading history, with the $24 strike highlighted in orange: For the various different available expirations for CNK options, ATMU options, or HUN options, visit StockOptionsChannel.com.
|
ee10665b-c06f-4861-9e2b-9c81ec80b768
|
711738.0
|
2023-12-13 00:00:00 UTC
|
Notable Friday Option Activity: EBIX, DDOG, RRX
|
DCOMP
|
https://www.nasdaq.com/articles/notable-friday-option-activity%3A-ebix-ddog-rrx
|
nan
|
nan
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Ebix Inc (Symbol: EBIX), where a total of 14,336 contracts have traded so far, representing approximately 1.4 million underlying shares. That amounts to about 77.9% of EBIX's average daily trading volume over the past month of 1.8 million shares. Especially high volume was seen for the $8 strike call option expiring December 22, 2023, with 2,779 contracts trading so far today, representing approximately 277,900 underlying shares of EBIX. Below is a chart showing EBIX's trailing twelve month trading history, with the $8 strike highlighted in orange:
Datadog Inc (Symbol: DDOG) options are showing a volume of 25,933 contracts thus far today. That number of contracts represents approximately 2.6 million underlying shares, working out to a sizeable 77.5% of DDOG's average daily trading volume over the past month, of 3.3 million shares. Especially high volume was seen for the $124 strike call option expiring December 15, 2023, with 1,293 contracts trading so far today, representing approximately 129,300 underlying shares of DDOG. Below is a chart showing DDOG's trailing twelve month trading history, with the $124 strike highlighted in orange:
And Regal Rexnord Corp (Symbol: RRX) saw options trading volume of 3,846 contracts, representing approximately 384,600 underlying shares or approximately 77% of RRX's average daily trading volume over the past month, of 499,710 shares. Especially high volume was seen for the $150 strike call option expiring February 16, 2024, with 1,501 contracts trading so far today, representing approximately 150,100 underlying shares of RRX. Below is a chart showing RRX's trailing twelve month trading history, with the $150 strike highlighted in orange:
For the various different available expirations for EBIX options, DDOG options, or RRX options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Institutional Holders of MNP
Top Ten Hedge Funds Holding AMRK
FTRE Options Chain
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Especially high volume was seen for the $8 strike call option expiring December 22, 2023, with 2,779 contracts trading so far today, representing approximately 277,900 underlying shares of EBIX. Especially high volume was seen for the $124 strike call option expiring December 15, 2023, with 1,293 contracts trading so far today, representing approximately 129,300 underlying shares of DDOG. Especially high volume was seen for the $150 strike call option expiring February 16, 2024, with 1,501 contracts trading so far today, representing approximately 150,100 underlying shares of RRX.
|
Especially high volume was seen for the $8 strike call option expiring December 22, 2023, with 2,779 contracts trading so far today, representing approximately 277,900 underlying shares of EBIX. Below is a chart showing EBIX's trailing twelve month trading history, with the $8 strike highlighted in orange: Datadog Inc (Symbol: DDOG) options are showing a volume of 25,933 contracts thus far today. Below is a chart showing DDOG's trailing twelve month trading history, with the $124 strike highlighted in orange: And Regal Rexnord Corp (Symbol: RRX) saw options trading volume of 3,846 contracts, representing approximately 384,600 underlying shares or approximately 77% of RRX's average daily trading volume over the past month, of 499,710 shares.
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Ebix Inc (Symbol: EBIX), where a total of 14,336 contracts have traded so far, representing approximately 1.4 million underlying shares. Below is a chart showing DDOG's trailing twelve month trading history, with the $124 strike highlighted in orange: And Regal Rexnord Corp (Symbol: RRX) saw options trading volume of 3,846 contracts, representing approximately 384,600 underlying shares or approximately 77% of RRX's average daily trading volume over the past month, of 499,710 shares. Below is a chart showing RRX's trailing twelve month trading history, with the $150 strike highlighted in orange: For the various different available expirations for EBIX options, DDOG options, or RRX options, visit StockOptionsChannel.com.
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Ebix Inc (Symbol: EBIX), where a total of 14,336 contracts have traded so far, representing approximately 1.4 million underlying shares. Below is a chart showing DDOG's trailing twelve month trading history, with the $124 strike highlighted in orange: And Regal Rexnord Corp (Symbol: RRX) saw options trading volume of 3,846 contracts, representing approximately 384,600 underlying shares or approximately 77% of RRX's average daily trading volume over the past month, of 499,710 shares. Below is a chart showing RRX's trailing twelve month trading history, with the $150 strike highlighted in orange: For the various different available expirations for EBIX options, DDOG options, or RRX options, visit StockOptionsChannel.com.
|
b5b7bf41-a683-49e5-bafc-507f17c9c68a
|
711739.0
|
2023-12-13 00:00:00 UTC
|
Noteworthy Friday Option Activity: SBGI, SUI, TOL
|
DCOMP
|
https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-sbgi-sui-tol
|
nan
|
nan
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sinclair Inc (Symbol: SBGI), where a total of 2,389 contracts have traded so far, representing approximately 238,900 underlying shares. That amounts to about 58.3% of SBGI's average daily trading volume over the past month of 409,480 shares. Especially high volume was seen for the $15 strike call option expiring December 20, 2024, with 2,000 contracts trading so far today, representing approximately 200,000 underlying shares of SBGI. Below is a chart showing SBGI's trailing twelve month trading history, with the $15 strike highlighted in orange:
Sun Communities Inc (Symbol: SUI) options are showing a volume of 4,327 contracts thus far today. That number of contracts represents approximately 432,700 underlying shares, working out to a sizeable 58.2% of SUI's average daily trading volume over the past month, of 743,110 shares. Especially high volume was seen for the $140 strike call option expiring January 19, 2024, with 2,118 contracts trading so far today, representing approximately 211,800 underlying shares of SUI. Below is a chart showing SUI's trailing twelve month trading history, with the $140 strike highlighted in orange:
And Toll Brothers Inc. (Symbol: TOL) options are showing a volume of 8,839 contracts thus far today. That number of contracts represents approximately 883,900 underlying shares, working out to a sizeable 57.1% of TOL's average daily trading volume over the past month, of 1.5 million shares. Especially high volume was seen for the $102 strike put option expiring December 15, 2023, with 482 contracts trading so far today, representing approximately 48,200 underlying shares of TOL. Below is a chart showing TOL's trailing twelve month trading history, with the $102 strike highlighted in orange:
For the various different available expirations for SBGI options, SUI options, or TOL options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Stocks with Recent Secondaries That Hedge Funds Are Buying
IE Insider Buying
Funds Holding KBLM
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Especially high volume was seen for the $15 strike call option expiring December 20, 2024, with 2,000 contracts trading so far today, representing approximately 200,000 underlying shares of SBGI. Especially high volume was seen for the $140 strike call option expiring January 19, 2024, with 2,118 contracts trading so far today, representing approximately 211,800 underlying shares of SUI. Especially high volume was seen for the $102 strike put option expiring December 15, 2023, with 482 contracts trading so far today, representing approximately 48,200 underlying shares of TOL.
|
Below is a chart showing SBGI's trailing twelve month trading history, with the $15 strike highlighted in orange: Sun Communities Inc (Symbol: SUI) options are showing a volume of 4,327 contracts thus far today. That number of contracts represents approximately 432,700 underlying shares, working out to a sizeable 58.2% of SUI's average daily trading volume over the past month, of 743,110 shares. Below is a chart showing SUI's trailing twelve month trading history, with the $140 strike highlighted in orange: And Toll Brothers Inc. (Symbol: TOL) options are showing a volume of 8,839 contracts thus far today.
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sinclair Inc (Symbol: SBGI), where a total of 2,389 contracts have traded so far, representing approximately 238,900 underlying shares. Especially high volume was seen for the $15 strike call option expiring December 20, 2024, with 2,000 contracts trading so far today, representing approximately 200,000 underlying shares of SBGI. Below is a chart showing TOL's trailing twelve month trading history, with the $102 strike highlighted in orange: For the various different available expirations for SBGI options, SUI options, or TOL options, visit StockOptionsChannel.com.
|
Especially high volume was seen for the $15 strike call option expiring December 20, 2024, with 2,000 contracts trading so far today, representing approximately 200,000 underlying shares of SBGI. That number of contracts represents approximately 432,700 underlying shares, working out to a sizeable 58.2% of SUI's average daily trading volume over the past month, of 743,110 shares. Below is a chart showing TOL's trailing twelve month trading history, with the $102 strike highlighted in orange: For the various different available expirations for SBGI options, SUI options, or TOL options, visit StockOptionsChannel.com.
|
ae407c18-f0b1-4a77-b84d-d55629e6b856
|
711740.0
|
2023-12-13 00:00:00 UTC
|
Noteworthy Friday Option Activity: ANET, NCNO, PEN
|
DCOMP
|
https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-anet-ncno-pen
|
nan
|
nan
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Arista Networks Inc (Symbol: ANET), where a total volume of 10,728 contracts has been traded thus far today, a contract volume which is representative of approximately 1.1 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 65.3% of ANET's average daily trading volume over the past month, of 1.6 million shares. Particularly high volume was seen for the $230 strike call option expiring December 15, 2023, with 919 contracts trading so far today, representing approximately 91,900 underlying shares of ANET. Below is a chart showing ANET's trailing twelve month trading history, with the $230 strike highlighted in orange:
nCino Inc (Symbol: NCNO) saw options trading volume of 3,625 contracts, representing approximately 362,500 underlying shares or approximately 65.1% of NCNO's average daily trading volume over the past month, of 556,760 shares. Especially high volume was seen for the $35 strike call option expiring May 17, 2024, with 2,001 contracts trading so far today, representing approximately 200,100 underlying shares of NCNO. Below is a chart showing NCNO's trailing twelve month trading history, with the $35 strike highlighted in orange:
And Penumbra Inc (Symbol: PEN) saw options trading volume of 2,209 contracts, representing approximately 220,900 underlying shares or approximately 64.2% of PEN's average daily trading volume over the past month, of 344,285 shares. Particularly high volume was seen for the $240 strike call option expiring December 15, 2023, with 631 contracts trading so far today, representing approximately 63,100 underlying shares of PEN. Below is a chart showing PEN's trailing twelve month trading history, with the $240 strike highlighted in orange:
For the various different available expirations for ANET options, NCNO options, or PEN options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
MACK market cap history
HOUR YTD Return
Institutional Holders of FRBK
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Particularly high volume was seen for the $230 strike call option expiring December 15, 2023, with 919 contracts trading so far today, representing approximately 91,900 underlying shares of ANET. Especially high volume was seen for the $35 strike call option expiring May 17, 2024, with 2,001 contracts trading so far today, representing approximately 200,100 underlying shares of NCNO. Particularly high volume was seen for the $240 strike call option expiring December 15, 2023, with 631 contracts trading so far today, representing approximately 63,100 underlying shares of PEN.
|
Particularly high volume was seen for the $230 strike call option expiring December 15, 2023, with 919 contracts trading so far today, representing approximately 91,900 underlying shares of ANET. Below is a chart showing ANET's trailing twelve month trading history, with the $230 strike highlighted in orange: nCino Inc (Symbol: NCNO) saw options trading volume of 3,625 contracts, representing approximately 362,500 underlying shares or approximately 65.1% of NCNO's average daily trading volume over the past month, of 556,760 shares. Below is a chart showing NCNO's trailing twelve month trading history, with the $35 strike highlighted in orange: And Penumbra Inc (Symbol: PEN) saw options trading volume of 2,209 contracts, representing approximately 220,900 underlying shares or approximately 64.2% of PEN's average daily trading volume over the past month, of 344,285 shares.
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Arista Networks Inc (Symbol: ANET), where a total volume of 10,728 contracts has been traded thus far today, a contract volume which is representative of approximately 1.1 million underlying shares (given that every 1 contract represents 100 underlying shares). Below is a chart showing ANET's trailing twelve month trading history, with the $230 strike highlighted in orange: nCino Inc (Symbol: NCNO) saw options trading volume of 3,625 contracts, representing approximately 362,500 underlying shares or approximately 65.1% of NCNO's average daily trading volume over the past month, of 556,760 shares. Below is a chart showing NCNO's trailing twelve month trading history, with the $35 strike highlighted in orange: And Penumbra Inc (Symbol: PEN) saw options trading volume of 2,209 contracts, representing approximately 220,900 underlying shares or approximately 64.2% of PEN's average daily trading volume over the past month, of 344,285 shares.
|
Especially high volume was seen for the $35 strike call option expiring May 17, 2024, with 2,001 contracts trading so far today, representing approximately 200,100 underlying shares of NCNO. Below is a chart showing NCNO's trailing twelve month trading history, with the $35 strike highlighted in orange: And Penumbra Inc (Symbol: PEN) saw options trading volume of 2,209 contracts, representing approximately 220,900 underlying shares or approximately 64.2% of PEN's average daily trading volume over the past month, of 344,285 shares. Today's Most Active Call & Put Options of the S&P 500 » Also see: MACK market cap history HOUR YTD Return Institutional Holders of FRBK The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
bf4ee775-7194-49d7-bf32-1342b56b4835
|
711741.0
|
2023-12-13 00:00:00 UTC
|
Notable Friday Option Activity: MCB, ENVX, CACC
|
DCOMP
|
https://www.nasdaq.com/articles/notable-friday-option-activity%3A-mcb-envx-cacc
|
nan
|
nan
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Metropolitan Bank Holding Corp (Symbol: MCB), where a total volume of 579 contracts has been traded thus far today, a contract volume which is representative of approximately 57,900 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 57.1% of MCB's average daily trading volume over the past month, of 101,330 shares. Particularly high volume was seen for the $50 strike call option expiring February 16, 2024, with 100 contracts trading so far today, representing approximately 10,000 underlying shares of MCB. Below is a chart showing MCB's trailing twelve month trading history, with the $50 strike highlighted in orange:
Enovix Corp (Symbol: ENVX) saw options trading volume of 20,177 contracts, representing approximately 2.0 million underlying shares or approximately 56.7% of ENVX's average daily trading volume over the past month, of 3.6 million shares. Especially high volume was seen for the $13 strike call option expiring December 15, 2023, with 2,312 contracts trading so far today, representing approximately 231,200 underlying shares of ENVX. Below is a chart showing ENVX's trailing twelve month trading history, with the $13 strike highlighted in orange:
And Credit Acceptance Corp (Symbol: CACC) saw options trading volume of 301 contracts, representing approximately 30,100 underlying shares or approximately 55.7% of CACC's average daily trading volume over the past month, of 54,075 shares. Particularly high volume was seen for the $550 strike call option expiring April 19, 2024, with 53 contracts trading so far today, representing approximately 5,300 underlying shares of CACC. Below is a chart showing CACC's trailing twelve month trading history, with the $550 strike highlighted in orange:
For the various different available expirations for MCB options, ENVX options, or CACC options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Lululemon Athletica Historical Earnings
STER Videos
KIPO Insider Buying
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Particularly high volume was seen for the $50 strike call option expiring February 16, 2024, with 100 contracts trading so far today, representing approximately 10,000 underlying shares of MCB. Especially high volume was seen for the $13 strike call option expiring December 15, 2023, with 2,312 contracts trading so far today, representing approximately 231,200 underlying shares of ENVX. Particularly high volume was seen for the $550 strike call option expiring April 19, 2024, with 53 contracts trading so far today, representing approximately 5,300 underlying shares of CACC.
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Metropolitan Bank Holding Corp (Symbol: MCB), where a total volume of 579 contracts has been traded thus far today, a contract volume which is representative of approximately 57,900 underlying shares (given that every 1 contract represents 100 underlying shares). Below is a chart showing MCB's trailing twelve month trading history, with the $50 strike highlighted in orange: Enovix Corp (Symbol: ENVX) saw options trading volume of 20,177 contracts, representing approximately 2.0 million underlying shares or approximately 56.7% of ENVX's average daily trading volume over the past month, of 3.6 million shares. Below is a chart showing ENVX's trailing twelve month trading history, with the $13 strike highlighted in orange: And Credit Acceptance Corp (Symbol: CACC) saw options trading volume of 301 contracts, representing approximately 30,100 underlying shares or approximately 55.7% of CACC's average daily trading volume over the past month, of 54,075 shares.
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Metropolitan Bank Holding Corp (Symbol: MCB), where a total volume of 579 contracts has been traded thus far today, a contract volume which is representative of approximately 57,900 underlying shares (given that every 1 contract represents 100 underlying shares). Below is a chart showing MCB's trailing twelve month trading history, with the $50 strike highlighted in orange: Enovix Corp (Symbol: ENVX) saw options trading volume of 20,177 contracts, representing approximately 2.0 million underlying shares or approximately 56.7% of ENVX's average daily trading volume over the past month, of 3.6 million shares. Below is a chart showing ENVX's trailing twelve month trading history, with the $13 strike highlighted in orange: And Credit Acceptance Corp (Symbol: CACC) saw options trading volume of 301 contracts, representing approximately 30,100 underlying shares or approximately 55.7% of CACC's average daily trading volume over the past month, of 54,075 shares.
|
Below is a chart showing MCB's trailing twelve month trading history, with the $50 strike highlighted in orange: Enovix Corp (Symbol: ENVX) saw options trading volume of 20,177 contracts, representing approximately 2.0 million underlying shares or approximately 56.7% of ENVX's average daily trading volume over the past month, of 3.6 million shares. Especially high volume was seen for the $13 strike call option expiring December 15, 2023, with 2,312 contracts trading so far today, representing approximately 231,200 underlying shares of ENVX. Particularly high volume was seen for the $550 strike call option expiring April 19, 2024, with 53 contracts trading so far today, representing approximately 5,300 underlying shares of CACC.
|
225e0937-1eea-465a-ab1e-eaedb9458bc2
|
711742.0
|
2023-12-13 00:00:00 UTC
|
Noteworthy Friday Option Activity: THO, BCO, MRNS
|
DCOMP
|
https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-tho-bco-mrns
|
nan
|
nan
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Thor Industries, Inc. (Symbol: THO), where a total of 3,215 contracts have traded so far, representing approximately 321,500 underlying shares. That amounts to about 60.3% of THO's average daily trading volume over the past month of 533,005 shares. Particularly high volume was seen for the $135 strike call option expiring March 15, 2024, with 1,511 contracts trading so far today, representing approximately 151,100 underlying shares of THO. Below is a chart showing THO's trailing twelve month trading history, with the $135 strike highlighted in orange:
Brinks Co (Symbol: BCO) options are showing a volume of 1,363 contracts thus far today. That number of contracts represents approximately 136,300 underlying shares, working out to a sizeable 59.7% of BCO's average daily trading volume over the past month, of 228,440 shares. Especially high volume was seen for the $85 strike call option expiring June 21, 2024, with 535 contracts trading so far today, representing approximately 53,500 underlying shares of BCO. Below is a chart showing BCO's trailing twelve month trading history, with the $85 strike highlighted in orange:
And Marinus Pharmaceuticals Inc (Symbol: MRNS) saw options trading volume of 1,985 contracts, representing approximately 198,500 underlying shares or approximately 59.1% of MRNS's average daily trading volume over the past month, of 335,630 shares. Especially high volume was seen for the $8 strike call option expiring January 19, 2024, with 1,727 contracts trading so far today, representing approximately 172,700 underlying shares of MRNS. Below is a chart showing MRNS's trailing twelve month trading history, with the $8 strike highlighted in orange:
For the various different available expirations for THO options, BCO options, or MRNS options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Shipping Dividend Stocks
Institutional Holders of EVN
AOS Average Annual Return
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Particularly high volume was seen for the $135 strike call option expiring March 15, 2024, with 1,511 contracts trading so far today, representing approximately 151,100 underlying shares of THO. Especially high volume was seen for the $85 strike call option expiring June 21, 2024, with 535 contracts trading so far today, representing approximately 53,500 underlying shares of BCO. Especially high volume was seen for the $8 strike call option expiring January 19, 2024, with 1,727 contracts trading so far today, representing approximately 172,700 underlying shares of MRNS.
|
Below is a chart showing THO's trailing twelve month trading history, with the $135 strike highlighted in orange: Brinks Co (Symbol: BCO) options are showing a volume of 1,363 contracts thus far today. Below is a chart showing BCO's trailing twelve month trading history, with the $85 strike highlighted in orange: And Marinus Pharmaceuticals Inc (Symbol: MRNS) saw options trading volume of 1,985 contracts, representing approximately 198,500 underlying shares or approximately 59.1% of MRNS's average daily trading volume over the past month, of 335,630 shares. Below is a chart showing MRNS's trailing twelve month trading history, with the $8 strike highlighted in orange: For the various different available expirations for THO options, BCO options, or MRNS options, visit StockOptionsChannel.com.
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Thor Industries, Inc. (Symbol: THO), where a total of 3,215 contracts have traded so far, representing approximately 321,500 underlying shares. Particularly high volume was seen for the $135 strike call option expiring March 15, 2024, with 1,511 contracts trading so far today, representing approximately 151,100 underlying shares of THO. Below is a chart showing BCO's trailing twelve month trading history, with the $85 strike highlighted in orange: And Marinus Pharmaceuticals Inc (Symbol: MRNS) saw options trading volume of 1,985 contracts, representing approximately 198,500 underlying shares or approximately 59.1% of MRNS's average daily trading volume over the past month, of 335,630 shares.
|
Especially high volume was seen for the $85 strike call option expiring June 21, 2024, with 535 contracts trading so far today, representing approximately 53,500 underlying shares of BCO. Below is a chart showing BCO's trailing twelve month trading history, with the $85 strike highlighted in orange: And Marinus Pharmaceuticals Inc (Symbol: MRNS) saw options trading volume of 1,985 contracts, representing approximately 198,500 underlying shares or approximately 59.1% of MRNS's average daily trading volume over the past month, of 335,630 shares. Below is a chart showing MRNS's trailing twelve month trading history, with the $8 strike highlighted in orange: For the various different available expirations for THO options, BCO options, or MRNS options, visit StockOptionsChannel.com.
|
ec0cfe46-207f-4303-a4e2-459877e8c023
|
711743.0
|
2023-12-13 00:00:00 UTC
|
Notable Friday Option Activity: CPE, AA, TGT
|
DCOMP
|
https://www.nasdaq.com/articles/notable-friday-option-activity%3A-cpe-aa-tgt
|
nan
|
nan
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Callon Petroleum Co. (Symbol: CPE), where a total volume of 16,328 contracts has been traded thus far today, a contract volume which is representative of approximately 1.6 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 99.6% of CPE's average daily trading volume over the past month, of 1.6 million shares. Especially high volume was seen for the $29 strike call option expiring December 15, 2023, with 2,603 contracts trading so far today, representing approximately 260,300 underlying shares of CPE. Below is a chart showing CPE's trailing twelve month trading history, with the $29 strike highlighted in orange:
Alcoa Corporation (Symbol: AA) saw options trading volume of 53,230 contracts, representing approximately 5.3 million underlying shares or approximately 98.7% of AA's average daily trading volume over the past month, of 5.4 million shares. Particularly high volume was seen for the $33 strike call option expiring January 19, 2024, with 2,009 contracts trading so far today, representing approximately 200,900 underlying shares of AA. Below is a chart showing AA's trailing twelve month trading history, with the $33 strike highlighted in orange:
And Target Corp (Symbol: TGT) saw options trading volume of 39,701 contracts, representing approximately 4.0 million underlying shares or approximately 87.7% of TGT's average daily trading volume over the past month, of 4.5 million shares. Especially high volume was seen for the $150 strike call option expiring January 19, 2024, with 3,311 contracts trading so far today, representing approximately 331,100 underlying shares of TGT. Below is a chart showing TGT's trailing twelve month trading history, with the $150 strike highlighted in orange:
For the various different available expirations for CPE options, AA options, or TGT options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Top Stocks Held By Daniel Loeb
CLW Price Target
BOOT Videos
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Especially high volume was seen for the $29 strike call option expiring December 15, 2023, with 2,603 contracts trading so far today, representing approximately 260,300 underlying shares of CPE. Particularly high volume was seen for the $33 strike call option expiring January 19, 2024, with 2,009 contracts trading so far today, representing approximately 200,900 underlying shares of AA. Especially high volume was seen for the $150 strike call option expiring January 19, 2024, with 3,311 contracts trading so far today, representing approximately 331,100 underlying shares of TGT.
|
Below is a chart showing CPE's trailing twelve month trading history, with the $29 strike highlighted in orange: Alcoa Corporation (Symbol: AA) saw options trading volume of 53,230 contracts, representing approximately 5.3 million underlying shares or approximately 98.7% of AA's average daily trading volume over the past month, of 5.4 million shares. Particularly high volume was seen for the $33 strike call option expiring January 19, 2024, with 2,009 contracts trading so far today, representing approximately 200,900 underlying shares of AA. Below is a chart showing AA's trailing twelve month trading history, with the $33 strike highlighted in orange: And Target Corp (Symbol: TGT) saw options trading volume of 39,701 contracts, representing approximately 4.0 million underlying shares or approximately 87.7% of TGT's average daily trading volume over the past month, of 4.5 million shares.
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Callon Petroleum Co. (Symbol: CPE), where a total volume of 16,328 contracts has been traded thus far today, a contract volume which is representative of approximately 1.6 million underlying shares (given that every 1 contract represents 100 underlying shares). Below is a chart showing CPE's trailing twelve month trading history, with the $29 strike highlighted in orange: Alcoa Corporation (Symbol: AA) saw options trading volume of 53,230 contracts, representing approximately 5.3 million underlying shares or approximately 98.7% of AA's average daily trading volume over the past month, of 5.4 million shares. Below is a chart showing AA's trailing twelve month trading history, with the $33 strike highlighted in orange: And Target Corp (Symbol: TGT) saw options trading volume of 39,701 contracts, representing approximately 4.0 million underlying shares or approximately 87.7% of TGT's average daily trading volume over the past month, of 4.5 million shares.
|
Below is a chart showing CPE's trailing twelve month trading history, with the $29 strike highlighted in orange: Alcoa Corporation (Symbol: AA) saw options trading volume of 53,230 contracts, representing approximately 5.3 million underlying shares or approximately 98.7% of AA's average daily trading volume over the past month, of 5.4 million shares. Particularly high volume was seen for the $33 strike call option expiring January 19, 2024, with 2,009 contracts trading so far today, representing approximately 200,900 underlying shares of AA. Below is a chart showing AA's trailing twelve month trading history, with the $33 strike highlighted in orange: And Target Corp (Symbol: TGT) saw options trading volume of 39,701 contracts, representing approximately 4.0 million underlying shares or approximately 87.7% of TGT's average daily trading volume over the past month, of 4.5 million shares.
|
50446a0f-14d0-47bf-a19d-cb6cf3ce3ce3
|
711744.0
|
2023-12-13 00:00:00 UTC
|
Is Walmart too big to prevail?
|
DCOMP
|
https://www.nasdaq.com/articles/is-walmart-too-big-to-prevail
|
nan
|
nan
|
Walmart Inc. (NYSE: WMT) is big, to say the least. It is the largest retailer in the world. It's the largest importer of goods in the United States. It is one of the largest consumer discretionary sector companies fiercely competing with Amazon.com Inc. (NASDAQ: AMZN). A strong dollar is a friend to Walmart as it imports goods cheaper and sells for a larger profit in the United States. Walmart is the largest employer in the United States, with 1.6 million workers, and the fourth largest in the world, with 2.3 million global workers. Some might say Walmart falls into the category of "too big to fail ."However, after its recent earnings reaction, investors may be wondering if Walmart has grown too big to prevail.
Window dressing accentuates the divergence.
While competitors like Target Co. (NYSE: TGT) experienced an 11% price gap that grew to a 21% gain in the following days, Walmart shares gapped down 4.8% on its fiscal Q3 2024 earnings release and proceeded to sell off 10% in the following days despite the S&P 500 index hitting yearly highs. This stark negative correlation is rare as these two retailers tend to move together in lockstep. However, this time of the year can cause portfolio managers to frantically dump the losers and buy the winners in the final window dressing period of the year. It’s worth noting that WMT shares are still up 5% year-to-date (YTD) compared to TGT shares trading down 10.9% YTD. Check out the sector heatmap on MarketBeat.
Growth is slowing but still growing.
On Nov. 16, 2023, Walmart released its fiscal third-quarter 2024 results for the quarter ending October 2023. The company reported an earnings-per-share (EPS) profit of $1.53 versus consensus analyst estimates for a profit of $1.52, a penny beat. Revenues climbed 5.2% YoY to $160.8 billion, beating analyst estimates of $159.65 billion. Consolidated gross margins rose 32 bps.
Comparable sales and e-commerce growth
U.S. comparable sales rose 4.9%, led by grocery and health wellness products. E-commerce spiked 24%, led by pickup and delivery. General merchandise grew low single-digit, reflecting softness in discretionary categories like apparel, home and toys. While unseasonal weather caused November sales to go up, Walmart expects sales growth to moderate in Q4 as grocery inflation normalizes to historic levels. Sam's Club U.S. comp sales without fuel rose 3.2%, and e-commerce rose 16% YoY.
Raised guidance still below analyst expectations
Walmart expects fiscal full-year 2024 EPS of $6.40 to $6.48, up from previous guidance of $6.36 to $6.46 but still shy of the $6.50 consensus analyst estimates. Fiscal full-year 2024 revenues are expected to rise 5% to 5.5%, up from 4% to 4.5% in previous estimates or $641.6 billion to $644.6 billion versus $642.43 billion.
Deflation will pressure the company.
Walmart CEO Doug McMillon noted that inflation is starting to fall for some grocery items, including chicken, seafood and dairy, but not so much with dry grocery. General merchandise prices are also falling, causing retailers to roll back prices. Consumers will benefit from the effects of deflation, which will put more pressure on the company to sell more products. McMillon stated, "In the U.S., we may be managing through a period of deflation in the months to come, and while that would put more unit pressure on us, we welcome it because it's better for our customers.” Investors didn't like this comment and reacted by selling.
Insights on consumers
CEO McMillon made many points in a CNBC interview following the earnings release. He emphasized that consumers are price-sensitive right now. Even richer consumers are shopping at Walmart for value. Foot traffic has increased with faster growth for curbside delivery. General merchandise is starting to experience price deflation. Next year could be a deflationary environment, but the company is not bracing for a recession and still expects growth in 2024.
Walmart analyst ratings and price targets are at MarketBeat. Walmart peers and competitor stocks can be found with the MarketBeat stock screener.
Daily ascending price channel breakdown
The daily candlestick chart for WMT illustrates the ascending price channel heading into the earnings as shares hit 52-week highs on the heels of Target's strong earning reaction. However, the sentiment reversed quickly upon the release as shares gapped down nearly 5% and proceeded to continue selling off 10% through the daily 200-period moving average support at $153.63. The daily market structure low (MSL) trigger formed at $155.27 but could not trigger. The daily relative strength index (RSI) plunged from the 70-band towards the 30-band. Pullback support levels are at $150.24, $145.50, $141.84 and $138.00.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
A strong dollar is a friend to Walmart as it imports goods cheaper and sells for a larger profit in the United States. McMillon stated, "In the U.S., we may be managing through a period of deflation in the months to come, and while that would put more unit pressure on us, we welcome it because it's better for our customers.” Investors didn't like this comment and reacted by selling. However, the sentiment reversed quickly upon the release as shares gapped down nearly 5% and proceeded to continue selling off 10% through the daily 200-period moving average support at $153.63.
|
Comparable sales and e-commerce growth U.S. comparable sales rose 4.9%, led by grocery and health wellness products. Raised guidance still below analyst expectations Walmart expects fiscal full-year 2024 EPS of $6.40 to $6.48, up from previous guidance of $6.36 to $6.46 but still shy of the $6.50 consensus analyst estimates. Daily ascending price channel breakdown The daily candlestick chart for WMT illustrates the ascending price channel heading into the earnings as shares hit 52-week highs on the heels of Target's strong earning reaction.
|
While competitors like Target Co. (NYSE: TGT) experienced an 11% price gap that grew to a 21% gain in the following days, Walmart shares gapped down 4.8% on its fiscal Q3 2024 earnings release and proceeded to sell off 10% in the following days despite the S&P 500 index hitting yearly highs. While unseasonal weather caused November sales to go up, Walmart expects sales growth to moderate in Q4 as grocery inflation normalizes to historic levels. Daily ascending price channel breakdown The daily candlestick chart for WMT illustrates the ascending price channel heading into the earnings as shares hit 52-week highs on the heels of Target's strong earning reaction.
|
It is one of the largest consumer discretionary sector companies fiercely competing with Amazon.com Inc. (NASDAQ: AMZN). While competitors like Target Co. (NYSE: TGT) experienced an 11% price gap that grew to a 21% gain in the following days, Walmart shares gapped down 4.8% on its fiscal Q3 2024 earnings release and proceeded to sell off 10% in the following days despite the S&P 500 index hitting yearly highs. Walmart analyst ratings and price targets are at MarketBeat.
|
130c9cc0-076e-45ba-9e58-dee1dc196fb7
|
711745.0
|
2023-12-13 00:00:00 UTC
|
Why DocuSign Stock Soared Today
|
DCOMP
|
https://www.nasdaq.com/articles/why-docusign-stock-soared-today
|
nan
|
nan
|
Shares of DocuSign (NASDAQ: DOCU) are up 13.7% as of 2:45 p.m. ET Friday afternoon after The Wall Street Journal reported the e-signature leader is exploring a potential sale.
Why DocuSign is exploring a sale
According to sources familiar with the situation, DocuSign is working with advisors to gauge interest in a potential sale of the company. The conversations remain in the early stages, and there are no guarantees a deal will be reached.
Any number of acquirers could be interested, though -- whether from the private equity space or publicly traded competitors like Adobe, which offers its own Acrobat Sign solution. Any deal would be substantial, given DocuSign's market cap at just over $13 billion as of this writing, potentially making it one of the largest leveraged buyouts in recent years.
DocuSign thrived during the pandemic as at-home work accelerated the transition to e-signature platforms. However, its shares have pulled back sharply from their late-2021 peak as top-line growth decelerated. Leading up to this news, DocuSign stock was roughly flat year to date in 2023.
What's next for DocuSign stock?
DocuSign has found solid financial footing in recent quarters. The company achieved better-than-expected 9% revenue growth in its latest quarter (announced last week), has steadily narrowed its losses in recent quarters, and remains on track to deliver its first-ever full-year profit this fiscal year.
That positive momentum could help DocuSign command a higher premium from prospective suitors. However, given the early stages of these reported talks, investors shouldn't hold their breath for a formal deal until the ink is dry.
Should you invest $1,000 in DocuSign right now?
Before you buy stock in DocuSign, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and DocuSign wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Steve Symington has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Adobe and DocuSign. The Motley Fool recommends the following options: long January 2024 $420 calls on Adobe, long January 2024 $60 calls on DocuSign, and short January 2024 $430 calls on Adobe. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Any number of acquirers could be interested, though -- whether from the private equity space or publicly traded competitors like Adobe, which offers its own Acrobat Sign solution. Any deal would be substantial, given DocuSign's market cap at just over $13 billion as of this writing, potentially making it one of the largest leveraged buyouts in recent years. However, given the early stages of these reported talks, investors shouldn't hold their breath for a formal deal until the ink is dry.
|
Before you buy stock in DocuSign, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and DocuSign wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Steve Symington has no position in any of the stocks mentioned. The Motley Fool recommends the following options: long January 2024 $420 calls on Adobe, long January 2024 $60 calls on DocuSign, and short January 2024 $430 calls on Adobe.
|
Why DocuSign is exploring a sale According to sources familiar with the situation, DocuSign is working with advisors to gauge interest in a potential sale of the company. Before you buy stock in DocuSign, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and DocuSign wasn't one of them. The Motley Fool recommends the following options: long January 2024 $420 calls on Adobe, long January 2024 $60 calls on DocuSign, and short January 2024 $430 calls on Adobe.
|
What's next for DocuSign stock? Before you buy stock in DocuSign, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and DocuSign wasn't one of them. The Motley Fool has positions in and recommends Adobe and DocuSign.
|
97f4f4fc-a23e-4869-8185-61eb6cf304b6
|
711746.0
|
2023-12-13 00:00:00 UTC
|
ANALYSIS-European luxury labels' distaste for discounts frustrates Farfetch ambitions
|
DCOMP
|
https://www.nasdaq.com/articles/analysis-european-luxury-labels-distaste-for-discounts-frustrates-farfetch-ambitions
|
nan
|
nan
|
By Mimosa Spencer and Abigail Summerville
PARIS, Dec 13 (Reuters) - A winding down of the post-pandemic spending frenzy is hitting European luxury companies from LVMH LVMH.PA to Kering PRTP.PA, but none more than Farfetch, an e-commerce pioneer.
Founded in 2007, Farfetch FTCH.N is one of the few global online retailers of high-end merchandise from a range of labels, such as a $5,690 Saint Laurent wool coat and a $5,900 white gold De Beers diamond necklace.
Lately, Farfetch has been touting discounts of up to 45% off clothing and accessories from a number of smaller brands - Diesel, Balmain, Lanvin and Balenciaga among them.
Its shares plunged over 50% on Nov. 28 after the company postponed its quarterly earnings report, saying that prior financial guidance "should no longer be relied upon".
On Tuesday, Moody's downgraded the company's credit rating deeper into "junk" territory and put it on review for a further cut, citing its deteriorating financial position.
Farfetch's woes reflect more than the economic headwinds dampening aspirational shoppers' demand for new fashions.
Its longer-term challenge is a drive among labels to seek greater control of their products, usually at their own retail boutiques – a strategy aimed at avoiding discounts that third party retailers like Farfetch rely on to attract shoppers.
Powerhouse brands Chanel, Hermes HRMS.PA, and LVMH's Louis Vuitton and Dior have led the charge to control all aspects of selling their products, while Burberry BRBY.L is reducing the number of third party retailers carrying its products and upgrading its boutiques. It opened 33 stores including in Los Angeles, Tokyo and London in the first half of the year.
Kering, which owns Gucci, Saint Laurent and Balenciaga, also recently opened stores in those cities.
"It is a trend that brands prefer to control their own distribution," said Caroline Reyl of Pictet, a Swiss multinational private bank and financial services firm that holds shares in Richemont CFR.S and LVMH, but not Farfetch.
By tightening their grip, also through shop-in-shop agreements in department stores, "they control everything, basically," including pricing, shoppers' data and brand positioning, Reyl said of the high-end brands.
Farfetch declined to comment when asked via email about the change in distribution trends.
The London-based company, which is listed in the United States, is working with JPMorgan and Evercore to explore options including a sale, two sources close to the matter have said.
Farfetch's founder Jose Neves is considering taking the company private, according to the Daily Telegraph newspaper.
Farfetch and JP Morgan declined to comment. Evercore did not immediately respond to requests for comment.
DIVERSIFICATION AND COMPLICATION
Richemont, facing similar challenges to its online business YNAP, which includes Net-a-Porter, entered an agreement in 2022 for Farfetch to eventually take control of YNAP – a deal involving the transfer of Richemont labels to Farfetch technology.
Farfetch is not just an online marketplace. It's also a tech company powering e-commerce for high-end UK department store Harrods, Italian fashion house Ferragamo, and is in the midst of doing the same for U.S. department store Bergdorf Goodman.
Richemont on Nov. 10 expressed confidence in Farfetch technology, but said it would into the company.
Farfetch and Net-a-Porter also seek to draw customers with exclusive offers from brands, with Farfetch recently offering early access to pre-spring looks like a 1,950 euro ($2,105) floral print dress from Dolce & Gabbana and Net-a-Porter selling a limited edition 1,700-euro wool skirt from Gucci, embellished with a horse bit, ahead of its official release this month.
But discounts, which labels fear cheapen their image, remain a key draw for shoppers of online marketplaces.
"Leading brands will be reluctant to engage, as they strive to implement high price discipline and stay away from promotions, while weaker brands will play ball," predicted Bernstein in a 2019 note to clients.
Farfetch embarked on a diversification strategy that year, buying brands and licences to distribute them, like streetwear label Off White, through the acquisition of New Guards Group.
In 2022, it added a licence deal to distribute Reebok products and expanded into beauty with the purchase of Violet Grey, gaining control of products to potentially pull shoppers to its site - though it has since retrenched from beauty and said in August it was considering options for Violet Grey.
But slowing demand for luxury products in China and the United States complicated its efforts to turn a profit, while critics say the business has become too complicated.
Olivier Abtan, a consultant at Alix Partners, said that when a retailer is under heavy sales pressure, coupled with profitability issues, it could be tempted to increase discount levels – but that can become a vicious circle.
"In my experience, when a company is not doing well, peak seasons don’t help them improve, but rather tend to exacerbate the decline," Abtan said.
($1 = 0.9264 euros)
(Reporting by Mimosa Spencer and Abigail Summerville Editing by Mark Potter)
((Mimosa.Spencer@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Mimosa Spencer and Abigail Summerville PARIS, Dec 13 (Reuters) - A winding down of the post-pandemic spending frenzy is hitting European luxury companies from LVMH LVMH.PA to Kering PRTP.PA, but none more than Farfetch, an e-commerce pioneer. Founded in 2007, Farfetch FTCH.N is one of the few global online retailers of high-end merchandise from a range of labels, such as a $5,690 Saint Laurent wool coat and a $5,900 white gold De Beers diamond necklace. "It is a trend that brands prefer to control their own distribution," said Caroline Reyl of Pictet, a Swiss multinational private bank and financial services firm that holds shares in Richemont CFR.S and LVMH, but not Farfetch.
|
By tightening their grip, also through shop-in-shop agreements in department stores, "they control everything, basically," including pricing, shoppers' data and brand positioning, Reyl said of the high-end brands. Richemont, facing similar challenges to its online business YNAP, which includes Net-a-Porter, entered an agreement in 2022 for Farfetch to eventually take control of YNAP – a deal involving the transfer of Richemont labels to Farfetch technology. ($1 = 0.9264 euros) (Reporting by Mimosa Spencer and Abigail Summerville Editing by Mark Potter) ((Mimosa.Spencer@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Its longer-term challenge is a drive among labels to seek greater control of their products, usually at their own retail boutiques – a strategy aimed at avoiding discounts that third party retailers like Farfetch rely on to attract shoppers. Richemont, facing similar challenges to its online business YNAP, which includes Net-a-Porter, entered an agreement in 2022 for Farfetch to eventually take control of YNAP – a deal involving the transfer of Richemont labels to Farfetch technology. Farfetch and Net-a-Porter also seek to draw customers with exclusive offers from brands, with Farfetch recently offering early access to pre-spring looks like a 1,950 euro ($2,105) floral print dress from Dolce & Gabbana and Net-a-Porter selling a limited edition 1,700-euro wool skirt from Gucci, embellished with a horse bit, ahead of its official release this month.
|
"It is a trend that brands prefer to control their own distribution," said Caroline Reyl of Pictet, a Swiss multinational private bank and financial services firm that holds shares in Richemont CFR.S and LVMH, but not Farfetch. By tightening their grip, also through shop-in-shop agreements in department stores, "they control everything, basically," including pricing, shoppers' data and brand positioning, Reyl said of the high-end brands. Farfetch and JP Morgan declined to comment.
|
e58d4ba8-5926-4131-86b4-1606bf03b9ef
|
711747.0
|
2023-12-13 00:00:00 UTC
|
Drugmaker Viatris appoints Theodora Mistras as CFO
|
DCOMP
|
https://www.nasdaq.com/articles/drugmaker-viatris-appoints-theodora-mistras-as-cfo
|
nan
|
nan
|
Adds appointment details throughout
Dec 15 (Reuters) - Global healthcare company Viatris VTRS.O on Friday appointed Theodora Mistras as its chief financial officer, effective March 1.
The company said the current CFO Sanjeev Narula will work closely with Mistras to support a smooth transition and will then depart the company on March 1.
Mistras most recently was the managing director of healthcare investment banking at Citigroup Global Markets and has almost two decades of leadership, advisory and capital markets experience, Viatris said.
The drugmaker also appointed Philippe Martin as chief research and development officer with immediate effect.
In October, Viatris said it had reached agreements to divest some of its businesses for a total of up to $3.6 billion as part of long-term strategy to streamline focus on three core therapeutic areas - ophthalmology, gastroenterology and dermatology.
(Reporting by Christy Santhosh and Granth Vanaik in Bengaluru; Editing by Maju Samuel)
((Christy.Santhosh@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The drugmaker also appointed Philippe Martin as chief research and development officer with immediate effect. In October, Viatris said it had reached agreements to divest some of its businesses for a total of up to $3.6 billion as part of long-term strategy to streamline focus on three core therapeutic areas - ophthalmology, gastroenterology and dermatology. (Reporting by Christy Santhosh and Granth Vanaik in Bengaluru; Editing by Maju Samuel) ((Christy.Santhosh@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds appointment details throughout Dec 15 (Reuters) - Global healthcare company Viatris VTRS.O on Friday appointed Theodora Mistras as its chief financial officer, effective March 1. The company said the current CFO Sanjeev Narula will work closely with Mistras to support a smooth transition and will then depart the company on March 1. Mistras most recently was the managing director of healthcare investment banking at Citigroup Global Markets and has almost two decades of leadership, advisory and capital markets experience, Viatris said.
|
Adds appointment details throughout Dec 15 (Reuters) - Global healthcare company Viatris VTRS.O on Friday appointed Theodora Mistras as its chief financial officer, effective March 1. Mistras most recently was the managing director of healthcare investment banking at Citigroup Global Markets and has almost two decades of leadership, advisory and capital markets experience, Viatris said. (Reporting by Christy Santhosh and Granth Vanaik in Bengaluru; Editing by Maju Samuel) ((Christy.Santhosh@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds appointment details throughout Dec 15 (Reuters) - Global healthcare company Viatris VTRS.O on Friday appointed Theodora Mistras as its chief financial officer, effective March 1. Mistras most recently was the managing director of healthcare investment banking at Citigroup Global Markets and has almost two decades of leadership, advisory and capital markets experience, Viatris said. In October, Viatris said it had reached agreements to divest some of its businesses for a total of up to $3.6 billion as part of long-term strategy to streamline focus on three core therapeutic areas - ophthalmology, gastroenterology and dermatology.
|
25aeb16a-4503-4a14-a4d9-9548e98206f8
|
711748.0
|
2023-12-13 00:00:00 UTC
|
Tesla Stock: Buy, Sell, or Hold for 2024 and Beyond?
|
DCOMP
|
https://www.nasdaq.com/articles/tesla-stock%3A-buy-sell-or-hold-for-2024-and-beyond
|
nan
|
nan
|
Tesla (NASDAQ: TSLA) stock has served investors well in 2023. The electric-car maker's shares have soared more than 90% year to date. Indeed, the growth stock's performance has been so staggering that investors are now regularly referencing the stock's membership in the elite club called the "Magnificent Seven." The group features seven large technology companies that collectively trounced the S&P 500's returns this year.
With such strong performance from Tesla in 2023, the growth stock once again became a Wall Street darling. Are more big returns ahead for the stock in 2024 and beyond? Or has the stock become overvalued? Let's explore whether the stock looks more like a buy, hold, or sell today.
Big growth drivers
There's no denying the array of strong growth drivers Tesla has supporting its business.
First, there's the secular momentum it's seeing from increasing demand for electric cars. This has played a big role in the company's 42% year-over-year growth in trailing-12-month deliveries.
Of course, Tesla is also seeing incredible momentum in its energy storage business as utilities are turning to the company's utility-scale battery pack systems to stabilize the grid, prevent outages, and reduce costs. Its energy storage deployments, measured in gigawatt hours, soared 90% year over year in Q3.
Additionally, the automaker delivered the first units of its new all-electric Cybertruck in late November. While deliveries of the vehicle likely won't ramp up to any meaningful volume until sometime around the end of 2024, the vehicle importantly gives Tesla access to the massive and lucrative pickup truck market.
Finally, investors shouldn't underestimate the potential of Tesla's full self-driving software. While the software is still in beta, it already has formidable pricing power with consumers. Even in beta, the software upgrade costs Tesla owners a whopping $12,000. Despite the high price tag, tons of customers are opting in. Impressively, Tesla's vehicle fleet has already cumulatively driven more than 0.5 billion miles using full self-driving software, giving Tesla a massive set of data and analytics to rapidly improve the artificial intelligence (AI) supporting the software.
It would be difficult to overstate the importance of Tesla's self-driving efforts to management. "We will continue to invest significantly in AI development as this is really the massive game changer," said Tesla CEO Elon Musk during the company's third-quarterearnings callwhen discussing its full self-driving technology development. "... success in this regard, in the long term, I think, has the potential to make Tesla the most valuable company in the world by far," Musk said.
Undeniable headwinds
With all of this said, three undeniable headwinds for the stock make it a hold at its current price rather than a buy.
Tesla stock's high valuation of more than 75 times earnings arguably already prices in significant success, leaving very little room for error.
High interest rates have made vehicle affordability more difficult and Tesla has had to respond by lowering prices (there's no telling how long interest rates could remain elevated).
There's always a risk that investors are underestimating how costly it will be for Tesla to execute on its growth plans.
For these three reasons, Tesla stock should be viewed more like a hold at its current valuation than a buy despite its business momentum and its long runway for further growth. However, if shares took a 25% to 30% haircut, it might be time to accumulate shares of this disruptive innovator.
Where to invest $1,000 right now
When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for two decades, Motley Fool Stock Advisor, has more than tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Tesla made the list -- but there are 9 other stocks you may be overlooking.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Daniel Sparks has no position in any of the stocks mentioned. His clients may own shares of the companies mentioned. The Motley Fool has positions in and recommends Tesla. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Of course, Tesla is also seeing incredible momentum in its energy storage business as utilities are turning to the company's utility-scale battery pack systems to stabilize the grid, prevent outages, and reduce costs. Tesla stock's high valuation of more than 75 times earnings arguably already prices in significant success, leaving very little room for error. For these three reasons, Tesla stock should be viewed more like a hold at its current valuation than a buy despite its business momentum and its long runway for further growth.
|
Big growth drivers There's no denying the array of strong growth drivers Tesla has supporting its business. Finally, investors shouldn't underestimate the potential of Tesla's full self-driving software. For these three reasons, Tesla stock should be viewed more like a hold at its current valuation than a buy despite its business momentum and its long runway for further growth.
|
For these three reasons, Tesla stock should be viewed more like a hold at its current valuation than a buy despite its business momentum and its long runway for further growth. * They just revealed what they believe are the ten best stocks for investors to buy right now... and Tesla made the list -- but there are 9 other stocks you may be overlooking. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Daniel Sparks has no position in any of the stocks mentioned.
|
Finally, investors shouldn't underestimate the potential of Tesla's full self-driving software. For these three reasons, Tesla stock should be viewed more like a hold at its current valuation than a buy despite its business momentum and its long runway for further growth. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Daniel Sparks has no position in any of the stocks mentioned.
|
4e1e10db-f18e-40c3-99c8-0ec7d1108d1a
|
711749.0
|
2023-12-13 00:00:00 UTC
|
3 Hydrogen Stocks to Turn $10,000 Into $1 Million: December 2023
|
DCOMP
|
https://www.nasdaq.com/articles/3-hydrogen-stocks-to-turn-%2410000-into-%241-million%3A-december-2023
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Millionaire-maker hydrogen stocks should be on your watch list. These companies have great upside potential via their strong catalysts and the industry’s progressive acceptance of hydrogen as a clean energy source.
We’ll discuss three hydrogen stocks that could mint new millionaires due to their explosive growth trajectories and low market caps. The following companies represent the best investors can hope for in terms of a moonshot toward $1 million on a $10,000 investment.
So here are three hydrogen stocks to consider.
Plug Power (PLUG)
Source: T. Schneider / Shutterstock.com
Plug Power (NASDAQ:PLUG) is known for its hydrogen fuel cell technology, particularly in electric vehicle power solutions. Because of its severely depressed share price and the uncertainty around it, PLUG is my contrarian pick of the three.
The company’s share price dropped by 31.5% in November. The company reported sales of $198.7 million and a $0.47 loss per share, falling short of analysts’ expectations. It’s also burning through cash at an alarming rate, requiring it to raise capital if it intends to stay in business.
However, there is a silver lining. The company’s CEO believes it will survive due to a new hydrogen tax credit and the expectation that it will turn its business around.
PLUG trades at just 2.93 times sales, significantly lower than 3.86 times sales for its industry peers. This means that if it can return to chart towards profitability, it could deliver substantial gains for investors. This makes it one of those hydrogen stocks to consider.
Ballard Power Systems (BLDP)
Source: Audio und werbung / Shutterstock
Ballard Power Systems (NASDAQ:BLDP) specializes in proton exchange membrane fuel cell development. Unlike PLUG, this company is in a significantly better financial position, with positive analyst surprises for its earnings and revenues last quarter.
Revenues grew 29.2% last quarter to $27.58 million, while the company’s EPS for the same period was -$0.12, which shows an improvement from -$0.14 a year ago.
Analysts also predict that there could be a modest upside in store for BLDP stockholders. The analyst consensus rating for this company is “Hold,” and its projected upside is 6.89%. However, its stock price is still low relative to other stocks in the same industry at just $3.92 per share, which implies a significant upside.
BLDP also holds a significant amount of cash on its balance sheet at $783 million, which will buy it a considerable amount of runway, considering it burnt through $156.52 million over the last 12 months.
So, for investors interested in a hydrogen stock less risky than PLUG, BLDP could be their winning ticket. The balance sheet and comparatively better quarterly results provide some safety.
ITM Power (ITMPF)
Source: Kaca Skokanova/ShutterStock.com
ITM Power (OTCMKTS:ITMPF) designs and manufactures electrolyzers crucial for producing green hydrogen. It’s a company in the U.K. that provides diversification benefits to U.S. investors.
ITMPF stock is one of my favorite hydrogen stocks on this list. This is because, on an adjusted EBITDA basis, it recently reported a loss of between £22-23.5 million for the first half of this year, which trends favorably against the lower end of its full-year expectation of £45-55 million. ITMPF also has plenty of cash on its balance sheet to continue growing its business at £253.7 million.
But what makes ITMPF truly a potential millionaire-making hydrogen stock is it plans to expand to the U.S. market and has undergone some significant cost-cutting measures in headcount to buy it time to execute this strategy. Commonly, when a company lays off its staff, it tends to outperform in future quarters due to having a sleeker and more efficient business model. The U.S. market is also expected to be a major growth driver for the hydrogen industry in general.
Finally, the CEO also remarked positively on the company’s efforts so far in 2023 and believes that it has made progress in all the major aspects of its development. This makes it a hydrogen stock that investors should consider if they’re interested in multi-bagger returns.
On the date of publication, Matthew Farley did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Matthew started writing coverage of the financial markets during the crypto boom of 2017 and was also a team member of several fintech startups. He then started writing about Australian and U.S. equities for various publications. His work has appeared in MarketBeat, FXStreet, Cryptoslate, Seeking Alpha, and the New Scientist magazine, among others.
More From InvestorPlace
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The #1 AI Investment Might Be This Company You’ve Never Heard Of
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post 3 Hydrogen Stocks to Turn $10,000 Into $1 Million: December 2023 appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
We’ll discuss three hydrogen stocks that could mint new millionaires due to their explosive growth trajectories and low market caps. But what makes ITMPF truly a potential millionaire-making hydrogen stock is it plans to expand to the U.S. market and has undergone some significant cost-cutting measures in headcount to buy it time to execute this strategy. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post 3 Hydrogen Stocks to Turn $10,000 Into $1 Million: December 2023 appeared first on InvestorPlace.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Millionaire-maker hydrogen stocks should be on your watch list. Plug Power (PLUG) Source: T. Schneider / Shutterstock.com Plug Power (NASDAQ:PLUG) is known for its hydrogen fuel cell technology, particularly in electric vehicle power solutions. PLUG trades at just 2.93 times sales, significantly lower than 3.86 times sales for its industry peers.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Millionaire-maker hydrogen stocks should be on your watch list. Plug Power (PLUG) Source: T. Schneider / Shutterstock.com Plug Power (NASDAQ:PLUG) is known for its hydrogen fuel cell technology, particularly in electric vehicle power solutions. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post 3 Hydrogen Stocks to Turn $10,000 Into $1 Million: December 2023 appeared first on InvestorPlace.
|
The analyst consensus rating for this company is “Hold,” and its projected upside is 6.89%. However, its stock price is still low relative to other stocks in the same industry at just $3.92 per share, which implies a significant upside. This makes it a hydrogen stock that investors should consider if they’re interested in multi-bagger returns.
|
b1be47ee-b882-426e-b350-c7f63b2a1e14
|
711750.0
|
2023-12-13 00:00:00 UTC
|
Top Stock Reports for JPMorgan, Abbott, Qualcomm & Others
|
DCOMP
|
https://www.nasdaq.com/articles/top-stock-reports-for-jpmorgan-abbott-qualcomm-others
|
nan
|
nan
|
Friday, December 15, 2023
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT) and Qualcomm Inc. (QCOM). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of JPMorgan have outperformed the Zacks Banks - Major Regional industry over the past year (+29.8% vs. +17.7%). High interest rates, buyouts, global expansion efforts and decent loan demand will aid net interest income (NII), though rising funding costs will weigh on it.
According to the Zacks analyst estimates for NII (managed) and loans imply a CAGR of 9.8% and 7.2%, respectively, by 2025. Aided by solid earnings strength and balance sheet, it will be able to sustain capital distributions. Despite visibility of some greenshoots in the investment banking (IB) business, IB fees are less likely to improve soon.
This, along with the volatile nature of the capital markets business and high mortgage rates, will likely hamper fee income growth. Owing to these challenges, we expect total non-interest income (managed) to witness a CAGR of just 3.6% by 2025. Mounting costs are a woe and we expect it to rise 11% in 2023.
(You can read the full research report on JPMorgan here >>>)
Abbott shares have outperformed the Zacks Medical - Products industry over the past year (+2.1% vs. -0.1%). The company is strategically expanding its global presence to address the unmet demand for advanced medical technologies. Within the EPD business, which is solely based in emerging markets, the Zacks analyst expects Abbott to register a sales CAGR of nearly 6% through fiscal 2025.
Within Core Diagnostics, Abbott is gaining market share following the end of the public health emergency, particularly in the United States and Europe region. Within Diabetes Care, Abbott is scaling up the production of Libre and gaining reimbursement approval in several countries. Innovations and market expansion efforts are helping it offset the impact of inflation and supply disruptions.
However, a steep year-over-year decline in COVID testing-related sales hurt growth. Further, the decision to exit the pediatric nutrition business in China continue to impede overall growth in Nutrition.
(You can read the full research report on Abbott here >>>)
Shares of Qualcomm have outperformed the Zacks Wireless Equipment industry over the past year (+24.6% vs. +9.2%). The company is well poised to benefit from solid 5G traction, greater visibility and a diversified revenue stream. Strength in the snapdragon portfolio is an additional tailwind as exemplified by the multi-year.
Apple deal for 5G modems for iPhones. It is focusing on a seamless transition from a wireless communications firm for the mobile industry to a connected processor firm for the intelligent edge. Qualcomm is also witnessing solid momentum in IoT.
However, it reported relatively soft fourth-quarter fiscal 2023 results owing to a challenging macroeconomic environment, inflationary pressures and soft recovery in China, resulting in lower-than-expected demand and elevated inventory levels.
Weakness in the smartphone industry and cautious client approach are weighing on margins. Rising geopolitical conflicts and high debt burden remain headwinds.
(You can read the full research report on QUALCOMM here >>>)
Other noteworthy reports we are featuring today include Johnson & Johnson (JNJ), Fomento Económico Mexicano, S.A.B. de C.V. (FMX) and BHP Group Ltd. (BHP).
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
Buyouts, Rates & Loans Aid JPMorgan (JPM), Fee Income Ails
Market Share Gain, EPD Business Growth Aid Abbott (ABT)
Qualcomm (QCOM) Rides on 5G Traction, Portfolio Strength
Featured Reports
J&J's (JNJ) Innovative Medicine & MedTech Units Drive Growth
J&J's Innovative Medicine sales are being driven by existing key drugs and new products. Per the Zacks analyst, the MedTech unit is showing improving trends due to recovery in surgical procedures.
Investments to Drive BHP Group (BHP) Amid Price Volatility
The Zacks analyst believes BHP's strong cash flow, focus on lowering debt, investment in growth projects and operational efficiency will aid growth despite decline in iron ore prices so far this year.
MetLife's (MET) Cost-Cut Efforts & Strategic Buyouts Aid
Per the Zacks analyst, MetLife's cost-control measures are driving margins, while acquisitions are expanding its portfolio. However, volatile variable investment income is concerning.
Hess (HES) Banks On Oil-Rich Offshore Guyana Resources
Hess achieves numerous world-class oil findings in the Stabroek Block, securing a strong production outlook. However, increasing operating costs concern the Zacks analyst.
IQVIA Benefits From Global IT Infrastructure, Liquidity Low
Per the Zacks Analyst, IQVIA's strong healthcare-specific global IT infrastructure places it firmly in the life sciences space. Low liquidity remains a concern.
Investments & Growing Regulated Base Aid FirstEnergy (FE)
Per the Zacks analyst, FirstEnergy's investment of $12 billion through 2025, will strengthen its existing operations. Energizing the Future program will boost its regulated transmission capabilities.
Robust Sports Betting & Expansion Efforts Aid MGM Resorts (MGM)
Per the Zacks analyst, MGM Resorts is likely to benefit from international expansion and sports betting. Also, its focus on asset light strategy and strategic partnerships bode well.
New Upgrades
Investments in Specialized Distribution to Aid FEMSA (FMX)
Per the Zacks analyst, FEMSA has been on track with its strategy of creating a national distribution platform in the United States, through the expansion in the specialized distribution industry.
Casey's (CASY) Gains From Grocery & Prepared Food Businesses
Per the Zacks analyst, solid performance of Casey's Grocery & Prepared Food businesses, fueled by strength in bakery, whole pizza pies and dispensed beverage categories, will lend momentum to it.
SkyWest (SKYW) Rides on Buybacks & Fleet Upgrade Efforts
SkyWest's fleet modernization program is praiseworthy. The Zacks analyst is also impressed by the company's shareholder-friendly approach.
New Downgrades
Sluggish Smartphone Market Hurts Skyworks' (SWKS) Prospects
Per Zacks analyst, Skyworks is struggling due a weak smartphone market and stiff competition from the likes of Qorvo.
Subdued IB Business, High Costs Hurt Raymond James (RJF)
Per the Zacks analyst, volatile nature of the investment banking business makes us apprehensive about Raymond James' prospects. Mounting expenses are expected to hurt the company's bottom line.
Rising costs and Stiff Rivalry Impede Envista' (NVST) Growth
The Zacks analyst is worried about Envista facing challenging macroeconomic conditions resulting in a significant escalation in its costs and expenses. Stiff rivalry remains a concern.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
JPMorgan Chase & Co. (JPM) : Free Stock Analysis Report
Abbott Laboratories (ABT) : Free Stock Analysis Report
QUALCOMM Incorporated (QCOM) : Free Stock Analysis Report
Johnson & Johnson (JNJ) : Free Stock Analysis Report
BHP Group Limited Sponsored ADR (BHP) : Free Stock Analysis Report
Fomento Economico Mexicano S.A.B. de C.V. (FMX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Within the EPD business, which is solely based in emerging markets, the Zacks analyst expects Abbott to register a sales CAGR of nearly 6% through fiscal 2025. Within Core Diagnostics, Abbott is gaining market share following the end of the public health emergency, particularly in the United States and Europe region. If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must Read Buyouts, Rates & Loans Aid JPMorgan (JPM), Fee Income Ails Market Share Gain, EPD Business Growth Aid Abbott (ABT) Qualcomm (QCOM) Rides on 5G Traction, Portfolio Strength Featured Reports J&J's (JNJ) Innovative Medicine & MedTech Units Drive Growth J&J's Innovative Medicine sales are being driven by existing key drugs and new products.
|
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT) and Qualcomm Inc. (QCOM). If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must Read Buyouts, Rates & Loans Aid JPMorgan (JPM), Fee Income Ails Market Share Gain, EPD Business Growth Aid Abbott (ABT) Qualcomm (QCOM) Rides on 5G Traction, Portfolio Strength Featured Reports J&J's (JNJ) Innovative Medicine & MedTech Units Drive Growth J&J's Innovative Medicine sales are being driven by existing key drugs and new products. Click to get this free report JPMorgan Chase & Co. (JPM) : Free Stock Analysis Report Abbott Laboratories (ABT) : Free Stock Analysis Report QUALCOMM Incorporated (QCOM) : Free Stock Analysis Report Johnson & Johnson (JNJ) : Free Stock Analysis Report BHP Group Limited Sponsored ADR (BHP) : Free Stock Analysis Report Fomento Economico Mexicano S.A.B.
|
If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must Read Buyouts, Rates & Loans Aid JPMorgan (JPM), Fee Income Ails Market Share Gain, EPD Business Growth Aid Abbott (ABT) Qualcomm (QCOM) Rides on 5G Traction, Portfolio Strength Featured Reports J&J's (JNJ) Innovative Medicine & MedTech Units Drive Growth J&J's Innovative Medicine sales are being driven by existing key drugs and new products. Investments to Drive BHP Group (BHP) Amid Price Volatility The Zacks analyst believes BHP's strong cash flow, focus on lowering debt, investment in growth projects and operational efficiency will aid growth despite decline in iron ore prices so far this year. Click to get this free report JPMorgan Chase & Co. (JPM) : Free Stock Analysis Report Abbott Laboratories (ABT) : Free Stock Analysis Report QUALCOMM Incorporated (QCOM) : Free Stock Analysis Report Johnson & Johnson (JNJ) : Free Stock Analysis Report BHP Group Limited Sponsored ADR (BHP) : Free Stock Analysis Report Fomento Economico Mexicano S.A.B.
|
You can see all of today’s research reports here >>> Qualcomm is also witnessing solid momentum in IoT. If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must Read Buyouts, Rates & Loans Aid JPMorgan (JPM), Fee Income Ails Market Share Gain, EPD Business Growth Aid Abbott (ABT) Qualcomm (QCOM) Rides on 5G Traction, Portfolio Strength Featured Reports J&J's (JNJ) Innovative Medicine & MedTech Units Drive Growth J&J's Innovative Medicine sales are being driven by existing key drugs and new products.
|
36af07b3-1d80-4601-bb88-c72333671ca8
|
711751.0
|
2023-12-13 00:00:00 UTC
|
Buying Ford Stock? Here Are 3 Things You Need to Know
|
DCOMP
|
https://www.nasdaq.com/articles/buying-ford-stock-here-are-3-things-you-need-to-know
|
nan
|
nan
|
Ford Motor Company (NYSE: F), a longtime staple in the auto industry, is a household name that investors are certainly familiar with. The shares, however, haven't made for a great investment. As of this writing, they are up just 30% in the last five years, less than half the gain of the S&P 500. But Ford's current price-to-earnings ratio of 7.3 and dividend yield of 5.3% might be too enticing to pass up.
If you're interested in buying this auto stock, though, you can't ignore these three negative factors. Here's what you need to know.
1. It has unimpressive financials
This company has been around since 1903, making Ford a legacy car manufacturer that has one of the longest histories in corporate America. You might find that impressive, adding to Ford's durability, but this business operates in an extremely mature industry. Vehicle unit sales in the U.S. are essentially flat compared to a decade ago.
That translates to weak growth prospects. In the 10-year period between 2012 and 2022, Ford's total revenue increased at a compound annual rate of just 1.6%. And from 2022 to 2027, consensus analyst estimates think the business will post annualized sales gains of 4.1%. That would be better than the past, but still isn't much to get excited about.
Another unattractive quality pertaining to Ford's financials is weak profitability. In the last decade, the company's operating margin has averaged a measly 7.5%. In fact, there hasn't been any clear indicator of margin expansion over the long term, which should worry investors.
This is a very capital-intensive business. Building factories, designing new automobiles, paying salaries and benefits for a massive workforce, spending on raw materials, and marketing to customers is very expensive. And there's no reason to believe this is going to change.
2. Its EVs are struggling
The transition to electric vehicles (EVs) is an ongoing shift, and Ford is aiming to be a leader. With the Model e division, the company is fully focused on ramping up its production capabilities in the coming years.
The issue, however, is that Ford's EV segment is burning through cash. In just the last quarter, Model e posted an operating loss of $1.3 billion. This was despite revenue growing by 26% year over year. No advantages to scale are apparent yet.
Making matters worse, and a possible sign that investors should be patient for things to improve, management has decided to delay about $12 billion in EV-related investments. Lower demand and rising costs are reasons to be a bit more cautious with these capital outlays.
There is a reason for investors to stay somewhat positive, though. Sales of Ford's popular EV models, the F-150 Lightning pick-up truck and the Mustang Mach-E, are a bright spot. The business can clearly rely on well-known car models to drum up interest as it relates to growth in the EV segment.
3. The competition is intense
The auto industry is one of the most competitive around. Think about it from the customer's perspective: There are a seemingly unlimited number of companies to choose from, all trying to compete on price, design, features, quality, and performance.
This means Ford likely doesn't benefit from an economic moat. Yes, the brand might be well known, but there are countless other automakers both domestically and in foreign markets that might have even greater recognition.
Furthermore, Ford hasn't shown any ability to develop economies of scale, as its disappointing margins trends attest to.
The incredibly competitive industry landscape makes it that much more difficult in regard to the two prior points I made. There's no reason to believe that Ford will be able to post growth that's meaningfully better than what we've seen over the past decade. And when it comes to EVs, the fact that nearly every automaker is focused on this area will make it harder for Ford to sell more units and become profitable in this segment.
Value-focused and income-seeking investors might still rush to buy this stock. But it's best not to ignore these three red flags.
Should you invest $1,000 in Ford Motor Company right now?
Before you buy stock in Ford Motor Company, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Ford Motor Company wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Neil Patel and his clients have no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Building factories, designing new automobiles, paying salaries and benefits for a massive workforce, spending on raw materials, and marketing to customers is very expensive. Making matters worse, and a possible sign that investors should be patient for things to improve, management has decided to delay about $12 billion in EV-related investments. And when it comes to EVs, the fact that nearly every automaker is focused on this area will make it harder for Ford to sell more units and become profitable in this segment.
|
And from 2022 to 2027, consensus analyst estimates think the business will post annualized sales gains of 4.1%. Before you buy stock in Ford Motor Company, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Ford Motor Company wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Neil Patel and his clients have no position in any of the stocks mentioned.
|
Ford Motor Company (NYSE: F), a longtime staple in the auto industry, is a household name that investors are certainly familiar with. Before you buy stock in Ford Motor Company, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Ford Motor Company wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Neil Patel and his clients have no position in any of the stocks mentioned.
|
In the last decade, the company's operating margin has averaged a measly 7.5%. There's no reason to believe that Ford will be able to post growth that's meaningfully better than what we've seen over the past decade. Before you buy stock in Ford Motor Company, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Ford Motor Company wasn't one of them.
|
4a23b4c1-f91e-454c-8435-1b33d714ea61
|
711752.0
|
2023-12-13 00:00:00 UTC
|
Acadia Healthcare (ACHC) Opens Facility to Serve California
|
DCOMP
|
https://www.nasdaq.com/articles/acadia-healthcare-achc-opens-facility-to-serve-california
|
nan
|
nan
|
Acadia Healthcare Company, Inc. ACHC recently inaugurated an acute care hospital in the Indio city of California. Named Coachella Valley Behavioral Health, the facility is equipped with 80 beds and was opened within the targeted period of 2023 end. Once the hospital concludes its final preparations to become fully operational, admissions of patients are expected to commence.
The newly-opened facility will provide a comprehensive suite of inpatient and outpatient behavioral healthcare services for treating the adult, older adult and pediatric patient populace grappling with severe symptoms of general mood disorders, thought disorders and dual diagnosis or substance use disorders. This will be made possible by the presence of a well-versed medical team at the facility plus the support of community health partners across Indio and neighboring communities, which will equip Acadia Healthcare to gain an in-depth understanding of the needs of the targeted region.
With increased access to enhanced behavioral healthcare services, patients across the greater Riverside County area are likely to breathe a sigh of relief. The establishment of the hospital across a region that suffers from inadequate access to high-quality behavioral healthcare services seems to be a time-opportune move on the part of Acadia Healthcare. The Riverside County area is expected to have a shortage of roughly 1,200 behavioral health beds, which highlights the importance of the new facility to the region’s patients.
Coachella Valley Behavioral Health also stands as the first freestanding behavioral health hospital in the region. Therefore, the latest move is expected to provide an opportunity for ACHC to establish a solid footprint across the Riverside County area and broadly, in the state of California. It remains committed to serving more of California communities by boosting access to behavioral health treatment programs.
In this manner, Acadia Healthcare intends to complement one of its longstanding endeavors of addressing the nationwide concern of growing mental health issues among Americans. An expanding behavioral healthcare facility portfolio as a result of moves similar to the latest one implies greater patient volumes, thereby making the way for increased usage of ACHC’s services. This, in turn, may fetch higher revenues to the behavioral healthcare services provider.
Acadia Healthcare makes efforts to upgrade its services portfolio and add beds to its existing facilities as a means to boost its revenue base. It also takes the help of renowned U.S. health systems to construct behavioral health hospitals. ACHC’s healthcare portfolio comprised 253 behavioral healthcare facilities across 39 states and Puerto Rico as of Sep 30, 2023. It remains on track to add roughly 300 beds to its existing facilities as well as inaugurate two inpatient de novo hospitals and a minimum of six comprehensive treatment centers this year. Management remains optimistic about ample growth opportunities in 2024.
Shares of Acadia Healthcare have rallied 5.7% in the past six months against the industry’s 5.5% decline. ACHC currently carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks in the Medical space are IRadimed Corporation IRMD, Penumbra, Inc. PEN and Medpace Holdings, Inc. MEDP. While IRadimed sports a Zacks Rank #1 (Strong Buy), Penumbra and Medpace carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
IRadimed’s earnings surpassed the Zacks Consensus Estimate in each of the last four quarters, the average beat being 11.67%. The Zacks Consensus Estimate for IRMD’s 2023 earnings suggests an improvement of 36.4% from the prior-year reported figure. The consensus mark for revenues indicates growth of 22.5% from the prior-year figure.
The Zacks Consensus Estimate for IRMD’s 2023 earnings has moved 7.9% north in the past 60 days. Shares of IRadimed have declined 10.1% in the past six months.
Penumbra’s earnings surpassed estimates in each of the last four quarters, the average surprise being 55.65%. The Zacks Consensus Estimate for PEN’s 2023 earnings is pegged at $2.04 per share, which indicates a nearly 13-fold increase from the year-ago reported figure. The consensus mark for revenues suggests an improvement of 25.3% from the year-ago figure.
The consensus mark for PEN’s 2023 earnings has moved 2.5% north in the past 30 days. Shares of Penumbra have lost 25% in the past six months.
Medpace’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 14.62%. The Zacks Consensus Estimate for MEDP’s 2023 earnings indicates an 18.8% rise from the prior-year figure. The consensus mark for revenues suggests an improvement of 29.4% from the prior-year figure.
The consensus mark for MEDP’s 2023 earnings has moved up 3.1% in the past 60 days. Shares of Medpace have gained 34.4% in the past six months.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Acadia Healthcare Company, Inc. (ACHC) : Free Stock Analysis Report
iRadimed Corporation (IRMD) : Free Stock Analysis Report
Penumbra, Inc. (PEN) : Free Stock Analysis Report
Medpace Holdings, Inc. (MEDP) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In this manner, Acadia Healthcare intends to complement one of its longstanding endeavors of addressing the nationwide concern of growing mental health issues among Americans. An expanding behavioral healthcare facility portfolio as a result of moves similar to the latest one implies greater patient volumes, thereby making the way for increased usage of ACHC’s services. It remains on track to add roughly 300 beds to its existing facilities as well as inaugurate two inpatient de novo hospitals and a minimum of six comprehensive treatment centers this year.
|
With increased access to enhanced behavioral healthcare services, patients across the greater Riverside County area are likely to breathe a sigh of relief. While IRadimed sports a Zacks Rank #1 (Strong Buy), Penumbra and Medpace carry a Zacks Rank #2 (Buy) at present. Click to get this free report Acadia Healthcare Company, Inc. (ACHC) : Free Stock Analysis Report iRadimed Corporation (IRMD) : Free Stock Analysis Report Penumbra, Inc. (PEN) : Free Stock Analysis Report Medpace Holdings, Inc. (MEDP) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The Zacks Consensus Estimate for IRMD’s 2023 earnings has moved 7.9% north in the past 60 days. The Zacks Consensus Estimate for PEN’s 2023 earnings is pegged at $2.04 per share, which indicates a nearly 13-fold increase from the year-ago reported figure. Click to get this free report Acadia Healthcare Company, Inc. (ACHC) : Free Stock Analysis Report iRadimed Corporation (IRMD) : Free Stock Analysis Report Penumbra, Inc. (PEN) : Free Stock Analysis Report Medpace Holdings, Inc. (MEDP) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The establishment of the hospital across a region that suffers from inadequate access to high-quality behavioral healthcare services seems to be a time-opportune move on the part of Acadia Healthcare. The Riverside County area is expected to have a shortage of roughly 1,200 behavioral health beds, which highlights the importance of the new facility to the region’s patients. The Zacks Consensus Estimate for PEN’s 2023 earnings is pegged at $2.04 per share, which indicates a nearly 13-fold increase from the year-ago reported figure.
|
d8fa0ed9-8c92-4cfc-8f41-ecb9234cd827
|
711753.0
|
2023-12-13 00:00:00 UTC
|
2 Reasons to Buy AMD, and 1 Reason to Sell
|
DCOMP
|
https://www.nasdaq.com/articles/2-reasons-to-buy-amd-and-1-reason-to-sell-0
|
nan
|
nan
|
Advanced Micro Devices (NASDAQ: AMD) has had one incredible year. The price of its shares has almost doubled in 2023, increasing 98% as of this writing. Indeed, when ranking all S&P 500 components by year-to-date performance, AMD ranks seventh -- overshadowed only by 2023 fireballs like Nvidia and Meta Platforms.
At any rate, as the year draws to an end, investors want to know if the good times will continue for AMD. Here are two reasons to think they will -- and one reason to believe they won't.
Image source: Getty Images.
Reason No. 1 to buy: AMD's latest AI chip is a beast
If there's one reason to buy AMD right now, it's artificial intelligence (AI). It seems that right now, every single day brings a new AI innovation. This means demand for the semiconductors that power AI supercomputers is booming.
Crucially, only a few companies design the graphics processing units (GPUs) favored by software designers that train the large language models (LLMs) behind today's cutting-edge AI. One of those companies is Nvidia. Its H100 GPU is the most-sought AI chip around. It often sells for tens of thousands of dollars, and wait times for new deliveries can be months long.
That's why AMD's latest chip offering could be such a game changer. On Dec. 6, the company debuted its new MI300X chip. With it, AMD aims to compete directly with Nvidia's H100. According to AMD, the MI300X is faster than the H100 and delivers up to 60% increased performance.
If those performance figures bear out, it could be a boon for the AI sector in general -- and AMD in particular. With demand for generative AI through the roof, AMD could see a windfall in sales and profits if it were to unseat Nvidia as the king of AI chips.
Reason No. 2 to buy: Customers are lining up for its new AI chips
At any rate, there's little doubt there will be a significant market for the MI300X. Even if the chip doesn't live up to AMD's hype, there's still a huge supply and demand mismatch within the industry. And with the MI300X, AMD is poised to increase supply and capture market share.
To that end, this is what AMD CEO Lisa Su said during the MI300X introduction:
We are seeing very strong demand for our new Instinct MI300 GPUs, which are the highest-performance accelerators in the world for generative AI. We are also building significant momentum for our data center AI solutions with the largest cloud companies, the industry's top server providers, and the most innovative AI start-ups -- who we are working closely with to rapidly bring Instinct MI300 solutions to market that will dramatically accelerate the pace of innovation across the entire AI ecosystem.
Customers are already on board with the new MI300X. Microsoft has announced that its new Azure virtual machines, designed for AI applications, will use the new AMD chips. In addition, AMD noted that Meta, Broadcom, and Cisco, among others, are working with AMD to develop advanced AI systems.
In short, there's plenty of room for AMD in the AI chip market. So, while the jury's still out on whether it can take significant market share from Nvidia, there's little doubt that the MI300X should provide a substantial boost to AMD's top and bottom lines.
One reason to sell: Valuation
Growth is one of the hardest things to find on Wall Street, which is why investors often have to pay up to get it. That's certainly the case for AMD.
The company's shares now trade at a price-to-sales (P/S) ratio of 10. That's the highest level since early 2022, and more than double the stock's 10-year average P/S ratio of 4.5.
AMD PS Ratio data by YCharts
In part, that's why AMD, despite its great leadership and solid growth prospects, isn't a fit for every investor. Its high valuation, combined with its reliance on a booming tech market, will rule it out for value-oriented investors or for those who already have a large concentration in the semiconductor industry or tech stocks in general.
However, for growth-oriented investors willing to hold for the long term, AMD should remain a name to watch. Thanks to its new AI chip, the company is well positioned to take the fight to Nvidia, which could send its stock much higher in the years to come.
Should you invest $1,000 in Advanced Micro Devices right now?
Before you buy stock in Advanced Micro Devices, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Advanced Micro Devices wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Jake Lerch has positions in Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Cisco Systems, Meta Platforms, and Nvidia. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
To that end, this is what AMD CEO Lisa Su said during the MI300X introduction: We are seeing very strong demand for our new Instinct MI300 GPUs, which are the highest-performance accelerators in the world for generative AI. So, while the jury's still out on whether it can take significant market share from Nvidia, there's little doubt that the MI300X should provide a substantial boost to AMD's top and bottom lines. The Motley Fool has positions in and recommends Advanced Micro Devices, Cisco Systems, Meta Platforms, and Nvidia.
|
In addition, AMD noted that Meta, Broadcom, and Cisco, among others, are working with AMD to develop advanced AI systems. Before you buy stock in Advanced Micro Devices, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Advanced Micro Devices wasn't one of them. The Motley Fool has positions in and recommends Advanced Micro Devices, Cisco Systems, Meta Platforms, and Nvidia.
|
1 to buy: AMD's latest AI chip is a beast If there's one reason to buy AMD right now, it's artificial intelligence (AI). With demand for generative AI through the roof, AMD could see a windfall in sales and profits if it were to unseat Nvidia as the king of AI chips. Before you buy stock in Advanced Micro Devices, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Advanced Micro Devices wasn't one of them.
|
1 to buy: AMD's latest AI chip is a beast If there's one reason to buy AMD right now, it's artificial intelligence (AI). One of those companies is Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Cisco Systems, Meta Platforms, and Nvidia.
|
21f9ebd9-bfea-4f8b-b05a-33fb8afc325e
|
711754.0
|
2023-12-13 00:00:00 UTC
|
Friday Sector Laggards: Financial, Utilities
|
DCOMP
|
https://www.nasdaq.com/articles/friday-sector-laggards%3A-financial-utilities-0
|
nan
|
nan
|
In afternoon trading on Friday, Financial stocks are the worst performing sector, showing a 1.5% loss. Within the sector, Zions Bancorporation, N.A. (Symbol: ZION) and Alexandria Real Estate Equities Inc (Symbol: ARE) are two of the day's laggards, showing a loss of 4.4% and 4.0%, respectively. Among financial ETFs, one ETF following the sector is the Financial Select Sector SPDR ETF (Symbol: XLF), which is down 0.8% on the day, and up 9.94% year-to-date. Zions Bancorporation, N.A., meanwhile, is down 6.55% year-to-date, and Alexandria Real Estate Equities Inc, is down 7.85% year-to-date. ZION makes up approximately 0.1% of the underlying holdings of XLF.
The next worst performing sector is the Utilities sector, showing a 1.4% loss. Among large Utilities stocks, Exelon Corp (Symbol: EXC) and Ameren Corp (Symbol: AEE) are the most notable, showing a loss of 5.2% and 3.7%, respectively. One ETF closely tracking Utilities stocks is the Utilities Select Sector SPDR ETF (XLU), which is down 1.4% in midday trading, and down 6.71% on a year-to-date basis. Exelon Corp, meanwhile, is down 13.43% year-to-date, and Ameren Corp, is down 15.53% year-to-date. Combined, EXC and AEE make up approximately 5.8% of the underlying holdings of XLU.
Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom:
Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Friday. As you can see, none of the sectors are up on the day, while nine sectors are down.
SECTOR % CHANGE
Technology & Communications -0.2%
Materials -0.3%
Industrial -0.5%
Services -0.7%
Energy -0.8%
Consumer Products -1.0%
Healthcare -1.1%
Utilities -1.4%
Financial -1.5%
10 ETFs With Stocks That Insiders Are Buying »
Also see:
Institutional Holders of NSLP
Funds Holding BHG
REVG Past Earnings
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In afternoon trading on Friday, Financial stocks are the worst performing sector, showing a 1.5% loss. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Friday. Technology & Communications -0.2% Materials -0.3% Industrial -0.5% Services -0.7% Energy -0.8% Consumer Products -1.0% Healthcare -1.1% Utilities -1.4% Financial -1.5% 10 ETFs With Stocks That Insiders Are Buying » Also see: Institutional Holders of NSLP Funds Holding BHG REVG Past Earnings The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In afternoon trading on Friday, Financial stocks are the worst performing sector, showing a 1.5% loss. Among financial ETFs, one ETF following the sector is the Financial Select Sector SPDR ETF (Symbol: XLF), which is down 0.8% on the day, and up 9.94% year-to-date. Among large Utilities stocks, Exelon Corp (Symbol: EXC) and Ameren Corp (Symbol: AEE) are the most notable, showing a loss of 5.2% and 3.7%, respectively.
|
Among financial ETFs, one ETF following the sector is the Financial Select Sector SPDR ETF (Symbol: XLF), which is down 0.8% on the day, and up 9.94% year-to-date. One ETF closely tracking Utilities stocks is the Utilities Select Sector SPDR ETF (XLU), which is down 1.4% in midday trading, and down 6.71% on a year-to-date basis. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Friday.
|
(Symbol: ZION) and Alexandria Real Estate Equities Inc (Symbol: ARE) are two of the day's laggards, showing a loss of 4.4% and 4.0%, respectively. Among financial ETFs, one ETF following the sector is the Financial Select Sector SPDR ETF (Symbol: XLF), which is down 0.8% on the day, and up 9.94% year-to-date. Among large Utilities stocks, Exelon Corp (Symbol: EXC) and Ameren Corp (Symbol: AEE) are the most notable, showing a loss of 5.2% and 3.7%, respectively.
|
c6f20e4c-10fd-49c3-9318-7f4e2ae5e70f
|
711755.0
|
2023-12-13 00:00:00 UTC
|
The 3 Most Undervalued Biotech Stocks to Buy in December
|
DCOMP
|
https://www.nasdaq.com/articles/the-3-most-undervalued-biotech-stocks-to-buy-in-december
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
As technology advances in our era, biotechnology is not far behind. Modern day medical advancements are impressive, and the company’s making these strides have incredible results to show for it. Let’s take a look at these biotech stocks.
Kiniksa (KNSA)
Source: aslysun / Shutterstock.com
Kiniksa Pharmaceuticals (NASDAQ:KNSA) is like the superhero of the biotech world. It is creating innovative treatments that work in sync with our immune system to fight various diseases. In the third quarter of 2023, its flagship product, ARCALYST, generated an impressive $64.8 million in revenue.
But that’s not all. Kiniksa also took a giant step forward by closing a global deal with Roche (OTCMKTS:RHHBY) and Genentech to develop and sell vixarelimab, a high-tech antibody. This deal injected Kiniksa with $100 million. If all goes well, it could receive up to $600 million more in milestones and royalties.
Moreover, Kiniksa is not limited to its home territory. It spread its wings into the Asia Pacific region by forming an alliance to bring its treatments to more people in need.
Kiniksa claims that, thanks to these strategic moves and its recent revenues, it has enough financial fuel to keep its operations going until at least 2025.
Neurocrine (NBIX)
Source: Dmytro Zinkevych / Shutterstock.com
Neurocrine Biosciences (NASDAQ:NBIX) stands out as an undiscovered gem. The company is passionately immersed in the neuroscience arena, dedicated to developing innovative solutions for various neurological diseases.
In the third quarter of 2023, it reported remarkable financial results, with net income and earnings per share up year-over-year. This solid growth reflects its continued commitment to research, development and the expansion of its clinical portfolio.
A crucial milestone was the successful resolution of patent litigation related to INGREZZA (valbenazine), a key Neurocrine treatment. This resolution will allow several companies to sell generic versions of INGREZZA in the United States from March 2038.
In addition, at an investor event, Neurocrine shared exciting advances in its R&D pipeline in 2024. The company is planning to submit a New Drug Application (NDA) for crinecerfont and the advancement of NBI-‘770 into Phase 2 for Major Depressive Disorder.
Neurocrine Biosciences presents itself as an attractive option for those seeking undervalued biotech stocks. NBIX offers a solid scientific and financial base, promising an exciting journey in the world of biotechnology.
Incyte (INCY)
Source: Billion Photos / Shutterstock
Incyte (NASDAQ:INCY) is famous for its pioneering work in immune pathways to combat various diseases. The company has caught the attention of savvy investors as an undervalued gem in the biotech sector.
In the third quarter of 2023, Incyte posted a significant year-on-year increase of 12%, with total revenues of $919 million. Its flagship product, Jakafi (ruxolitinib), posted $636 million in net revenues in the third quarter, up 3% year-on-year.
Opzelura (ruxolitinib) cream also grabbed the spotlight, with a 141% year-on-year increase in net product revenue to $92 million in the third quarter.
Incyte’s product pipeline hit a milestone with the Phase 2 trial of povorcitinib for nodular prurigo. The trial achieved a remarkable response rate of 74% of patients at the 0.3 mg/kg dose in the first six months of treatment. This success sets the stage for the submission of a Biologics License Application (BLA) for axatilimab by 2024.
Its commitment to scientific innovation took center stage at the 2023 65th Annual Meeting of the American Society of Hematology. Sixteen oral presentations, a plenary session and poster presentations showcased the company’s progress. The Plenary Scientific Session featured groundbreaking data from AGAVE-201, which evaluates axatilimab in patients with chronic graft-versus-host disease (GVHD).
To engage stakeholders, Incyte organized a face-to-face event for analysts and investors on December 11, 2023. This event will provide a unique opportunity to delve deeper into key data presentations at the American Society of Hematology Annual Meeting and foster a deeper understanding of Incyte’s promising future.
As of this writing, Gabriel Osorio-Mazzilli did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines (no position)
Gabriel Osorio is a former Goldman Sachs and Citigroup employee. He possesses discipline in bottom-up value investing and volatility-based long/short equities trading.
More From InvestorPlace
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The #1 AI Investment Might Be This Company You’ve Never Heard Of
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post The 3 Most Undervalued Biotech Stocks to Buy in December appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Kiniksa also took a giant step forward by closing a global deal with Roche (OTCMKTS:RHHBY) and Genentech to develop and sell vixarelimab, a high-tech antibody. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines (no position) Gabriel Osorio is a former Goldman Sachs and Citigroup employee. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post The 3 Most Undervalued Biotech Stocks to Buy in December appeared first on InvestorPlace.
|
Neurocrine (NBIX) Source: Dmytro Zinkevych / Shutterstock.com Neurocrine Biosciences (NASDAQ:NBIX) stands out as an undiscovered gem. In addition, at an investor event, Neurocrine shared exciting advances in its R&D pipeline in 2024. This event will provide a unique opportunity to delve deeper into key data presentations at the American Society of Hematology Annual Meeting and foster a deeper understanding of Incyte’s promising future.
|
Kiniksa (KNSA) Source: aslysun / Shutterstock.com Kiniksa Pharmaceuticals (NASDAQ:KNSA) is like the superhero of the biotech world. Incyte (INCY) Source: Billion Photos / Shutterstock Incyte (NASDAQ:INCY) is famous for its pioneering work in immune pathways to combat various diseases. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post The 3 Most Undervalued Biotech Stocks to Buy in December appeared first on InvestorPlace.
|
This deal injected Kiniksa with $100 million. In addition, at an investor event, Neurocrine shared exciting advances in its R&D pipeline in 2024. Neurocrine Biosciences presents itself as an attractive option for those seeking undervalued biotech stocks.
|
72be01bd-7694-4195-b093-c03230a5e9ae
|
711756.0
|
2023-12-13 00:00:00 UTC
|
This Stock Is Up 186% Since 2018, and Most Investors Have Still Never Heard of It
|
DCOMP
|
https://www.nasdaq.com/articles/this-stock-is-up-186-since-2018-and-most-investors-have-still-never-heard-of-it
|
nan
|
nan
|
Successful investing requires many things. From patience to discipline to resolve, those who win at investing often hone a variety of qualities. Absent from this list, however, is an interest in riding the bandwagon. Investors need not pack their portfolios with popular stocks to generate outsized returns. Take Linde (NASDAQ: LIN), for example, a leader in the production of industrial gases that flies under most investors' radars.
Although most investors don't recognize its name, Linde stock has outperformed the S&P 500 index considerably over the past five years. Soaring more than 186%, Linde stock has generated a total return that more than doubles the 90% total return of the S&P 500. And there's no reason to think that its best days are behind it -- especially with a backlog that exceeds $8 billion.
Let's look at market leader Linde
Not every market leader will turn out to be a successful investment, but finding stalwart businesses that hold dominant positions in their industries is a great place to start -- such is the case with Linde, which has extensive global operations and is the largest industrial gases stock by market capitalization. Building a robust infrastructure of broad industrial gas production and distribution is no simple feat. Consequently, the company is not likely to find new companies pressuring to compete with it.
In fact, Linde recognizes the value of these assets in its 2022 10-K, where it states, "Major pipeline complexes are primarily located in the United States and China. These networks are a competitive advantage, providing the foundation of reliable product supply to the company's customer base." In 2022, the United States and China accounted for 32% and 8% of revenue, respectively.
Serving various industries helps to reduce risk and generate strong cash flow
Spanning a wide swath of industries that use industrial gases in their operations, Linde's customers -- located throughout the world -- include healthcare, food and beverage, mining, electronics, and a variety of other businesses. This diversity in its customer base helps Linde to mitigate the risks associated with a downturn in an individual industry. Consumer-facing businesses such as healthcare, electronics, and food and beverage customers, for instance, are more resilient, according to Linde. They are steadier in nature and don't fluctuate wildly. Industrial customers, on the other hand, like those operating in manufacturing, metals and mining, and chemicals and energy, are more cyclical.
Besides its advantageous customer base, Linde is adept at translating revenue into cash. While some investors prize earnings per share (EPS), it's important to remember that earnings per share can misrepresent a company's performance since the metric includes noncash charges. Free cash flow, however, is not vulnerable to creative accounting, leading many to prioritize it over EPS.
With this in mind, consider how Linde measures up against its leading industrial gas competitor, Air Products (NYSE: APD). The comparison isn't perfect since there's some disparity between the two companies: Linde and Air Products have market caps of $198 billion and $58.8 billion, respectively. But it's a worthwhile exercise, nonetheless.
LIN EPS Diluted (Annual) data by YCharts.
Air Products has reported higher EPS over the past few years, but Linde is generating substantially more cash. And that's something smart investors are eager to celebrate.
There's growth left in the gas tank
While Linde's business may be boring, there's a major -- and exciting -- growth opportunity that the company is enthusiastic about pursuing -- hydrogen. In addition to oxygen, nitrogen, and argon (among several others), Linde is committed to producing and distributing hydrogen. Based on its leadership position in the United States alone, Linde brandished itself as the "largest supplier of liquid hydrogen in the country."
Earlier this month, the company announced that it has increased daily production at a facility in Alabama to 30 tons for manufacturing and electronics customers as well as others. This complements another deal the company inked in the U.S. in 2023: a $1.8 billion blue hydrogen plant to be located in Texas. Linde expects the project to commence operations in 2025.
Should you gas up on Linde stock today?
Think that the only path to investing success is via high-risk/high-reward stocks? Think again. Boring stocks, like Linde, can provide impressive, market-beating returns. For investors looking to fortify their holdings with a resilient ticker that has ample growth opportunities ahead of it, Linde is a compelling choice.
Should you invest $1,000 in Linde Plc right now?
Before you buy stock in Linde Plc, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Linde Plc wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Scott Levine has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Linde Plc. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Based on its leadership position in the United States alone, Linde brandished itself as the "largest supplier of liquid hydrogen in the country." Earlier this month, the company announced that it has increased daily production at a facility in Alabama to 30 tons for manufacturing and electronics customers as well as others. For investors looking to fortify their holdings with a resilient ticker that has ample growth opportunities ahead of it, Linde is a compelling choice.
|
Serving various industries helps to reduce risk and generate strong cash flow Spanning a wide swath of industries that use industrial gases in their operations, Linde's customers -- located throughout the world -- include healthcare, food and beverage, mining, electronics, and a variety of other businesses. With this in mind, consider how Linde measures up against its leading industrial gas competitor, Air Products (NYSE: APD). Before you buy stock in Linde Plc, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Linde Plc wasn't one of them.
|
Let's look at market leader Linde Not every market leader will turn out to be a successful investment, but finding stalwart businesses that hold dominant positions in their industries is a great place to start -- such is the case with Linde, which has extensive global operations and is the largest industrial gases stock by market capitalization. Serving various industries helps to reduce risk and generate strong cash flow Spanning a wide swath of industries that use industrial gases in their operations, Linde's customers -- located throughout the world -- include healthcare, food and beverage, mining, electronics, and a variety of other businesses. Before you buy stock in Linde Plc, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Linde Plc wasn't one of them.
|
Serving various industries helps to reduce risk and generate strong cash flow Spanning a wide swath of industries that use industrial gases in their operations, Linde's customers -- located throughout the world -- include healthcare, food and beverage, mining, electronics, and a variety of other businesses. Before you buy stock in Linde Plc, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Linde Plc wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Scott Levine has no position in any of the stocks mentioned.
|
9bb907ef-e5dd-4f70-aa4e-7f85be1dbb4c
|
711757.0
|
2023-12-13 00:00:00 UTC
|
BILL (BILL) Expands SMB Footprint With New Integrated Solution
|
DCOMP
|
https://www.nasdaq.com/articles/bill-bill-expands-smb-footprint-with-new-integrated-solution
|
nan
|
nan
|
Bill Holdings BILL is transforming the financial landscape for small and midsize businesses (SMBs) through its integrated platform that consolidates leading capabilities in Accounts Payable, Accounts Receivable and Spend and Expense management.
In a recent announcement, BILL introduced a set of robust enhancements to its Spend & Expense solution, previously recognized as Divvy, by introducing robust enhancements aimed at offering SMBs and accounting firms heightened visibility and control over their business finances.
The upgraded features encompass a redesigned budget interface that allows for flexible customization of spending limits, consolidated controls for simplified management and the introduction of an innovative budget groups feature for efficient oversight of multiple budgets.
With customizable controls, including target spending limits and enhanced policy controls, businesses can tailor budgets to their specific needs, fostering efficiency and adaptability.
BILL Holdings, Inc. Price and Consensus
BILL Holdings, Inc. price-consensus-chart | BILL Holdings, Inc. Quote
The updated interface not only simplifies budget monitoring but also introduces a comprehensive budget groups feature, streamlining the management of various budgets and reducing complexity.
BILL’s Strong Content Portfolio to Aid Growth
BILL’s latest initiative underscores its unwavering commitment to empowering SMBs and accounting firms with the necessary tools for effective and controlled budget management in today's dynamic business landscape.
The company also benefits from an expanding range of strategic advancements and partnerships, solidifying its position in the financial technology sector.
In September, BILL launched an integrated Financial Operations Platform for SMBs, offering comprehensive solutions for accounts payable, accounts receivable and spend management, empowering businesses with real-time cash flow insights and diverse payment options.
The company reported strong customer adoption and satisfaction, with more than 470,000 businesses using BILL's solutions and transacting more than $280 billion in annualized payment volume.
In October, BILL introduced automation technology for SMBs and accounting firms using Intuit QuickBooks Desktop, enabling seamless synchronization of purchase orders, receipts and invoices in one workspace, enhancing control, accuracy, and efficiency in accounts payable workflows.
BILL also announced an agreement with Regions Bank, one of the 10 largest SMB banks in the United States. This partnership involves powering a new digital account payable (AP) and accounts receivable (AR) solution for commercial segment customers, leveraging BILL's payment modalities.
Q2 View Positive
For the second quarter of fiscal 2024, BILL expects revenues between $293 million and $303 million, suggesting year-over-year growth of 13-17%. The Zacks Consensus Estimate for second-quarter revenues is pegged at $296.73 million, suggesting a year-over-year rise of 14.12%.
Non-GAAP earnings are expected between 35 cents and 44 cents per share. The consensus mark for earnings is up by a penny in the past 30 days to 41 cents per share.
Zacks Rank & Stocks to Consider
Currently, BILL carries a Zacks Rank #3 (Hold).
BILL’s shares have plunged 29.1% year to date and the Zacks Computer & Technology sector has surged to 49.1%.
Flex FLEX, NetEase NTES and Badger Meter BMI are a few better-ranked stocks that investors can consider from the broader sector, each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
FLEX, NTES and BMI shares have returned 33.6%, 43.8% and 44.1%, respectively, on a year-to-date basis.
Long-term earnings growth rates for Flex, NetEase and Badger Meter are pegged at 12.39%,15.98% and 20.39%, respectively.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Badger Meter, Inc. (BMI) : Free Stock Analysis Report
Flex Ltd. (FLEX) : Free Stock Analysis Report
NetEase, Inc. (NTES) : Free Stock Analysis Report
BILL Holdings, Inc. (BILL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The company also benefits from an expanding range of strategic advancements and partnerships, solidifying its position in the financial technology sector. The company reported strong customer adoption and satisfaction, with more than 470,000 businesses using BILL's solutions and transacting more than $280 billion in annualized payment volume. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
BILL Holdings, Inc. Price and Consensus BILL Holdings, Inc. price-consensus-chart | BILL Holdings, Inc. Quote The updated interface not only simplifies budget monitoring but also introduces a comprehensive budget groups feature, streamlining the management of various budgets and reducing complexity. In September, BILL launched an integrated Financial Operations Platform for SMBs, offering comprehensive solutions for accounts payable, accounts receivable and spend management, empowering businesses with real-time cash flow insights and diverse payment options. Click to get this free report Badger Meter, Inc. (BMI) : Free Stock Analysis Report Flex Ltd. (FLEX) : Free Stock Analysis Report NetEase, Inc. (NTES) : Free Stock Analysis Report BILL Holdings, Inc. (BILL) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Bill Holdings BILL is transforming the financial landscape for small and midsize businesses (SMBs) through its integrated platform that consolidates leading capabilities in Accounts Payable, Accounts Receivable and Spend and Expense management. BILL Holdings, Inc. Price and Consensus BILL Holdings, Inc. price-consensus-chart | BILL Holdings, Inc. Quote The updated interface not only simplifies budget monitoring but also introduces a comprehensive budget groups feature, streamlining the management of various budgets and reducing complexity. Click to get this free report Badger Meter, Inc. (BMI) : Free Stock Analysis Report Flex Ltd. (FLEX) : Free Stock Analysis Report NetEase, Inc. (NTES) : Free Stock Analysis Report BILL Holdings, Inc. (BILL) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
BILL’s Strong Content Portfolio to Aid Growth BILL’s latest initiative underscores its unwavering commitment to empowering SMBs and accounting firms with the necessary tools for effective and controlled budget management in today's dynamic business landscape. Zacks Rank & Stocks to Consider Currently, BILL carries a Zacks Rank #3 (Hold). Click to get this free report Badger Meter, Inc. (BMI) : Free Stock Analysis Report Flex Ltd. (FLEX) : Free Stock Analysis Report NetEase, Inc. (NTES) : Free Stock Analysis Report BILL Holdings, Inc. (BILL) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
128a4b72-350a-4d96-9bc3-535e5e509613
|
711758.0
|
2023-12-13 00:00:00 UTC
|
FDA Expands Merck's (MRK) Welireg Label in Renal Cell Carcinoma
|
DCOMP
|
https://www.nasdaq.com/articles/fda-expands-mercks-mrk-welireg-label-in-renal-cell-carcinoma
|
nan
|
nan
|
Merck MRK announced that the FDA has expanded the label of its oral HIF-2α inhibitor, Welireg (belzutifan), in certain patients with advanced renal cell carcinoma (“RCC”).
Welireg is now approved in the United States to treat adult patients with advanced RCC whose cancer has progressed following treatment with a PD-1/L1 inhibitor and a VEGF-TKI inhibitor. Per management, this approval marks the first time a new treatment has been approved in a novel therapeutic class in advanced RCC since 2015.
Merck aims to introduce Welireg as a new treatment option that can reduce the risk of disease progression or death for an indication with low survival rates.
The FDA’s approval is based on data from the phase III LITESPARK-005 study, which evaluated Welireg in adult patients with advanced RCC that progressed following treatment with a PD-1/L1 checkpoint inhibitor and VEGF-TKI therapy, which was announced in August.
Data from the LITESPARK-005 study showed that treatment with Welireg achieved statistically significant and clinically meaningful improvement in progression-free survival(“PFS”), one of the study’s dual primary endpoints. The study also achieved its secondary endpoint of statistically significant improvement in the objective response rate (“ORR”).
Welireg is already approved in the United States and Europe to treat adult patients with von Hippel-Lindau (“VHL”) disease who require therapy for associated RCC, central nervous system hemangioblastomas or pancreatic neuroendocrine tumors, not requiring immediate surgery.
Merck’s shares have lost 4.6% year to date against the industry’s 5.9% growth.
Image Source: Zacks Investment Research
The LITESPARK-005 study is part of Merck's comprehensive late-stage development program on Welireg in RCC. The program comprises three other late-stage studies – LITESPARK-011, LITESPARK-012 and LITESPARK-022. While LITESPARK-011 and LITESPARK-012 evaluate Welireg in the second-line and treatment-naïve advanced disease settings, respectively, LITESPARK-022 evaluates Welireg in the adjuvant setting.
In a separate press release, Merck, along with partner Moderna MRNA, reported three-year follow-up data from the phase IIb KEYNOTE study evaluating their investigational individualized neoantigen therapy (INT) candidate mRNA-4157/V940 in melanoma indication.
At a median planned follow-up of approximately three years, treatment with the combination of mRNA-4157 and Keytruda reduced the risk of recurrence or death by 49% compared with those treated with Keytruda alone. Treatment with this mRNA-4157/Keytruda combination also reduced the risk of developing distant metastasis or death by 62%, compared to Keytruda alone.
The above results demonstrate the meaningful benefit of combining mRNA-4157 with Keytruda, compared with Keytruda alone, over a longer period. Earlier in first-half 2023, Moderna/Merck reported two-year follow-up data from the KEYNOTE-942 study wherein treatment with the mRNA-4157/Keytruda combination cut the risks of recurrence/death by 44% and the risk of distant metastasis or death by 65%.
Merck and Moderna entered a strategic partnership in 2016 to develop and commercialize mRNA-based therapeutics to treat various types of cancer. Last year, Merck exercised its option to develop the INT with Moderna. Per the terms of the collaboration, the companies will share costs and profits equally.
Merck & Co., Inc. Price
Merck & Co., Inc. price | Merck & Co., Inc. Quote
Zacks Rank & Stocks to Consider
Merck currently carries a Zacks Rank #3 (Hold). A couple of better-ranked stocks in the overall healthcare sector include Galapagos GLPG and Ocuphire Pharma OCUP, each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, Galapagos’ estimates for 2023 have improved from a loss of $1.96 per share to 79 cents. During the same period, loss estimates per share for 2024 have narrowed from $3.22 to $1.68. Galapagos’ shares have lost 9.2% in the year-to-date period.
Galapagos’ earnings beat estimates in three of the last four quarters while missing the estimates on one occasion. On average, the company witnessed an average surprise of 91.97%. In the last reported quarter, Galapagos’ earnings beat estimates by 140.78%.
In the past 60 days, Ocuphire’s estimates for 2023 have improved from a loss of 60 cents per share to 42 cents. During the same period, loss estimates per share for 2024 have narrowed from 85 cents to 57 cents. Shares of Ocuphire have lost 25.2% in the year-to-date period.
Ocuphire’s earnings beat estimates in three of the last four quarters while missing the estimates on one occasion. On average, the company witnessed an earnings surprise of 59.28%. In the last reported quarter, Ocuphire’s earnings beat estimates by 178.13%.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Merck & Co., Inc. (MRK) : Free Stock Analysis Report
Moderna, Inc. (MRNA) : Free Stock Analysis Report
Galapagos NV (GLPG) : Free Stock Analysis Report
Ocuphire Pharma, Inc. (OCUP) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The FDA’s approval is based on data from the phase III LITESPARK-005 study, which evaluated Welireg in adult patients with advanced RCC that progressed following treatment with a PD-1/L1 checkpoint inhibitor and VEGF-TKI therapy, which was announced in August. In a separate press release, Merck, along with partner Moderna MRNA, reported three-year follow-up data from the phase IIb KEYNOTE study evaluating their investigational individualized neoantigen therapy (INT) candidate mRNA-4157/V940 in melanoma indication. A couple of better-ranked stocks in the overall healthcare sector include Galapagos GLPG and Ocuphire Pharma OCUP, each sporting a Zacks Rank #1 (Strong Buy) at present.
|
Welireg is now approved in the United States to treat adult patients with advanced RCC whose cancer has progressed following treatment with a PD-1/L1 inhibitor and a VEGF-TKI inhibitor. The FDA’s approval is based on data from the phase III LITESPARK-005 study, which evaluated Welireg in adult patients with advanced RCC that progressed following treatment with a PD-1/L1 checkpoint inhibitor and VEGF-TKI therapy, which was announced in August. Click to get this free report Merck & Co., Inc. (MRK) : Free Stock Analysis Report Moderna, Inc. (MRNA) : Free Stock Analysis Report Galapagos NV (GLPG) : Free Stock Analysis Report Ocuphire Pharma, Inc. (OCUP) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The FDA’s approval is based on data from the phase III LITESPARK-005 study, which evaluated Welireg in adult patients with advanced RCC that progressed following treatment with a PD-1/L1 checkpoint inhibitor and VEGF-TKI therapy, which was announced in August. Merck & Co., Inc. Price Merck & Co., Inc. price | Merck & Co., Inc. Quote Zacks Rank & Stocks to Consider Merck currently carries a Zacks Rank #3 (Hold). Click to get this free report Merck & Co., Inc. (MRK) : Free Stock Analysis Report Moderna, Inc. (MRNA) : Free Stock Analysis Report Galapagos NV (GLPG) : Free Stock Analysis Report Ocuphire Pharma, Inc. (OCUP) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Welireg is now approved in the United States to treat adult patients with advanced RCC whose cancer has progressed following treatment with a PD-1/L1 inhibitor and a VEGF-TKI inhibitor. The FDA’s approval is based on data from the phase III LITESPARK-005 study, which evaluated Welireg in adult patients with advanced RCC that progressed following treatment with a PD-1/L1 checkpoint inhibitor and VEGF-TKI therapy, which was announced in August. On average, the company witnessed an earnings surprise of 59.28%.
|
fb9ee826-c65c-4f84-bd4d-dec9f72544a5
|
711759.0
|
2023-12-13 00:00:00 UTC
|
Here's Why Investors Should Retain Kirby (KEX) Stock Now
|
DCOMP
|
https://www.nasdaq.com/articles/heres-why-investors-should-retain-kirby-kex-stock-now
|
nan
|
nan
|
Kirby Corporation KEX is benefiting from its segmental performance and its ability to generate cash.
Factors Favoring KEX
In the distribution and services segment, Kirby is seeing increased demand for products and services. In the third quarter of 2023, revenues in the segment improved 7% to $334.8 million. Overall, oil and gas represented 37% of segmental revenues. Oil and gas operating margins were in the low double digits. In the fourth quarter, segmental revenues are expected to be up in the low to mid-single digits sequentially. The operating margin is expected to be flat or slightly down from third-quarter levels.
Kirby’s cash flow-generating ability is strong. In 2022, Kirby generated $121.5 million of cash from operating activities. Net cash flow provided by operating activities is anticipated in the $475-$525 million band for 2023. Capital expenditures are expected to be between $330 million and $380 million. Current-year free cash flow generation is projected in the range of $100-$150 million.
Key Risks
Kirby’s liquidity position is a concern. As of Sep 30, 2023, Kirby had cash and cash equivalents of $42.1 million compared with $80.57 million at the end of December 2022. Total debt was $1,067.9 million at the third-quarter end compared with $1,079.62 million at the end of December 2022.
Zacks Rank
KEX currently carries Zacks Rank #3 (Hold).
Key Picks
Some better-ranked stocks for investors interested in the Zacks Transportation sector are Air Canada ACDVF and SkyWest SKYW.
Air Canada currently sports a Zacks Rank #1 (Strong Buy). An uptick in passenger traffic is aiding ACDVF. Recently, management announced plans to launch a new year-round route between Montreal and Madrid. You can see the complete list of today’s Zacks #1 Rank stocks here.
The service will commence in May of the following year as part of its expanded international summer 2024 flying schedule to cater to increased demand.
SkyWest currently carries a Zacks Rank #2 (Buy). SKYW's fleet-modernization efforts are commendable. Initiatives to reward its shareholders also bode well. The Zacks Consensus Estimate for current-quarter earnings has surged 83.3% in the past 60 days.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
SkyWest, Inc. (SKYW) : Free Stock Analysis Report
Kirby Corporation (KEX) : Free Stock Analysis Report
Air Canada (ACDVF) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Key Picks Some better-ranked stocks for investors interested in the Zacks Transportation sector are Air Canada ACDVF and SkyWest SKYW. The service will commence in May of the following year as part of its expanded international summer 2024 flying schedule to cater to increased demand. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
Zacks Rank KEX currently carries Zacks Rank #3 (Hold). Key Picks Some better-ranked stocks for investors interested in the Zacks Transportation sector are Air Canada ACDVF and SkyWest SKYW. Click to get this free report SkyWest, Inc. (SKYW) : Free Stock Analysis Report Kirby Corporation (KEX) : Free Stock Analysis Report Air Canada (ACDVF) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
As of Sep 30, 2023, Kirby had cash and cash equivalents of $42.1 million compared with $80.57 million at the end of December 2022. Zacks Rank KEX currently carries Zacks Rank #3 (Hold). Click to get this free report SkyWest, Inc. (SKYW) : Free Stock Analysis Report Kirby Corporation (KEX) : Free Stock Analysis Report Air Canada (ACDVF) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
In 2022, Kirby generated $121.5 million of cash from operating activities. Capital expenditures are expected to be between $330 million and $380 million. Key Picks Some better-ranked stocks for investors interested in the Zacks Transportation sector are Air Canada ACDVF and SkyWest SKYW.
|
3f6e75fd-7a26-427f-9a5b-c7380216cfc5
|
711760.0
|
2023-12-13 00:00:00 UTC
|
Got $1,000? Here Are 2 Stocks to Buy for the Long Haul
|
DCOMP
|
https://www.nasdaq.com/articles/got-%241000-here-are-2-stocks-to-buy-for-the-long-haul-0
|
nan
|
nan
|
The new year is right around the corner, with now an excellent time to consider investing in stocks likely to flourish in 2024 and beyond.
As two companies that have won over consumers worldwide, Apple (NASDAQ: AAPL) and Amazon (NASDAQ: AMZN) are two attractive options. One dominates consumer tech, with leading market shares in smartphones, tablets, headphones, and wearables. Meanwhile, the other is killing it in e-commerce alongside a leading position in cloud computing that could see it profit significantly from artificial intelligence (AI).
Over the last five years, shares in Apple and Amazon have risen around 365% and 79%, respectively. While past growth isn't always an indicator of what's to come, these companies have the financial resources and brand recognition to continue expanding well into the future.
The massive potential of these tech giants means you won't need tens of thousands of dollars to see big gains over the long term. So, got $1,000? Here are two stocks to buy for the long haul.
1. Apple
Apple's stock has hit record heights this year, achieving a market cap above $3 trillion for the first time in June. The milestone came even while the company faced repeated declines in its product segments, which suffered from macroeconomic headwinds affecting businesses across tech.
The iPhone maker posted a revenue dip of 3% year over year in fiscal 2023. Yet loyal investors have largely stuck with the company, trusting its ability to overcome current challenges and deliver stellar gains over the long term.
Their faith in Apple is not unfounded. The tech giant remains a favorite among consumers, who continued to show preference for Apple's products. U.S. smartphone shipments fell throughout this year, tumbling 19% year over year in the third quarter of 2023.
As a result, Samsung's market share fell from 27% in Q1 2023 to 22% in Q3. However, Apple has outperformed its biggest competitor by growing its market share from 52% to 55% in the same period. The popularity of Apple products suggests it has much to gain from the market's inevitable recovery.
In the meantime, it is massively profiting from its digital services business, which posted revenue growth of 9% in fiscal 2023. Income from the App Store and subscription services like Apple TV+ and iCloud make up the company's fastest-growing division, delivering profit margins around 70%.
Data by YCharts
Apple's forward price-to-earnings ratio of 30 makes it a slightly expensive buy. However, as the chart shows, the company hit close to $100 billion in free cash flow, more than some of its biggest competitors in tech. The company has earned its high valuation and will likely go far over the long term, as it has the funds to continue investing in its business.
Dedicating a little over half of your $1,000 investment would yield three shares in Apple, costing about $580 at its current position.
2. Amazon
Amazon has come a long way since starting as an online book retailer in Seattle almost 30 years ago. The company now boasts majority market shares in e-commerce in dozens of countries and is home to the world's largest cloud platform, Amazon Web Services (AWS). Meanwhile, the potency of its services has resulted in leading positions in countless other sectors, such as attaining the second-largest market share in streaming with Prime Video.
The vast user base of its online retail site has even seen Amazon become the biggest video game retailer in the U.S., responsible for 68% of sales as of September (per Statista).
Amazon's expansion across tech means it has countless opportunities for growth over the long term. According to Fortune Business Insights, the cloud market alone is projected to hit a value of $678 billion this year and expand at a compound annual growth rate of 20% until at least 2030.
Amazon has the largest cloud market share and is heavily investing in expanding its position, adding new AI capabilities to AWS as it cashes in on increased demand for the technology.
Data by YCharts
Amazon currently has the lowest price-to-sales ratio (P/S) of the tech firms in the chart above. The metric is calculated by dividing a company's market cap by its trailing-12-month revenue, with Amazon's P/S a bargain compared to its peers. Regarding revenue, Amazon's stock offers the most value out of these companies, making it an attractive option right now.
The remainder of your $1,000 investment (and maybe an additional $20, depending on price fluctuation) would buy about three shares in Amazon. The company has a solid outlook over the next decade, with its shares the perfect buy for investors in for the long haul.
Should you invest $1,000 in Apple right now?
Before you buy stock in Apple, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Apple wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Dani Cook has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Meta Platforms, and Microsoft. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Yet loyal investors have largely stuck with the company, trusting its ability to overcome current challenges and deliver stellar gains over the long term. The company now boasts majority market shares in e-commerce in dozens of countries and is home to the world's largest cloud platform, Amazon Web Services (AWS). Amazon has the largest cloud market share and is heavily investing in expanding its position, adding new AI capabilities to AWS as it cashes in on increased demand for the technology.
|
Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Apple wasn't one of them. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Meta Platforms, and Microsoft.
|
Apple Apple's stock has hit record heights this year, achieving a market cap above $3 trillion for the first time in June. The company now boasts majority market shares in e-commerce in dozens of countries and is home to the world's largest cloud platform, Amazon Web Services (AWS). Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Apple wasn't one of them.
|
The tech giant remains a favorite among consumers, who continued to show preference for Apple's products. Should you invest $1,000 in Apple right now? Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Apple wasn't one of them.
|
3c818485-fab5-4427-90d5-9edb6be75eeb
|
711761.0
|
2023-12-13 00:00:00 UTC
|
Here's Why Investors Should Retain Expeditors (EXPD) Stock Now
|
DCOMP
|
https://www.nasdaq.com/articles/heres-why-investors-should-retain-expeditors-expd-stock-now
|
nan
|
nan
|
Expeditors International of Washington, Inc. EXPD is benefiting from a healthy current ratio and shareholder-friendly steps.
Factors Favoring EXPD
We are impressed by Expeditors' efforts to reward its shareholders. In May 2022, the company announced a 15.5% hike in semi-annual cash dividend to 67 cents per share (annualized $1.34 per share). EXPD hiked its dividend by a further 3% this year, raising its semi-annual cash dividend to 69 cents per share. The company is also active on the buyback front. In the coronavirus-ravaged 2020, the company repurchased 4.6 million shares, with an average price of $72.26 per share. During 2021, the company repurchased 4.4 million shares at an average price of $117.54 per share. In 2022, EXPD repurchased 14.5 million shares of common stock at an average price of $108.88 per share. In the first nine months of 2023, EXPD repurchased 10.5 million shares of common stock at an average price of $113.97 per share.
Expeditors' healthy current ratio (a measure of liquidity) is encouraging. The measure stood at 2.11 at the end of the third quarter of 2023. A current ratio in excess of 1 indicates that a company has enough short-term assets on hand to cover all short-term liabilities.
Key Risks
High capital expenditures are also likely to hurt the bottom line. Capital expenditures for 2022 were $86.8 million, much higher than the $36.2 million reported in 2021. Such high capex in such a weak demand environment is not a welcome development.
Zacks Rank
EXPD currently carries Zacks Rank #3 (Hold).
Key Picks
Some better-ranked stocks for investors interested in the Zacks Transportation sector are Air Canada ACDVF and SkyWest SKYW.
Air Canada currently sports a Zacks Rank #1 (Strong Buy). An uptick in passenger traffic is aiding ACDVF. Recently, management announced plans to launch a new year-round route between Montreal and Madrid. You can see the complete list of today’s Zacks #1 Rank stocks here.
The service will commence in May of the following year as part of its expanded international summer 2024 flying schedule to cater to increased demand.
SkyWest currently carries a Zacks Rank #2 (Buy). SKYW's fleet-modernization efforts are commendable. Initiatives to reward its shareholders bode well. The Zacks Consensus Estimate for current-quarter earnings has surged 83.3% in the past 60 days.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Expeditors International of Washington, Inc. (EXPD) : Free Stock Analysis Report
SkyWest, Inc. (SKYW) : Free Stock Analysis Report
Air Canada (ACDVF) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Key Picks Some better-ranked stocks for investors interested in the Zacks Transportation sector are Air Canada ACDVF and SkyWest SKYW. The service will commence in May of the following year as part of its expanded international summer 2024 flying schedule to cater to increased demand. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
In the first nine months of 2023, EXPD repurchased 10.5 million shares of common stock at an average price of $113.97 per share. Zacks Rank EXPD currently carries Zacks Rank #3 (Hold). Click to get this free report Expeditors International of Washington, Inc. (EXPD) : Free Stock Analysis Report SkyWest, Inc. (SKYW) : Free Stock Analysis Report Air Canada (ACDVF) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
In 2022, EXPD repurchased 14.5 million shares of common stock at an average price of $108.88 per share. In the first nine months of 2023, EXPD repurchased 10.5 million shares of common stock at an average price of $113.97 per share. Click to get this free report Expeditors International of Washington, Inc. (EXPD) : Free Stock Analysis Report SkyWest, Inc. (SKYW) : Free Stock Analysis Report Air Canada (ACDVF) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Factors Favoring EXPD We are impressed by Expeditors' efforts to reward its shareholders. In the first nine months of 2023, EXPD repurchased 10.5 million shares of common stock at an average price of $113.97 per share. Key Picks Some better-ranked stocks for investors interested in the Zacks Transportation sector are Air Canada ACDVF and SkyWest SKYW.
|
6a48cc54-b63f-4649-92a2-b8884c85d130
|
711762.0
|
2023-12-13 00:00:00 UTC
|
Haemonetics (HAE) is an Incredible Growth Stock: 3 Reasons Why
|
DCOMP
|
https://www.nasdaq.com/articles/haemonetics-hae-is-an-incredible-growth-stock%3A-3-reasons-why-0
|
nan
|
nan
|
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy to find a great growth stock.
By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.
However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.
Our proprietary system currently recommends Haemonetics (HAE) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank.
Studies have shown that stocks with the best growth features consistently outperform the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.
While there are numerous reasons why the stock of this provider blood management systems for health care providers and blood collectors is a great growth pick right now, we have highlighted three of the most important factors below:
Earnings Growth
Arguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for Haemonetics is 4.1%, investors should actually focus on the projected growth. The company's EPS is expected to grow 28.4% this year, crushing the industry average, which calls for EPS growth of 23.5%.
Impressive Asset Utilization Ratio
Asset utilization ratio -- also known as sales-to-total-assets (S/TA) ratio -- is often overlooked by investors, but it is an important indicator in growth investing. This metric exhibits how efficiently a firm is utilizing its assets to generate sales.
Right now, Haemonetics has an S/TA ratio of 0.64, which means that the company gets $0.64 in sales for each dollar in assets. Comparing this to the industry average of 0.61, it can be said that the company is more efficient.
While the level of efficiency in generating sales matters a lot, so does the sales growth of a company. And Haemonetics looks attractive from a sales growth perspective as well. The company's sales are expected to grow 8.7% this year versus the industry average of 0%.
Promising Earnings Estimate Revisions
Beyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
The current-year earnings estimates for Haemonetics have been revising upward. The Zacks Consensus Estimate for the current year has surged 0.7% over the past month.
Bottom Line
While the overall earnings estimate revisions have made Haemonetics a Zacks Rank #2 stock, it has earned itself a Growth Score of A based on a number of factors, including the ones discussed above.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination indicates that Haemonetics is a potential outperformer and a solid choice for growth investors.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Haemonetics Corporation (HAE) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements. This combination indicates that Haemonetics is a potential outperformer and a solid choice for growth investors. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
Impressive Asset Utilization Ratio Asset utilization ratio -- also known as sales-to-total-assets (S/TA) ratio -- is often overlooked by investors, but it is an important indicator in growth investing. Bottom Line While the overall earnings estimate revisions have made Haemonetics a Zacks Rank #2 stock, it has earned itself a Growth Score of A based on a number of factors, including the ones discussed above. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
|
However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects. While there are numerous reasons why the stock of this provider blood management systems for health care providers and blood collectors is a great growth pick right now, we have highlighted three of the most important factors below: Earnings Growth Arguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.
|
The company's sales are expected to grow 8.7% this year versus the industry average of 0%. Promising Earnings Estimate Revisions Beyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. Free: See Our Top Stock and 4 Runners Up >> Want the latest recommendations from Zacks Investment Research?
|
8bf1e854-168c-4e24-98da-15d0230aa3fe
|
711763.0
|
2023-12-13 00:00:00 UTC
|
3 Reasons Growth Investors Will Love TopBuild (BLD)
|
DCOMP
|
https://www.nasdaq.com/articles/3-reasons-growth-investors-will-love-topbuild-bld
|
nan
|
nan
|
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.
In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.
However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.
TopBuild (BLD) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.
Research shows that stocks carrying the best growth features consistently beat the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy).
While there are numerous reasons why the stock of this insulation products company is a great growth pick right now, we have highlighted three of the most important factors below:
Earnings Growth
Arguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for TopBuild is 41.9%, investors should actually focus on the projected growth. The company's EPS is expected to grow 14.9% this year, crushing the industry average, which calls for EPS growth of 13.9%.
Cash Flow Growth
While cash is the lifeblood of any business, higher-than-average cash flow growth is more important and beneficial for growth-oriented companies than for mature companies. That's because, growth in cash flow enables these companies to expand their businesses without depending on expensive outside funds.
Right now, year-over-year cash flow growth for TopBuild is 54.4%, which is higher than many of its peers. In fact, the rate compares to the industry average of 3.8%.
While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 41.8% over the past 3-5 years versus the industry average of 8.8%.
Promising Earnings Estimate Revisions
Superiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
There have been upward revisions in current-year earnings estimates for TopBuild. The Zacks Consensus Estimate for the current year has surged 0.8% over the past month.
Bottom Line
TopBuild has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination positions TopBuild well for outperformance, so growth investors may want to bet on it.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
TopBuild Corp. (BLD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The company's annualized cash flow growth rate has been 41.8% over the past 3-5 years versus the industry average of 8.8%. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Click to get this free report TopBuild Corp. (BLD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects. While there are numerous reasons why the stock of this insulation products company is a great growth pick right now, we have highlighted three of the most important factors below: Earnings Growth Arguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. Cash Flow Growth While cash is the lifeblood of any business, higher-than-average cash flow growth is more important and beneficial for growth-oriented companies than for mature companies.
|
In addition to a favorable Growth Score, it carries a top Zacks Rank. The company's annualized cash flow growth rate has been 41.8% over the past 3-5 years versus the industry average of 8.8%. Bottom Line TopBuild has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.
|
abd0d9a0-69e2-4da9-9312-18965fb6f5d4
|
711764.0
|
2023-12-13 00:00:00 UTC
|
Dorian LPG (LPG) is an Incredible Growth Stock: 3 Reasons Why
|
DCOMP
|
https://www.nasdaq.com/articles/dorian-lpg-lpg-is-an-incredible-growth-stock%3A-3-reasons-why
|
nan
|
nan
|
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.
By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.
However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.
Dorian LPG (LPG) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.
Studies have shown that stocks with the best growth features consistently outperform the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy).
While there are numerous reasons why the stock of this liquified petroleum gas shipping company is a great growth pick right now, we have highlighted three of the most important factors below:
Earnings Growth
Arguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for Dorian LPG is 34.6%, investors should actually focus on the projected growth. The company's EPS is expected to grow 73.2% this year, crushing the industry average, which calls for EPS growth of -19.7%.
Cash Flow Growth
Cash is the lifeblood of any business, but higher-than-average cash flow growth is more beneficial and important for growth-oriented companies than for mature companies. That's because, high cash accumulation enables these companies to undertake new projects without raising expensive outside funds.
Right now, year-over-year cash flow growth for Dorian LPG is 84.2%, which is higher than many of its peers. In fact, the rate compares to the industry average of 30.6%.
While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 44.3% over the past 3-5 years versus the industry average of 32.4%.
Promising Earnings Estimate Revisions
Beyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
There have been upward revisions in current-year earnings estimates for Dorian LPG. The Zacks Consensus Estimate for the current year has surged 22.4% over the past month.
Bottom Line
Dorian LPG has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #1 because of the positive earnings estimate revisions.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination positions Dorian LPG well for outperformance, so growth investors may want to bet on it.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Dorian LPG Ltd. (LPG) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The company's annualized cash flow growth rate has been 44.3% over the past 3-5 years versus the industry average of 32.4%. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Click to get this free report Dorian LPG Ltd. (LPG) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects. While there are numerous reasons why the stock of this liquified petroleum gas shipping company is a great growth pick right now, we have highlighted three of the most important factors below: Earnings Growth Arguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.
|
While the historical EPS growth rate for Dorian LPG is 34.6%, investors should actually focus on the projected growth. The company's annualized cash flow growth rate has been 44.3% over the past 3-5 years versus the industry average of 32.4%. This combination positions Dorian LPG well for outperformance, so growth investors may want to bet on it.
|
210009fa-a595-4c02-a4a7-d7eb8fd3de2a
|
711765.0
|
2023-12-13 00:00:00 UTC
|
Meritage Homes (MTH) Up 94% in a Year: More Room to Run?
|
DCOMP
|
https://www.nasdaq.com/articles/meritage-homes-mth-up-94-in-a-year%3A-more-room-to-run
|
nan
|
nan
|
Shares of Meritage Homes Corporation MTH have appreciated 93.5% in the past year compared with the Zacks Building Products - Home Builders industry’s 78.6% rise. Improved cycle times, spec strategy implementation and strategic efforts resulted in this uptick. The company’s strategy of capitalizing on the solid demand for entry-level and first-move-up homes will likely produce a higher volume in the future.
Furthermore, the Federal Reserve recently opted to keep interest rates stable, providing a sense of reassurance to companies operating in the homebuilding market. In the past 60 days, earnings estimates for this Zacks Rank #3 (Hold) company have witnessed an upward revision of 1.5% to $19.65 per share.
However, the company’s earnings and sales in 2023 are likely to decline 4.5% and 26.5% year over year, respectively. Higher mortgage rates, inflation and macroeconomic risks are headwinds.
Image Source: Zacks Investment Research
Let’s check the factors supporting positive investor sentiments amid ongoing headwinds.
Optimizing Growth Through the Spec Home Strategy
Spec homes, constructed without a prior-buyer lineup, are a key growth driver for Meritage Homes. The strategy focuses on efficient construction and in-demand features, minimizing wait times for buyers. It aims to have a few months’ worth of supply ready for moving in. This ensures comparatively lower wait time for home buyers compared with traditional homebuilding. This approach enables the company to maintain a lower average selling price, boosting demand in comparison to traditional homebuilding.
During the third quarter of 2023, the company’s closings of 3,630 homes were 4% greater than the prior year’s thanks to a shortened cycle time and the commitment to its spec-building strategy.
Focus on First-Time/Entry-Level Buyers Bodes Well
In response to rising interest rates and home prices, the company addresses the demand for affordable homes with its LiVE.NOW product. Emphasizing profitability through strategic initiatives, the company focuses on entry-level LiVE.NOW homes. Consistently building speculative homes for LiVE.NOW communities, the company anticipates meeting the growing demand as millennials express interest in homeownership, leading to higher volumes.
The company believes that its strategy of targeting entry-level and first-move-up buyers is gaining traction and will continue to boost performance over the long haul. Entry-level buyers represented 88% of third-quarter 2023 orders. In the quarter, the cancellation rate was 11%, down from 30% in the year-ago period.
Strategic Efforts to Drive Performance
Despite industry headwinds, the performance of Meritage Homes continues to improve, given strong earnings and revenue growth and improving gross margin. The company's focus on maximizing profits involves building speculative homes for faster, cost-effective delivery. MTH strategically shifts to being a pure-play entry-level and first-move-up builder, expecting higher absorptions with an improving community count growth trajectory.
During the third quarter of 2023, MTH accelerated its investment in internal growth, with $537 million spent on land acquisition and development. The investment was up 41% from the prior year’s levels and 31% sequentially. As of Sep 30, 2023, the total lots controlled were 60,700. For 2023, the company plans to spend more than $2 billion on land acquisition and development, as it expects to grow its community count from 10% to 15% on an annual basis.
Concerns
MTH is highly dependent on housing market demand. Currently, the housing industry remains challenging, given higher mortgage rates and inflationary pressure. Apart from this, labor constraint remains a concern. Although these factors have been stabilizing in recent months, they may dampen Meritage Homes’ operating performance in the future.
However, the Federal Reserve has recently signaled the end of the current rate cycle, maintaining the interest rates at a 22-year high of 5.25-5.5%. The central bank has also indicated three interest rate cuts by the end of 2024. This is a relief for the housing industry as it suggests stability and affordability for potential homebuyers, boosting home sales and supporting overall industry health.
The decline in total backlog is a concern for the company. At the end of third-quarter 2023, the total backlog was 3,608 units, down 41% year over year. The value of the backlog fell 45% year over year to $1.56 billion. The downside was due to the pull-forward of sales last year on expansive rate locks.
Key Picks
Some better-ranked stocks from the Zacks Construction sector are:
EMCOR Group, Inc. EME sports a Zacks Rank #1 (Strong Buy). It has a trailing four-quarter earnings surprise of 25%, on average. Shares of EME have surged 47.5% in the past year. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for EME’s 2023 sales and earnings per share (EPS) suggests growth of 12% and 52.8%, respectively, from the year-ago period’s levels.
M-tron Industries, Inc. MPTI currently sports a Zacks Rank of 1. MPTI delivered a trailing four-quarter earnings surprise of 35.6%, on average. It has surged 222.3% in the past year.
The Zacks Consensus Estimate for MPTI’s 2023 sales and EPS indicates growth of 30.6% and 156.7%, respectively, from the previous year’s levels.
AECOM ACM carries a Zacks Rank of #2 (Buy). It has a trailing four-quarter earnings surprise of 2.1%, on average. Shares of ACM have surged 12.7% in the past year.
The Zacks Consensus Estimate for ACM’s 2024 sales and EPS indicates an increase of 4.5% and 17.5%, respectively, from the year-ago period’s levels.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AECOM (ACM) : Free Stock Analysis Report
EMCOR Group, Inc. (EME) : Free Stock Analysis Report
Meritage Homes Corporation (MTH) : Free Stock Analysis Report
M-tron Industries, Inc. (MPTI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Consistently building speculative homes for LiVE.NOW communities, the company anticipates meeting the growing demand as millennials express interest in homeownership, leading to higher volumes. The company believes that its strategy of targeting entry-level and first-move-up buyers is gaining traction and will continue to boost performance over the long haul. MTH strategically shifts to being a pure-play entry-level and first-move-up builder, expecting higher absorptions with an improving community count growth trajectory.
|
Shares of Meritage Homes Corporation MTH have appreciated 93.5% in the past year compared with the Zacks Building Products - Home Builders industry’s 78.6% rise. Strategic Efforts to Drive Performance Despite industry headwinds, the performance of Meritage Homes continues to improve, given strong earnings and revenue growth and improving gross margin. Click to get this free report AECOM (ACM) : Free Stock Analysis Report EMCOR Group, Inc. (EME) : Free Stock Analysis Report Meritage Homes Corporation (MTH) : Free Stock Analysis Report M-tron Industries, Inc. (MPTI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Shares of Meritage Homes Corporation MTH have appreciated 93.5% in the past year compared with the Zacks Building Products - Home Builders industry’s 78.6% rise. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year. Click to get this free report AECOM (ACM) : Free Stock Analysis Report EMCOR Group, Inc. (EME) : Free Stock Analysis Report Meritage Homes Corporation (MTH) : Free Stock Analysis Report M-tron Industries, Inc. (MPTI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
In the past 60 days, earnings estimates for this Zacks Rank #3 (Hold) company have witnessed an upward revision of 1.5% to $19.65 per share. However, the company’s earnings and sales in 2023 are likely to decline 4.5% and 26.5% year over year, respectively. Focus on First-Time/Entry-Level Buyers Bodes Well In response to rising interest rates and home prices, the company addresses the demand for affordable homes with its LiVE.NOW product.
|
8807e451-7f6b-42f3-ac4c-f4e6eb5f945e
|
711766.0
|
2023-12-13 00:00:00 UTC
|
Micron (MU) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
|
DCOMP
|
https://www.nasdaq.com/articles/micron-mu-q1-earnings-on-the-horizon%3A-analysts-insights-on-key-performance-measures
|
nan
|
nan
|
Analysts on Wall Street project that Micron (MU) will announce quarterly loss of $1 per share in its forthcoming report, representing a decline of 2400% year over year. Revenues are projected to reach $4.6 billion, increasing 12.6% from the same quarter last year.
Over the last 30 days, there has been an upward revision of 16.9% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Micron metrics that are commonly tracked and forecasted by Wall Street analysts.
The consensus among analysts is that 'Revenue by Technology- DRAM' will reach $3.22 billion. The estimate suggests a change of +14% year over year.
Analysts expect 'Revenue by Technology- Other (primarily NOR)' to come in at $62.58 million. The estimate suggests a change of -59.1% year over year.
It is projected by analysts that the 'Revenue by Technology- NAND' will reach $1.22 billion. The estimate indicates a year-over-year change of +10.7%.
View all Key Company Metrics for Micron here>>>
Shares of Micron have demonstrated returns of +7.2% over the past month compared to the Zacks S&P 500 composite's +5.2% change. With a Zacks Rank #3 (Hold), MU is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Micron Technology, Inc. (MU) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock. While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights. In light of this perspective, let's dive into the average estimates of certain Micron metrics that are commonly tracked and forecasted by Wall Street analysts.
|
Analysts on Wall Street project that Micron (MU) will announce quarterly loss of $1 per share in its forthcoming report, representing a decline of 2400% year over year. While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights. Click to get this free report Micron Technology, Inc. (MU) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Analysts on Wall Street project that Micron (MU) will announce quarterly loss of $1 per share in its forthcoming report, representing a decline of 2400% year over year. While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come.
|
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights. View all Key Company Metrics for Micron here>>> You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come.
|
f38d6f40-a260-4876-b941-28e525fcb87d
|
711767.0
|
2023-12-13 00:00:00 UTC
|
US STOCKS-S&P 500 posts longest weekly winning streak since 2017; ends flat on day
|
DCOMP
|
https://www.nasdaq.com/articles/us-stocks-sp-500-posts-longest-weekly-winning-streak-since-2017-ends-flat-on-day
|
nan
|
nan
|
By Caroline Valetkevitch
NEW YORK, Dec 15 (Reuters) - The S&P 500 ended little changed on Friday but registered a seventh straight week of gains in its longest weekly winning streak since 2017 after this week's dovish pivot by the Federal Reserve.
Comments Friday by Fed Bank of New York President John Williams that it was too soon to be talking about rate cuts dampened some of the optimism.
Also, the rate sensitive real estate .SPLRCR and utilities .SPLRCU sectors gave back some of their big gains tied to the Fed statement.
Stocks rallied this week after the Fed in its policy statement Wednesday signaled lower borrowing costs in 2024.
The Dow Jones Average industrial notched another record high closes on Friday, and an index of semiconductors .SOXhad its big weeks gains since May.
"I don't know if we're going to get whatever is considered a Santa Claus rally, but it looks like all things being considered, we could drift higher from here."
According to preliminary data, the S&P 500 .SPX lost 4.52 points, or 0.10%, to end at 4,715.03 points, while the Nasdaq Composite .IXIC gained 52.36 points, or 0.25%, to 14,798.43. The Dow Jones Industrial Average .DJI rose 35.59 points, or 0.10%, to 37,276.95.
The day also marked the expiry of quarterly derivatives contracts tied to stocks, index options and futures, also known as "triple witching."
Shares of Costco WholesaleCOST.Ojumped after the retailer topped Wall Street estimates for first-quarter results due to demand for cheaper groceries.
Earlier on Friday, a survey showed domestic business activity picked up in December amid rising orders and demand for workers, which could further help to allay fears of a sharp slowdown in economic growth in the fourth quarter.
(Reporting by Caroline Valetkevitch; additional reporting by Shristi Achar A and Johann M Cherian in Bengaluru; Editing by Shounak Dasgupta, Maju Samuel and Aurora Ellis)
((caroline.valetkevitch@thomsonreuters.com))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Also, the rate sensitive real estate .SPLRCR and utilities .SPLRCU sectors gave back some of their big gains tied to the Fed statement. The Dow Jones Average industrial notched another record high closes on Friday, and an index of semiconductors .SOXhad its big weeks gains since May. Earlier on Friday, a survey showed domestic business activity picked up in December amid rising orders and demand for workers, which could further help to allay fears of a sharp slowdown in economic growth in the fourth quarter.
|
Also, the rate sensitive real estate .SPLRCR and utilities .SPLRCU sectors gave back some of their big gains tied to the Fed statement. The Dow Jones Average industrial notched another record high closes on Friday, and an index of semiconductors .SOXhad its big weeks gains since May. The Dow Jones Industrial Average .DJI rose 35.59 points, or 0.10%, to 37,276.95.
|
By Caroline Valetkevitch NEW YORK, Dec 15 (Reuters) - The S&P 500 ended little changed on Friday but registered a seventh straight week of gains in its longest weekly winning streak since 2017 after this week's dovish pivot by the Federal Reserve. The Dow Jones Average industrial notched another record high closes on Friday, and an index of semiconductors .SOXhad its big weeks gains since May. According to preliminary data, the S&P 500 .SPX lost 4.52 points, or 0.10%, to end at 4,715.03 points, while the Nasdaq Composite .IXIC gained 52.36 points, or 0.25%, to 14,798.43.
|
Comments Friday by Fed Bank of New York President John Williams that it was too soon to be talking about rate cuts dampened some of the optimism. The Dow Jones Average industrial notched another record high closes on Friday, and an index of semiconductors .SOXhad its big weeks gains since May. The Dow Jones Industrial Average .DJI rose 35.59 points, or 0.10%, to 37,276.95.
|
9a67ae6a-c9d3-4788-b9cb-fc794a0f67db
|
711768.0
|
2023-12-13 00:00:00 UTC
|
Technology Sector Update for 12/13/2023: PLAB, MYNA, BBAI
|
DCOMP
|
https://www.nasdaq.com/articles/technology-sector-update-for-12-13-2023%3A-plab-myna-bbai
|
nan
|
nan
|
Technology stocks were slightly up pre-bell Wednesday. The Technology Select Sector SPDR Fund (XLK) advanced 0.5%, while the iShares Semiconductor ETF (SOXX) was up 0.1%.
In company news, Photronics (PLAB) advanced past 6%, after reporting fiscal Q4 adjusted earnings Wednesday of $0.60 per diluted share, up from $0.51 a year earlier. An analyst polled by Capital IQ expected $0.53. Revenue also rose.
Mynaric (MYNA) surged 14%, after saying it has agreed with Northrop Grumman (NOC) to deliver optical communication terminals for the Space Development Agency Tranche 2 Transport Layer-Alpha program.
BigBear.ai Holdings (BBAI) said late Tuesday it won a contract extension worth $17.9 million to continue as the prime contractor for the US Army's global force information management system. The company's shares rose 3.4%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In company news, Photronics (PLAB) advanced past 6%, after reporting fiscal Q4 adjusted earnings Wednesday of $0.60 per diluted share, up from $0.51 a year earlier. Mynaric (MYNA) surged 14%, after saying it has agreed with Northrop Grumman (NOC) to deliver optical communication terminals for the Space Development Agency Tranche 2 Transport Layer-Alpha program. BigBear.ai Holdings (BBAI) said late Tuesday it won a contract extension worth $17.9 million to continue as the prime contractor for the US Army's global force information management system.
|
In company news, Photronics (PLAB) advanced past 6%, after reporting fiscal Q4 adjusted earnings Wednesday of $0.60 per diluted share, up from $0.51 a year earlier. The company's shares rose 3.4%. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The Technology Select Sector SPDR Fund (XLK) advanced 0.5%, while the iShares Semiconductor ETF (SOXX) was up 0.1%. In company news, Photronics (PLAB) advanced past 6%, after reporting fiscal Q4 adjusted earnings Wednesday of $0.60 per diluted share, up from $0.51 a year earlier. BigBear.ai Holdings (BBAI) said late Tuesday it won a contract extension worth $17.9 million to continue as the prime contractor for the US Army's global force information management system.
|
Technology stocks were slightly up pre-bell Wednesday. The Technology Select Sector SPDR Fund (XLK) advanced 0.5%, while the iShares Semiconductor ETF (SOXX) was up 0.1%. The company's shares rose 3.4%.
|
05a6d0d9-8905-4c46-b7f7-f2767e7819cd
|
711769.0
|
2023-12-13 00:00:00 UTC
|
This Artificial Intelligence (AI) Stock Looks Dirt Cheap. Here's Why.
|
DCOMP
|
https://www.nasdaq.com/articles/this-artificial-intelligence-ai-stock-looks-dirt-cheap.-heres-why.
|
nan
|
nan
|
The last couple of years have been brutal for social media giant Meta Platforms (NASDAQ: META). After spending billions on its metaverse ambitions, Meta lost sight of its core advertising business -- and investors didn't like that.
Specifically, famed venture capitalist Brad Gerstner of Altimeter Capital wrote an open letter to Meta CEO Mark Zuckerberg and the board of directors, urging the company to "get fit." The rationale behind Gerstner's stance stemmed from an upside-down operation at Meta that was unfolding in the public eye. The company's cash cow of advertising was taking a hit, all while expenses focused on other areas such as virtual reality (VR) were mounting, causing overall profits to shrink.
To Zuckerberg's credit, he listened to Gerstner and pivoted to a steadfast focus on accelerating advertising revenue and reducing expenses (mostly in the form of layoffs). 2023 has been a solid year for Meta, both operationally and for the stock -- which has returned nearly 180% this year.
Nonetheless, there are some glaring reasons to think Meta stock is incredibly undervalued, making now an opportunity to scoop up shares at a bargain price.
Why 2024 could be huge for Meta
Meta is the parent company of social media platforms Facebook, Instagram, and WhatsApp. Facebook is the third-most visited website in the world while Instagram is close behind at No. 6. These two sites combine for over 25 billion visits per month, according to analytics research firm Semrush.
The obvious takeaway here is that Meta's surface area on the Internet is enormous, making brands eager to place advertisements on the company's platforms. While 2023 has been an impressive year for Meta, 2024 could be even better because it marks the beginning of a new election cycle.
According to data from AdImpact, political advertising could set a record next year as estimates suggest spending could eclipse $10 billion. Of this spend, AdImpact is forecasting roughly $1.2 billion to be allocated toward digital advertising formats. Although it's too early to know if these figures are accurate, the basic theme is that Meta's high traffic across its social media ecosystem will likely garner a premium from political advertising campaigns.
Given these tailwinds, investors might think that the markets are placing a premium on Meta stock. But a valuation analysis comparing Meta to its "Magnificent Seven" cohorts may suggest otherwise.
Image source: Getty Images.
Looking underneath the hood
The chart below illustrates the forward price-to-earnings (P/E) ratio of Meta benchmarked against its megacap technology peers. At a multiple of just 23.4, Meta stock is the second-lowest-valued stock among the "Magnificent Seven" on a forward P/E basis, only narrowly beating its advertising rival Alphabet.
META PE Ratio (Forward) data by YCharts
Taking this a step further, Meta's profitability profile, while robust, could actually be even better. The table below illustrates Meta's operating income across its advertising and metaverse businesses, reported as Family of Apps and Reality Labs, respectively.
CATEGORY Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023
Family of Apps operating income $11.5 billion $11.2 billion $9.3 billion $10.7 billion $11.2 billion $13.1 billion $17.5 billion
Reality Labs operating income/(loss) ($2.9 billion) ($2.8 billion) ($3.7 billion) ($4.3 billion) ($3.9 billion) ($3.7 billion) ($3.7 billion)
Data source: Meta Platforms Investor Relations.
Investors can see that the Family of Apps segment is consistently operating at a profit while Reality Labs is still burning cash. As such, Reality Labs eats into Meta's overall operating income and net profit, and is showing no signs of slowing down.
Is Meta stock undervalued?
Another way of thinking about the financial picture above is that Meta's profits could be much higher. As I've expressed about Meta stock before, the company's valuation multiples specific to profits can be challenging to digest.
For example, the price-to-earnings and price-to-free-cash-flow multiples in the charts below could appear misleading given the impact Reality Labs has on the overall business. Nonetheless, considering that each ratio is trading below 10-year averages, it could signal that Meta stock is trading at some of its most attractive valuation levels ever.
META Price to Free Cash Flow data by YCharts
Owning Meta stock will require investors to accept the current state of Reality Labs. The company is investing aggressively into areas beyond advertising as it looks to transform the business. For now, the high profit margins derived from advertising are essentially funding non-core initiatives in the metaverse. As a result, the company's total profits are cannibalized.
This is not entirely unreasonable, though, as artificial intelligence (AI) will have myriad applications in the metaverse. In a way, while owning Meta stock for the highly profitable advertising business warrants merit, a position in the company could represent a hedge to other AI plays you might own.
Meta's current valuation multiples suggest that the stock does not deserve a premium commensurate with its competition. But given the high likelihood that the company will experience increased ad spend next year from both political campaigns and brands, coupled with the long-term secular themes of AI that can benefit both sides of Meta's business, the stock looks dirt cheap right now. Long-term investors have a lucrative opportunity to start dollar-cost averaging into Meta stock at an absolute bargain.
Should you invest $1,000 in Meta Platforms right now?
Before you buy stock in Meta Platforms, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Meta Platforms wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Adam Spatacco has positions in Alphabet, Amazon, Apple, Meta Platforms, Microsoft, Nvidia, and Tesla. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Meta Platforms, Microsoft, Nvidia, and Tesla. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Specifically, famed venture capitalist Brad Gerstner of Altimeter Capital wrote an open letter to Meta CEO Mark Zuckerberg and the board of directors, urging the company to "get fit." Although it's too early to know if these figures are accurate, the basic theme is that Meta's high traffic across its social media ecosystem will likely garner a premium from political advertising campaigns. But given the high likelihood that the company will experience increased ad spend next year from both political campaigns and brands, coupled with the long-term secular themes of AI that can benefit both sides of Meta's business, the stock looks dirt cheap right now.
|
Family of Apps operating income $11.5 billion $11.2 billion $9.3 billion $10.7 billion $11.2 billion $13.1 billion $17.5 billion Reality Labs operating income/(loss) ($2.9 billion) ($2.8 billion) ($3.7 billion) ($4.3 billion) ($3.9 billion) ($3.7 billion) ($3.7 billion) Data source: Meta Platforms Investor Relations. Adam Spatacco has positions in Alphabet, Amazon, Apple, Meta Platforms, Microsoft, Nvidia, and Tesla. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Meta Platforms, Microsoft, Nvidia, and Tesla.
|
Family of Apps operating income $11.5 billion $11.2 billion $9.3 billion $10.7 billion $11.2 billion $13.1 billion $17.5 billion Reality Labs operating income/(loss) ($2.9 billion) ($2.8 billion) ($3.7 billion) ($4.3 billion) ($3.9 billion) ($3.7 billion) ($3.7 billion) Data source: Meta Platforms Investor Relations. META Price to Free Cash Flow data by YCharts Owning Meta stock will require investors to accept the current state of Reality Labs. Before you buy stock in Meta Platforms, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Meta Platforms wasn't one of them.
|
2023 has been a solid year for Meta, both operationally and for the stock -- which has returned nearly 180% this year. As I've expressed about Meta stock before, the company's valuation multiples specific to profits can be challenging to digest. Before you buy stock in Meta Platforms, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Meta Platforms wasn't one of them.
|
e88bc619-0dea-47cc-aa47-3574a178b09e
|
711770.0
|
2023-12-13 00:00:00 UTC
|
Canada to keep pressure on Facebook to pay for news, Trudeau says
|
DCOMP
|
https://www.nasdaq.com/articles/canada-to-keep-pressure-on-facebook-to-pay-for-news-trudeau-says
|
nan
|
nan
|
OTTAWA, Dec 15 (Reuters) - Ottawa will keep pushing Meta META.O to comply with a new law requiring large internet companies to pay Canadian news publishers for their content, Prime Minister Justin Trudeau said on Friday, but the Facebook parent stood by its decision to block news sharing rather than pay.
The government on Friday published final regulations for the Online News Act before enforcement starts Dec. 19. The law requires technology companies with 20 million unique monthly users and annual revenues of C$1 billion ($748 million) or more to compensate Canadian news outlets for publishing links to their pages.
Alphabet's GOOGL.O Google and Meta are the only platforms that fall under those criteria in Canada. Google agreed last month to pay C$100 million annually to news publishers in the country. Meta, in contrast, decided to block news on Facebook and Instagram in Canada to avoid the payments.
"We will continue to push Meta, that makes billions of dollars in profits, even though it is refusing to invest in the journalistic rigor and stability of the media," Trudeau told reporters in Vancouver.
Meta said it will stick to its decision. "News outlets choose to use our free services because it helps their bottom line, and today's release of final regulations does not change our business decision," said Rachel Curran, head of public policy for Meta Canada.
The law, part of a global trend, is designed to address Canadian media industry concerns about declining revenue as internet companies elbow news businesses out of the online advertising market.
Meta started blocking news sharing on Facebook and Instagram in August, saying news holds no economic value for its businesses.
Heritage Minister Pascale St-Onge said the Canadian Radio-television and Telecommunications Commission (CRTC) would "pay close attention to Facebook and Meta" as part of its enforcement.
Paul Deegan, CEO of industry body News Media Canada, said the government had delivered a "durable, world-leading framework that is balanced and predictable for both news publishers and platforms," and called on Meta to follow Google's lead.
($1 = 1.3372 Canadian dollars)
(Reporting by Ismail Shakil in Ottawa; Editing by Cynthia Osterman)
((ismail.shakil@tr.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
"We will continue to push Meta, that makes billions of dollars in profits, even though it is refusing to invest in the journalistic rigor and stability of the media," Trudeau told reporters in Vancouver. "News outlets choose to use our free services because it helps their bottom line, and today's release of final regulations does not change our business decision," said Rachel Curran, head of public policy for Meta Canada. The law, part of a global trend, is designed to address Canadian media industry concerns about declining revenue as internet companies elbow news businesses out of the online advertising market.
|
OTTAWA, Dec 15 (Reuters) - Ottawa will keep pushing Meta META.O to comply with a new law requiring large internet companies to pay Canadian news publishers for their content, Prime Minister Justin Trudeau said on Friday, but the Facebook parent stood by its decision to block news sharing rather than pay. The government on Friday published final regulations for the Online News Act before enforcement starts Dec. 19. The law requires technology companies with 20 million unique monthly users and annual revenues of C$1 billion ($748 million) or more to compensate Canadian news outlets for publishing links to their pages.
|
OTTAWA, Dec 15 (Reuters) - Ottawa will keep pushing Meta META.O to comply with a new law requiring large internet companies to pay Canadian news publishers for their content, Prime Minister Justin Trudeau said on Friday, but the Facebook parent stood by its decision to block news sharing rather than pay. Meta started blocking news sharing on Facebook and Instagram in August, saying news holds no economic value for its businesses. Paul Deegan, CEO of industry body News Media Canada, said the government had delivered a "durable, world-leading framework that is balanced and predictable for both news publishers and platforms," and called on Meta to follow Google's lead.
|
OTTAWA, Dec 15 (Reuters) - Ottawa will keep pushing Meta META.O to comply with a new law requiring large internet companies to pay Canadian news publishers for their content, Prime Minister Justin Trudeau said on Friday, but the Facebook parent stood by its decision to block news sharing rather than pay. The government on Friday published final regulations for the Online News Act before enforcement starts Dec. 19. Meta started blocking news sharing on Facebook and Instagram in August, saying news holds no economic value for its businesses.
|
a43493fc-6bb1-4fe8-af72-6c0efb76de49
|
711771.0
|
2023-12-13 00:00:00 UTC
|
3 Reasons Etsy Stock Could Rebound in 2024
|
DCOMP
|
https://www.nasdaq.com/articles/3-reasons-etsy-stock-could-rebound-in-2024
|
nan
|
nan
|
Shopping for deep discounts can be risky business for investors. A sharp price decline often means Wall Street has reasons to be pessimistic about a company's growth and earnings prospects. These concerns are often short-term in nature, but they can reflect fundamental competitive and financial challenges that will expose your portfolio to unwelcome volatility.
Despite that risk, it's still worth looking at whether a sell-off has gone too far. Investors could see excellent returns from a beaten-down stock that's simply going through a rough patch, after all.
Etsy (NASDAQ: ETSY) might be in this exact position. The marketplace specialist's shares have been pummeled since reaching their highs in late 2021, potentially setting investors up for a big rebound ahead. Here are a few catalysts that could set the stage for that spike.
1. Low expectations
Etsy has a very low bar it needs to clear to give Wall Street some positive surprises in the coming year. Analysts expect sales to rise just 6% in 2024, even as other e-commerce specialists like Shopify grow at a 20%-plus rate.
Sure, Etsy faces significant demand challenges. Shoppers aren't as excited to spend on the discretionary products that make up most of its sales volume.
But pessimism around lackluster growth trends is already reflected in the stock's valuation. Etsy stock is trading for just 4.2 times sales today compared to nearly 8 times sales earlier this year. That steep decline could set the stage for a rebound in Etsy shares, assuming the company can reaccelerate its sales gains over the coming quarters.
2. Attracting more buyers and sellers
There are encouraging signs the business has already stabilized. Etsy's buyer pool grew for a second straight quarter in Q3, for example, after dropping for much of the past year. Declines in average spending for these shoppers has moderated too. And overall revenue gains are being supplemented by Etsy's rising seller fees and growth in complementary services like advertising and payments processing. The company reported a 7% sales increase last quarter, beating eBay's 5% uptick for Q3.
Investors will want to watch the key growth metrics of Etsy's buyer pool and overall sales volumes. Gross merchandise sales (GMS) were up just 1% last quarter, and there will need to be a rebound there for the stock to reverse its negative trends.
Management is hoping to engineer this acceleration by marketing more toward previously engaged buyers and by making the platform more intuitive. A revamped shopping recommendation engine has the potential to make a big difference here given that Etsy's merchandise skews toward the unique and handmade. That fact sets the company apart from e-commerce peers like eBay, but it also means Etsy has to help customers along more in their shopping experience.
3. Profits and cash trends
Etsy's earnings trends look quite weak today, but they don't reflect the company's wider opportunities. Net income was barely positive last quarter despite growing sales and marketplace revenue. Strip out the impact of one-time charges, though, and you'll see more potential for robust earnings ahead.
Its non-GAAP adjusted EBITDA margin declined only slightly in the first nine months of 2023 to 27.2% of sales. And Etsy generated $410 million of operating cash in that period, up from $391 million a year earlier.
These results came despite Etsy spending aggressively on improving the platform and boosting marketing. More progress in margin expansion, then, is the most direct path toward a rebounding stock price for 2024 and beyond.
Should you invest $1,000 in Etsy right now?
Before you buy stock in Etsy, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Etsy wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Demitri Kalogeropoulos has positions in Shopify. The Motley Fool has positions in and recommends Etsy and Shopify. The Motley Fool recommends eBay and recommends the following options: short January 2024 $45 calls on eBay. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The marketplace specialist's shares have been pummeled since reaching their highs in late 2021, potentially setting investors up for a big rebound ahead. That steep decline could set the stage for a rebound in Etsy shares, assuming the company can reaccelerate its sales gains over the coming quarters. A revamped shopping recommendation engine has the potential to make a big difference here given that Etsy's merchandise skews toward the unique and handmade.
|
That steep decline could set the stage for a rebound in Etsy shares, assuming the company can reaccelerate its sales gains over the coming quarters. Profits and cash trends Etsy's earnings trends look quite weak today, but they don't reflect the company's wider opportunities. Before you buy stock in Etsy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Etsy wasn't one of them.
|
Etsy stock is trading for just 4.2 times sales today compared to nearly 8 times sales earlier this year. That steep decline could set the stage for a rebound in Etsy shares, assuming the company can reaccelerate its sales gains over the coming quarters. Before you buy stock in Etsy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Etsy wasn't one of them.
|
Etsy (NASDAQ: ETSY) might be in this exact position. That steep decline could set the stage for a rebound in Etsy shares, assuming the company can reaccelerate its sales gains over the coming quarters. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
|
9a4f5440-f662-4c16-9f12-8364332e99f0
|
711772.0
|
2023-12-13 00:00:00 UTC
|
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
|
DCOMP
|
https://www.nasdaq.com/articles/pharmas-frontline%3A-3-stocks-driving-revolutionary-drug-development
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The pharma stock leaders can at times seem overly risk averse with their approach to developing new medicines and cures. With the difficulty of clinical trials and the uncertainty of Federal Drug Administration (FDA) approval, many pharma companies prefer to play it safe rather than bet big. But not everyone is content making minor changes forever.
There are still revolutionary drug stocks out there fighting to be noticed. These companies may be much smaller than their competitors, but their dreams are much bigger. Companies that promise to treat the untreatable and cure the incurable are working to bring entirely new classes of medicine to market. Some of these revolutionary drug stocks are backed by Nobel Prize laureates. Others have proven their business acumen in a tough monetary environment. But all have brought new drugs, new ideas and a determination to succeed.
An increasing number of pharma stock leaders are running into the limits of what old technology can bring us, and more people are born every year who will go on to develop conditions that some believe may never be cured. But cancer was once seen as a death sentence and polio was once seen as just a fact of life. Nothing is impossible when science and business work hand in hand.
So for those who don’t want to invest in a stereotypical pharma company but know that biotech is the future, here are three revolutionary pharma stock leaders you won’t want to miss.
CRISPR Therapeutics (CRSP)
Source: Catalin Rusnac/ShutterStock.com
Shares in CRISPR Therapeutics (NASDAQ:CRSP) have gained ground this year while many pharma stock leaders have lagged. In a world of higher interest rates, it seems investors are less keen to bet on revolutionary drug stocks. But CRISPR Therapeutics has what its competitors lack: a proven drug and a pipeline to create many more.
Just a week ago, CRISPR Therapeutics and its collaborator Vertex Pharmaceuticals (NASDAQ:VRTX) announced the FDA approval of CASGEVY, the first FDA approved CRISPR-Cas9 based therapy. This approval puts them in the driver’s seat of one of the biggest revolutions in medicine. The ability to directly edit genes using CRISPR-Cas9 means previously untreatable diseases can now be cured. With this discovery, new markets are being blown open.
But with new markets, comes new challenges. The newly-approved CASGEVY is a treatment for sickle cell anemia and beta thalassemia. It’s no accident these were targeted as they are genetic diseases of the blood. CASGEVY works by the comparatively easy process of removing a small sample of a patient’s blood, altering it with CRISPR-Cas9 then injecting it back into the patient. It’s much harder to remove and replace organs, so treating non-bloodborne genetic diseases will be more challenging.
Nevertheless, getting the first FDA approval for a CRISPR-Cas9 therapy shows CRISPR Therapeutics has the expertise to meet those challenges. The approval of CASGEVY is good news for CRISPR Therapeutics and great news for patients. Watch what the company follows it up with, because CRISPR Therapeutics has catapulted itself to being a pharma stock leader.
Revolution Medicines (RVMD)
Source: CI Photos / Shutterstock.com
Sometimes a revolution in drug design requires a long look at old data. The rat sarcoma (RAS) family of genes was discovered in the 1960s and they cause up to one third of all human cancers. With so many diseases having a single known cause, a cure could be revolutionary. But RAS-caused cancers are highly resistant to treatment, and even considered “undruggable.”
But Revolution Medicines (NASDAQ:RVMD) has a deep pipeline of RAS-targeting drugs. The company has an entirely new way of looking at RAS and RAS-caused cancers. Pharma stock leaders have long seen their drugs fail because RAS simply escapes binding to drugs and remains active. But Revolution Medicines has found that RAS can’t escape when it’s held by two other proteins in the body. These two proteins plus RAS form a tri-complex, which Revolution Medicines has targeted for drugging. An innovative solution to one of medicines most-studied problems.
Revolution Medicines doesn’t just have good science, it also have good business sense. Clinical trials are expensive, and so Revolution Medicines has raised cash by buying its competitor EQRx in an all-stock deal. EQRx’s intellectual property (IP) will be sold off and Revolution will remain solely committed to its RAS-based therapies.
The EQRx deal will be good for Revolution’s balance sheet. Its most recent earnings statement shows $455 million in cash and cash equivalents. But that has swollen by about $1 billion now that EQRx’s cash is added to the pile. With a quarterly net loss of $108 million, this ensures Revolution has the cash to pursue its novel RAS-based strategy.
Everything is undruggable until it isn’t, and Revolution Medicines is one of the revolutionary drug stocks you won’t want to miss.
Arcellx (ACLX)
Source: Gorodenkoff / Shutterstock.com
Multiple myeloma may not be the most common cancer, but for the 35,000 new patients every year, it remains sadly incurable. But Arcellx (NASDAQ:ACLX) is leading a new era with its drugs that target B-cell maturation antigen (BCMA). BCMA is relatively rare in normal cells, but highly expressed in tumors. And higher BCMA correlates with lower odds of survival. This makes BCMA a key target for treating this untreatable disease.
Arcellx doesn’t just have science on its side, it also has deep-pocketed investors. The pharma stock leader Gilead (NASDAQ:GILD) recently bought $200 million worth of Arcellx stock and gave a cash payment of $85 million on top of that. And Arcellx could be eligible for more milestone payments down the line.
Those milestone payments will rely on CART-ddBCMA, for which Arcellx just announced positive results in phase one clinical trials. Phase two trials are ongoing, with an estimated primary completion date of May 2024. That means an investment now could reap a big reward very soon.
In the short term, Arcellx’s price will likely move based on its big-name trials completing in 2024. In the long term, it has an even deeper pipeline of drugs behind that. Bringing those drugs to market will take time and money though. Arcellx’s most recent earnings report shows $440 million in cash and investments with a net loss of $39.3 million. But that was before the Gilead investment, and the Gilead investment plus milestone payments down the line should give Arcellx all the time it needs to succeed.
Multiple myeloma is currently incurable, but it doesn’t have to be. Revolutionary drug stocks like Arcellx are changing that and bringing treatment to even the most stubborn diseases.
On the date of publication, John Blankenhorn did not hold any positions (either directly or indirectly) in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
John Blankenhorn is a neuroscientist at Emory University. He has significant experience in biochemistry, biotechnology and pharmaceutical research.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
With the difficulty of clinical trials and the uncertainty of Federal Drug Administration (FDA) approval, many pharma companies prefer to play it safe rather than bet big. An increasing number of pharma stock leaders are running into the limits of what old technology can bring us, and more people are born every year who will go on to develop conditions that some believe may never be cured. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development appeared first on InvestorPlace.
|
CRISPR Therapeutics (CRSP) Source: Catalin Rusnac/ShutterStock.com Shares in CRISPR Therapeutics (NASDAQ:CRSP) have gained ground this year while many pharma stock leaders have lagged. Just a week ago, CRISPR Therapeutics and its collaborator Vertex Pharmaceuticals (NASDAQ:VRTX) announced the FDA approval of CASGEVY, the first FDA approved CRISPR-Cas9 based therapy. The pharma stock leader Gilead (NASDAQ:GILD) recently bought $200 million worth of Arcellx stock and gave a cash payment of $85 million on top of that.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The pharma stock leaders can at times seem overly risk averse with their approach to developing new medicines and cures. Pharma stock leaders have long seen their drugs fail because RAS simply escapes binding to drugs and remains active. The pharma stock leader Gilead (NASDAQ:GILD) recently bought $200 million worth of Arcellx stock and gave a cash payment of $85 million on top of that.
|
The company has an entirely new way of looking at RAS and RAS-caused cancers. This makes BCMA a key target for treating this untreatable disease. But that was before the Gilead investment, and the Gilead investment plus milestone payments down the line should give Arcellx all the time it needs to succeed.
|
6156428f-2b6d-4964-8a65-3af8b0cfcbfc
|
711773.0
|
2023-12-13 00:00:00 UTC
|
This Landlord Thinks Improving the Customer Experience Is a Huge Opportunity
|
DCOMP
|
https://www.nasdaq.com/articles/this-landlord-thinks-improving-the-customer-experience-is-a-huge-opportunity
|
nan
|
nan
|
Real estate investment trust (REIT) UDR (NYSE: UDR) is one of the largest owners of apartment properties in the United States. Although the business of renting an apartment is fairly simple to understand, there are a lot of little things that go into the process. UDR has spent two years examining one of the more difficult aspects of the customer relationship, move outs. Management thinks it can bend the curve.
UDR is technology driven
One of the things that UDR's management team spends a lot of time talking about is technology. For example, it provides online tools for renting an apartment and online tools for scheduling maintenance once a person becomes a renter. The company is very big on digitizing the business in whatever ways it can to both increase efficiency and to improve the customer experience.
Image source: Getty Images.
That's a good thing to do, of course. But there's more to the effort because it also allows for better tracking of the business overall. For example, management can specifically see how maintenance efforts are playing out and step in if there are problems. But there's one area where UDR isn't doing so well, its retention rate lags a few percentage points behind those of its closest peers.
That basically means that more people tend to move out of a UDR property then move out of peer operated properties. That's a problem for the REIT because it is far more costly to fill an empty apartment than it is to retain an existing tenant. For example, a vacant apartment needs cleaning and maintenance work -- perhaps a coat of paint -- before it can be released. Then the unit has to be advertised. And convincing a new tenant to move in might require rent concessions, like free months of rent. More importantly, all through the turnover period the apartment isn't generating any revenue. Simply keeping the old tenant around for another year would be a much better financial outcome.
UDR is throwing technology at the move out problem
UDR hasn't stuck its head in the sand hoping that things get better. It has examined a decade's worth of data to see why tenants are moving out and it believes that roughly 50% of the issue is controllable. It all boils down to the customer experience. Specific touch points that can be improved include making the move in process better, improved execution on maintenance requests, and an effort to better handle trash, pet waste, and noise issues. In fact, of the top 15 factors the company found, only one was tightly related to the actual cost of the apartment.
The company is putting in place processes to start addressing the issues it thinks it can control. So far the news has been positive, with management noting that it believes it can not only get back on par with its peers, but that it can improve its turnover to above industry average levels. This is a bigger issue than it sounds like, particularly right now.
UDR ended up trimming its full-year 2023 guidance when it reported third quarter earnings because of an onslaught of new properties coming to market. That's making it tougher to attract new tenants because aggressive pricing at new buildings is allowing renters to get into higher-quality properties (Class A) for what it would have traditionally cost to rent at a lower-quality asset (Class B). If non-rent related issues are leading tenants to leave and UDR can improve those issues, it may be able to retain up to 50% of the move outs it has faced in recent years.
That, in turn, will lead to higher occupancy levels and improved financial results because of less down time and lower turnover related expenses. In other words, fixing this problem will blunt the impact of the new supply that is coming to market right now.
Is it time to buy UDR?
UDR's decision to lower full-year guidance on top of the ongoing headwinds from new supply have resulted in a depressed stock price for the apartment REIT. The 4.8% dividend yield is near its highest levels in a decade, suggesting the stock is attractively priced right now. Although there's no quick fix for all the problems facing UDR, the fact that management has taken its technology skills and put them to work around retention is a sign of the company's strength and long-term focus.
Assuming it can get back on par with its peers with this effort, retention will no longer be the problem it is today and investors will be rewarded with a more stable business. That's worth watching if you own this REIT. It might even be worth taking the risk and buying the REIT if you don't own it, given the historically high yield and the opportunity that solving the turnover problem offers.
Should you invest $1,000 in UDR right now?
Before you buy stock in UDR, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and UDR wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
UDR's decision to lower full-year guidance on top of the ongoing headwinds from new supply have resulted in a depressed stock price for the apartment REIT. Although there's no quick fix for all the problems facing UDR, the fact that management has taken its technology skills and put them to work around retention is a sign of the company's strength and long-term focus. It might even be worth taking the risk and buying the REIT if you don't own it, given the historically high yield and the opportunity that solving the turnover problem offers.
|
That basically means that more people tend to move out of a UDR property then move out of peer operated properties. Specific touch points that can be improved include making the move in process better, improved execution on maintenance requests, and an effort to better handle trash, pet waste, and noise issues. Before you buy stock in UDR, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and UDR wasn't one of them.
|
UDR is throwing technology at the move out problem UDR hasn't stuck its head in the sand hoping that things get better. If non-rent related issues are leading tenants to leave and UDR can improve those issues, it may be able to retain up to 50% of the move outs it has faced in recent years. Before you buy stock in UDR, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and UDR wasn't one of them.
|
The company is putting in place processes to start addressing the issues it thinks it can control. If non-rent related issues are leading tenants to leave and UDR can improve those issues, it may be able to retain up to 50% of the move outs it has faced in recent years. Before you buy stock in UDR, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and UDR wasn't one of them.
|
61335da7-1160-4139-a7ea-0191f64b3a9e
|
711774.0
|
2023-12-13 00:00:00 UTC
|
$23 Billion of Warren Buffett-led Berkshire Hathaway's Portfolio Is in This Stock. Is It a Buy in 2024?
|
DCOMP
|
https://www.nasdaq.com/articles/%2423-billion-of-warren-buffett-led-berkshire-hathaways-portfolio-is-in-this-stock.-is-it-a
|
nan
|
nan
|
Famed investor Warren Buffett has spent his lifetime building Berkshire Hathaway into one of the world's largest companies. Inside Berkshire is a massive stock portfolio of some of Buffett's best investments over his lifetime.
Among them is Coca-Cola (NYSE: KO), Berkshire's fourth-largest position, worth more than $23 billion. The dividends alone are funneling $736 million into the company's coffers.
Should investors follow suit and build their own Coca-Cola dividend machines? Unfortunately, it's not that simple. Here is what you need to know.
Years and years of dividends
Buffett's Coca-Cola investment wasn't always this big. He originally invested $1 billion in 1988, and it's grown for decades. Dividends have been a big part of that. Coca-Cola has paid shareholders a little more each year for decades -- 61 consecutive years of raises, to be exact.
You can see below how that can snowball over time. Warren Buffett's $736 million in annual dividends from Coca-Cola today is almost like getting his initial investment back each year.
KO Dividend data by YCharts
How does Coca-Cola do it? It's the world's largest non-alcoholic beverage company, with hundreds of products and brands many people worldwide know -- including Coca-Cola, Sprite, and almost two dozen others -- that generate over a billion dollars in annual sales.
Just think about the world's population as a market with eight billion customers. Everyone gets thirsty. Competitors lack the size and leverage to get their products on store shelves like Coca-Cola. The company can manufacture growth organically as the population grows; by acquiring and developing new products and brands; or by raising prices.
Coca-Cola may not be a growth stock, but it's consistently growing. The global beverage market is so big that Coca-Cola's winning recipe for steady growth should continue for the foreseeable future. Analysts believe the company's earnings will grow by an average of six percent annually over the long term.
Combine that with a healthy 76% dividend payout ratio, and Coca-Cola's dividend should keep growing. Invest, wait, collect your growing dividend, and prosper.
Buffett seized a rare opportunity
However, there is a significant hurdle investors must watch for in the stock's valuation. See, Coca-Cola isn't growing fast enough that you can buy at any price and make a lot of money. Buffett bought shares in 1988 after the famous 1987 stock market crash dragged the stock 30% off its highs.
KO data by YCharts
Virtually everyone has heard of Coca-Cola and admires the company's admirable dividend growth streak. Stocks in high esteem don't often come cheap.
You can see above that Coca-Cola is susceptible to the occasional stock market crash, but isn't that volatile otherwise. The stock's beta is 0.58, meaning it's less volatile than the broader stock market.
The stock is trading at a hefty price tag
It's great that the S&P 500 is near all-time highs today, but that also means that Coca-Cola is carrying its usual price tag. Shares trade at a price-to-earnings ratio (P/E) of 22 against its estimated 2023 profits. At a six percent long-term growth rate, that's a PEG ratio of nearly four.
Go ahead if you want to prioritize building up that dividend income, but Coca-Cola's total returns could languish some until the company's earnings catch up to its share price. Ideally, one could buy shares at a P/E of around 15 to 17, but Coca-Cola rarely goes that low. Keep the stock on your watchlist and wait for the opportunity to strike.
Should you invest $1,000 in Coca-Cola right now?
Before you buy stock in Coca-Cola, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coca-Cola wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Justin Pope has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool recommends the following options: long January 2024 $47.50 calls on Coca-Cola. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Famed investor Warren Buffett has spent his lifetime building Berkshire Hathaway into one of the world's largest companies. It's the world's largest non-alcoholic beverage company, with hundreds of products and brands many people worldwide know -- including Coca-Cola, Sprite, and almost two dozen others -- that generate over a billion dollars in annual sales. Go ahead if you want to prioritize building up that dividend income, but Coca-Cola's total returns could languish some until the company's earnings catch up to its share price.
|
Years and years of dividends Buffett's Coca-Cola investment wasn't always this big. Warren Buffett's $736 million in annual dividends from Coca-Cola today is almost like getting his initial investment back each year. Before you buy stock in Coca-Cola, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coca-Cola wasn't one of them.
|
Years and years of dividends Buffett's Coca-Cola investment wasn't always this big. Before you buy stock in Coca-Cola, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coca-Cola wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Justin Pope has no position in any of the stocks mentioned.
|
Years and years of dividends Buffett's Coca-Cola investment wasn't always this big. Coca-Cola may not be a growth stock, but it's consistently growing. Before you buy stock in Coca-Cola, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coca-Cola wasn't one of them.
|
c92b6414-aef7-4c34-9b9a-c0b2318f9562
|
711775.0
|
2023-12-13 00:00:00 UTC
|
EXCLUSIVE-Restaurant chain Chuck E. Cheese explores sale-sources
|
DCOMP
|
https://www.nasdaq.com/articles/exclusive-restaurant-chain-chuck-e.-cheese-explores-sale-sources
|
nan
|
nan
|
By Abigail Summerville
Dec 14 (Reuters) - Chuck E. Cheese, the U.S. restaurant chain that emerged from bankruptcy three years ago, is exploring a sale amid acquisition interest, according to people familiar with the matter.
The Irving, Texas-based company, known for its arcade games and rat mascot Charles Entertainment "Chuck E." Cheese, is working with investment bank Goldman Sachs GS.N on an auction process that could attract private equity firms as well as peers such as Dave & Busters Entertainment PLAY.O, the sources said.
CEC Entertainment, the parent company of Chuck E. Cheese, has told potential acquirers it expects to generate around 1.2 billion in revenue and $195 million in earnings before interest, taxes, depreciation and amortization (EBITDA) this year, the sources added. Based on the valuation metrics of its peers, the company could fetch well over $1 billion in a sale, according to the sources.
The sources cautioned that no deal is certain and asked not to be identified because the matter is confidential. Goldman Sachs declined to comment. CEC Entertainment and Dave & Busters did not immediately respond to requests for comment.
Private equity firm Apollo Global Management Inc APO.N acquired Chuck E. Cheese in 2014 for $1.3 billion, including debt. The company filed for bankruptcy in June 2020 after the onset of the COVID-19 pandemic weighed on its business.
Chuck E. Cheese emerged from bankruptcy in December 2020 after ownership was passed to its creditors, including investment firms Monarch Alternative Capital and Redan Advisors, who agreed to eliminate $705 million in debt from its balance sheet.
The company and its franchisees operate nearly 600 Chuck E. Cheese locations and over 120 Peter Piper Pizza locations globally. It also owns virtual kitchen concept Pasqually's Pizza & Wings.
(Reporting by Abigail Summerville in New York; Editing by Daniel Wallis)
((abigail.summerville@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Abigail Summerville Dec 14 (Reuters) - Chuck E. Cheese, the U.S. restaurant chain that emerged from bankruptcy three years ago, is exploring a sale amid acquisition interest, according to people familiar with the matter. CEC Entertainment, the parent company of Chuck E. Cheese, has told potential acquirers it expects to generate around 1.2 billion in revenue and $195 million in earnings before interest, taxes, depreciation and amortization (EBITDA) this year, the sources added. Chuck E. Cheese emerged from bankruptcy in December 2020 after ownership was passed to its creditors, including investment firms Monarch Alternative Capital and Redan Advisors, who agreed to eliminate $705 million in debt from its balance sheet.
|
The Irving, Texas-based company, known for its arcade games and rat mascot Charles Entertainment "Chuck E." Cheese, is working with investment bank Goldman Sachs GS.N on an auction process that could attract private equity firms as well as peers such as Dave & Busters Entertainment PLAY.O, the sources said. CEC Entertainment and Dave & Busters did not immediately respond to requests for comment. Private equity firm Apollo Global Management Inc APO.N acquired Chuck E. Cheese in 2014 for $1.3 billion, including debt.
|
By Abigail Summerville Dec 14 (Reuters) - Chuck E. Cheese, the U.S. restaurant chain that emerged from bankruptcy three years ago, is exploring a sale amid acquisition interest, according to people familiar with the matter. The Irving, Texas-based company, known for its arcade games and rat mascot Charles Entertainment "Chuck E." Cheese, is working with investment bank Goldman Sachs GS.N on an auction process that could attract private equity firms as well as peers such as Dave & Busters Entertainment PLAY.O, the sources said. CEC Entertainment, the parent company of Chuck E. Cheese, has told potential acquirers it expects to generate around 1.2 billion in revenue and $195 million in earnings before interest, taxes, depreciation and amortization (EBITDA) this year, the sources added.
|
The Irving, Texas-based company, known for its arcade games and rat mascot Charles Entertainment "Chuck E." Cheese, is working with investment bank Goldman Sachs GS.N on an auction process that could attract private equity firms as well as peers such as Dave & Busters Entertainment PLAY.O, the sources said. CEC Entertainment and Dave & Busters did not immediately respond to requests for comment. Private equity firm Apollo Global Management Inc APO.N acquired Chuck E. Cheese in 2014 for $1.3 billion, including debt.
|
028be56a-a0a2-44bc-b0b3-89e722d2587b
|
711776.0
|
2023-12-13 00:00:00 UTC
|
Is Aramark Stock a Buy for 2024?
|
DCOMP
|
https://www.nasdaq.com/articles/is-aramark-stock-a-buy-for-2024
|
nan
|
nan
|
Aramark (NYSE: ARMK) may not be a household name, but there's a very good chance you or someone living in your household regularly benefits from its services. The company provides solutions ranging from kitchen catering to building maintenance to supply chain management for hotels, schools, prisons, sports stadiums, and more.
Its service and expertise is "for hire" to institutions looking to focus their time and attention on more important operations. And the company is good at what it does.
Being a great company, however, doesn't inherently mean its stock is a great investment. Sometimes there are simply too many other, better options in a particular environment. You could do worse than owning a stake in Aramark, to be sure. But right now, you could also certainly do far better.
Aramark on the defensive
Don't panic if you already own this stock. Your portfolio isn't doomed. You'll be fine.
On the flip side, there's nothing on the horizon suggesting 2024 is going to be an especially great year for the company. Aramark stock's per-share earnings, in fact, are projected to slide from last fiscal year's (ending in September) $1.70 to 1.51 per share. That can largely be attributed to an 8% year-over-year tumble in revenue.
The culprit behind this revenue contraction? The recent spinoff of its slower-growth uniform business is a factor to be sure. Without that, Aramark expects to see some top- and bottom-line growth in 2024. A combination of inflation and its subsequent economic malaise, though, should keep any growth in check.
With the rising costs of running kitchens and taking care of campuses being passed along to schools, hotels, and other such entities, institutions are now shopping around for more cost-effective options. Just this year, Aramark lost contracts serving a seven-hospital network in Texas, a couple of different colleges, and the maintenance contract for Providence, Rhode Island's public schools, just to name a few. The loss of these customers is a taste of a bigger, broader headwind.
In the meantime, the industries that could create new opportunities for Aramark are struggling in other ways. Plans to construct a $1.2 billion mixed-use condo, retail, and office building in San Francisco were halted in August "until markets normalize," while in April, Google parent Alphabet stopped work on an 80-acre campus development in San Jose due to economic lethargy.
Again, these instances are part of a more pervasive 2023 theme that's drifting into 2024 -- institutions are culling spending when and where they can. It's hitting Aramark right in the gut.
A recovery is still pretty far down the road
There is some good news: Analysts believe the domestic and global economy will bounce back in 2025 following whatever weakness is in the cards for 2024. That bodes well for Aramark in the long run, and it's certainly survived worse than what's likely brewing for the near term. The uncertain timing of such a turnaround, however, makes shares of this slow-moving company tough to stick with in the meantime.
The Federal Reserve laid out the bigger-picture framework on Wednesday. As was widely expected, it didn't raise interest rates (again) this month. Indeed, with consumer spending, income, and price increases all continuing to moderate back to more nominal levels, the Fed's governors now collectively believe they'll be able to safely cut interest rates three times in the coming year.
At first blush, it's bullish. Take a step back and think about the bigger picture, though. The Fed generally cuts interest rates when the economy needs help, rather than as a means of cooling it off.
Also bear in mind that the yield curve remains inverted, where interest rates on shorter-term debt instruments are uncharacteristically above rates on longer-term bonds and debt. Inverted yield curves don't outright guarantee a recession is in the offing, but it's a rarity when they don't correctly flag one coming in the foreseeable future.
10-2 Year Treasury Yield Spread data by YCharts
At the very least, the current inversion suggests a so-called soft landing is the best possible economic scenario for 2024. That's certainly better than a hard landing, but it's still far from the robust economic growth we'd like to see coming.
More important to investors, it's not a scenario that favors Aramark. There are plenty of other companies that can do so much better in the same lethargic environment.
Aramark stock is not your best bet anytime soon
Still like it? No problem. As mentioned, Aramark will certainly hang on while we're all waiting for better days. It's possible the stock will rally anyway despite the company's current challenges. Shareholders will continue collecting dividends in the meantime. From a risk-versus-reward perspective, though, the modest risk here is being paired with even more modest reward potential.
In other words, there aren't enough prospective gains in the cards here to justify taking the risk when you can find a more compelling risk/reward scenario with so many other stocks. You'll want to see major building projects get going again at the same time schools, hotels, and other major institutions start worrying a little less about costs before Aramark is an investment prospect worth a shot.
Should you invest $1,000 in Aramark right now?
Before you buy stock in Aramark, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Aramark wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. James Brumley has positions in Alphabet. The Motley Fool has positions in and recommends Alphabet. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The company provides solutions ranging from kitchen catering to building maintenance to supply chain management for hotels, schools, prisons, sports stadiums, and more. Indeed, with consumer spending, income, and price increases all continuing to moderate back to more nominal levels, the Fed's governors now collectively believe they'll be able to safely cut interest rates three times in the coming year. 10-2 Year Treasury Yield Spread data by YCharts At the very least, the current inversion suggests a so-called soft landing is the best possible economic scenario for 2024.
|
Indeed, with consumer spending, income, and price increases all continuing to moderate back to more nominal levels, the Fed's governors now collectively believe they'll be able to safely cut interest rates three times in the coming year. Before you buy stock in Aramark, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Aramark wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors.
|
Aramark on the defensive Don't panic if you already own this stock. Before you buy stock in Aramark, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Aramark wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors.
|
And the company is good at what it does. Aramark on the defensive Don't panic if you already own this stock. Before you buy stock in Aramark, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Aramark wasn't one of them.
|
c0d84122-8556-473b-9a48-a91a242e7d43
|
711777.0
|
2023-12-13 00:00:00 UTC
|
Better Cloud Stock: Snowflake vs. Oracle
|
DCOMP
|
https://www.nasdaq.com/articles/better-cloud-stock%3A-snowflake-vs.-oracle
|
nan
|
nan
|
Snowflake (NYSE: SNOW) and Oracle (NYSE: ORCL) represent two different ways to invest in the growing cloud market. Snowflake helps companies clean up and aggregate large amounts of data for third-party applications through its cloud-based data warehouses. Oracle is the world's largest database software company, and it's transformed a lot of its on-site applications into cloud-based services over the past decade.
Snowflake usually attracts growth-oriented investors, while Oracle's slower expansion rates, stable profits, and steady dividends make it more appealing to value-oriented investors. But over the past three years, Snowflake's stock declined about 45% as Oracle's shares soared 66%. Let's see why that happened and whether Oracle is still the better buy.
Image source: Getty Images.
Snowflake's valuation is limiting its gains
Snowflake has grown like a weed since its public debut in September 2020. Its product revenue (which accounts for most of its top line) soared 120% in fiscal 2021 (ended in January 2021), 106% in fiscal 2022, and 70% in fiscal 2023.
It grew rapidly for three reasons. First, it was compatible with a wide range of public cloud platforms -- including Amazon Web Services (AWS) and Microsoft Azure -- and didn't lock its clients into a stickier cloud ecosystem. Second, it only charged its users for the computing power and storage they used instead of locking them into subscriptions. Finally, it broke down the silos across different departments and computing platforms by pulling all of an organization's data into a centralized location where it could be easily analyzed to make business decisions.
But in fiscal 2024, Snowflake only expects its product revenue to rise 37% to $2.65 billion as macro headwinds drive companies to rein in their cloud spending. However, it still forecasts $10 billion in product revenue by fiscal 2029, which implies its top line will climb at a compound annual growth rate (CAGR) of 30% from fiscal 2024 to fiscal 2029. That long-term outlook is ambitious, but a lot of growth has been baked into its stock, which is priced 22 times this year's sales.
Snowflake's adjusted operating margins have been expanding, but it remains deeply unprofitable on a generally accepted accounting principles (GAAP) basis. All of that red ink -- along with its slowing growth and frothy valuation -- made it an easy target for the bears as interest rates rose over the past two years.
Oracle became an attractive safe-haven stock
Oracle is growing a lot slower than Snowflake. Its revenue only rose 4% in fiscal 2021 (ended in May 2021), climbed 5% in fiscal 2022, and increased 7% on an organic basis (excluding its acquisition of the healthcare giant Cerner) in fiscal 2023. But it's also firmly profitable, has generated plenty of cash, and has consistently bought back its shares.
Most of Oracle's recent growth has been driven by its cloud-based software and infrastructure services, which accounted for 37% of its top line in its latest quarter. Its cloud growth has decelerated amid the macro headwinds over the past year, but it's still offsetting the slower expansion of its legacy on-site hardware and software businesses.
Oracle's operating margins also continue to widen as it scales up its cloud segment, streamlines Cerner's lower-margin business, and executes other cost-cutting measures. At the end of the second quarter of fiscal 2024, its trailing-12-month free cash flow (FCF) had risen 20% year over year to $10.1 billion. That robust cash flow growth enabled it to buy back $600 million in shares in the first half of fiscal 2024 while paying out $2.2 billion in dividends.
Analysts expect Oracle's revenue and adjusted EPS to both increase 8% this year. Its stock still seems reasonably valued at 18 times forward earnings and it pays a decent forward yield of 1.4%. Oracle probably won't impress growth, value, or income investors anytime soon, but its stability has made it an appealing safe-haven stock as rising interest rates rattled the market. That's probably why it outperformed Snowflake over the past three years.
The better buy: Oracle
Snowflake is still growing, but its high valuation could limit its gains over the next few years. Oracle's growth rates are less impressive, but it should remain the better investment as long as interest rates stay high in this tough macro environment.
Should you invest $1,000 in Snowflake right now?
Before you buy stock in Snowflake, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Snowflake wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Leo Sun has positions in Amazon. The Motley Fool has positions in and recommends Amazon, Microsoft, Oracle, and Snowflake. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Finally, it broke down the silos across different departments and computing platforms by pulling all of an organization's data into a centralized location where it could be easily analyzed to make business decisions. Its cloud growth has decelerated amid the macro headwinds over the past year, but it's still offsetting the slower expansion of its legacy on-site hardware and software businesses. Oracle probably won't impress growth, value, or income investors anytime soon, but its stability has made it an appealing safe-haven stock as rising interest rates rattled the market.
|
Snowflake usually attracts growth-oriented investors, while Oracle's slower expansion rates, stable profits, and steady dividends make it more appealing to value-oriented investors. But in fiscal 2024, Snowflake only expects its product revenue to rise 37% to $2.65 billion as macro headwinds drive companies to rein in their cloud spending. Oracle became an attractive safe-haven stock Oracle is growing a lot slower than Snowflake.
|
But over the past three years, Snowflake's stock declined about 45% as Oracle's shares soared 66%. Oracle became an attractive safe-haven stock Oracle is growing a lot slower than Snowflake. Before you buy stock in Snowflake, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Snowflake wasn't one of them.
|
Oracle became an attractive safe-haven stock Oracle is growing a lot slower than Snowflake. Before you buy stock in Snowflake, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Snowflake wasn't one of them. The Motley Fool has positions in and recommends Amazon, Microsoft, Oracle, and Snowflake.
|
c39e7812-916f-4a55-8ee8-b4c93a489063
|
711778.0
|
2023-12-13 00:00:00 UTC
|
Beyond Meat's Business Came Up Against a Major Problem in 2023. Management Will Try a Different Strategy in 2024.
|
DCOMP
|
https://www.nasdaq.com/articles/beyond-meats-business-came-up-against-a-major-problem-in-2023.-management-will-try-a
|
nan
|
nan
|
When I first bought shares of plant-based meat company Beyond Meat (NASDAQ: BYND) in 2020, two words were on my mind: price parity.
I believed that Beyond Meat would have an explosive growth opportunity if it could reduce the prices of its products until they cost the same as (or even less than) animal-based protein. In that scenario, its products could go mainstream as ordinary consumers switched to plant-based meat to save money. This would drive sales volume growth, allowing Beyond Meat to gain scale and give it a competitive advantage on the cost of manufacturing.
That was my investment thesis for Beyond Meat, but unfortunately, I've been dead wrong. And what happened in 2023 is proof that I need to go back to the drawing board.
Here's what happened to Beyond Meat this year
On the third-quarter earnings call, Beyond Meat founder and CEO Ethan Brown said, "Over the last year, we've used pricing in an effort to bring new consumers into the category." In other words, the company lowered prices hoping that people would give its products a try for the first time.
There are plenty of downsides to this price-cutting strategy, the most prominent of which is what it does to profitability. But give Beyond Meat a lot of credit: To support that plan, it lowered its cost of goods sold by 18% year over year in Q3. That's enormous.
Unfortunately, it wasn't enough. The company reported a gross loss on its revenue that quarter.
Data by YCharts.
One could argue that Beyond Meat's current situation is acceptable. After all, if lowering prices brings new consumers to the category, then near-term gross losses would simply be the path to higher future revenues and eventually better profits as it gains efficiencies of scale.
Unfortunately, this glass-half-full assessment wasn't Beyond Meat's reality in 2023. On the Q3earnings call Brown went on to say, "While these pricing programs are effective in generating cash and inventory, they did not help us move from early adopters to mainstream consumers."
And that's the problem: Beyond Meat hasn't been gaining enough new customers.
Its major problem is most visible within its U.S. retail business. In Q3, the company's products were available at 79,000 retail points of distribution domestically, which was slightly more than in the prior-year period. However, its sales volume (measured in pounds) via U.S. retail fell 30% year over year.
For clarification, I'm focusing on Beyond Meat's U.S. retail business because that's its biggest segment. There are a few promising signs internationally and with its foodservice partnerships, but U.S. retail has accounted for 46% of its revenue year to date and 43% of the volume, so it's the most important part of the company for investors to focus on.
Beyond Meat is changing strategies for 2024
Beyond Meat's 2023 price cuts decimated its bottom line and failed to win it new customers or boost sales volume. Since the strategy clearly didn't work, management will take a different approach in 2024.
The details of Beyond Meat's plans are still being worked out, but Brown said, "As we look to 2024, we expect to implement a more nuanced pricing strategy, keeping certain programs and pricing in place while adjusting others in support of gross margin expansion."
In other words, it appears Beyond Meat will raise its prices for certain products in an effort to return the company to gross profitability. I'm not sure what other choices it has at this point, but that doesn't necessarily mean I believe its revised strategy will work.
Beyond Meat is stuck between a rock and a hard place. It can keep lowering prices and exacerbate its losses in hopes of gaining new customers -- a strategy that hasn't worked so far -- or it can raise prices to improve its profitability at the risk of losing some of its early adopters by increasing prices beyond what they're willing to pay.
The company can't turn itself into a winning investment simply by adjusting its pricing model. To be a winning investment, it needs to grow its customer base. That hasn't happened lately, and I'm not sure it will happen in the coming year, leaving me with no choice but to considering selling my shares.
Should you invest $1,000 in Beyond Meat right now?
Before you buy stock in Beyond Meat, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Beyond Meat wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Jon Quast has positions in Beyond Meat. The Motley Fool has positions in and recommends Beyond Meat. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This would drive sales volume growth, allowing Beyond Meat to gain scale and give it a competitive advantage on the cost of manufacturing. After all, if lowering prices brings new consumers to the category, then near-term gross losses would simply be the path to higher future revenues and eventually better profits as it gains efficiencies of scale. There are a few promising signs internationally and with its foodservice partnerships, but U.S. retail has accounted for 46% of its revenue year to date and 43% of the volume, so it's the most important part of the company for investors to focus on.
|
After all, if lowering prices brings new consumers to the category, then near-term gross losses would simply be the path to higher future revenues and eventually better profits as it gains efficiencies of scale. In other words, it appears Beyond Meat will raise its prices for certain products in an effort to return the company to gross profitability. Before you buy stock in Beyond Meat, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Beyond Meat wasn't one of them.
|
Here's what happened to Beyond Meat this year On the third-quarter earnings call, Beyond Meat founder and CEO Ethan Brown said, "Over the last year, we've used pricing in an effort to bring new consumers into the category." Beyond Meat is changing strategies for 2024 Beyond Meat's 2023 price cuts decimated its bottom line and failed to win it new customers or boost sales volume. Before you buy stock in Beyond Meat, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Beyond Meat wasn't one of them.
|
The details of Beyond Meat's plans are still being worked out, but Brown said, "As we look to 2024, we expect to implement a more nuanced pricing strategy, keeping certain programs and pricing in place while adjusting others in support of gross margin expansion." In other words, it appears Beyond Meat will raise its prices for certain products in an effort to return the company to gross profitability. It can keep lowering prices and exacerbate its losses in hopes of gaining new customers -- a strategy that hasn't worked so far -- or it can raise prices to improve its profitability at the risk of losing some of its early adopters by increasing prices beyond what they're willing to pay.
|
6f5f7f04-c45e-4245-b8ea-fed9cfa0da86
|
711779.0
|
2023-12-13 00:00:00 UTC
|
Health Care Sector Update for 12/15/2023: VRCA, AADI, HCSG, ELV, CI, ACIU
|
DCOMP
|
https://www.nasdaq.com/articles/health-care-sector-update-for-12-15-2023%3A-vrca-aadi-hcsg-elv-ci-aciu
|
nan
|
nan
|
Health care stocks were declining late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both down nearly 1%.
The iShares Biotechnology ETF (IBB) fell 0.7%.
In corporate news, Verrica Pharmaceuticals (VRCA) shares soared 57% after it said Friday a phase 3 trial of TO-208 in Japan to treat molluscum contagiosum yielded positive top-line results.
Health Care Service (HCSG) and Elevance Health (ELV) emerged as potential buyers of Cigna's (CI) Medicare Advantage business, Bloomberg reported Friday. Health Care Service shares were down 1%, Elevance Health stock was shedding 2.7% and Cigna fell 3.2%.
AC Immune (ACIU) shares jumped 3.2% after it said that a phase 2b trial to evaluate ACI-35.030 in people with preclinical Alzheimer's disease, or those individuals not yet showing symptoms, is set to be launched.
Aadi Biosciences (AADI) shares sank 57% after the company reported late Thursday an overall response rate of up to 26% in a tumor-agnostic trial assessing nab-sirolimus.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In corporate news, Verrica Pharmaceuticals (VRCA) shares soared 57% after it said Friday a phase 3 trial of TO-208 in Japan to treat molluscum contagiosum yielded positive top-line results. Health Care Service (HCSG) and Elevance Health (ELV) emerged as potential buyers of Cigna's (CI) Medicare Advantage business, Bloomberg reported Friday. AC Immune (ACIU) shares jumped 3.2% after it said that a phase 2b trial to evaluate ACI-35.030 in people with preclinical Alzheimer's disease, or those individuals not yet showing symptoms, is set to be launched.
|
Health care stocks were declining late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both down nearly 1%. Health Care Service (HCSG) and Elevance Health (ELV) emerged as potential buyers of Cigna's (CI) Medicare Advantage business, Bloomberg reported Friday. Health Care Service shares were down 1%, Elevance Health stock was shedding 2.7% and Cigna fell 3.2%.
|
Health care stocks were declining late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both down nearly 1%. Health Care Service (HCSG) and Elevance Health (ELV) emerged as potential buyers of Cigna's (CI) Medicare Advantage business, Bloomberg reported Friday. Health Care Service shares were down 1%, Elevance Health stock was shedding 2.7% and Cigna fell 3.2%.
|
In corporate news, Verrica Pharmaceuticals (VRCA) shares soared 57% after it said Friday a phase 3 trial of TO-208 in Japan to treat molluscum contagiosum yielded positive top-line results. Health Care Service shares were down 1%, Elevance Health stock was shedding 2.7% and Cigna fell 3.2%. AC Immune (ACIU) shares jumped 3.2% after it said that a phase 2b trial to evaluate ACI-35.030 in people with preclinical Alzheimer's disease, or those individuals not yet showing symptoms, is set to be launched.
|
15e11f6a-d4c4-4346-8365-77e5de7acd83
|
711780.0
|
2023-12-13 00:00:00 UTC
|
After Hours Most Active for Dec 15, 2023 : UBER, LCID, PFE, KO, AAPL, PCG, EBAY, ALK, MSFT, SEE, CSCO, XP
|
DCOMP
|
https://www.nasdaq.com/articles/after-hours-most-active-for-dec-15-2023-%3A-uber-lcid-pfe-ko-aapl-pcg-ebay-alk-msft-see-csco
|
nan
|
nan
|
The NASDAQ 100 After Hours Indicator is down -15.94 to 16,607.51. The total After hours volume is currently 693,412,919 shares traded.
The following are the most active stocks for the after hours session:
Uber Technologies, Inc. (UBER) is -0.25 at $61.61, with 63,192,526 shares traded. As reported by Zacks, the current mean recommendation for UBER is in the "buy range".
Lucid Group, Inc. (LCID) is +0.01 at $4.78, with 50,992,533 shares traded. As reported in the last short interest update the days to cover for LCID is 10.347728; this calculation is based on the average trading volume of the stock.
Pfizer, Inc. (PFE) is unchanged at $26.63, with 29,902,776 shares traded. PFE's current last sale is 73.97% of the target price of $36.
Coca-Cola Company (The) (KO) is +0.08 at $58.68, with 17,162,260 shares traded. As reported by Zacks, the current mean recommendation for KO is in the "buy range".
Apple Inc. (AAPL) is -1.23 at $196.34, with 16,645,942 shares traded. As reported by Zacks, the current mean recommendation for AAPL is in the "buy range".
Pacific Gas & Electric Co. (PCG) is -0.12 at $17.64, with 15,690,322 shares traded. As reported by Zacks, the current mean recommendation for PCG is in the "buy range".
eBay Inc. (EBAY) is unchanged at $41.75, with 13,980,742 shares traded. EBAY's current last sale is 92.78% of the target price of $45.
Alaska Air Group, Inc. (ALK) is +0.0016 at $38.95, with 13,911,522 shares traded. As reported by Zacks, the current mean recommendation for ALK is in the "buy range".
Microsoft Corporation (MSFT) is -0.83 at $369.90, with 13,513,771 shares traded. As reported by Zacks, the current mean recommendation for MSFT is in the "buy range".
Sealed Air Corporation (SEE) is +0.0016 at $35.70, with 13,430,373 shares traded. SEE's current last sale is 91.54% of the target price of $39.
Cisco Systems, Inc. (CSCO) is unchanged at $49.87, with 12,634,216 shares traded. CSCO's current last sale is 90.67% of the target price of $55.
XP Inc. (XP) is +0.1 at $24.64, with 12,332,857 shares traded. As reported by Zacks, the current mean recommendation for XP is in the "buy range".
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
As reported by Zacks, the current mean recommendation for UBER is in the "buy range". As reported in the last short interest update the days to cover for LCID is 10.347728; this calculation is based on the average trading volume of the stock. As reported by Zacks, the current mean recommendation for XP is in the "buy range".
|
The total After hours volume is currently 693,412,919 shares traded. As reported by Zacks, the current mean recommendation for UBER is in the "buy range". As reported by Zacks, the current mean recommendation for KO is in the "buy range".
|
The total After hours volume is currently 693,412,919 shares traded. As reported by Zacks, the current mean recommendation for UBER is in the "buy range". As reported by Zacks, the current mean recommendation for XP is in the "buy range".
|
As reported by Zacks, the current mean recommendation for UBER is in the "buy range". As reported by Zacks, the current mean recommendation for KO is in the "buy range". As reported by Zacks, the current mean recommendation for AAPL is in the "buy range".
|
fb77e1a0-0efd-474b-bdd9-042b4a707c28
|
711781.0
|
2023-12-13 00:00:00 UTC
|
Where Will Adobe Stock Be in 1 Year?
|
DCOMP
|
https://www.nasdaq.com/articles/where-will-adobe-stock-be-in-1-year-0
|
nan
|
nan
|
Adobe (NASDAQ: ADBE) posted its latest earnings report on Dec. 13. For the fourth quarter of fiscal 2023 (which ended on Dec. 1), the cloud software giant's revenue rose 12% year over year (13% in constant currency terms) to $5.05 billion and surpassed analysts' estimates by $30 million. Its adjusted EPS grew 19% to $4.27 and beat expectations by $0.13 per share.
Those headline numbers seemed healthy, but Adobe's stock dropped in response to its lackluster guidance and regulatory challenges. Let's see whether that decline was justified -- and if Adobe's stock might still head higher over the next 12 months.
Image source: Getty Images.
The key numbers on Adobe
For the full year, Adobe generated 73% of its revenue from its digital media business, which houses its Creative Cloud (Photoshop, Premiere Pro, Illustrator, and other digital media applications) and Document Cloud (Acrobat and Sign) services. It generated 25% of its revenue from its digital experience segment, which provides other enterprise-oriented marketing, commerce, and analytics services. Here's how those two businesses fared over the past year in constant currency terms.
GROWTH BY SEGMENT (YOY)
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Digital media revenue
14%
14%
14%
14%
14%
Digital experience revenue
16%
14%
14%
11%
11%
Total revenue
14%
13%
13%
13%
13%
Data source: Adobe. Constant currency terms. YOY = year over year.
The stable growth of Adobe's digital media segment offset the slower growth of its digital experience business, which faced tougher macro headwinds as large companies reined in their cloud spending. Digital media held steady because most media professionals won't cancel their subscriptions for its industry-standard production tools just to save a few dollars.
Adobe didn't execute any major layoffs over the past year, but it did optimize its R&D and marketing expenses. That's why its adjusted operating margin rose from 45.1% in fiscal 2022 to 45.9% in fiscal 2023. During the conference call, CFO Dan Durn said it would strive to keep its adjusted operating margin in the "mid-40s" -- even as it ramps up its spending on new artificial intelligence (AI) services and works toward closing its $20 billion acquisition of Figma.
Why did Adobe's stock drop?
Adobe's core businesses are still growing, but its guidance disappointed investors. For the full year, its revenue rose 13% in constant currency terms and 10% on a reported basis. But for fiscal 2024, it only expects its revenue to climb 10%-11% on a reported basis versus the consensus forecast for 12% growth.
That softer-than-expected outlook suggested that Adobe's new generative AI tools wouldn't significantly boost its near-term revenue, even though they could potentially increase the stickiness of its ecosystem with tools for creating AI-generated images, photos, and 3D models while accelerating tasks across its enterprise-oriented services.
Adobe also disclosed that the Federal Trade Commission (FTC) had been investigating the strict rules for canceling its subscriptions over the past 18 months. It warned that it could incur "significant monetary costs" to resolve that matter. Its pending acquisition of Figma, which was originally scheduled to close this year, also remains in limbo amid antitrust challenges in Europe. Opponents of the deal claim the purchase of Figma -- Adobe XD's top competitor in the user interface and user experience design markets -- would enable it to dominate the niche space and unfairly strengthen its ecosystem.
Adobe expects its adjusted EPS to rise 10%-12% in fiscal 2024, which was slightly higher than analysts' forecast for a 10% increase. However, that would still represent a slowdown from its 17% growth in fiscal 2023, and it doesn't include the potential impacts from the Figma deal or the ongoing FTC investigation on its bottom line.
Those issues seemed to drive investors to finally take profits in Adobe stock, which had already risen 86% year to date prior to the company's latest earnings report. A lot of that growth was driven by the buying frenzy in AI stocks, which boosted its valuation to historical highs. But at $590 per share, Adobe still doesn't look cheap at 33 times forward earnings.
Where will Adobe's stock be in a year?
Adobe had a great run over the past year, but I believe 2024 will be tougher as it struggles to meaningfully ramp up its generative AI services, navigates a tricky FTC investigation, and tries to close its takeover of Figma. Adobe's stock probably won't plunge off a cliff, but it could struggle to outperform the market and justify its premium valuation.
Should you invest $1,000 in Adobe right now?
Before you buy stock in Adobe, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Adobe wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Leo Sun has positions in Adobe. The Motley Fool has positions in and recommends Adobe. The Motley Fool recommends the following options: long January 2024 $420 calls on Adobe and short January 2024 $430 calls on Adobe. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
During the conference call, CFO Dan Durn said it would strive to keep its adjusted operating margin in the "mid-40s" -- even as it ramps up its spending on new artificial intelligence (AI) services and works toward closing its $20 billion acquisition of Figma. Those issues seemed to drive investors to finally take profits in Adobe stock, which had already risen 86% year to date prior to the company's latest earnings report. Adobe had a great run over the past year, but I believe 2024 will be tougher as it struggles to meaningfully ramp up its generative AI services, navigates a tricky FTC investigation, and tries to close its takeover of Figma.
|
For the fourth quarter of fiscal 2023 (which ended on Dec. 1), the cloud software giant's revenue rose 12% year over year (13% in constant currency terms) to $5.05 billion and surpassed analysts' estimates by $30 million. The key numbers on Adobe For the full year, Adobe generated 73% of its revenue from its digital media business, which houses its Creative Cloud (Photoshop, Premiere Pro, Illustrator, and other digital media applications) and Document Cloud (Acrobat and Sign) services. Digital media revenue 14% 14% 14% 14% 14% Digital experience revenue 16% 14% 14% 11% 11% Total revenue 14% 13% 13% 13% 13% Data source: Adobe.
|
The key numbers on Adobe For the full year, Adobe generated 73% of its revenue from its digital media business, which houses its Creative Cloud (Photoshop, Premiere Pro, Illustrator, and other digital media applications) and Document Cloud (Acrobat and Sign) services. Digital media revenue 14% 14% 14% 14% 14% Digital experience revenue 16% 14% 14% 11% 11% Total revenue 14% 13% 13% 13% 13% Data source: Adobe. Before you buy stock in Adobe, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Adobe wasn't one of them.
|
For the full year, its revenue rose 13% in constant currency terms and 10% on a reported basis. Where will Adobe's stock be in a year? Before you buy stock in Adobe, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Adobe wasn't one of them.
|
d4070b17-2897-4981-a77a-835e06aa3ab2
|
711782.0
|
2023-12-13 00:00:00 UTC
|
Celanese (CE) Rallies 48% YTD: What's Driving the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/celanese-ce-rallies-48-ytd%3A-whats-driving-the-stock
|
nan
|
nan
|
Celanese Corporation’s CE shares have shot up 48.5% year to date. The company has also outperformed its industry’s rise of 16.7% over the same time frame. Moreover, it has topped the S&P 500’s roughly 22.6% rise over the same period.
Let’s dive into the factors behind this Zacks Rank #3 (Hold) stock’s price appreciation.
Image Source: Zacks Investment Research
What’s Aiding CE?
Celanese is gaining from its investments in organic projects, strategic acquisitions and productivity measures amid challenges from weak demand and customer destocking in certain end markets.
The company is actively pursuing acquisitions, which are providing it opportunities for additional growth, investment and synergies. The acquisition of the majority of DuPont’s Mobility & Materials (“M&M”) business has allowed Celanese to enhance its growth in high-value applications. M&M contributed $125 million to the company’s operating EBITDA in third-quarter 2023, up 15% sequentially. Celanese sees a sequential increase in contribution in the fourth quarter.
The acquisitions of SO.F.TER., Nilit and Omni Plastics are also expected to contribute to earnings expansion in the company's Engineered Materials segment. The Elotex acquisition also strengthened the company’s position in the vinyl acetate ethylene emulsions space. Moreover, the purchase of Exxon Mobil's Santoprene business broadened the company’s portfolio of engineered solutions and enables it to offer a wider range of functionalized solutions to targeted growth areas, including future mobility, medical and sustainability.
Celanese also remains focused on executing its productivity programs that include the implementation of a number of cost reduction capital projects. Productivity actions are expected to support to its margins in 2023.
The company is proactively implementing strategic initiatives recognizing the volatility and unpredictability of the current market landscape and competitive environment. These actions involve strengthening its commercial teams, aligning production and inventory levels with prevailing demand, implementing cost-saving measures, and optimizing cash flow.
These endeavors are expected to result in robust cash generation and a continuation of earnings growth. The company's incremental cost actions are expected to deliver $60-$80 million in savings in the second half of 2023.
Celanese Corporation Price and Consensus
Celanese Corporation price-consensus-chart | Celanese Corporation Quote
Stocks to Consider
Better-ranked stocks worth a look in the basic materials space include Denison Mines Corp. DNN, Axalta Coating Systems Ltd. AXTA and Hawkins, Inc. HWKN.
Denison Mines has a projected earnings growth rate of 100% for the current year. DNN has a trailing four-quarter earnings surprise of roughly 225%, on average. The stock is up around 57% in a year. It currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, the Zacks Consensus Estimate for Axalta Coating Systems’ current-year earnings has been revised upward by 8.2%. AXTA, carrying a Zacks Rank #1, beat the Zacks Consensus Estimate in three of the last four quarters while missing in one quarter, with the average earnings surprise being 6.7%. The company’s shares have gained around 32% in the past year.
Hawkins has a projected earnings growth rate of 21% for the current year. It currently carries a Zacks Rank #2 (Buy). Hawkins has a trailing four-quarter earnings surprise of roughly 27.5%, on average. HWKN shares have rallied around 86% in a year.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Celanese Corporation (CE) : Free Stock Analysis Report
Denison Mine Corp (DNN) : Free Stock Analysis Report
Axalta Coating Systems Ltd. (AXTA) : Free Stock Analysis Report
Hawkins, Inc. (HWKN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Celanese is gaining from its investments in organic projects, strategic acquisitions and productivity measures amid challenges from weak demand and customer destocking in certain end markets. Celanese also remains focused on executing its productivity programs that include the implementation of a number of cost reduction capital projects. These actions involve strengthening its commercial teams, aligning production and inventory levels with prevailing demand, implementing cost-saving measures, and optimizing cash flow.
|
Celanese Corporation Price and Consensus Celanese Corporation price-consensus-chart | Celanese Corporation Quote Stocks to Consider Better-ranked stocks worth a look in the basic materials space include Denison Mines Corp. DNN, Axalta Coating Systems Ltd. AXTA and Hawkins, Inc. HWKN. In the past 60 days, the Zacks Consensus Estimate for Axalta Coating Systems’ current-year earnings has been revised upward by 8.2%. Click to get this free report Celanese Corporation (CE) : Free Stock Analysis Report Denison Mine Corp (DNN) : Free Stock Analysis Report Axalta Coating Systems Ltd. (AXTA) : Free Stock Analysis Report Hawkins, Inc. (HWKN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Celanese Corporation Price and Consensus Celanese Corporation price-consensus-chart | Celanese Corporation Quote Stocks to Consider Better-ranked stocks worth a look in the basic materials space include Denison Mines Corp. DNN, Axalta Coating Systems Ltd. AXTA and Hawkins, Inc. HWKN. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year. Click to get this free report Celanese Corporation (CE) : Free Stock Analysis Report Denison Mine Corp (DNN) : Free Stock Analysis Report Axalta Coating Systems Ltd. (AXTA) : Free Stock Analysis Report Hawkins, Inc. (HWKN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The stock is up around 57% in a year. AXTA, carrying a Zacks Rank #1, beat the Zacks Consensus Estimate in three of the last four quarters while missing in one quarter, with the average earnings surprise being 6.7%. The company’s shares have gained around 32% in the past year.
|
e0cd78c3-52a8-4b91-9e8c-4e3e0e253894
|
711783.0
|
2023-12-13 00:00:00 UTC
|
A Bull Market Is Coming: 1 Stock-Split Growth Stock to Buy Now With $50
|
DCOMP
|
https://www.nasdaq.com/articles/a-bull-market-is-coming%3A-1-stock-split-growth-stock-to-buy-now-with-%2450
|
nan
|
nan
|
In this video, I will be talking about an energy drink company called Celsius Holdings (NASDAQ: CELH). Celsius stock has been outperforming the market these past few years, had a 3-to-1 stock split, and has seen its stock go down 30% in the past few months.
*Stock prices used were from the trading day of Dec. 12, 2023. The video was published on Dec. 13, 2023.
Should you invest $1,000 in Celsius right now?
Before you buy stock in Celsius, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Celsius wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Neil Rozenbaum has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Celsius. The Motley Fool has a disclosure policy. Neil is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In this video, I will be talking about an energy drink company called Celsius Holdings (NASDAQ: CELH). The 10 stocks that made the cut could produce monster returns in the coming years. If you choose to subscribe through his link, he will earn some extra money that supports his channel.
|
Before you buy stock in Celsius, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Celsius wasn't one of them. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Neil Rozenbaum has no position in any of the stocks mentioned.
|
Celsius stock has been outperforming the market these past few years, had a 3-to-1 stock split, and has seen its stock go down 30% in the past few months. Before you buy stock in Celsius, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Celsius wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Neil Rozenbaum has no position in any of the stocks mentioned.
|
Before you buy stock in Celsius, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Celsius wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Neil Rozenbaum has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Celsius.
|
95437b59-4a52-4280-bbff-99e6a5a3407e
|
711784.0
|
2023-12-13 00:00:00 UTC
|
Why Intel Stock Popped Today
|
DCOMP
|
https://www.nasdaq.com/articles/why-intel-stock-popped-today
|
nan
|
nan
|
Shares of Intel (NASDAQ: INTC) rose as much as 4.6% early Friday, then settled to trade up 1.7% as of 3:30 p.m. ET after the company announced a new generative artificial intelligence (AI) chip that could rival competitive offerings from Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD).
Intel gains ground in the AI chip race
Intel introduced several new chips at its AI Everywhere launch event in New York City on Thursday. But investors were arguably most excited after the company offered its first sneak peek at the new Intel Gaudi3 AI accelerator, a powerful chip focused on deep learning and large-scale generative AI models.
Intel says the Gaudi3 will offer a significant performance increase from its predecessor, the Gaudi2, that should make it competitive with rival AI accelerators already unveiled by both Nvidia and AMD. In its launch event press release yesterday, Intel added that it's enjoyed a "rapid expansion of its Guadi pipeline due to growing and proven performance advantages combined with highly competitive TCO [total cost of ownership] and pricing."
What's next for Intel stock?
AMD stock also soared last week after the company launched its new line of large accelerated processing units (APUs) designed for AI workloads. AMD CEO Lisa Su suggested at the time that the new products should enable her company to "get a nice piece" of what they expect will grow into a more than $400 billion market opportunity for AI chips by 2027.
Nvidia currently dominates that industry, commanding an estimated 80% market share in AI chips and leaving plenty of room for competitors like AMD and Intel to muscle their way in. With Intel's new Gaudi3 AI accelerator on schedule to arrive in 2024, it should be sufficiently early to capitalize on this mammoth opportunity.
Should you invest $1,000 in Intel right now?
Before you buy stock in Intel, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Intel wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Steve Symington has positions in Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices and Nvidia. The Motley Fool recommends Intel and recommends the following options: long January 2023 $57.50 calls on Intel, long January 2025 $45 calls on Intel, and short February 2024 $47 calls on Intel. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In its launch event press release yesterday, Intel added that it's enjoyed a "rapid expansion of its Guadi pipeline due to growing and proven performance advantages combined with highly competitive TCO [total cost of ownership] and pricing." AMD CEO Lisa Su suggested at the time that the new products should enable her company to "get a nice piece" of what they expect will grow into a more than $400 billion market opportunity for AI chips by 2027. Nvidia currently dominates that industry, commanding an estimated 80% market share in AI chips and leaving plenty of room for competitors like AMD and Intel to muscle their way in.
|
ET after the company announced a new generative artificial intelligence (AI) chip that could rival competitive offerings from Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD). Before you buy stock in Intel, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Intel wasn't one of them. The Motley Fool recommends Intel and recommends the following options: long January 2023 $57.50 calls on Intel, long January 2025 $45 calls on Intel, and short February 2024 $47 calls on Intel.
|
Intel gains ground in the AI chip race Intel introduced several new chips at its AI Everywhere launch event in New York City on Thursday. Before you buy stock in Intel, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Intel wasn't one of them. The Motley Fool recommends Intel and recommends the following options: long January 2023 $57.50 calls on Intel, long January 2025 $45 calls on Intel, and short February 2024 $47 calls on Intel.
|
ET after the company announced a new generative artificial intelligence (AI) chip that could rival competitive offerings from Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD). What's next for Intel stock? The Motley Fool has positions in and recommends Advanced Micro Devices and Nvidia.
|
32d9fa68-351a-4f1d-80fa-18c60e9d09ed
|
711785.0
|
2023-12-13 00:00:00 UTC
|
Why Microsoft Stock Could Run Out of Steam in 2024
|
DCOMP
|
https://www.nasdaq.com/articles/why-microsoft-stock-could-run-out-of-steam-in-2024
|
nan
|
nan
|
Microsoft (NASDAQ: MSFT) is one of the "Magnificent Seven" -- a small set of massive tech companies that were key drivers of the S&P 500's impressive 20%-plus returns so far this year. The company's role in artificial intelligence (AI) -- including its investment in and partnership with ChatGPT-maker OpenAI -- made it a popular stock for growth-oriented investors. But that attraction could face a big test next year when some investors will be looking for rapid signs that AI truly is having a game-changing effect on the business.
Given how well the stock performed this year, they will likely expect a lot from the business in 2024. It won't be easy for Microsoft to meet those expectations.
Microsoft is on track for another huge year
Share prices of Microsoft are up by more than 50% this year. And in four of the past five years (2022 being the only exception), the tech stock's price has gained at least 40%. Since 2019, the stock has climbed by an incredible 260%. The S&P 500, by comparison, has risen by a more modest 84%.
The challenge with such a fast-growing stock can be, however, that its profits aren't able to keep pace. And while Microsoft has generated strong revenue and earnings growth in recent years, they haven't grown at nearly the rate that the stock price has. Microsoft finished its fiscal 2019 with $39.2 billion in profit. In its fiscal 2023 (which ended in June), profits were $72.4 billion -- only 84% higher.
That means new investors are now paying a big premium for a piece of the business, which also means they are effectively paying for a lot of expected future growth.
The tech stock's valuation is much higher than normal
While there have been periods when investors have paid higher multiples for Microsoft than they're paying today, the stock's average price-to-earnings ratio over the past decade is close to 31.
MSFT PE Ratio data by YCharts.
There's a lot of excitement surrounding the company's growth prospects related to AI and gaming, with its acquisition of Activision Blizzard now complete. The danger, however, is that the company might not deliver the kind of growth that investors expect.
Why Microsoft might disappoint investors
Over the past year, Microsoft generated some decent revenue growth, but not as much as you might expect for a stock that's trading at 35 times earnings.
MSFT Revenue (Quarterly YoY Growth) data by YCharts.
Investors are eager to believe that Microsoft's AI-powered products will be a huge catalyst for the business. One way Microsoft is using AI is to enhance its existing Office software suite. For $30 a month per seat, businesses can gain access to Microsoft 365 Copilot, which uses AI to make Word, Excel, Outlook, and PowerPoint more powerful.
However, I'm skeptical about how much interest there will be in this service, especially as businesses remain cautious about their spending in an uncertain economy. The possibility of a recession is still a concern heading into 2024. And with many other chatbots out there, as well as other rivals offering similar services, I'm not convinced that the widening use of AI will lead to the huge revenue growth investors expect from Microsoft.
I do believe AI can help improve Microsoft's products, but I'm a bit more of a skeptic on the question of whether there will be enough value added there for it to lead to huge sales growth. While management predicts that AI will add $10 billion in annual revenue, that's still a relatively small chunk (less than 5%) of the more than $210 billion in revenue that Microsoft generated last year. AI can help grow the business, but investors may be expecting too much of it as a catalyst, especially in the near term.
Should you buy Microsoft's stock?
If you're investing for the long term (i.e., with a planned holding period of 10 years or more), then Microsoft could still be a solid stock to buy at its current level. But investors should temper their expectations for how it will perform over the next year, as the stock could start to run out of steam given its inflated valuation.
Should you invest $1,000 in Microsoft right now?
Before you buy stock in Microsoft, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Microsoft wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Microsoft. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Microsoft (NASDAQ: MSFT) is one of the "Magnificent Seven" -- a small set of massive tech companies that were key drivers of the S&P 500's impressive 20%-plus returns so far this year. The company's role in artificial intelligence (AI) -- including its investment in and partnership with ChatGPT-maker OpenAI -- made it a popular stock for growth-oriented investors. And with many other chatbots out there, as well as other rivals offering similar services, I'm not convinced that the widening use of AI will lead to the huge revenue growth investors expect from Microsoft.
|
Why Microsoft might disappoint investors Over the past year, Microsoft generated some decent revenue growth, but not as much as you might expect for a stock that's trading at 35 times earnings. And with many other chatbots out there, as well as other rivals offering similar services, I'm not convinced that the widening use of AI will lead to the huge revenue growth investors expect from Microsoft. Before you buy stock in Microsoft, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Microsoft wasn't one of them.
|
The tech stock's valuation is much higher than normal While there have been periods when investors have paid higher multiples for Microsoft than they're paying today, the stock's average price-to-earnings ratio over the past decade is close to 31. Why Microsoft might disappoint investors Over the past year, Microsoft generated some decent revenue growth, but not as much as you might expect for a stock that's trading at 35 times earnings. Before you buy stock in Microsoft, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Microsoft wasn't one of them.
|
Given how well the stock performed this year, they will likely expect a lot from the business in 2024. And in four of the past five years (2022 being the only exception), the tech stock's price has gained at least 40%. Before you buy stock in Microsoft, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Microsoft wasn't one of them.
|
f096a134-21ba-45d5-957d-ed9c86796f94
|
711786.0
|
2023-12-13 00:00:00 UTC
|
General Mills (GIS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
DCOMP
|
https://www.nasdaq.com/articles/general-mills-gis-earnings-expected-to-grow%3A-what-to-know-ahead-of-next-weeks-release
|
nan
|
nan
|
General Mills (GIS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended November 2023. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on December 20. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on theearnings callwill mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus Estimate
This maker of Cheerios cereal, Yoplait yogurt and other packaged foods is expected to post quarterly earnings of $1.16 per share in its upcoming report, which represents a year-over-year change of +5.5%.
Revenues are expected to be $5.36 billion, up 2.6% from the year-ago quarter.
Estimate Revisions Trend
The consensus EPS estimate for the quarter has been revised 0.35% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Earnings Whisper
Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for General Mills?
For General Mills, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.86%.
On the other hand, the stock currently carries a Zacks Rank of #4.
So, this combination makes it difficult to conclusively predict that General Mills will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?
Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that General Mills would post earnings of $1.08 per share when it actually produced earnings of $1.09, delivering a surprise of +0.93%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom Line
An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
General Mills doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
General Mills, Inc. (GIS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. While management's discussion of business conditions on theearnings callwill mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. Zacks Consensus Estimate This maker of Cheerios cereal, Yoplait yogurt and other packaged foods is expected to post quarterly earnings of $1.16 per share in its upcoming report, which represents a year-over-year change of +5.5%.
|
General Mills (GIS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended November 2023. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
|
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). For General Mills, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects.
|
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on December 20. For the last reported quarter, it was expected that General Mills would post earnings of $1.08 per share when it actually produced earnings of $1.09, delivering a surprise of +0.93%. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
1612d2bf-6cf4-4fa6-bf25-bf5208083daf
|
711787.0
|
2023-12-13 00:00:00 UTC
|
1 Biotech Stock That Could Be the Next Amgen
|
DCOMP
|
https://www.nasdaq.com/articles/1-biotech-stock-that-could-be-the-next-amgen
|
nan
|
nan
|
The human genome project, which was completed in 2003, marked a milestone for biotechnology. It opened the door for the creation of hundreds of medicines based on biology, which have improved the outcomes of many acute and chronic diseases.
One of the main winners of this trend is biotech pioneer Amgen (NASDAQ: AMGN). The company's stock has produced total returns (including dividends and before taxes) of 109,200% in the last 40 years. In comparison, an investment in a vehicle tracking the S&P 500 would have yielded total returns of only 2,600%.
Amgen's success story is legendary in biotech. The company was able to capitalize on the emergence of therapeutic antibodies, which triggered a long-lasting bull market in its stock. No other biotech company has yet to replicate Amgen's extraordinary shareholder returns since its IPO. This is why investors often say "This stock could be the next Amgen" when referring to a stock that could offer unusually high returns on capital.
While reality has never matched the expectation of this often-used phrase, there is one up-and-coming biotech company that really could be the next Amgen.
Image source: Getty Images.
The next big thing in human medicine
Two decades after we first learned to read the human genome, CRISPR Therapeutics (NASDAQ: CRSP) is proving we can also successfully edit it. In a watershed moment for genomic medicine, CRISPR and partner Vertex Pharmaceuticals (NASDAQ: VRTX) secured the first approval ever from the Food and Drug Administration (FDA) for a CRISPR/Cas9 gene-edited product earlier this month. The therapy, known as Casgevy, is indicated for patients with sickle cell disease.
Despite this landmark approval and its potential as a future blockbuster, CRISPR's shares are highly likely to be on the volatile side during the early years of Casgevy's commercial launch. After all, the therapy will likely require Vertex and CRISPR to invest in patient and prescriber education initiatives, and these programs will probably take time to bear fruit. However, this genomic medicine pioneer seems to be walking a nearly identical path as fellow trailblazer Amgen, which bodes well for the long-term performance of its shares.
What's next for the biotech? With its first approval in hand, CRISPR can now focus on accelerating the development of its other pipeline candidates, establishing new partnerships and deepening already established ones, and consider taking bigger clinical risks in high-value settings such as chronic diseases.
Keeping with this theme, the company recently decided to pivot to earlier assets in immuno-oncology to chase a potentially superior clinical profile. Even though this move likely pushed back its commercial debut in cancer by a few years, it's a smart strategy that speaks volumes about management's confidence in the company's platform.
Lastly, the biotech should have plenty of firepower for bolt-on acquisitions as Casgevy's launch ramps. This is an important potential bonus from being the first to market. In effect, CRISPR will likely become cash flow positive before any of its rivals, giving it fuel for value-creating M&A.
The potential of CRISPR
CRISPR screens as a potential long-term winner in the genomic medicine space, and investors who can tolerate short-term volatility should be rewarded handsomely for holding this stock over the next decade or longer. Gene editing is a revolutionary technology that is already disrupting human medicine, and CRISPR is at the forefront of this paradigm shift.
Should you invest $1,000 in CRISPR Therapeutics right now?
Before you buy stock in CRISPR Therapeutics, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CRISPR Therapeutics wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
George Budwell has positions in CRISPR Therapeutics. The Motley Fool has positions in and recommends CRISPR Therapeutics and Vertex Pharmaceuticals. The Motley Fool recommends Amgen. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In a watershed moment for genomic medicine, CRISPR and partner Vertex Pharmaceuticals (NASDAQ: VRTX) secured the first approval ever from the Food and Drug Administration (FDA) for a CRISPR/Cas9 gene-edited product earlier this month. Despite this landmark approval and its potential as a future blockbuster, CRISPR's shares are highly likely to be on the volatile side during the early years of Casgevy's commercial launch. Even though this move likely pushed back its commercial debut in cancer by a few years, it's a smart strategy that speaks volumes about management's confidence in the company's platform.
|
The company's stock has produced total returns (including dividends and before taxes) of 109,200% in the last 40 years. Before you buy stock in CRISPR Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CRISPR Therapeutics wasn’t one of them. The Motley Fool has positions in and recommends CRISPR Therapeutics and Vertex Pharmaceuticals.
|
The potential of CRISPR CRISPR screens as a potential long-term winner in the genomic medicine space, and investors who can tolerate short-term volatility should be rewarded handsomely for holding this stock over the next decade or longer. Before you buy stock in CRISPR Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CRISPR Therapeutics wasn’t one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 George Budwell has positions in CRISPR Therapeutics.
|
Before you buy stock in CRISPR Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CRISPR Therapeutics wasn’t one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 George Budwell has positions in CRISPR Therapeutics. The Motley Fool has positions in and recommends CRISPR Therapeutics and Vertex Pharmaceuticals.
|
b34d52e8-e8ad-459f-8855-577886ea7656
|
711788.0
|
2023-12-13 00:00:00 UTC
|
Sohu.com (SOHU) Up 0.6% Since Last Earnings Report: Can It Continue?
|
DCOMP
|
https://www.nasdaq.com/articles/sohu.com-sohu-up-0.6-since-last-earnings-report%3A-can-it-continue
|
nan
|
nan
|
It has been about a month since the last earnings report for Sohu.com (SOHU). Shares have added about 0.6% in that time frame, underperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Sohu.com due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Sohu.com Q3 Loss Narrower Than Expected, Revenues Fall Y/Y
Sohu reported mixed third-quarter 2023 results, with the bottom line surpassing the Zacks Consensus Estimate but the top line missing the same. The company reported lower revenues year over year owing to declining trends in all verticals. However, management’s twin-engine strategy to generate and distribute enhanced short-form content and unique marketing campaigns has boosted user engagement and improved monetization. Despite weakness in older games, various content updates have partially reversed the net sales decline from online games.
Net Income
On a GAAP basis, Sohu registered a net loss of $14.1 million or a loss of 41 cents per ADS from continuing operations compared with a net loss of $21.6 million or a loss of 63 cents per ADS in the year-ago quarter. Lower operating expenses and higher interest income led to a narrower loss during the quarter.
Non-GAAP net loss was $10.2 million or a loss of 30 cents per ADS compared with a net loss of $17.4 million or a loss of 50 cents per ADS in the year-ago quarter. Non-GAAP net loss for the September quarter was narrower than the consensus estimate of a loss of 59 cents.
Revenues
Quarterly revenues declined to $145.4 million from $185.3 million in the prior-year quarter. Weak demand for older games and lower brand advertising revenues impeded revenue growth. The top line fell short of the consensus estimate of $163 million.
Brand advertising generated $22.1 million in revenues compared with $25.8 million in the year-earlier quarter. The top line missed our estimate of $22.6 million.
Net sales from Online Game were $117 million, down 21% year over year. The declining demand for older games impacted the top line from this vertical. However, the top line marginally beat our estimate of $116.8 million.
For PC games, the company registered a total average monthly active user account (MAU) of 2.2 million, up 3% year over year. Total quarterly aggregate active paying accounts (APA) were 1 million, down 5% year over year. However, a 12% sequential uptick was propelled by the introduction of various promotional activities in TLBB PC game.
For mobile games, the total average MAU totaled 2.3 million, down 9% year over year, while the total quarterly APA was 0.5 million, down 18% year over year. The downside was caused by the natural decline trend of older games.
Other Details
Non-GAAP gross profit in the September quarter was $111 million with a margin of 76%, down from the respective figures of $131.7 million and 71% a year ago. Non-GAAP gross margin for brand advertising business rose to 15% from 2% in the year-earlier quarter. Non-GAAP gross margin for online games was 87%, up from 84% in the year-ago quarter.
Non-GAAP operating expenses declined to $131 million, down 12% year over year. Reduction in Changyou‘s marketing and promotion-related expenses for online games resulted in lower operating costs.
Cash Flow & Liquidity
As of Sep 30, 2023, the company had $335.9 million in cash and cash equivalents with $462.2 million of long-term tax liabilities.
Outlook
For the fourth quarter of 2023, revenues from brand advertising are projected in the range of $20-$23 million, indicating a 20-31%% year-over-year decline. Online Game revenues are estimated in the band of $106-$116 million, which implies a decrease of 4% to 13% year over year. The company expects a non-GAAP net loss between $10 million and $20 million, while GAAP net loss is estimated between $13 million and $23 million.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates.
The consensus estimate has shifted -84.44% due to these changes.
VGM Scores
At this time, Sohu.com has a subpar Growth Score of D, however its Momentum Score is doing a lot better with a B. However, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Sohu.com has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry Player
Sohu.com is part of the Zacks Internet - Services industry. Over the past month, Shopify (SHOP), a stock from the same industry, has gained 10.7%. The company reported its results for the quarter ended September 2023 more than a month ago.
Shopify reported revenues of $1.71 billion in the last reported quarter, representing a year-over-year change of +25.5%. EPS of $0.24 for the same period compares with -$0.02 a year ago.
For the current quarter, Shopify is expected to post earnings of $0.25 per share, indicating a change of +257.1% from the year-ago quarter. The Zacks Consensus Estimate has changed -2.9% over the last 30 days.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Shopify. Also, the stock has a VGM Score of C.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sohu.com Inc. (SOHU) : Free Stock Analysis Report
Shopify Inc. (SHOP) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. However, management’s twin-engine strategy to generate and distribute enhanced short-form content and unique marketing campaigns has boosted user engagement and improved monetization. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
|
Net Income On a GAAP basis, Sohu registered a net loss of $14.1 million or a loss of 41 cents per ADS from continuing operations compared with a net loss of $21.6 million or a loss of 63 cents per ADS in the year-ago quarter. For PC games, the company registered a total average monthly active user account (MAU) of 2.2 million, up 3% year over year. Click to get this free report Sohu.com Inc. (SOHU) : Free Stock Analysis Report Shopify Inc. (SHOP) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Net Income On a GAAP basis, Sohu registered a net loss of $14.1 million or a loss of 41 cents per ADS from continuing operations compared with a net loss of $21.6 million or a loss of 63 cents per ADS in the year-ago quarter. For mobile games, the total average MAU totaled 2.3 million, down 9% year over year, while the total quarterly APA was 0.5 million, down 18% year over year. The company expects a non-GAAP net loss between $10 million and $20 million, while GAAP net loss is estimated between $13 million and $23 million.
|
It has been about a month since the last earnings report for Sohu.com (SOHU). The company expects a non-GAAP net loss between $10 million and $20 million, while GAAP net loss is estimated between $13 million and $23 million. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
17693cd8-d6e1-442f-97f6-6fce964a762f
|
711789.0
|
2023-12-13 00:00:00 UTC
|
APG vs. AFRM: Which Stock Should Value Investors Buy Now?
|
DCOMP
|
https://www.nasdaq.com/articles/apg-vs.-afrm%3A-which-stock-should-value-investors-buy-now
|
nan
|
nan
|
Investors with an interest in Business - Services stocks have likely encountered both APi (APG) and Affirm Holdings (AFRM). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
Currently, both APi and Affirm Holdings are holding a Zacks Rank of # 2 (Buy). This means that both companies have witnessed positive earnings estimate revisions, so investors should feel comfortable knowing that both of these stocks have an improving earnings outlook. But this is just one piece of the puzzle for value investors.
Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.
The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors.
APG currently has a forward P/E ratio of 20.13, while AFRM has a forward P/E of 95.46. We also note that APG has a PEG ratio of 1.10. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. AFRM currently has a PEG ratio of 6.54.
Another notable valuation metric for APG is its P/B ratio of 3.32. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, AFRM has a P/B of 4.64.
These are just a few of the metrics contributing to APG's Value grade of A and AFRM's Value grade of D.
Both APG and AFRM are impressive stocks with solid earnings outlooks, but based on these valuation figures, we feel that APG is the superior value option right now.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
APi Group Corporation (APG) : Free Stock Analysis Report
Affirm Holdings, Inc. (AFRM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits. Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
|
The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits. The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors. Click to get this free report APi Group Corporation (APG) : Free Stock Analysis Report Affirm Holdings, Inc. (AFRM) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors. These are just a few of the metrics contributing to APG's Value grade of A and AFRM's Value grade of D. Both APG and AFRM are impressive stocks with solid earnings outlooks, but based on these valuation figures, we feel that APG is the superior value option right now. Click to get this free report APi Group Corporation (APG) : Free Stock Analysis Report Affirm Holdings, Inc. (AFRM) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors. These are just a few of the metrics contributing to APG's Value grade of A and AFRM's Value grade of D. Both APG and AFRM are impressive stocks with solid earnings outlooks, but based on these valuation figures, we feel that APG is the superior value option right now. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
e1a7c042-81b6-45e4-a385-8301079adecf
|
711790.0
|
2023-12-13 00:00:00 UTC
|
TGT vs. ROST: Which Stock Is the Better Value Option?
|
DCOMP
|
https://www.nasdaq.com/articles/tgt-vs.-rost%3A-which-stock-is-the-better-value-option
|
nan
|
nan
|
Investors interested in Retail - Discount Stores stocks are likely familiar with Target (TGT) and Ross Stores (ROST). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.
Currently, Target has a Zacks Rank of #2 (Buy), while Ross Stores has a Zacks Rank of #3 (Hold). This system places an emphasis on companies that have seen positive earnings estimate revisions, so investors should feel comfortable knowing that TGT is likely seeing its earnings outlook improve to a greater extent. However, value investors will care about much more than just this.
Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.
TGT currently has a forward P/E ratio of 16.27, while ROST has a forward P/E of 25.27. We also note that TGT has a PEG ratio of 1.15. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. ROST currently has a PEG ratio of 2.14.
Another notable valuation metric for TGT is its P/B ratio of 5. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, ROST has a P/B of 9.95.
These metrics, and several others, help TGT earn a Value grade of A, while ROST has been given a Value grade of C.
TGT sticks out from ROST in both our Zacks Rank and Style Scores models, so value investors will likely feel that TGT is the better option right now.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Target Corporation (TGT) : Free Stock Analysis Report
Ross Stores, Inc. (ROST) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels. The only question is “Will you get into the right stocks early when their growth potential is greatest?” Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
|
The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits. These metrics, and several others, help TGT earn a Value grade of A, while ROST has been given a Value grade of C. TGT sticks out from ROST in both our Zacks Rank and Style Scores models, so value investors will likely feel that TGT is the better option right now. Click to get this free report Target Corporation (TGT) : Free Stock Analysis Report Ross Stores, Inc. (ROST) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use. These metrics, and several others, help TGT earn a Value grade of A, while ROST has been given a Value grade of C. TGT sticks out from ROST in both our Zacks Rank and Style Scores models, so value investors will likely feel that TGT is the better option right now. Click to get this free report Target Corporation (TGT) : Free Stock Analysis Report Ross Stores, Inc. (ROST) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
ROST currently has a PEG ratio of 2.14. These metrics, and several others, help TGT earn a Value grade of A, while ROST has been given a Value grade of C. TGT sticks out from ROST in both our Zacks Rank and Style Scores models, so value investors will likely feel that TGT is the better option right now. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
a4bc8c82-644c-47b2-a58a-adbf5f0a7344
|
711791.0
|
2023-12-13 00:00:00 UTC
|
Why Canopy Growth Stock Is Getting Smoked Today
|
DCOMP
|
https://www.nasdaq.com/articles/why-canopy-growth-stock-is-getting-smoked-today
|
nan
|
nan
|
Canopy Growth's (NASDAQ: CGC) share price is getting hit hard in Wednesday's trading. The marijuana stock was down 23.2% as of 10:45 a.m. ET, according to data from S&P Global Market Intelligence.
Canopy Growth published a press release before the market opened today announcing that it will carry out a 10-for-1 reverse stock split. The move will allow the company's stock to continue trading on the Nasdaq stock exchange, but it seems some investors are worried that the reverse stock split is a sign that the business and its share price could be on a potentially irreversible long-term slide.
Investors aren't happy with Canopy's move
According to Canopy's press release, the 10-for-1 reverse stock split is scheduled to become effective prior the market's open on Dec. 20. The move should push the company's share price above the $1 threshold needed to continue trading on the Nasdaq stock exchange.
While the reverse stock split was authorized by the company's board of directors on Sept. 25, today's announcement about the capital restructuring move comes with an important detail that shareholders are likely unhappy about.
When the capital restructuring is completed, investors will not receive any fractional shares if their number of shares is not a multiple of 10. Per the press release from today, "Any fractional Common Shares arising from the Consolidation will be deemed to have been tendered by its registered owner to the Company for cancellation for no consideration."
This means that if a shareholder owns 109 shares of Canopy stock, they will receive only 10 shares of stock on a reverse-split-adjusted basis. No fractional shares will be issued for the extra nine shares owned by the investor.
What comes next for Canopy Growth stock?
Following the restructuring, Canopy Growth should be able to continue trading on the Nasdaq in the near term. That's ostensibly good news for shareholders, but it's a complicated situation.
Reverse stock splits tend to reduce the overall trading volume for a stock. In turn, this can make it more difficult for buy and sell orders to be placed and met at the prices desired by investors. Reverse stock splits are also typically used by struggling companies with struggling stocks -- and Canopy Growth falls into that category.
The cannabis industry has become fiercely competitive, and these pressures seem unlikely to dissipate any time soon. A glut of production in the legal market has had the effect of pushing prices down and hurt profitability for producers and vendors. Legalization and decriminalization measures and a trend toward increased social acceptability have also removed some pressures on the black market.
Should you invest $1,000 in Canopy Growth right now?
Before you buy stock in Canopy Growth, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Canopy Growth wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool recommends Nasdaq. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Canopy Growth published a press release before the market opened today announcing that it will carry out a 10-for-1 reverse stock split. While the reverse stock split was authorized by the company's board of directors on Sept. 25, today's announcement about the capital restructuring move comes with an important detail that shareholders are likely unhappy about. Per the press release from today, "Any fractional Common Shares arising from the Consolidation will be deemed to have been tendered by its registered owner to the Company for cancellation for no consideration."
|
Canopy Growth published a press release before the market opened today announcing that it will carry out a 10-for-1 reverse stock split. Investors aren't happy with Canopy's move According to Canopy's press release, the 10-for-1 reverse stock split is scheduled to become effective prior the market's open on Dec. 20. Before you buy stock in Canopy Growth, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Canopy Growth wasn't one of them.
|
The move will allow the company's stock to continue trading on the Nasdaq stock exchange, but it seems some investors are worried that the reverse stock split is a sign that the business and its share price could be on a potentially irreversible long-term slide. This means that if a shareholder owns 109 shares of Canopy stock, they will receive only 10 shares of stock on a reverse-split-adjusted basis. Before you buy stock in Canopy Growth, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Canopy Growth wasn't one of them.
|
Investors aren't happy with Canopy's move According to Canopy's press release, the 10-for-1 reverse stock split is scheduled to become effective prior the market's open on Dec. 20. Following the restructuring, Canopy Growth should be able to continue trading on the Nasdaq in the near term. Before you buy stock in Canopy Growth, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Canopy Growth wasn't one of them.
|
c2495693-df13-4da9-af15-83161783c7d1
|
711792.0
|
2023-12-13 00:00:00 UTC
|
STRL vs. HWM: Which Stock Is the Better Value Option?
|
DCOMP
|
https://www.nasdaq.com/articles/strl-vs.-hwm%3A-which-stock-is-the-better-value-option-3
|
nan
|
nan
|
Investors interested in stocks from the Engineering - R and D Services sector have probably already heard of Sterling Infrastructure (STRL) and Howmet (HWM). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
Right now, Sterling Infrastructure is sporting a Zacks Rank of #2 (Buy), while Howmet has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that STRL has an improving earnings outlook. However, value investors will care about much more than just this.
Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.
The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors.
STRL currently has a forward P/E ratio of 17.54, while HWM has a forward P/E of 30.50. We also note that STRL has a PEG ratio of 0.88. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. HWM currently has a PEG ratio of 1.43.
Another notable valuation metric for STRL is its P/B ratio of 3.86. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, HWM has a P/B of 5.85.
Based on these metrics and many more, STRL holds a Value grade of A, while HWM has a Value grade of D.
STRL has seen stronger estimate revision activity and sports more attractive valuation metrics than HWM, so it seems like value investors will conclude that STRL is the superior option right now.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sterling Infrastructure, Inc. (STRL) : Free Stock Analysis Report
Howmet Aerospace Inc. (HWM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits. Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
|
The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits. Based on these metrics and many more, STRL holds a Value grade of A, while HWM has a Value grade of D. STRL has seen stronger estimate revision activity and sports more attractive valuation metrics than HWM, so it seems like value investors will conclude that STRL is the superior option right now. Click to get this free report Sterling Infrastructure, Inc. (STRL) : Free Stock Analysis Report Howmet Aerospace Inc. (HWM) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that STRL has an improving earnings outlook. Based on these metrics and many more, STRL holds a Value grade of A, while HWM has a Value grade of D. STRL has seen stronger estimate revision activity and sports more attractive valuation metrics than HWM, so it seems like value investors will conclude that STRL is the superior option right now. Click to get this free report Sterling Infrastructure, Inc. (STRL) : Free Stock Analysis Report Howmet Aerospace Inc. (HWM) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
HWM currently has a PEG ratio of 1.43. Based on these metrics and many more, STRL holds a Value grade of A, while HWM has a Value grade of D. STRL has seen stronger estimate revision activity and sports more attractive valuation metrics than HWM, so it seems like value investors will conclude that STRL is the superior option right now. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
7b31a038-da95-4296-94d7-82233d2b24e5
|
711793.0
|
2023-12-13 00:00:00 UTC
|
ENLAY or NEE: Which Is the Better Value Stock Right Now?
|
DCOMP
|
https://www.nasdaq.com/articles/enlay-or-nee%3A-which-is-the-better-value-stock-right-now
|
nan
|
nan
|
Investors looking for stocks in the Utility - Electric Power sector might want to consider either Enel SpA (ENLAY) or NextEra Energy (NEE). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
Currently, Enel SpA has a Zacks Rank of #2 (Buy), while NextEra Energy has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that ENLAY has an improving earnings outlook. But this is just one factor that value investors are interested in.
Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.
ENLAY currently has a forward P/E ratio of 10.48, while NEE has a forward P/E of 19.08. We also note that ENLAY has a PEG ratio of 1.47. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. NEE currently has a PEG ratio of 2.33.
Another notable valuation metric for ENLAY is its P/B ratio of 1.61. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, NEE has a P/B of 2.17.
These are just a few of the metrics contributing to ENLAY's Value grade of B and NEE's Value grade of D.
ENLAY stands above NEE thanks to its solid earnings outlook, and based on these valuation figures, we also feel that ENLAY is the superior value option right now.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Enel SpA (ENLAY) : Free Stock Analysis Report
NextEra Energy, Inc. (NEE) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
|
Investors looking for stocks in the Utility - Electric Power sector might want to consider either Enel SpA (ENLAY) or NextEra Energy (NEE). The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits. Click to get this free report Enel SpA (ENLAY) : Free Stock Analysis Report NextEra Energy, Inc. (NEE) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use. These are just a few of the metrics contributing to ENLAY's Value grade of B and NEE's Value grade of D. ENLAY stands above NEE thanks to its solid earnings outlook, and based on these valuation figures, we also feel that ENLAY is the superior value option right now. Click to get this free report Enel SpA (ENLAY) : Free Stock Analysis Report NextEra Energy, Inc. (NEE) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
NEE currently has a PEG ratio of 2.33. These are just a few of the metrics contributing to ENLAY's Value grade of B and NEE's Value grade of D. ENLAY stands above NEE thanks to its solid earnings outlook, and based on these valuation figures, we also feel that ENLAY is the superior value option right now. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
65ac1bb2-af9c-402e-bf60-7fa37d885974
|
711794.0
|
2023-12-13 00:00:00 UTC
|
Tyson (TSN) Up 5.1% Since Last Earnings Report: Can It Continue?
|
DCOMP
|
https://www.nasdaq.com/articles/tyson-tsn-up-5.1-since-last-earnings-report%3A-can-it-continue
|
nan
|
nan
|
A month has gone by since the last earnings report for Tyson Foods (TSN). Shares have added about 5.1% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Tyson due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Tyson Foods Q4 Earnings Beat Estimates, Sales Dip Y/Y
Tyson Foods posted mixed results for fourth-quarter fiscal 2023, with the top line lagging the Zacks Consensus Estimate, while the bottom line beat the same. Earnings and sales declined year over year on tough market dynamics. The company has posted adjusted earnings of 37 cents per share, beating the Zacks Consensus Estimate of earnings of 33 cents per share. The bottom line significantly declined from earnings of $1.63 per share reported in the year-ago period.
Quarter in Detail
Total sales were $13,348 million, down 2.8% from the year-ago quarter figure. The top line lagged the Zacks Consensus Estimate of $13,706 million. Average price changes had a 1.4% adverse impact on the top line, while total volumes dipped 0.6%.
The gross profit in the quarter was $459 million, down from the $1,307 million reported in the prior-year quarter. As a percentage of sales, the gross profit was 3.4%, down from the 9.5% reported in the year-ago quarter. Tyson Foods’ adjusted operating income plunged 71.3% to $236 million. The adjusted operating margin contracted to 1.8% from the 6% reported in the year-ago quarter.
Segmental Details
Beef: Sales in the segment declined to $5,029 million from the $4,859 million reported in the year-ago quarter. Volumes dropped 6.7% and the average price increased 10.2% in the segment.
Pork: Sales in the segment fell to $1,494 million from the $1,604 million reported in the year-ago quarter. Volumes dipped 0.2%, while the average price tumbled 6.7%.
Chicken: Sales in the segment decreased to $4,155 million from the $4,619 million reported in the year-ago quarter. Sales volumes rose 1.7% and the average price decreased 9.2%.
Prepared Foods: Sales in the segment fell to $2,502 million from the $2,516 million reported in the year-ago quarter. Prepared Foods’ sales volumes inched up 1% and the average price decreased 1.6%.
International/Other: Sales in the segment were $636 million, down from the $638 million reported in the year-ago quarter. Volumes jumped 4.9% and the average sales price fell 5.2%.
Other Financial Updates
The company exited the quarter with cash and cash equivalents of $573 million, long-term debt of $7,611 million and total shareholders’ equity (including non-controlling interests) of $18,255 million. For the fiscal year, cash provided by operating activities amounted to $1,752 million. Liquidity was about $3 billion as of Sep 30, 2023. Management expects liquidity to exceed the company’s minimum target of $1 billion.
Effective Nov 10, 2023, the company’s board increased the quarterly dividend earlier declared on Aug 10, 2023,to $0.49 per share on its Class A common stock and $0.441 per share on its Class B common stock. This dividend is payable on Dec 15, 2023, to shareholders of record as of Dec 1, 2023. The company’s board also declared a quarterly dividend of $0.49 per share on its Class A common stock and $0.441 per share on its Class B common stock, payable on Mar 15, 2024, to shareholders of record as of March 1. Management expects the balance quarterly dividends in fiscal 2024 to be $0.49 and $0.441 per share of its Class A and Class B common stock, respectively.
Tyson Foods projects capital expenditure to be nearly $1-$1.5 billion for fiscal 2024. These include expenditures related to capacity expansion, automation, and product and brand innovation.
Guidance
For fiscal 2024, the United States Department of Agriculture (“USDA”) projects domestic protein production for beef to decline 5% versus fiscal 2023. For pork, USDA projects domestic production to jump 2% from fiscal 2023. For chicken, USDA expects projects domestic protein production to rise slightly from fiscal 2023. Management anticipates improved results from the company’s foreign operations during fiscal 2024. Revenues are projected to be relatively flat in fiscal 2024 versus fiscal 2023. It forecasts adjusted operating income to be $1-$1.5 billion for fiscal 2024. Net interest expenses are expected to be $400 million. The adjusted tax rate is likely to be nearly 23% in fiscal 2023.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates.
The consensus estimate has shifted -48.2% due to these changes.
VGM Scores
At this time, Tyson has a subpar Growth Score of D, though it is lagging a bit on the Momentum Score front with an F. However, the stock was allocated a grade of A on the value side, putting it in the top quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Tyson has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Tyson Foods, Inc. (TSN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. The only question is “Will you get into the right stocks early when their growth potential is greatest?” Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
|
Tyson Foods Q4 Earnings Beat Estimates, Sales Dip Y/Y Tyson Foods posted mixed results for fourth-quarter fiscal 2023, with the top line lagging the Zacks Consensus Estimate, while the bottom line beat the same. The company has posted adjusted earnings of 37 cents per share, beating the Zacks Consensus Estimate of earnings of 33 cents per share. The company’s board also declared a quarterly dividend of $0.49 per share on its Class A common stock and $0.441 per share on its Class B common stock, payable on Mar 15, 2024, to shareholders of record as of March 1.
|
Tyson Foods Q4 Earnings Beat Estimates, Sales Dip Y/Y Tyson Foods posted mixed results for fourth-quarter fiscal 2023, with the top line lagging the Zacks Consensus Estimate, while the bottom line beat the same. Segmental Details Beef: Sales in the segment declined to $5,029 million from the $4,859 million reported in the year-ago quarter. Prepared Foods: Sales in the segment fell to $2,502 million from the $2,516 million reported in the year-ago quarter.
|
A month has gone by since the last earnings report for Tyson Foods (TSN). Tyson Foods projects capital expenditure to be nearly $1-$1.5 billion for fiscal 2024. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
015971be-7cbf-412d-bfb4-9d9029ba3024
|
711795.0
|
2023-12-13 00:00:00 UTC
|
Why Is Aecom (ACM) Up 6.7% Since Last Earnings Report?
|
DCOMP
|
https://www.nasdaq.com/articles/why-is-aecom-acm-up-6.7-since-last-earnings-report
|
nan
|
nan
|
It has been about a month since the last earnings report for Aecom Technology (ACM). Shares have added about 6.7% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Aecom due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
AECOM Q4 Earnings Meet, Revenues Beat, NSR Rises Y/Y
AECOM reported decent fourth-quarter fiscal 2023 results, with earnings meeting the Zacks Consensus Estimate and revenues topping the same. On a year-over-year basis, the top and the bottom line increased, backed by double-digit organic net service revenues (NSR) growth in its design business.
Inside the Headline
The company reported adjusted earnings of $1.01 per share, in line with the Zacks Consensus Estimate. In the prior-year quarter, the company reported adjusted earnings per share (EPS) of 83 cents.
Revenues of $3.84 billion beat the consensus mark of $3.58 billion by 7.2% and rose 12% on a year-over-year basis. NSR moved up 8% to $1.73 billion.
Segment Details
Americas’ revenues came in at $2.94 billion during the reported quarter, up 12% from the prior-year quarter’s levels. Our estimate for the metric was $2.74 billion. NSR of $1 billion moved up 6% year over year, backed by 9% growth in the design business. Our estimate for the segment’s NSR was $695.6 million.
Adjusted operating income of $190 million was up 10% year over year. Adjusted operating margin (on an NSR basis) also expanded by 60 basis points (bps) year over year to 19%.
The total backlog at the fiscal fourth-quarter end was $34.9 billion versus $35.11 billion a year ago.
International revenues were up 12% year over year to $905.2 million. Our estimate for the metric was $848.7 million. During the quarter, NSR increased 11% year over year to $722.4 million, reflecting growth in the largest and most profitable markets.
Adjusted operating income in the segment rose 25% year over year to $72 million. Adjusted operating margin (on an NSR basis) also moved up 100 bps year over year to 10%. This marked the company's success in attaining a double-digit margin in the International business, achieving the set target.
The total backlog at the end of the fiscal reported quarter was $6.27 billion versus $5.07 billion from a year ago.
AECOM Capital's quarterly revenues stood at $0.54 million.
Operating Highlights
Adjusted segment operating profit amounted to $225 million, up 15% from the year-ago quarter’s level. The segment’s adjusted operating margin (NSR) improved by 60 basis points to 15.2%. The upside reflects strong execution and ongoing investments in organic growth initiatives. Adjusted EBITDA also rose 10% year over year to $252 million.
Backlogs
As of the fiscal fourth quarter end, the total backlog came in at $41.17 billion compared with $40.18 billion reported in the prior-year period. The current backlog level includes 54.8% contracted backlog growth.
A record-high 12.7% growth in the design business backlog (on a constant currency basis) reflects solid quarterly wins and a pipeline of opportunities.
Liquidity & Cash Flow
At the fiscal fourth quarter’s end, AECOM’s cash and cash equivalents totaled $1.26 billion compared with $1.17 billion at the fiscal 2022 end. The total debt (excluding unamortized debt issuance costs) as of Sep 30, 2023, stood at $2.22 billion, in line with fiscal 2022-end.
For fiscal 2023, operating cash flow decreased 2% year over year to $696 million. Adjusted free cash flow increased 1% year over year $591 million.
Fiscal 2023 Highlights
AECOM reported adjusted EPS of $3.71, up 9% year over year. Revenues of $14.38 billion were up 9% and NSR rose 8% year over year. Adjusted segment operating margin came in at 14.7%, up 60 bps from fiscal 2022. Adjusted EBITDA also increased 9% year over year to $964 million.
Fiscal 2024 Guidance
For next year, the company anticipates generating 8-10% organic NSR growth.
The company expects adjusted EPS in the range of $4.35-$4.55. This indicates a 20% improvement from the fiscal 2023 levels on a constant-currency basis, considering the mid-point of the guidance.
Also, it projects an adjusted operating margin of 15.6%, suggesting a 90 basis points increase on a year-over-year basis. AECOM expects adjusted EBITDA guidance in the range of $1,065-$1,105 million, indicating 13% year-over-year growth at the midpoint.
The company anticipates more than 100% adjusted net income to free cash flow conversion, an average fully diluted share count of 138 million and an effective tax rate of 24-26%.
How Have Estimates Been Moving Since Then?
Analysts were quiet during the last two month period as none of them issued any earnings estimate revisions.
VGM Scores
Currently, Aecom has a nice Growth Score of B, a grade with the same score on the momentum front. Following the exact same course, the stock was allocated a grade of B on the value side, putting it in the top 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Aecom has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry Player
Aecom belongs to the Zacks Engineering - R and D Services industry. Another stock from the same industry, Quanta Services (PWR), has gained 12.3% over the past month. More than a month has passed since the company reported results for the quarter ended September 2023.
Quanta Services reported revenues of $5.62 billion in the last reported quarter, representing a year-over-year change of +26%. EPS of $2.24 for the same period compares with $1.77 a year ago.
For the current quarter, Quanta Services is expected to post earnings of $1.97 per share, indicating a change of +17.3% from the year-ago quarter. The Zacks Consensus Estimate has changed -1.4% over the last 30 days.
Quanta Services has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of C.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AECOM (ACM) : Free Stock Analysis Report
Quanta Services, Inc. (PWR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
On a year-over-year basis, the top and the bottom line increased, backed by double-digit organic net service revenues (NSR) growth in its design business. The company anticipates more than 100% adjusted net income to free cash flow conversion, an average fully diluted share count of 138 million and an effective tax rate of 24-26%. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
|
AECOM Q4 Earnings Meet, Revenues Beat, NSR Rises Y/Y AECOM reported decent fourth-quarter fiscal 2023 results, with earnings meeting the Zacks Consensus Estimate and revenues topping the same. On a year-over-year basis, the top and the bottom line increased, backed by double-digit organic net service revenues (NSR) growth in its design business. Click to get this free report AECOM (ACM) : Free Stock Analysis Report Quanta Services, Inc. (PWR) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
AECOM Q4 Earnings Meet, Revenues Beat, NSR Rises Y/Y AECOM reported decent fourth-quarter fiscal 2023 results, with earnings meeting the Zacks Consensus Estimate and revenues topping the same. Fiscal 2023 Highlights AECOM reported adjusted EPS of $3.71, up 9% year over year. Click to get this free report AECOM (ACM) : Free Stock Analysis Report Quanta Services, Inc. (PWR) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Our estimate for the segment’s NSR was $695.6 million. Fiscal 2023 Highlights AECOM reported adjusted EPS of $3.71, up 9% year over year. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
87d5514e-6934-44ad-9f86-257a6685efa9
|
711796.0
|
2023-12-13 00:00:00 UTC
|
HMY or FNV: Which Is the Better Value Stock Right Now?
|
DCOMP
|
https://www.nasdaq.com/articles/hmy-or-fnv%3A-which-is-the-better-value-stock-right-now
|
nan
|
nan
|
Investors interested in Mining - Gold stocks are likely familiar with Harmony Gold (HMY) and Franco-Nevada (FNV). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.
Currently, Harmony Gold has a Zacks Rank of #2 (Buy), while Franco-Nevada has a Zacks Rank of #3 (Hold). Investors should feel comfortable knowing that HMY likely has seen a stronger improvement to its earnings outlook than FNV has recently. But this is only part of the picture for value investors.
Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.
The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.
HMY currently has a forward P/E ratio of 7.63, while FNV has a forward P/E of 30.97. We also note that HMY has a PEG ratio of 0.34. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. FNV currently has a PEG ratio of 4.68.
Another notable valuation metric for HMY is its P/B ratio of 1.75. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, FNV has a P/B of 2.95.
These metrics, and several others, help HMY earn a Value grade of A, while FNV has been given a Value grade of D.
HMY stands above FNV thanks to its solid earnings outlook, and based on these valuation figures, we also feel that HMY is the superior value option right now.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Harmony Gold Mining Company Limited (HMY) : Free Stock Analysis Report
Franco-Nevada Corporation (FNV) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
|
Investors interested in Mining - Gold stocks are likely familiar with Harmony Gold (HMY) and Franco-Nevada (FNV). The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. Click to get this free report Harmony Gold Mining Company Limited (HMY) : Free Stock Analysis Report Franco-Nevada Corporation (FNV) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Investors interested in Mining - Gold stocks are likely familiar with Harmony Gold (HMY) and Franco-Nevada (FNV). These metrics, and several others, help HMY earn a Value grade of A, while FNV has been given a Value grade of D. HMY stands above FNV thanks to its solid earnings outlook, and based on these valuation figures, we also feel that HMY is the superior value option right now. Click to get this free report Harmony Gold Mining Company Limited (HMY) : Free Stock Analysis Report Franco-Nevada Corporation (FNV) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
FNV currently has a PEG ratio of 4.68. These metrics, and several others, help HMY earn a Value grade of A, while FNV has been given a Value grade of D. HMY stands above FNV thanks to its solid earnings outlook, and based on these valuation figures, we also feel that HMY is the superior value option right now. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
9491720e-dfa4-4428-8612-0eb6c89c0cf2
|
711797.0
|
2023-12-13 00:00:00 UTC
|
Why Is Sun Life (SLF) Up 3% Since Last Earnings Report?
|
DCOMP
|
https://www.nasdaq.com/articles/why-is-sun-life-slf-up-3-since-last-earnings-report
|
nan
|
nan
|
A month has gone by since the last earnings report for Sun Life (SLF). Shares have added about 3% in that time frame, underperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Sun Life due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Sun Life Q3 Earnings Surpass Estimates, Decrease Y/Y
Sun Life Financial Inc. delivered a third-quarter 2023 underlying net income of $1.19 per share, which beat the Zacks Consensus Estimate by 3.4%. However, the bottom line decreased 4% year over year. The underlying net income was reported at $693.2 million (C$930 million), which decreased 4.7% year over year.
Wealth sales decreased 11.2% year over year to $29.30 billion (C$39.32 billion) in the quarter under review. The new business contractual service margin was $275.79 million (C$370 million).
Segment Results
SLF Canada’s underlying net income increased 9.5% year over year to $251.9 million (C$338 million). Canada witnessed higher net investment income, driven by increased volume and yields, and improved disability experience, reflecting higher margins and shorter claims duration.
SLF U.S.’ underlying net income was $140 million, which decreased 19% year over year, reflecting lower dental results.
SLF Asset Management reported an underlying net income of $245.9 million (C$330 million), which grew 8.7% year over year. Asset Management witnessed higher average net assets, higher net investment income, favorable foreign exchange translation, higher fee-related earnings and favorable tax rate.
SLF Asia reported an underlying net income of $123.7 million (C$166 million). Asia witnessed good sales momentum and favorable mortality from lower claims volumes, offset by higher incentive compensation and expense experience.
Financial Update
Global assets under management were $970.47 billion (C$1,340 billion), up 4.2% year over year.
Sun Life Assurance’s Life Insurance Capital Adequacy Test (LICAT) ratio was 138% as of Sep 30, 2023, down 100 basis points (bps) from Jan 1, 2023.
The LICAT ratio for Sun Life (including cash and other liquid assets) was 147%, which expanded 500 bps from Jan 1, 2023. Sun Life’s return on equity was 16.6% in the third quarter, which expanded 1,430 bps year over year. The underlying return on equity of 17.7% contracted 170 bps year over year. The leverage ratio of 21.8% contracted 190 bps from Jan 1, 2023.
Dividend Update
In the reported quarter, the company’s board of directors increased its dividend by 4% to 78 cents per share. The amount will be paid out on Dec 29, 2023, to shareholders of record at the close of business on Nov 29.
How Have Estimates Been Moving Since Then?
It turns out, estimates revision flatlined during the past month.
VGM Scores
At this time, Sun Life has a subpar Growth Score of D, however its Momentum Score is doing a bit better with a C. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Sun Life has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.
Performance of an Industry Player
Sun Life belongs to the Zacks Insurance - Life Insurance industry. Another stock from the same industry, Brighthouse Financial (BHF), has gained 7.9% over the past month. More than a month has passed since the company reported results for the quarter ended September 2023.
Brighthouse Financial reported revenues of $2.09 billion in the last reported quarter, representing a year-over-year change of +9.6%. EPS of $4.18 for the same period compares with -$0.04 a year ago.
Brighthouse Financial is expected to post earnings of $3.97 per share for the current quarter, representing a year-over-year change of +13.1%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.6%.
Brighthouse Financial has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of F.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sun Life Financial Inc. (SLF) : Free Stock Analysis Report
Brighthouse Financial, Inc. (BHF) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Sun Life Financial Inc. delivered a third-quarter 2023 underlying net income of $1.19 per share, which beat the Zacks Consensus Estimate by 3.4%. Asia witnessed good sales momentum and favorable mortality from lower claims volumes, offset by higher incentive compensation and expense experience. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
|
Segment Results SLF Canada’s underlying net income increased 9.5% year over year to $251.9 million (C$338 million). Asset Management witnessed higher average net assets, higher net investment income, favorable foreign exchange translation, higher fee-related earnings and favorable tax rate. Click to get this free report Sun Life Financial Inc. (SLF) : Free Stock Analysis Report Brighthouse Financial, Inc. (BHF) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The underlying net income was reported at $693.2 million (C$930 million), which decreased 4.7% year over year. SLF Asset Management reported an underlying net income of $245.9 million (C$330 million), which grew 8.7% year over year. Click to get this free report Sun Life Financial Inc. (SLF) : Free Stock Analysis Report Brighthouse Financial, Inc. (BHF) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
A month has gone by since the last earnings report for Sun Life (SLF). Sun Life’s return on equity was 16.6% in the third quarter, which expanded 1,430 bps year over year. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
326db44b-7151-4b95-886e-1b95bb736338
|
711798.0
|
2023-12-13 00:00:00 UTC
|
What Are The Best Stocks To Invest In Now? 2 Health Care Stocks To Watch
|
DCOMP
|
https://www.nasdaq.com/articles/what-are-the-best-stocks-to-invest-in-now-2-health-care-stocks-to-watch
|
nan
|
nan
|
The healthcare sector encompasses a wide range of companies involved in medical services, pharmaceuticals, medical equipment, and health insurance. This sector is essential due to its direct impact on human health and well-being. It is known for its resilience, as healthcare demand often remains stable regardless of economic cycles. This sector is continuously evolving, driven by technological advancements and research breakthroughs.
Investing in healthcare stocks offers certain advantages. These stocks can provide stability, as the demand for healthcare services and products is relatively inelastic. This sector is also poised for long-term growth due to aging populations and increasing health awareness. However, there are also disadvantages. The healthcare industry is subject to stringent regulations, which can affect company profits. Additionally, high research and development costs, especially in the pharmaceutical sub-sector, can impact earnings.
Healthcare stocks also face unique market risks, such as patent expirations and drug approval uncertainties. These factors can lead to volatility in stock prices. Investors looking into this sector should have an understanding of these dynamics. With this being said, here are two healthcare stocks to watch in the stock market today.
Health Care Stocks To Watch Now
Eli Lilly and Company (NYSE: LLY)
Merck & Company Inc. (NYSE: MRK)
Eli Lilly & Co. (LLY Stock)
Firstly, Eli Lilly and Company (LLY) is a global pharmaceutical company with a significant presence in the healthcare industry. The company focuses on discovering, developing, and marketing pharmaceutical products, particularly in areas like endocrinology, oncology, and mental health. Eli Lilly is also known for its contributions to insulin production and treatments for diabetes, among other therapeutic areas.
Earlier this month, Eli Lilly & Co. announced its first-quarter 2024 dividend. Diving in, the company’s Board of Directors has declared a dividend for Q1 2024 of $1.30 per share on common stock. For context, this is a 15% increase in the company’s quarterly dividend. Furthermore, the dividend is payable on March 8, 2024, to shareholders of record on February 15, 2023.
In 2023 thus far, shares of LLY stock have advanced by 62.37%. Meanwhile, during Wednesday’s late morning trading session, Eli Lilly & Co. stock is trading higher on the day up 1.40% so far, trading at $592.64 a share.
[Read More] Best Stocks To Buy In December 2023? 3 Mag 7 Stocks To Watch
Merck & Company Inc. (MRK Stock)
Next, Merck & Company Inc. (MRK) is a global pharmaceutical company. Merck focuses on the development, manufacturing, and marketing of a wide range of innovative medicines, vaccines, and animal health products. The company has a strong focus on areas including oncology, infectious diseases, and cardiovascular health.
At the end of last month, Merck also announced its first quarter 2024 dividend. In detail, the company’s Board of Directors has declared a quarterly dividend of $0.77 per share on common stock. Moreover, the dividend will be payable on January 8, 2024, to shareholders of record on December 15, 2023.
Year-to-date, shares of MRK stock have pulled back by 5.39% so far. While, during Wednesday’s late morning trading session, Merck & Company stock is trading green up 0.77%, at $105.16 a share.
If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel.
CLICK HERE RIGHT NOW!!
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The company focuses on discovering, developing, and marketing pharmaceutical products, particularly in areas like endocrinology, oncology, and mental health. Merck focuses on the development, manufacturing, and marketing of a wide range of innovative medicines, vaccines, and animal health products. If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel.
|
Health Care Stocks To Watch Now Eli Lilly and Company (NYSE: LLY) Merck & Company Inc. (NYSE: MRK) Eli Lilly & Co. (LLY Stock) Firstly, Eli Lilly and Company (LLY) is a global pharmaceutical company with a significant presence in the healthcare industry. Meanwhile, during Wednesday’s late morning trading session, Eli Lilly & Co. stock is trading higher on the day up 1.40% so far, trading at $592.64 a share. 3 Mag 7 Stocks To Watch Merck & Company Inc. (MRK Stock) Next, Merck & Company Inc. (MRK) is a global pharmaceutical company.
|
Health Care Stocks To Watch Now Eli Lilly and Company (NYSE: LLY) Merck & Company Inc. (NYSE: MRK) Eli Lilly & Co. (LLY Stock) Firstly, Eli Lilly and Company (LLY) is a global pharmaceutical company with a significant presence in the healthcare industry. 3 Mag 7 Stocks To Watch Merck & Company Inc. (MRK Stock) Next, Merck & Company Inc. (MRK) is a global pharmaceutical company. While, during Wednesday’s late morning trading session, Merck & Company stock is trading green up 0.77%, at $105.16 a share.
|
With this being said, here are two healthcare stocks to watch in the stock market today. Health Care Stocks To Watch Now Eli Lilly and Company (NYSE: LLY) Merck & Company Inc. (NYSE: MRK) Eli Lilly & Co. (LLY Stock) Firstly, Eli Lilly and Company (LLY) is a global pharmaceutical company with a significant presence in the healthcare industry. 3 Mag 7 Stocks To Watch Merck & Company Inc. (MRK Stock) Next, Merck & Company Inc. (MRK) is a global pharmaceutical company.
|
ea1fd638-d365-4ddb-8d10-c162d7e4f0e8
|
711799.0
|
2023-12-13 00:00:00 UTC
|
Why You Should Retain S&P Global (SPGI) in Your Portfolio Now
|
DCOMP
|
https://www.nasdaq.com/articles/why-you-should-retain-sp-global-spgi-in-your-portfolio-now
|
nan
|
nan
|
S&P Global SPGI has been focusing on acquisitions for innovation, with recent additions like Market Scan, ChartIQ, Shades of Green and the IHS Markit merger. To emphasize shareholder value, it distributed $1 billion in dividends and allocated $12 billion for repurchases in 2022, thus displaying commitment and confidence. These actions enhance investor confidence and positively impact earnings per share.
Factors in Favor
New service launches are bolstering S&P Global’s growth and are positively impacting the company’s market positioning. Recently, Platts (S&P Global Commodity Insights) introduced the Platts Dry Index for the dry bulk freight industry, incorporating the Capesize, Panamax/Kamsarmax, Ultramax and Supramax segments. S&P Global Market Intelligence has also launched the Supply Chain Console, which offers a comprehensive view of supply-chain dynamics.
The S&P Global Canada Services Purchasing Managers' Index completed the suite for all G-7 countries. Platts also introduced daily Southeast Asia LNG cargo assessments to enhance price transparency. Additionally, Platts, in collaboration with REsurety, pioneered Emissions-Adjusted Renewable Energy Certificates price assessments, advancing innovation in commodities and energy markets.
S&P Global Inc. Revenue (TTM)
S&P Global Inc. revenue-ttm | S&P Global Inc. Quote
S&P Global's growth strategy centers on acquisitions for persistent innovation. Recent key acquisitions include Market Scan for mobility offerings, ChartIQ for market intelligence, Shades of Green for enhanced environmental impact assessments and the merger with IHS Markit to boost data and analytics. The completion of The Climate Service acquisition further strengthens S&P Global's ESG insights and solutions, refining its climate-related offerings.
The company's commitment to shareholder value is evident in its rewarding initiatives. In 2022, it distributed $1 billion in dividends and allocated $12 billion for share repurchases. In 2021, $743 million was returned to shareholders, and in 2020, $1.8 billion was distributed, comprising $1.2 billion in repurchases and $645 million in dividends. Such measures not only boost investor confidence but also contribute positively to earnings per share.
Factors Against
S&P Global is experiencing rising expenses attributed to ongoing productivity programs, increased compensation costs from investments in growth initiatives, acquisitions and higher incentive expenses. In 2022, total expenses surged more than 100% year over year to $8.2 billion, suggesting continued pressure on the bottom line in the foreseeable future.
SPGI currently carries Zacks Rank #3 (Hold).
Stocks to Consider
Here are a few better-ranked stocks from the Business Services sector:
Gartner IT: The Zacks Consensus Estimate for Gartner’s 2023 revenues indicates 7.9% growth from the year-ago figure while earnings are expected to decline 1.9%. The company beat the consensus estimate in all the trailing four quarters, with an average surprise of 34.4%.
IT currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
FTI Consulting FCN: The Zacks Consensus Estimate for FCN’s 2023 revenues indicates 12.1% growth from the year-ago figure while earnings are expected to grow 3.4%. The company beat the consensus estimate in three of the trailing four quarters and missed on one instance, the average surprise being 8.5%.
FCN carries a Zacks Rank #2 (Buy) at present.
Broadridge Financial Solutions BR: The Zacks Consensus Estimate for Broadridge’s 2023 revenues indicates 7.7% growth from the year-ago figure while earnings are expected to grow 10.1%. The company beat the consensus estimate in three of the past four quarters and matched on one instance, the average surprise being 5.4%.
BR currently has a Zacks Rank of 2.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Broadridge Financial Solutions, Inc. (BR) : Free Stock Analysis Report
FTI Consulting, Inc. (FCN) : Free Stock Analysis Report
Gartner, Inc. (IT) : Free Stock Analysis Report
S&P Global Inc. (SPGI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
S&P Global SPGI has been focusing on acquisitions for innovation, with recent additions like Market Scan, ChartIQ, Shades of Green and the IHS Markit merger. The completion of The Climate Service acquisition further strengthens S&P Global's ESG insights and solutions, refining its climate-related offerings. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
|
Recent key acquisitions include Market Scan for mobility offerings, ChartIQ for market intelligence, Shades of Green for enhanced environmental impact assessments and the merger with IHS Markit to boost data and analytics. Broadridge Financial Solutions BR: The Zacks Consensus Estimate for Broadridge’s 2023 revenues indicates 7.7% growth from the year-ago figure while earnings are expected to grow 10.1%. Click to get this free report Broadridge Financial Solutions, Inc. (BR) : Free Stock Analysis Report FTI Consulting, Inc. (FCN) : Free Stock Analysis Report Gartner, Inc. (IT) : Free Stock Analysis Report S&P Global Inc. (SPGI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
S&P Global Inc. Revenue (TTM) S&P Global Inc. revenue-ttm | S&P Global Inc. Quote S&P Global's growth strategy centers on acquisitions for persistent innovation. Stocks to Consider Here are a few better-ranked stocks from the Business Services sector: Gartner IT: The Zacks Consensus Estimate for Gartner’s 2023 revenues indicates 7.9% growth from the year-ago figure while earnings are expected to decline 1.9%. Click to get this free report Broadridge Financial Solutions, Inc. (BR) : Free Stock Analysis Report FTI Consulting, Inc. (FCN) : Free Stock Analysis Report Gartner, Inc. (IT) : Free Stock Analysis Report S&P Global Inc. (SPGI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
In 2022, it distributed $1 billion in dividends and allocated $12 billion for share repurchases. You can see the complete list of today’s Zacks #1 Rank stocks here. Download FREE: How To Profit From Trillions On Spending For Infrastructure >> Want the latest recommendations from Zacks Investment Research?
|
b093c427-db6b-4ef8-bd0a-b702f9e7f2da
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.